Medical Properties Trust, Inc. (NYSE: MPW)

View:

REGISTRATION NO. 333-119957

AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JUNE 3, 2005.

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------------

AMENDMENT NO. 4

TO
FORM S-11
FOR REGISTRATION UNDER THE SECURITIES ACT OF 1933
OF SECURITIES OF CERTAIN REAL ESTATE COMPANIES
---------------------
MEDICAL PROPERTIES TRUST, INC.
(Exact name of registrant as specified in its governing instruments)
1000 URBAN CENTER DRIVE, SUITE 501, BIRMINGHAM, ALABAMA 35242
(205) 969-3755
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)

EDWARD K. ALDAG, JR.
CHAIRMAN, PRESIDENT AND CHIEF EXECUTIVE OFFICER
MEDICAL PROPERTIES TRUST, INC.
1000 URBAN CENTER DRIVE, SUITE 501, BIRMINGHAM, ALABAMA 35242
(205) 969-3755
(Name, address, including zip code, and telephone number, including area code,
of agent for service)
WITH A COPY TO:

THOMAS O. KOLB DANIEL M. LEBEY
B.G. MINISMAN, JR. EDWARD W. ELMORE, JR.
BAKER, DONELSON, BEARMAN, CALDWELL & BERKOWITZ, PC HUNTON & WILLIAMS LLP
SUITE 1600 RIVERFRONT PLAZA, EAST TOWER
420 20TH STREET NORTH 951 EAST BYRD STREET
BIRMINGHAM, ALABAMA 35203 RICHMOND, VIRGINIA 23219-4074
(205) 328-0480 (804) 788-8200

APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC: As soon
as practicable after this registration statement becomes effective.

If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering: [ ] ____________

If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering: [ ] ____________

If this Form is a post-effective amendment filed pursuant to Rule 462(d)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering: [ ] ____________

If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box: [ ]

CALCULATION OF REGISTRATION FEE

- -------------------------------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------------------------------
TITLE OF SECURITIES PROPOSED MAXIMUM AGGREGATE
BEING REGISTERED OFFERING PRICE(1) AMOUNT OF REGISTRATION FEE(2)
- -------------------------------------------------------------------------------------------------------------------

Common Stock, $.001 par value.................. $175,000,000 $22,050
- -------------------------------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------------------------------

(1) Estimated solely for the purpose of computing the registration fee in
accordance with Rule 457(o) under the Securities Act.

(2) Previously paid.

THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR
DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL
FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION
STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF
THE SECURITIES ACT OF 1933 OR UNTIL THIS REGISTRATION STATEMENT SHALL BECOME
EFFECTIVE ON SUCH DATE AS THE SECURITIES AND EXCHANGE COMMISSION, ACTING
PURSUANT TO SAID SECTION 8(a), MAY DETERMINE.

The information in this prospectus is not complete and may be changed. We cannot
sell any of the securities described in this prospectus until the registration
statement that we have filed to cover the securities has become effective under
the rules of the Securities and Exchange Commission. This prospectus is not an
offer to sell the securities, nor is it a solicitation of an offer to buy the
securities, in any state where an offer or sale of the securities is not
permitted.

SUBJECT TO COMPLETION, DATED JUNE 3, 2005

PROSPECTUS

11,365,000 SHARES OF COMMON STOCK

(MEDICAL PROPERTIES TRUST LOGO)

We are a self-advised real estate company that acquires, develops and
net-leases healthcare facilities. We expect to qualify as a real estate
investment trust, or REIT, for federal income tax purposes and will elect to be
taxed as a REIT under the federal income tax laws.

This is our initial public offering of common stock. No public market
currently exists for our common stock. We are offering 11,365,000 shares of
common stock and shares of common stock are being offered by the selling
stockholders described in this prospectus. We will not receive any of the
proceeds from the sale of shares of common stock by the selling stockholders.

We expect the initial public offering price to be between $10.00 and $12.00
per share. We have applied to list our common stock on the New York Stock
Exchange under the symbol "MPW."

SEE "RISK FACTORS" BEGINNING ON PAGE 16 OF THIS PROSPECTUS FOR THE MOST
SIGNIFICANT RISKS RELEVANT TO AN INVESTMENT IN OUR COMMON STOCK, INCLUDING,
AMONG OTHERS:

- We were formed in August 2003 and have a limited operating history; our
management has a limited history of operating a REIT and a public company
and may therefore have difficulty in successfully and profitably operating
our business.

- We may be unable to acquire or develop the facilities we have under letter
of commitment or contract or facilities we have identified as potential
candidates for acquisition or development as quickly as we expect or at
all, which could harm our future operating results and adversely affect
our ability to make distributions to our stockholders.

- Our real estate investments will be concentrated in net-leased healthcare
facilities, making us more vulnerable economically than if our investments
were more diversified across several industries or property types.

- Our facilities are currently leased to three tenants, two of which were
recently organized and have limited or no operating histories, and the
failure of any of these tenants to meet its obligations to us, including
payment of rent, payment of loan commitment fees and repayment of loans we
have made or intend to make to them, would have a material adverse effect
on our revenues and our ability to make distributions to our stockholders.

- Development and construction risks, including delays in construction,
exceeding original estimates and failure to obtain financing, could
adversely affect our ability to make distributions to our stockholders.

- Reductions in reimbursement from third-party payors, including Medicare
and Medicaid, could adversely affect the profitability of our tenants and
hinder their ability to make rent or loan payments to us.

- The healthcare industry is heavily regulated and existing and new laws or
regulations, changes to existing laws or regulations, loss of licensure or
certification or failure to obtain licensure or certification could result
in the inability of our tenants to make lease or loan payments to us.

- Failure to obtain or loss of our tax status as a REIT would have
significant adverse consequences to us and the value of our common stock.

- Our loans to Vibra could be recharacterized as equity, in which case our
rental income from Vibra would not be qualifying income under the REIT
rules and we could lose our REIT status.

- Common stock eligible for future sale, including up to shares that
may be resold by our existing stockholders upon effectiveness of our
resale registration statement, may result in increased selling which may
have an adverse effect on our stock price.

- If you purchase common stock in this offering, you will experience
immediate dilution of approximately $ in net tangible book value per
share.
---------------------

PER SHARE TOTAL
--------- --------

Public offering price.......................................
Underwriting discount.......................................
Proceeds, before expenses, to us............................
Proceeds, before expenses, to selling stockholders..........

The underwriters may also purchase up to an additional 1,704,750 shares of
common stock from us at the public offering price, less the underwriting
discount, within 30 days after the date of this prospectus solely to cover
over-allotments, if any.

NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES
COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR DETERMINED IF THIS
PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A
CRIMINAL OFFENSE.

We expect the shares of common stock to be available for delivery on or
about , 2005.

FRIEDMAN BILLINGS RAMSEY JPMORGAN

THE DATE OF THIS PROSPECTUS IS , 2005.

TABLE OF CONTENTS

SUMMARY...................................... 1
Our Company.................................. 1
Our Portfolio................................ 2
Competitive Strengths........................ 6
Summary Risk Factors......................... 7
Market Opportunity........................... 8
Our Target Facilities........................ 8
Our Formation Transactions................... 9
Our Structure................................ 10
Registration Rights and Lock-Up Agreements... 11
Selling Stockholders......................... 12
Restrictions on Ownership of Our Common
Stock...................................... 12
Distribution Policy.......................... 12
The Offering................................. 13
Tax Status................................... 13
Summary Financial Information................ 13
RISK FACTORS................................. 16
Risks Relating to Our Business and Growth
Strategy................................... 16
Risks Relating to Real Estate Investments.... 23
Risks Relating to the Healthcare Industry.... 27
Risks Relating to Our Organization and
Structure.................................. 30
Tax Risks Associated With Our Status as a
REIT....................................... 34
Risks Relating to This Offering.............. 36
A WARNING ABOUT FORWARD LOOKING STATEMENTS... 39
USE OF PROCEEDS.............................. 40
CAPITALIZATION............................... 41
DILUTION..................................... 42
Net Tangible Book Value...................... 42
Dilution After This Offering................. 42
Differences Between New and Existing
Stockholders in Number of Shares and Amount
Paid....................................... 43
DISTRIBUTION POLICY.......................... 44
SELECTED FINANCIAL INFORMATION............... 45
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF
OPERATIONS................................. 47
OUR BUSINESS................................. 56
Our Company.................................. 56
Market Opportunity........................... 58
Our Target Facilities........................ 60
Underwriting Process......................... 61
Asset Management............................. 62
Our Formation Transactions................... 62
Our Operating Partnership.................... 63
MPT Development Services, Inc. .............. 64
Depreciation................................. 65
Our Leases................................... 65
Environmental Matters........................ 65
Competition.................................. 66
Healthcare Regulatory Matters................ 66
Insurance.................................... 71
Employees.................................... 71
Legal Proceedings............................ 71
OUR PORTFOLIO................................ 71
Our Current Portfolio........................ 71
Our Pending Acquisitions and Developments.... 83
Other Letters of Commitment.................. 84
Our Acquisition and Development Pipeline..... 92
MANAGEMENT................................... 96
Our Directors and Executive Officers......... 96
Corporate Governance -- Board of Directors
and Committees............................. 98
Limited Liability and Indemnification........ 101
Director Compensation........................ 101
Executive Compensation....................... 102
Employment Agreements........................ 102
Benefit Plans................................ 105
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER
PARTICIPATION.............................. 107
INSTITUTIONAL TRADING OF OUR COMMON STOCK.... 107
PRINCIPAL STOCKHOLDERS....................... 108
SELLING STOCKHOLDERS......................... 109
REGISTRATION RIGHTS AND LOCK-UP AGREEMENTS... 109
CERTAIN RELATIONSHIPS AND RELATED
TRANSACTIONS............................... 112
INVESTMENT POLICIES AND POLICIES WITH RESPECT
TO CERTAIN ACTIVITIES...................... 114
DESCRIPTION OF CAPITAL STOCK................. 118
Authorized Stock............................. 118
Common Stock................................. 118
Preferred Stock.............................. 119
Warrant...................................... 119
Power to Increase Authorized Stock and Issue
Additional Shares of Our Common Stock and
Preferred Stock............................ 119
Restrictions on Ownership and Transfer....... 119
Transfer Agent and Registrar................. 121
MATERIAL PROVISIONS OF MARYLAND LAW AND OF
OUR CHARTER AND BYLAWS..................... 122
The Board of Directors....................... 122
Business Combinations........................ 122
Control Share Acquisitions................... 123
Maryland Unsolicited Takeovers Act........... 124
Amendment to Our Charter..................... 124
Dissolution of Our Company................... 124
Advance Notice of Director Nominations and
New Business............................... 124
Indemnification and Limitation of Directors'
and Officers' Liability.................... 125
PARTNERSHIP AGREEMENT........................ 127
Management of Our Operating Partnership...... 127
Transferability of Interests................. 127
Capital Contribution......................... 128
Redemption Rights............................ 128
Distributions................................ 129
Allocations.................................. 130
Term......................................... 130
Tax Matters.................................. 130
UNITED STATES FEDERAL INCOME TAX
CONSIDERATIONS............................. 131
Taxation of Our Company...................... 131
Requirements for Qualification............... 133
Other Tax Consequences....................... 147
Income Taxation of the Partnerships and Their
Partners................................... 148
UNDERWRITING................................. 151
LEGAL MATTERS................................ 155
EXPERTS...................................... 155
WHERE YOU CAN FIND MORE INFORMATION.......... 155
INDEX TO FINANCIAL STATEMENTS................ F-1

SUMMARY

The following summary highlights information contained elsewhere in this
prospectus. You should read the entire prospectus, including "Risk Factors" and
our financial statements and pro forma financial information and related notes
appearing elsewhere in this prospectus, before making a decision to invest in
our common stock. In this prospectus, unless the context suggests otherwise,
references to "MPT," "the company," "we," "us" and "our" mean Medical Properties
Trust, Inc., including our operating partnership, MPT Operating Partnership,
L.P., its general partner and our wholly-owned limited liability company,
Medical Properties Trust, LLC, as well as our other direct and indirect
subsidiaries. Unless otherwise indicated, the information included in this
prospectus assumes no exercise by the underwriters of their over-allotment
option to purchase up to an additional 1,704,750 shares of common stock and that
the common stock to be sold in this offering is sold at $11.00 per share, which
is the midpoint of the range set forth on the cover page of this prospectus.

OUR COMPANY

We are a self-advised real estate company that acquires, develops and
leases healthcare facilities providing state-of-the-art healthcare services. We
lease our facilities to healthcare operators pursuant to long-term net-leases,
which require the tenant to bear most of the costs associated with the property.
From time to time, we also make loans to our tenants. We were formed in August
2003 and completed a private placement of our common stock in April 2004 in
which we raised net proceeds of approximately $233.5 million. Shortly after
completion of our private placement, we began to acquire our current portfolio
of nine facilities, consisting of seven facilities that are in operation and two
facilities that are under development. We acquired six operating facilities in
July and August of 2004 for an aggregate purchase price of $127.4 million,
including acquisition costs, from Care Ventures, Inc. We also made loans of
approximately $49.1 million to the new tenant of these facilities. One of the
loans has been repaid and the remaining loan has a principal balance of
approximately $41.4 million. We acquired one operating facility in February 2005
for a purchase price of $28.0 million from Prime A Investments, LLC.

We focus on acquiring and developing rehabilitation hospitals, long-term
acute care hospitals, regional and community hospitals, women's and children's
hospitals and ambulatory surgery centers as well as other specialized
single-discipline and ancillary facilities. We believe that these types of
facilities will capture an increasing share of expenditures for healthcare
services. We believe that our strategy for acquisition and development of these
types of net-leased facilities, which generally require a physician's order for
patient admission, distinguishes us as a unique investment alternative among
real estate investment trusts, or REITs.

We believe that the U.S. healthcare delivery system is becoming
decentralized and is evolving away from the traditional "one stop," large-scale
acute care hospital. We believe that this change is the result of a number of
trends, including increasing specialization and technological innovation within
the healthcare industry and the desire of both physicians and patients to
utilize more convenient facilities. We also believe that demographic trends in
the U.S., including, in particular, an aging population, will result in
continued growth in the demand for healthcare services, which in turn will lead
to an increasing need for a greater supply of modern healthcare facilities. In
response to these trends, we believe that healthcare operators increasingly
prefer to conserve their capital for investment in operations and new
technologies rather than investing in real estate and, therefore, increasingly
prefer to lease, rather than own, their facilities. Given these trends and the
size, scope and growth of this dynamic industry, we believe that there are
significant opportunities to acquire and develop net-leased healthcare
facilities at attractive, risk-adjusted returns.

We believe that our management's ability to combine traditional real estate
investment expertise with an understanding of healthcare operations enables us
to successfully implement our strategy.

We intend to make an election to be taxed as a REIT under the Internal
Revenue Code, or the Code, commencing with our taxable year that began on April
6, 2004 and ended on December 31, 2004.

Our principal executive offices are located at 1000 Urban Center Drive,
Suite 501, Birmingham, Alabama 35242. Our telephone number is (205) 969-3755.
Our Internet address is www.medicalpropertiestrust.com. The information on our
website does not constitute a part of this prospectus.

OUR PORTFOLIO

OUR CURRENT PORTFOLIO OF FACILITIES

Our current portfolio of facilities consists of nine healthcare facilities,
seven of which are in operation and two of which are under development. Six of
the facilities in operation, which consist of four rehabilitation hospitals and
two long-term acute care hospitals, are leased to subsidiaries of Vibra
Healthcare, LLC, or Vibra, formerly known as Highmark Healthcare, LLC, a
recently formed specialty healthcare provider with operations in six states. We
refer to these facilities in this prospectus as the Vibra Facilities. The
seventh facility in operation, a community hospital which has an integrated
medical office building, is leased to Desert Valley Hospital, Inc., or DVH. We
refer to this facility in this prospectus as the Desert Valley Facility. The
facilities under development are a community hospital, which we refer to in this
prospectus as the West Houston Hospital, and an adjacent medical office
building, which we refer to in this prospectus as the West Houston MOB, and are
leased to Stealth, L.P., or Stealth, a recently organized healthcare facility
operator with no current operations. We refer to the West Houston Hospital and
the West Houston MOB together in this prospectus as the West Houston Facilities.
All of the leases for the hospitals currently in operation have initial terms of
15 years. The initial lease term for the West Houston Hospital began when
construction commenced in July 2004 and will end 15 years after completion of
construction. The initial lease term for the West Houston MOB began when
construction commenced in July 2004 and will end 10 years after completion of
construction. We target completion of construction of the West Houston MOB for
August 2005 and completion of construction of the West Houston Hospital for
October 2005. The leases for all of the facilities in our current portfolio
provide for contractual base rent and an annual rent escalator. The leases for
the Vibra Facilities also provide for "percentage rent," which means that once
the tenant achieves a certain revenue threshold then, in addition to base rent,
we will receive periodic rent payments based on an agreed percentage of the
tenant's gross revenue. The following tables set forth information, as of March
31, 2005, regarding our current portfolio of facilities:

Operating Facilities 2005 2006
2004 CONTRACTUAL CONTRACTUAL
NUMBER OF ANNUALIZED BASE BASE
LOCATION TYPE TENANT BEDS(1) BASE RENT RENT(2) RENT(2)
- -------- ----------------- -------------- --------- ----------- -------------- ---------------

Bowling Green,
Kentucky............... Rehabilitation Vibra
hospital Healthcare,
LLC(4) 60 $ 3,916,695 $ 4,294,990 $ 4,790,118
Marlton, New
Jersey(5).............. Rehabilitation(6) Vibra
hospital Healthcare,
LLC(4) 76 3,401,791 3,730,354 4,160,390
Victorville,
California(7).......... Community Desert Valley
hospital/medical Hospital, Inc. 83 -- 2,341,004 2,856,000
office building
New Bedford,
Massachusetts.......... Long-term Vibra
acute care Healthcare,
hospital LLC(4) 90 2,262,979 2,426,320 2,767,624
Fresno, California...... Rehabilitation Vibra
hospital Healthcare,
LLC(4) 62 1,914,829 2,099,773 2,341,835
Thornton, Colorado...... Rehabilitation Vibra
hospital Healthcare,
LLC(4) 117 870,377 933,200 1,064,471

Operating Facilities
GROSS
PURCHASE LEASE
LOCATION PRICE(3) EXPIRATION
- -------- ------------ ---------------

Bowling Green,
Kentucky...............

$ 38,211,658 July 2019
Marlton, New
Jersey(5)..............

32,267,622 July 2019
Victorville,
California(7)..........
28,000,000 February 2020

New Bedford,
Massachusetts..........

22,077,847 August 2019
Fresno, California......

18,681,255 July 2019
Thornton, Colorado......

8,491,481 August 2019

Kentfield, California... Long-term Vibra
acute care Healthcare,
hospital LLC(4) 60 783,339 858,998 958,024
--- ----------- ----------- -----------
TOTAL................... -- -- 548 $13,150,010 $16,684,639 $18,938,462
=== =========== =========== ===========

Operating Facilities
GROSS
PURCHASE LEASE
LOCATION PRICE(3) EXPIRATION
- -------- ------------ ---------------

Kentfield, California...
7,642,332 July 2019
------------
TOTAL................... $155,372,195 --
============

- ---------------

(1) Based on the number of licensed beds.

(2) Based on leases in place as of the date of this prospectus.

(3) Includes acquisition costs.

(4) The tenant in each case is a separate, wholly-owned subsidiary of Vibra
Healthcare, LLC.

(5) Our interest in this facility is held through a ground lease on the
property. The purchase price shown for this facility does not include our
payment obligations under the ground lease, the present value of which we
have calculated to be $920,579. The calculation of the base rent to be
received from Vibra for this facility takes into account the present value
of the ground lease payments.

(6) Thirty of the 76 beds are pediatric rehabilitation beds operated by HBA
Management, Inc.

(7) At any time after February 28, 2007, the tenant has the option to purchase
the facility at a purchase price equal to the sum of (i) the purchase price
of the facility, and (ii) that amount determined under a formula that would
provide us an internal rate of return of 10% per year, increased by 2% of
such percentage each year, taking into account all payments of base rent
received by us.

Facilities Under
Development

2005 2006
2004 CONTRACTUAL CONTRACTUAL
NUMBER OF ANNUALIZED BASE BASE
LOCATION TYPE TENANT BEDS(1) BASE RENT RENT(2) RENT(2)
- -------- ----------------- -------------- --------- ----------- -------------- ---------------

Houston, Texas.......... Community
hospital(4) Stealth, L.P. 105(5) $ -- $ 772,196 $ 4,749,005
Houston, Texas.......... Medical office
building(7) Stealth, L.P. n/a -- 670,840 2,052,769
--- ----------- ----------- -----------
TOTAL................... -- -- 105 $ -- $ 1,443,036 $ 6,801,774
=== =========== =========== ===========

PROJECTED
DEVELOPMENT LEASE
LOCATION COST(3) EXPIRATION
- -------- ------------ ---------------

Houston, Texas..........
$ 43,099,310 October 2020(6)
Houston, Texas..........
20,855,119 August 2015(8)
------------
TOTAL................... $ 63,954,429 --
============

- ---------------

(1) Based on the number of licensed beds.

(2) Based on leases in place as of the date of this prospectus, estimated total
development costs and estimated dates of completion. Assumes completion of
construction in October 2005 for the West Houston Hospital and in August
2005 for the West Houston MOB. Does not include rents that accrue during the
construction period and are payable over the remaining lease term following
the completion of construction.

(3) Includes acquisition costs.

(4) Expected to be completed in October 2005.

(5) Seventy-one of the 105 beds will be acute care beds operated by Stealth,
L.P. and the remaining 34 beds will be long-term acute care beds operated by
Triumph Southwest, L.P.

(6) Following completion, the lease term will extend for a period of 15 years.
At any time during the term of the lease, the tenant has the right to
terminate the lease and purchase the community hospital from us at a
purchase price equal to the greater of (i) that amount determined under a
formula which would provide us an internal rate of return of at least 18% or
(ii) appraised value assuming the lease is still in place.

(7) Expected to be completed in August 2005.

(8) Following completion, the lease term will extend for a period of 10 years.
At any time during the term of the lease, the tenant has the right to
terminate the lease and purchase the medical office building from us at a
purchase price equal to the greater of (i) that amount determined under a
formula which would provide us an internal rate of return of at least 18% or
(ii) appraised value assuming the lease is still in place.

OUR CURRENT LOANS AND FEES RECEIVABLE

At the time we acquired the Vibra Facilities, we made a secured acquisition
loan to Vibra, the parent entity of our current tenants in those facilities, to
enable Vibra to acquire the healthcare operations at these locations. The
principal balance of this loan is approximately $41.4 million and is to be
repaid over 15 years. Payment of the acquisition loan is secured by pledges of
membership interests in Vibra and its subsidiaries. In addition, we have
obtained guaranty agreements from Brad E. Hollinger, the principal owner of
Vibra, Vibra Management, LLC and The Hollinger Group that obligate them to make
loan payments in the event that Vibra fails to do so. However, we do not believe
that these parties have sufficient financial resources to satisfy a material
portion of the loan obligations. Mr. Hollinger's guaranty is limited to $5.0
million, and Vibra Management, LLC and The Hollinger Group do not have
substantial assets. Vibra pays interest on this loan at an annual rate of 10.25%
with interest only for the first three years and the principal balance amortizes
over the remaining 12 year period. The acquisition loan may be prepaid at any
time without penalty. In connection with the Vibra transactions, Vibra agreed to
pay us commitment fees of approximately $1.5 million. We also made secured loans
totaling approximately $6.2 million to Vibra and its subsidiaries for working
capital purposes. The commitment fees were paid, and the working capital loans
were repaid, on February 9, 2005.

In connection with the development of the West Houston Facilities, Stealth
has agreed to pay us a commitment fee of approximately $932,125, to be paid over
15 years following completion of the West

Houston Hospital. The commitment fee is based on a percentage of total
development costs and may be adjusted upon completion of construction of the
West Houston Facilities based on actual development costs. We have agreed to
make a working capital loan to Stealth of up to $1.62 million, to be repaid over
15 years. No funds have been borrowed by Stealth to date under the working
capital loan. The promissory notes evidencing the loan and commitment fee
provide for interest at an annual rate of 10.75% and are unsecured, but the
promissory notes are cross-defaulted with our related facility leases with
Stealth. Stealth is obligated to pay us a project inspection fee for
construction coordination services of $100,000 in the case of the West Houston
Hospital and $50,000 in the case of the adjacent West Houston MOB. These fees
are to be paid, with interest at the rate of 10.75% per year, over a 15 year
period beginning on the date that the West Houston Hospital is completed, which
we expect to be in October 2005. The obligation to pay these fees is evidenced
by promissory notes and is unsecured, but the promissory notes are
cross-defaulted with our related facility leases with Stealth. Any of the fees
or the working capital loan may be prepaid at any time without penalty, except
that a minimum prepayment of $500,000 is required for the working capital loan.

OUR PENDING ACQUISITIONS AND DEVELOPMENTS

We intend to use the net proceeds of this offering and a portion of our
available cash and cash equivalents to expand our portfolio by acquiring or
developing additional net-leased healthcare facilities that we have under
contract or letter of commitment and consider to be probable acquisitions or
developments as of the date of this prospectus, which we refer to in this
prospectus as our Pending Acquisition and Development Facilities. Under the
terms of the contracts or letters of commitment relating to these facilities, we
expect the leases for each of these facilities to provide for contractual base
rent and an annual rent escalator. The letters of commitment constitute
agreements of the parties to consummate the acquisition or development
transactions and enter into leases on the terms set forth in the letters of
commitment subject to the satisfaction of certain conditions, including the
execution of mutually-acceptable definitive agreements. The following tables
contain information regarding our Pending Acquisition and Development
Facilities:

Operating Facilities -- Acquisitions

ANNUAL
YEAR ONE MINIMUM GROSS
NUMBER OF CONTRACTUAL INCREASE IN PURCHASE LEASE
LOCATION TYPE TENANT BEDS(1) BASE RENT RENT PRICE EXPIRATION
- -------- ---- --------------- --------- ----------- ----------- ----------- ----------

Covington, Louisiana*............. Long-term Gulf States 58 $1,170,750(2) 2.5%(3) $11,500,000 June 2020(4)
acute Long Term Acute
care Care of
hospital Covington,
L.L.C.
Denham Springs, Louisiana*........ Long-term Gulf States 59 630,000(2) 2.5%(3) 6,000,000 June 2020(4)
acute Long Term Acute
care Care of Denham
hospital Springs, L.L.C.
---- ---------- -----------
TOTAL............................. 117 $1,800,750 $17,500,000 --
--------- --------------- ---- ---------- ----------- ---------

- ---------------

* Under letter of commitment.
(1) Based on the number of licensed beds.

(2) Year One is the 12 month period commencing on an expected closing date in
June 2005.

(3) The annual rent increase is the greater of 2.5% and any change in the
Consumer Price Index, or CPI.

(4) The lease expiration is based upon a 15 year term commencing on an expected
closing date in June 2005.

Operating Facility -- Loan with Purchase Option

YEAR ONE
NUMBER OF CONTRACTUAL LOAN LEASE
LOCATION TYPE TENANT BEDS(1) INTEREST AMOUNT EXPIRATION
- -------- --------- ------------- --------- ----------- ---------- ----------

Hammond, Louisiana*(2)............................. Long-term Hammond 40 $840,000(3) $8,000,000 June 2021
acute Rehabilitation
care Hospital, LLC
hospital

- ---------------

* Under letter of commitment.
(1) Based on the number of licensed beds.
(2) On April 1, 2005, we entered into a letter of commitment with Hammond
Healthcare Properties, LLC, or Hammond Properties, and Hammond
Rehabilitation Hospital, LLC, or Hammond Hospital, pursuant to which we
have agreed to lend Hammond Properties $8.0 million and have agreed to a
put-call option pursuant to which, during the 90 day period commencing on
the first anniversary of the date of the loan closing, we expect to
purchase from Hammond Properties a long-term acute care hospital located in
Hammond, Louisiana for a purchase price between $10.3 million and $11.0
million. If we purchase the facility, we will lease it back to Hammond
Hospital for an initial term of 15 years. The lease would be a net lease
and would provide for contractual base rent and, beginning January 1, 2007,
an annual rent escalator.

(3) Based on one year contractual interest at the rate of 10.5% per year on the
$8.0 million mortgage loan to Hammond Properties. We expect to exercise our
option to purchase the Hammond Facility in 2006. For the one year period
following our purchase of the facility, contractual base rent would equal
$1,079,925, based on 10.5% of an estimated purchase price of $10,285,000.

Development Facilities

ANNUAL
MINIMUM PROJECTED
NUMBER OF INCREASE IN DEVELOPMENT LEASE
TYPE TENANT BEDS(1) RENT COST EXPIRATION
---- --------------- --------- ----------- ------------ ----------

Bensalem, Pennsylvania**....................... Women's Bucks County 30 2.5%(2) $ 38,000,000 (3)
hospital/ Oncoplastic
medical Institute, LLC
office
building
Bloomington, Indiana*.......................... Community Monroe 32 2.5%(2) 28,000,000 (3)
hospital Hospital, LLC
Houston, Texas*................................ Community North Cypress 64 2.5%(2) 51,000,000 (3)
hospital Medical Center
Operating
Company, Ltd.
--- ------------
TOTAL.......................................... -- -- 126 $117,000,000 --
=== ============

- ---------------

* Under letter of commitment.
** Under contract.
(1) Based on the number of licensed beds.
(2) The annual rent increase is the greater of 2.5% and any change in the CPI.

(3) We expect that each of these leases will have a 15 year term commencing on
the date that construction of the facility is completed.

OUR ACQUISITION AND DEVELOPMENT PIPELINE

We have also identified a number of opportunities to acquire or develop
additional healthcare facilities. In some cases, we are actively negotiating
agreements or letters of intent with the owners or prospective tenants. In other
instances, we have only identified the potential opportunity and had preliminary
discussions with the owner or prospective tenant. We cannot assure you that we
will complete any of these potential acquisitions or developments.

OUR DEBT

We employ leverage in our capital structure in amounts we determine from
time to time. At present, we intend to limit our debt to approximately 60% of
the aggregate cost of our facilities, although we may exceed that level from
time to time. We expect our borrowings to be a combination of long-term, fixed-
rate, non-recourse mortgage loans, variable-rate secured term and revolving
credit facilities, and other fixed and variable-rate short to medium-term loans.

We borrowed $75.0 million from Merrill Lynch Capital under a loan agreement
with a term of three years for acquisition and development of additional
facilities and other working capital needs. The loan bears interest at one month
LIBOR (3.15% at June 2, 2005) plus 300 basis points. The loan is secured by our
interests in the Vibra Facilities and requires us to comply with certain
financial covenants. There was $74.1 million outstanding under this loan as of
March 31, 2005. We have accepted a term sheet from Merrill Lynch Capital for an
up to $100.0 million senior secured revolving credit facility with a term of
four years, with one 12-month extension option, to refinance the outstanding
amount under our existing loan agreement with Merrill Lynch Capital and for
general corporate purposes. If we enter into this facility, during the term of
the loan we will have the right to increase the amount available under the
facility by an amount up to $75.0 million, subject to no event of default
continuing or occurring at the time of our request to increase the amount.

We have also entered into construction loan agreements in an aggregate
amount of $43.4 million with Colonial Bank to fund construction costs for the
West Houston Facilities being developed in Houston, Texas. Each construction
loan has a term of up to 18 months and an option on the part of the borrower to
convert the loan to a 30-month term loan upon completion of construction of the
West Houston Facility securing that loan. The loans are secured by mortgages on
the West Houston Facilities, as well as assignments of rents and leases on those
facilities, and require us to comply with certain financial

covenants. The loans bear interest at one month LIBOR plus 225 basis points
during the construction period and one month LIBOR plus 250 basis points
thereafter. The Colonial Bank loans are cross-defaulted. As of the date of this
prospectus, we have made no borrowings under the Colonial Bank loans.

COMPETITIVE STRENGTHS

We believe that the following competitive strengths will enable us to
execute our business strategy successfully:

- Experienced Management Team. Our management team's experience enables us
to offer innovative acquisition and net-lease structures that we believe
will appeal to a variety of healthcare operators. We believe that our
management's depth of experience in both traditional real estate
investment and healthcare operations positions us favorably to take
advantage of the available opportunities in the healthcare real estate
market.

- Comprehensive Underwriting Process. Our underwriting process focuses on
both real estate investment and healthcare operations. Our acquisition
and development selection process includes a comprehensive analysis of a
targeted healthcare facility's profitability, cash flow, occupancy and
patient and payor mix, financial trends in revenues and expenses,
barriers to competition, the need in the market for the type of
healthcare services provided by the facility, the strength of the
location and the underlying value of the facility, as well as the
financial strength and experience of the tenant and the tenant's
management team. Through our detailed underwriting of healthcare
acquisitions, which includes an analysis of both the underlying real
estate and ongoing or expected healthcare operations at the property, we
expect to deliver attractive risk-adjusted returns to our stockholders.

- Active Asset Management. We actively monitor the operating results of
our tenants by reviewing periodic financial reporting and operating data,
as well as visiting each facility and meeting with the management of our
tenants on a regular basis. Integral to our asset management philosophy
is our desire to build long-term relationships with our tenants and,
accordingly, we have developed a partnering approach which we believe
results in the tenant viewing us as a member of its team.

- Favorable Lease Terms. We lease our facilities to healthcare operators
pursuant to long-term net-lease agreements. A net-lease requires the
tenant to bear most of the costs associated with the property, including
property taxes, utilities, insurance and maintenance. Our current
net-leases are for terms of at least 10 years, provide for annual base
rental increases and, in the case of the Vibra Facilities, percentage
rent. Similarly, we anticipate that our future leases will generally
provide for base rent with annual escalators, tenant payment of operating
costs and, when feasible and in compliance with applicable healthcare
laws and regulations, percentage rent.

- Diversified Portfolio Strategy. We focus on a portfolio of several
different types of healthcare facilities in a variety of geographic
regions. We also intend to diversify our tenant base as we acquire and
develop additional healthcare facilities.

- Access to Investment Opportunities. We believe our network of
relationships in both the real estate and healthcare industries provides
us access to a large volume of potential acquisition and development
opportunities. The net proceeds of this offering will enhance our ability
to capitalize on these and other investment opportunities.

- Local Physician Investment. When feasible and in compliance with
applicable healthcare laws and regulations, we expect to offer physicians
an opportunity to invest in the facilities that we own, thereby
strengthening our relationship with the local physician community.

SUMMARY RISK FACTORS

You should carefully consider the matters discussed in the section "Risk
Factors" beginning on page 16 prior to deciding whether to invest in our common
stock. Some of these risks include:

- We may be unable to acquire or develop the Pending Acquisition and
Development Facilities or facilities we have identified as potential
candidates for acquisition or development as quickly as we expect or at
all, which could harm our future operating results and adversely affect
our ability to make distributions to our stockholders.

- We expect to continue to experience rapid growth and may not be able to
adapt our management and operational systems to integrate the net-leased
facilities we have acquired and are developing or those that we expect to
acquire and develop without unanticipated disruption or expense.

- Our real estate investments will be concentrated in net-leased healthcare
facilities, making us more vulnerable economically than if our
investments were more diversified across several industries or property
types.

- Failure by our tenants to repay loans currently outstanding or loans we
have committed to make or to pay us commitment and other fees that they
are obligated to pay, in an aggregate amount of approximately $44.1
million, would have a material adverse effect on our revenues and our
ability to make distributions to our stockholders.

- Our facilities are currently leased to only three tenants, two of which
were recently organized and have limited or no operating histories, and
the failure of any of these tenants to meet its obligations to us,
including payment of rent, payment of commitment fees and repayment of
loans we have made or intend to make to them, would have a material
adverse effect on our revenues and our ability to make distributions to
our stockholders.

- The healthcare industry is heavily regulated and existing and new laws or
regulations, changes to existing laws or regulations, loss of licensure
or certification or failure to obtain licensure or certification could
result in the inability of our tenants to make lease or loan payments to
us.

- Our use of debt financing will subject us to significant risks, including
foreclosure and refinancing risks and the risk that debt service
obligations will reduce the amount of cash available for distribution to
our stockholders. We have entered into loan agreements pursuant to which
we may borrow up to $117.5 million, $74.1 million of which was
outstanding as of March 31, 2005. Our charter and other organizational
documents do not limit the amount of debt we may incur.

- Provisions of Maryland law, our charter and our bylaws may prevent or
deter changes in management and third-party acquisition proposals that
you may believe to be in our best interest, depress our stock price or
cause dilution.

- We depend on key personnel, the loss of any one of whom could threaten
our ability to operate our business successfully.

- Failure to obtain or loss of our tax status as a REIT would have
significant adverse consequences to us and the value of our common stock.
7

- Our loans to Vibra could be recharacterized as equity, in which case our
rental income from Vibra would not be qualifying income under the REIT
rules and we could lose our REIT status.

- There is currently no public market for our common stock, and an active
trading market for our common stock may never develop.

- Our engagement agreement with Friedman, Billings, Ramsey & Co., Inc. may
preclude us from engaging investment banking firms other than Friedman,
Billings, Ramsey & Co., Inc, until April 7, 2006 for future financing and
other strategic transactions, and Friedman, Billings, Ramsey & Co., Inc.
has an interest in this offering other than underwriting discounts and
commissions.

- If you purchase common stock in this offering, you will experience
immediate dilution of approximately $2.04 in net tangible book value per
share.

MARKET OPPORTUNITY

According to the United States Department of Commerce, Bureau of Economic
Analysis, healthcare is one of the largest industries in the U.S., and was
responsible for approximately 15.3% of U.S. gross domestic product in 2003.
Healthcare spending has consistently grown at rates greater than overall
spending growth and inflation. We expect this trend to continue. According to
the United States Department of Health and Human Services, Centers for Medicare
and Medicaid Services, or CMS, healthcare expenditures are projected to increase
by more than 7% in 2004 and 2005 to $1.8 trillion and $1.9 trillion,
respectively, and are expected to reach $3.1 trillion by 2012.

To satisfy this growing demand for healthcare services, a significant
amount of new construction of healthcare facilities has been undertaken, and we
expect significant construction of additional healthcare facilities in the
future. In 2003 alone, $24.5 billion was spent on the construction of healthcare
facilities, according to CMS. This represented more than a 9% increase over the
$22.4 billion in healthcare construction spending for 2002. We believe that a
significant part of this healthcare construction spending was for the types of
facilities that we target.

OUR TARGET FACILITIES

The market for healthcare real estate is extensive and includes real estate
owned by a variety of healthcare operators. We focus on acquiring, developing
and net leasing to healthcare operators facilities that are designed to address
what we view as the latest trends in healthcare delivery methods. These
facilities include:

- Rehabilitation Hospitals: Rehabilitation hospitals provide inpatient and
outpatient rehabilitation services for patients recovering from multiple
traumatic injuries, organ transplants, amputations, cardiovascular
surgery, strokes, and complex neurological, orthopedic, and other
conditions. These hospitals are often the best medical alternative to
traditional acute care hospitals where under the Medicare prospective
payment system there is pressure to discharge patients after relatively
short stays.

- Long-term Acute Care Hospitals: Long-term acute care hospitals focus on
extended hospital care, generally at least 25 days, for the
medically-complex patient. Long-term acute care hospitals have arisen
from a need to provide care to patients in acute care settings, including
daily physician observation and treatment, before they are able to move
to a rehabilitation hospital or return home. These facilities are
reimbursed in a manner more appropriate for a longer length of stay than
is typical for an acute care hospital.

- Regional and Community Hospitals: We define regional and community
hospitals as general medical/surgical hospitals whose practicing
physicians generally serve a market specific area,
8

whether urban, suburban or rural. We intend to limit our ownership of
these facilities to those with market, ownership, competitive or
technological characteristics that provide barriers to entry for
potential competitors.

- Women's and Children's Hospitals: These hospitals serve the specialized
areas of obstetrics and gynecology, other women's healthcare needs,
neonatology and pediatrics. We anticipate substantial development of
facilities designed to meet the needs of women and children and their
physicians as a result of the decentralization and specialization trends
described above.

- Ambulatory Surgery Centers: Ambulatory surgery centers are freestanding
facilities designed to allow patients to have outpatient surgery, spend a
short time recovering at the center, then return home to complete their
recoveries. Ambulatory surgery centers offer a lower cost alternative to
general hospitals for many surgical procedures in an environment that is
more convenient for both patients and physicians. Outpatient procedures
commonly performed include those related to gastrointestinal, general
surgery, plastic surgery, ear, nose and throat/audiology, as well as
orthopedics and sports medicine.

- Other Single-Discipline Facilities: The decentralization and
specialization trends in the healthcare industry are also creating
demands and opportunities for physicians to practice in hospital
facilities in which the design, layout and medical equipment are
specifically developed, and healthcare professional staff are educated,
for medical specialties. These facilities include heart hospitals,
ophthalmology centers, orthopedic hospitals and cancer centers.

- Medical Office Buildings: Medical office buildings are office and clinic
facilities occupied and used by physicians and other healthcare providers
in the provision of healthcare services to their patients. The medical
office buildings that we target are or will be master-leased and
generally adjacent to our other targeted healthcare facilities.

OUR FORMATION TRANSACTIONS

The following is a summary of our formation transactions:

- We were formed as a Maryland corporation on August 27, 2003 to succeed to
the business of Medical Properties Trust, LLC, a Delaware limited
liability company, which was formed by certain of our founders in
December 2002. In connection with our formation, we issued our founders
1,630,435 shares of our common stock in exchange for nominal cash
consideration and the membership interests of Medical Properties Trust,
LLC. Upon completion of our private placement in April 2004, 1,108,527
shares of the 1,630,435 shares of common stock held by our founders were
redeemed for nominal value and they now collectively hold 557,908 shares
of our common stock, including shares purchased in our April 2004 private
placement.

- Our operating partnership, MPT Operating Partnership, L.P., was formed in
September 2003. Our wholly-owned subsidiary, Medical Properties Trust,
LLC, is the sole general partner of our operating partnership. We
currently own all of the limited partnership interests in our operating
partnership.

- MPT Development Services, Inc., a Delaware corporation that we formed in
January 2004, operates as our wholly-owned taxable REIT subsidiary.

- In April 2004 we completed a private placement of 25,300,000 shares of
common stock at an offering price of $10.00 per share. Friedman,
Billings, Ramsey & Co., Inc., which is serving as a lead underwriter in
this offering, acted as the initial purchaser and sole placement agent.
The total net proceeds to us, after deducting fees and expenses of the
offering, were approximately $233.5 million. The net proceeds of our
private placement, together with borrowed funds, have been or will be
used to acquire our current portfolio of nine facilities, consisting of
seven facilities that are in operation and two that are under
development, lend funds to one of our tenants, repay debt, pay
pre-offering operating expenses and for working capital. Thus far we have
utilized

approximately $155.4 million to acquire our seven existing facilities,
have loaned $47.6 million to Vibra to acquire the operations at the Vibra
Facilities and for working capital purposes, $6.2 million of which has
been repaid, and have funded approximately $35.1 million of a projected
total of approximately $63.1 million of development costs for the West
Houston Facilities. There are approximately 316 beneficial holders of our
common stock as of the date of this prospectus.

OUR STRUCTURE

We conduct our business through a traditional umbrella partnership REIT, or
UPREIT, in which our facilities are owned by our operating partnership, MPT
Operating Partnership, L.P., and limited partnerships, limited liability
companies or other subsidiaries of our operating partnership. Through our
wholly-owned limited liability company, Medical Properties Trust, LLC, we are
the sole general partner of our operating partnership and we presently own all
of the limited partnership units of our operating partnership. In the future, we
may issue limited partnership units to third parties from time to time in
connection with facility acquisitions or developments. In addition, we may sell
equity interests in subsidiaries of our operating partnership in connection with
facility acquisitions or developments.

MPT Development Services, Inc., our taxable REIT subsidiary, is authorized
to engage in development, management, lending, including but not limited to
acquisition and working capital loans to our tenants, and other activities that
we are unable to engage in directly under applicable REIT tax rules. The
following chart illustrates our structure upon completion of this offering:

(CHART)
- ---------------

(1) We own and in the future expect to own interests in our facilities through
wholly owned or majority owned subsidiaries of our operating partnership,
MPT Operating Partnership, L.P. Our operating partnership is a limited
partner of MPT West Houston MOB, L.P. and MPT West Houston Hospital, L.P.,
which own, respectively, the West Houston MOB and the West Houston Hospital.
MPT West Houston MOB, LLC and MPT West Houston Hospital, LLC, both of which
are wholly-owned by our operating partnership, are, respectively, the
general partners of these entities. We have sold limited partnership
interests representing approximately 24% of the aggregate equity interests
in MPT West Houston MOB, L.P. to physicians and others associated with our
tenant or subtenants of the West Houston MOB. Stealth, the tenant of the
West Houston Hospital, owns a 6% limited partnership interest in MPT West
Houston Hospital, L.P.

REGISTRATION RIGHTS AND LOCK-UP AGREEMENTS

Registration Rights Agreement. Pursuant to a registration rights agreement
among us, Friedman, Billings, Ramsey & Co., Inc. and certain holders of our
common stock, we were required, among other things, to file with the SEC by
January 6, 2005 a resale shelf registration statement registering all of the
shares of common stock sold in our April 2004 private placement, and all of the
shares of common stock issued to Friedman, Billings, Ramsey & Co., Inc. for
financial advisory services. We are required to use our reasonable best efforts
to cause the resale registration statement to become effective under the
Securities Act as promptly as practicable after the filing and to maintain the
resale registration statement continuously effective under the Securities Act of
1933, or the Securities Act, for a specified period.

The resale registration statement was filed on January 6, 2005. If we
default on our obligation to use reasonable best efforts to cause the
effectiveness of, or fail to maintain the effectiveness of, the resale
registration statement for the time periods described above, or certain other
events occur, we may be

required to pay the holders of registrable shares, other than our affiliates,
liquidated damages during the period of the default.

Lock-up Agreements. All of our directors and executive officers, subject
to limited exceptions, have agreed to be bound by lock-up agreements that
prohibit these holders from selling or otherwise disposing of any of our common
stock or securities convertible into our common stock that they own or acquire
for 180 days after the date of this prospectus. In addition, the underwriters
will require that all of our stockholders other than our executive officers and
directors agree not to sell or otherwise dispose of any of the shares of our
common stock or securities convertible into our common stock that they have
acquired prior to the date of this prospectus and are not selling in this
offering until 60 days after the date of this prospectus, subject to limited
exceptions. Friedman, Billings, Ramsey & Co., Inc., on behalf of the
underwriters, may, in its discretion, release all or any portion of the common
stock subject to the lock-up agreements with our directors and executive
officers at any time and without notice or stockholder approval, in which case
our other stockholders would also be released from the restrictions under the
registration rights agreement.

SELLING STOCKHOLDERS

Pursuant to, and subject to the terms and conditions of, the registration
rights agreement among us, Friedman, Billings, Ramsey & Co., Inc. and certain
holders of our common stock, persons who purchased our common stock in our
private placement in April 2004 and their transferees have the right to sell
their common stock in this offering. We are including shares of our
common stock in this offering to be sold by selling stockholders.

RESTRICTIONS ON OWNERSHIP OF OUR COMMON STOCK

The Code imposes limitations on the concentration of ownership of REIT
shares. Our charter generally prohibits any stockholder from actually or
constructively owning more than 9.8% of our outstanding shares of common stock.
The ownership limitation in our charter is more restrictive than the
restrictions on ownership of our common stock imposed by the Code. Our board
may, in its sole discretion, waive this ownership limitation with respect to
particular stockholders if our board is presented with evidence satisfactory to
it that the ownership will not then or in the future jeopardize our status as a
REIT.

DISTRIBUTION POLICY

We intend to distribute to our stockholders each year all or substantially
all of our REIT taxable income so as to avoid paying corporate income tax and
excise tax on our REIT income and to qualify for the tax benefits afforded to
REITs under the Code. The actual amount and timing of distributions, if any,
will be at the discretion of our board of directors and will depend upon our
actual results of operations and a number of other factors discussed in the
section "Distribution Policy."

The table below is a summary of our distributions.

DISTRIBUTION PER SHARE
DECLARATION DATE RECORD DATE DATE OF DISTRIBUTION OF COMMON STOCK
- ---------------- ----------- -------------------- ----------------------

May 19, 2005 June 20, 2005 July 14, 2005 $0.16
March 4, 2005 March 16, 2005 April 15, 2005 $0.11
November 11, 2004 December 16, 2004 January 11, 2005 $0.11
September 2, 2004 September 16, 2004 October 11, 2004 $0.10

The two distributions declared in 2004, aggregating $0.21 per share, were
comprised of approximately $0.13 per share in ordinary income and $0.08 per
share in return of capital. For federal income tax purposes, our distributions
were limited in 2004 to our tax basis earnings and profits of $0.13 per share.
Accordingly, for tax purposes, $0.08 per share of the distributions we paid in
January 2005 will be treated as a 2005 distribution; the tax character of this
amount, along with that of the April 15, 2005 and July 14, 2005 distributions,
will be determined subsequent to determination of our 2005 taxable income.

THE OFFERING

Shares of common stock offered
by us(1)...................... 11,365,000 shares

Shares of common stock offered
by selling stockholders....... shares

Shares of common stock to be
outstanding after this
offering(1)(2)................ 37,635,862 shares

Use of Proceeds............... The net proceeds to us from the sale of the
shares of common stock offered by this
prospectus, after deducting the underwriting
discount and the estimated offering expenses
payable by us, will be approximately $115.0
million, or approximately $132.3 million if the
underwriters exercise their over-allotment
option in full. We intend to use the net
proceeds as follows:

- approximately $51.0 million to fund the
development of a community hospital in
Houston, Texas that we have under letter of
commitment;

- approximately $38.0 million to fund the
development of a women's hospital and
integrated medical office building in
Bensalem, Pennsylvania that we have under
contract;

- approximately $18.0 million to fund a portion
of the development costs of a community
hospital in Bloomington, Indiana that we have
under letter of commitment; and

- approximately $8.0 million to lend to Hammond
Properties pursuant to a mortgage loan we
have entered into a letter of commitment to
provide.

Pending these uses, we intend to invest the net
offering proceeds in interest-bearing,
short-term marketable investment grade
securities or money-market accounts which are
consistent with our intention to qualify as a
REIT.

Proposed NYSE symbol.......... MPW
- ---------------

(1) Excludes up to 1,704,750 shares of common stock that may be issued by us
upon exercise of the underwriters' overallotment option.

(2) Based on 26,164,862 shares outstanding as of June 2, 2005. Includes 106,000
shares of restricted common stock to be awarded upon completion of this
offering under our Amended and Restated 2004 Equity Incentive Plan, which we
refer to in this prospectus as our equity incentive plan. Excludes (i)
100,000 shares of common stock issuable upon the exercise of stock options
granted to our independent directors under our equity incentive plan,
one-third of which are vested; (ii) 5,000 shares of common stock issuable in
October 2007 and 7,500 shares of common stock issuable in March 2008
pursuant to deferred stock units awarded under our equity incentive plan to
our independent directors; (iii) 35,000 shares of common stock issuable upon
the exercise of a warrant granted to an unaffiliated third-party; and (iv)
490,680 shares of common stock available for future awards under our equity
incentive plan.

TAX STATUS

As long as we qualify for and maintain our REIT status, we will generally
not incur federal income tax on our income to the extent that we distribute this
income to our stockholders. However, we will be subject to tax at normal
corporate rates on net income or capital gains not distributed to stockholders.
Moreover, our taxable REIT subsidiary will be subject to federal and state
income taxation on its taxable income.

SUMMARY FINANCIAL INFORMATION

You should read the following pro forma and historical information in
conjunction with "Management's Discussion and Analysis of Financial Condition
and Results of Operations" and our historical and pro forma consolidated
financial statements and related notes thereto included elsewhere in this
prospectus.

The following table sets forth our summary financial and operating data on
an historical and pro forma basis. Our summary historical balance sheet
information as of December 31, 2004, and the historical statement of operations
and other data for the year ended December 31, 2004, have been derived from our
historical financial statements audited by KPMG LLP, independent registered
public accounting firm, whose report with respect thereto is included elsewhere
in this prospectus. The historical balance sheet information as of March 31,
2005 and the historical statement of operations and other data for the three
months ended March 31, 2005 have been derived from our unaudited historical
balance sheet as of March 31, 2005 and from our unaudited statement of
operations for the three months ended March 31, 2005 included elsewhere in this
prospectus. The unaudited historical financial statements include all
adjustments, consisting of normal recurring adjustments, that we consider
necessary for a fair presentation of our financial condition and results of
operations as of such dates and for such periods under accounting principles
generally accepted in the U.S.

The unaudited pro forma consolidated balance sheet data as of March 31,
2005 are presented as if completion of this offering and completion of our
probable acquisitions had occurred on March 31, 2005.

The unaudited pro forma consolidated statement of operations and other data
for the three months ended March 31, 2005 are presented as if acquisition of the
Desert Valley Facility, completion of this offering and completion of our
probable acquisitions had occurred on January 1, 2005, and our December 31, 2004
unaudited pro forma consolidated statement of operations are presented as if our
acquisition of the current portfolio of facilities (the six Vibra Facilities and
the Desert Valley Facility), our making of the Vibra loans, completion of this
offering and completion of our probable acquisitions had occurred on January 1,
2004. The pro forma information does not give effect to any of our facilities
under development or probable development transactions. The pro forma
information is not necessarily indicative of what our actual financial position
or results of operations would have been as of the dates or for the periods
indicated, nor does it purport to represent our future financial position or
results of operations.

FOR THE THREE MONTHS ENDED FOR THE YEAR ENDED
MARCH 31, 2005 DECEMBER 31, 2004
--------------------------- ---------------------------
PRO FORMA HISTORICAL PRO FORMA HISTORICAL
------------ ------------ ------------ ------------

OPERATING INFORMATION:
Revenues
Rent income..................... $ 6,669,856 $ 5,268,490 $ 25,101,257 $ 8,611,344
Interest income from loans...... 1,212,038 1,212,038 5,037,049 2,282,115
------------ ------------ ------------ ------------
Total revenues.................. 7,881,894 6,480,528 30,138,306 10,893,459
Operating expenses
Depreciation and amortization... 1,130,162 842,407 4,520,645 1,478,470
General and administrative...... 1,698,249 1,698,249 5,057,284 5,057,284
Total operating expenses........ 2,880,972 2,593,217 10,350,278 7,214,601
Operating income................ 5,000,922 3,887,311 19,788,028 3,678,858
Net other income (expense)...... (327,377) (327,377) 897,491 897,491
Net income......................... 4,673,545 3,559,934 20,685,519 4,576,349
Net income per share, basic and
diluted......................... 0.12 0.14 0.67 0.24
Weighted average shares
outstanding -- basic............ 37,652,195 26,099,195 30,863,833 19,310,833
Weighted average shares
outstanding -- diluted.......... 37,656,259 26,103,259 30,865,634 19,312,634

AS OF
AS OF MARCH 31, 2005 DECEMBER 31, 2004
------------------------------------ -----------------
PRO FORMA HISTORICAL HISTORICAL
------------ ------------ -----------------

BALANCE SHEET INFORMATION:
Gross investment in real estate assets......... $219,914,624 $192,129,624 $151,690,293
Net investment in real estate.................. 217,593,747 189,808,747 150,211,823
Construction in progress....................... 36,757,429 36,757,429 24,318,098
Cash and cash equivalents...................... 162,226,562 82,053,255 97,543,677
Loans receivable............................... 42,498,111 42,498,111 50,224,069(1)
Total assets................................... 434,262,386 326,304,079 306,506,063
Total debt..................................... 74,141,667 74,141,667 56,000,000
Total liabilities.............................. 89,178,201 92,047,316 73,777,619
Total stockholders' equity..................... 343,321,685 232,494,263 231,728,444
Total liabilities and stockholders' equity..... 434,262,386 326,304,079 306,506,063

FOR THE THREE MONTHS ENDED FOR THE YEAR ENDED DECEMBER 31,
MARCH 31, 2005 2004
--------------------------- -------------------------------
PRO FORMA HISTORICAL PRO FORMA HISTORICAL
----------- ------------- ------------- ---------------

OTHER INFORMATION:
Funds from operations(2)............. $5,803,707 $ 4,402,341 $25,206,164 $ 6,054,819
Cash Flows:
Provided by operating
activities...................... 1,643,836 9,918,898
Used for investing activities..... (32,729,071) (195,600,642)
Provided by financing
activities...................... 15,594,813 283,125,421

- ---------------

(1) Includes $1.5 million in commitment fees payable to us by Vibra.

(2) Funds from operations, or FFO, represents net income (computed in accordance
with GAAP), excluding gains (or losses) from sales of property, plus real
estate related depreciation and amortization (excluding amortization of loan
origination costs) and after adjustments for unconsolidated partnerships and
joint ventures. Management considers funds from operations a useful
additional measure of performance for an equity REIT because it facilitates
an understanding of the operating performance of our properties without
giving effect to real estate depreciation and amortization, which assumes
that the value of real estate assets diminishes predictably over time. Since
real estate values have historically risen or fallen with market conditions,
we believe that funds from operations provides a meaningful supplemental
indication of our performance. We compute funds from operations in
accordance with standards established by the Board of Governors of the
National Association of Real Estate Investment Trusts, or NAREIT, in its
March 1995 White Paper (as amended in November 1999 and April 2002), which
may differ from the methodology for calculating funds from operations
utilized by other equity REITs and, accordingly, may not be comparable to
such other REITs. FFO does not represent amounts available for management's
discretionary use because of needed capital replacement or expansion, debt
service obligations, or other commitments and uncertainties, nor is it
indicative of funds available to fund our cash needs, including our ability
to make distributions. Funds from operations should not be considered as an
alternative to net income (loss) (computed in accordance with GAAP) as
indicators of our financial performance or to cash flow from operating
activities (computed in accordance with GAAP) as an indicator of our
liquidity.

The following table presents a reconciliation of FFO to net income for the
three months ended March 31, 2005 and for the year ended December 31, 2004 on
an actual and pro forma basis.

FOR THE THREE MONTHS FOR THE YEAR ENDED
ENDED MARCH 31, 2005 DECEMBER 31, 2004
----------------------- ------------------------
PRO FORMA HISTORICAL PRO FORMA HISTORICAL
---------- ---------- ----------- ----------

FUNDS FROM OPERATIONS:
Net income................................................. $4,673,545 $3,559,934 $20,685,519 $4,576,349
Depreciation and amortization.............................. 1,130,162 842,407 4,520,645 1,478,470
---------- ---------- ----------- ----------
Funds from operations...................................... $5,803,707 $4,402,341 $25,206,164 $6,054,819
========== ========== =========== ==========

RISK FACTORS

An investment in our common stock involves a number of risks. Before making
an investment decision, you should carefully consider all of the risks described
below and the other information contained in this prospectus. If any of the
risks discussed in this prospectus actually occurs, our business, financial
condition and results of operations could be materially adversely affected. If
this were to occur, the value of our common stock could decline and you may lose
all or part of your investment.

RISKS RELATING TO OUR BUSINESS AND GROWTH STRATEGY

WE WERE FORMED IN AUGUST 2003 AND HAVE A LIMITED OPERATING HISTORY; OUR
MANAGEMENT HAS A LIMITED HISTORY OF OPERATING A REIT AND A PUBLIC COMPANY AND
MAY THEREFORE HAVE DIFFICULTY IN SUCCESSFULLY AND PROFITABLY OPERATING OUR
BUSINESS.

We have only recently been organized and have a limited operating history.
We are subject to the risks generally associated with the formation of any new
business, including unproven business models, untested plans, uncertain market
acceptance and competition with established businesses. Our management has
limited experience in operating a REIT and a public company. Therefore, you
should be especially cautious in drawing conclusions about the ability of our
management team to execute our business plan.

WE MAY NOT BE SUCCESSFUL IN DEPLOYING THE NET PROCEEDS OF THIS OFFERING FOR
THEIR INTENDED USES AS QUICKLY AS WE INTEND OR AT ALL, WHICH COULD HARM OUR CASH
FLOW AND ABILITY TO MAKE DISTRIBUTIONS TO OUR STOCKHOLDERS.

Upon completion of this offering, we will experience a capital infusion
from the net offering proceeds, which we intend to use to develop additional
net-leased facilities. If we are unable to use the net proceeds in this manner,
we will have no specific designated use for a substantial portion of the net
proceeds from this offering. In that case, or in the event we allocate a portion
of the net proceeds to other uses during the pendency of the developments, you
would be unable to evaluate the manner in which we invest the net proceeds or
the economic merits of the assets acquired with the proceeds. We may not be able
to invest this capital on acceptable terms or timeframes, or at all, which may
harm our cash flow and ability to make distributions to our stockholders.

WE MAY BE UNABLE TO ACQUIRE OR DEVELOP THE PENDING ACQUISITION AND DEVELOPMENT
FACILITIES, WHICH COULD HARM OUR FUTURE OPERATING RESULTS AND ADVERSELY AFFECT
OUR ABILITY TO MAKE DISTRIBUTIONS TO OUR STOCKHOLDERS.

Our future success depends in large part on our ability to continue to grow
our business through the acquisition or development of additional facilities. We
cannot assure you that we will acquire or develop any of the Pending Acquisition
and Development Facilities on the terms described, or at all, because each of
these transactions is subject to a variety of conditions, including, in the case
of facilities under contract, our satisfactory completion of due diligence and
the satisfaction of customary closing conditions, including the obtaining of any
required government approvals and consents and, in the case of facilities under
letters of commitment, execution of mutually-acceptable definitive agreements,
our satisfactory completion of due diligence, receipt of appraisals and other
third-party reports, receipt of government and third-party approvals and
consents, approval by our board of directors and other customary closing
conditions. In addition, our development of one of the Pending Acquisition and
Development Facilities is dependent upon our proposed tenant's completion of the
acquisition of the property on which the facilities are to be built from the
current owner. We have incurred losses of $585,345 in connection with
acquisitions that we were unable to complete, consisting primarily of legal
fees, costs of third-party reports and travel expenses. If we are unsuccessful
in completing the acquisition or development of additional facilities in the
future, we will incur similar costs without achieving corresponding revenues,
our future operating results will not meet expectations and our ability to make
distributions to our stockholders will be adversely affected.

WE MAY NOT CONSUMMATE THE TRANSACTIONS CONTEMPLATED BY OUR OTHER ARRANGEMENTS,
WHICH COULD ADVERSELY AFFECT OUR ABILITY TO MAKE DISTRIBUTIONS TO OUR
STOCKHOLDERS.

We have entered into letter agreements with DVH to fund a $20.0 million
expansion of the Desert Valley Facility and with DSI to fund $50.0 million of
acquisitions and development facilities. Our funding of the expansion of the
Desert Valley Facility is subject to receipt of a development agreement from DVH
which we may not receive until February 28, 2006. DVH is not obligated to
present us with a development agreement, and, if it does not, we have no
obligation to provide funding to DVH for the expansion. If we enter into a
development agreement, we may not begin construction on the expansion for
several months after that time and the expansion could take up to approximately
one year to complete. Any acquisition or development of facilities pursuant to
the DSI commitment is subject to DSI's identification, and our approval, of
acquisition or development facilities. DSI is not required to identify
facilities for acquisition or development and, if it does not, we have no
obligation to provide funding to DSI. We have also entered into arrangements
with Vibra and Prime Healthcare to acquire hospital facilities in California for
an aggregate amount of $45.8 million, subject to our tenants' acquisition of
those facilities. One of those potential tenants only has a non-binding letter
of intent to acquire the property we intend to purchase from it and the other
has no agreement or letter of intent to acquire the property. Each of these
arrangements is subject to a number of additional conditions. Thus we may not
engage in any of these transactions in the near future, or at all, and may not
in the near future, or ever, generate any revenues from these arrangements.

WE MAY BE UNABLE TO ACQUIRE OR DEVELOP ANY OF THE FACILITIES WE HAVE IDENTIFIED
AS POTENTIAL CANDIDATES FOR ACQUISITION OR DEVELOPMENT, WHICH COULD HARM OUR
FUTURE OPERATING RESULTS AND ADVERSELY AFFECT OUR ABILITY TO MAKE DISTRIBUTIONS
TO OUR STOCKHOLDERS.

We have identified numerous other facilities that we believe would be
suitable candidates for acquisition or development; however, we cannot assure
you that we will be successful in completing the acquisition or development of
any of these facilities. Consummation of any of these acquisitions or
developments is subject to, among other things, the willingness of the parties
to proceed with a contemplated transaction, negotiation of mutually acceptable
definitive agreements, satisfactory completion of due diligence and satisfaction
of customary closing conditions. If we are unsuccessful in completing the
acquisition or development of additional facilities in the future, our future
operating results will not meet expectations and our ability to make
distributions to our stockholders will be adversely affected.

WE EXPECT TO CONTINUE TO EXPERIENCE RAPID GROWTH AND MAY NOT BE ABLE TO ADAPT
OUR MANAGEMENT AND OPERATIONAL SYSTEMS TO INTEGRATE THE NET-LEASED FACILITIES WE
HAVE ACQUIRED AND ARE DEVELOPING OR THOSE THAT WE MAY ACQUIRE OR DEVELOP IN THE
FUTURE WITHOUT UNANTICIPATED DISRUPTION OR EXPENSE.

We are currently experiencing a period of rapid growth. We cannot assure
you that we will be able to adapt our management, administrative, accounting and
operational systems, or hire and retain sufficient operational staff, to
integrate and manage the facilities we have acquired and are developing and
those that we may acquire or develop. Our failure to successfully integrate and
manage our current portfolio of facilities or any future acquisitions or
developments could have a material adverse effect on our results of operations
and financial condition and our ability to make distributions to our
stockholders.

WE MAY BE UNABLE TO ACCESS CAPITAL, WHICH WOULD SLOW OUR GROWTH.

Our business plan contemplates growth through acquisitions and developments
of facilities. As a REIT, we are required to make cash distributions which
reduces our ability to fund acquisitions and developments with retained
earnings. We are dependent on acquisition financings and access to the capital
markets for cash to make investments in new facilities. Due to market or other
conditions, there will be times when we will have limited access to capital from
the equity and debt markets. During such periods, virtually all of our available
capital will be required to meet existing commitments and to reduce existing
debt. We may not be able to obtain additional equity or debt capital or dispose
of assets, on favorable terms, if at all, at the time we need additional capital
to acquire healthcare properties on a competitive

basis or to meet our obligations. Our ability to grow through acquisitions and
developments will be limited if we are unable to obtain debt or equity
financing, which could have a material adverse effect on our results of
operations and our ability to make distributions to our stockholders.

DEPENDENCE ON OUR TENANTS FOR RENT MAY ADVERSELY IMPACT OUR ABILITY TO MAKE
DISTRIBUTIONS TO OUR STOCKHOLDERS.

We expect to qualify as a REIT and, accordingly, as a REIT operating in the
healthcare industry, we are not permitted by current tax law to operate or
manage the businesses conducted in our facilities. Accordingly, we rely almost
exclusively on rent payments from our tenants for cash with which to make
distributions to our stockholders. We have no control over the success or
failure of these tenants' businesses. Significant adverse changes in the
operations of any facility, or the financial condition of any tenant, could have
a material adverse effect on our ability to collect rent payments and,
accordingly, on our ability to make distributions to our stockholders. Facility
management by our tenants and their compliance with state and federal healthcare
laws could have a material impact on our tenants' operating and financial
condition and, in turn, their ability to pay rent to us. Failure on the part of
a tenant to comply materially with the terms of a lease could give us the right
to terminate our lease with that tenant, repossess the applicable facility,
cross default certain other leases with that tenant and enforce the payment
obligations under the lease. However, we then would be required to find another
tenant-operator.

The transfer of most types of healthcare facilities is highly regulated,
which may result in delays and increased costs in locating a suitable
replacement tenant. The sale or lease of these properties to entities other than
healthcare operators may be difficult due to the added cost and time of
refitting the properties. If we are unable to re-let the properties to
healthcare operators, we may be forced to sell the properties at a loss due to
the repositioning expenses likely to be incurred by non-healthcare purchasers.
Alternatively, we may be required to spend substantial amounts to adapt the
facility to other uses. There can be no assurance that we would be able to find
another tenant in a timely fashion, or at all, or that, if another tenant were
found, we would be able to enter into a new lease on favorable terms. Defaults
by our tenants under our leases may adversely affect the timing of and our
ability to make distributions to our stockholders.

FAILURE BY OUR TENANTS TO REPAY LOANS CURRENTLY OUTSTANDING OR LOANS WE HAVE
COMMITTED TO MAKE OR TO PAY US COMMITMENT OR OTHER FEES THAT THEY ARE OBLIGATED
TO PAY, IN AN AGGREGATE AMOUNT OF APPROXIMATELY $44.1 MILLION, WOULD HAVE A
MATERIAL ADVERSE EFFECT ON OUR REVENUES AND OUR ABILITY TO MAKE DISTRIBUTIONS TO
OUR STOCKHOLDERS.

In connection with the acquisition of the Vibra Facilities, our taxable
REIT subsidiary made a secured loan to Vibra of approximately $41.4 million to
acquire the operations at the Vibra Facilities. Payment of this loan is secured
by pledges of equity interests in Vibra and its subsidiaries that are tenants of
ours. The Vibra leases and loan are cross-defaulted. If Vibra defaulted on this
loan, our primary recourse would be to foreclose on the equity interests in
Vibra and its affiliates. This recourse may be impractical because of
limitations imposed by the REIT tax rules on our ability to own these interests.
Failure to adhere to these limitations could cause us to lose our REIT status.
We have obtained guaranty agreements from Mr. Hollinger, Vibra Management, LLC
and The Hollinger Group that obligate them to make loan payments in the event
that Vibra fails to do so. However, we do not believe that these parties have
sufficient financial resources to satisfy a material portion of the loan
obligations. Mr. Hollinger's guaranty is limited to $5.0 million and Vibra
Management, LLC and The Hollinger Group do not have

substantial assets. Vibra has entered into a $14 million credit facility with
Merrill Lynch, and that loan is secured by an interest in Vibra's receivables.
There was approximately $11 million outstanding under the facility on March 31,
2005. At March 31, 2005, Vibra was not in compliance with a facility rent
coverage covenant under its Merrill Lynch credit facility. The Merrill Lynch
credit facility documents were subsequently amended to retroactively change the
rent coverage covenant from a by-facility rent coverage to a consolidated rent
coverage calculation, so that Vibra was in compliance with the amended covenant
at March 31, 2005. Our loan is subordinate to Merrill Lynch with respect to
Vibra's receivables.

We have also agreed to make a working capital loan to Stealth of up to
$1.62 million, although no amounts have been loaned to date. Stealth also owes
us commitment and other fees of approximately $1.1 million. Payment of these
fees and loan amounts is unsecured. We have also agreed to make a mortgage loan
in the amount of $8.0 million to Hammond Properties. We are dependent upon the
ability of these two tenants and Hammond Properties to repay these loans and
fees. Failure by these tenants or Hammond Properties to meet these obligations
would have a material adverse effect on our revenues and our ability to make
distributions to our stockholders.

ACCOUNTING RULES MAY REQUIRE CONSOLIDATION OF ENTITIES IN WHICH WE INVEST AND
OTHER ADJUSTMENTS TO OUR FINANCIAL STATEMENTS.

The Financial Accounting Standards Board, or FASB, issued FASB
Interpretation No. 46, "Consolidation of Variable Interest Entities, an
interpretation of Accounting Research Bulletin No. 51 (ARB No. 51)," in January
2003, and a further interpretation of FIN 46 in December 2003 (FIN 46-R, and
collectively FIN 46). FIN 46 clarifies the application of ARB No. 51,
"Consolidated Financial Statements," to certain entities in which equity
investors do not have the characteristics of a controlling financial interest or
do not have sufficient equity at risk for the entity to finance its activities
without additional subordinated financial support from other parties, referred
to as variable interest entities. FIN 46 generally requires consolidation by the
party that has a majority of the risk and/or rewards, referred to as the primary
beneficiary. FIN 46 applies immediately to variable interest entities created
after January 31, 2003. Under certain circumstances, generally accepted
accounting principles may require us to account for loans to thinly capitalized
companies such as Vibra as equity investments. The resulting accounting
treatment of certain income and expense items may adversely affect our results
of operations, and consolidation of balance sheet amounts may adversely affect
any loan covenants.

THE BANKRUPTCY OR INSOLVENCY OF OUR TENANTS UNDER OUR LEASES COULD SERIOUSLY
HARM OUR OPERATING RESULTS AND FINANCIAL CONDITION.

Two of our existing tenants, Stealth and Vibra, are, and some of our
prospective tenants may be, newly organized, have limited or no operating
history and may be dependent on loans from us to acquire the facility's
operations and for initial working capital. Any bankruptcy filings by or
relating to one of our tenants could bar us from collecting pre-bankruptcy debts
from that tenant or their property, unless we receive an order permitting us to
do so from the bankruptcy court. A tenant bankruptcy could delay our efforts to
collect past due balances under our leases and loans, and could ultimately
preclude collection of these sums. If a lease is assumed by a tenant in
bankruptcy, we expect that all pre-bankruptcy balances due under the lease would
be paid to us in full. However, if a lease is rejected by a tenant in
bankruptcy, we would have only a general unsecured claim for damages. Any
secured claims we have against our tenants may only be paid to the extent of the
value of the collateral, which may not cover any or all of our losses. Any
unsecured claim we hold against a bankrupt entity may be paid only to the extent
that funds are available and only in the same percentage as is paid to all other
holders of unsecured claims. We may recover none or substantially less than the
full value of any unsecured claims, which would harm our financial condition.

OUR FACILITIES ARE CURRENTLY LEASED TO ONLY THREE TENANTS, TWO OF WHICH WERE
RECENTLY ORGANIZED AND HAVE LIMITED OR NO OPERATING HISTORIES, AND FAILURE OF
ANY OF THESE TENANTS AND THE GUARANTORS OF THEIR LEASES TO MEET THEIR
OBLIGATIONS TO US WOULD HAVE A MATERIAL ADVERSE EFFECT ON OUR REVENUES AND OUR
ABILITY TO MAKE DISTRIBUTIONS TO OUR STOCKHOLDERS.

Our existing facilities and the facilities we have under development are
currently leased to subsidiaries of Vibra, DVH and Stealth. Vibra and Stealth
were recently organized, have limited or no operating histories and Vibra was
dependent on us for an aggregate amount of $47.6 million in loans to acquire
operations at the facilities and for initial working capital needs. As of
December 31, 2004, Vibra had total assets of approximately $59 million (of which
approximately $28.8 million were goodwill and other intangible assets), total
liabilities of approximately $62.8 million, a deficit in owner's capital of
approximately $3.8 million, and for the period from inception through December
31, 2004 had a loss from operations of approximately $5.1 million and a net loss
of approximately $3.8 million. Stealth had approximately $5.7 million in equity
as of December 31, 2004 and will have substantial pre-opening and start-up costs
upon completion of construction of its facilities. We cannot assure you that,
should Stealth's equity be insufficient to cover its costs, it could access
additional debt or equity financing. Each Vibra lease is guaranteed by Brad E.
Hollinger, chief executive officer of The Hollinger Group, Vibra, Vibra
Management, LLC and The Hollinger Group. However, we do not believe that these
parties have sufficient financial resources to satisfy a material portion of the
total lease obligations. Mr. Hollinger's guaranty is limited to $5.0 million,
Vibra Management, LLC and The Hollinger Group do not have substantial assets,
and Vibra's assets are substantially comprised of the Vibra Facilities. As of
December 31, 2004, DVH had tangible assets of approximately $18.4 million,
liabilities of approximately $18.4 million and $0 stockholders' equity, and for
the year ended December 31, 2004 had net income of approximately $8.3 million.
The lease for the Desert Valley Facility is guaranteed by Desert Valley Health
System, Inc., Desert Valley Medical Group, Inc. and Prime A Investments, LLC. If
any of our tenants were to experience financial difficulties, the tenant may not
be able to pay its rent. Guarantors of our lease with DVH may not have
sufficient assets for us to recover amounts due to us under that lease. The
failure of our tenants and their guarantors to meet their obligations to us
would have a material adverse effect on our revenues and our ability to make
distributions to our stockholders.

OUR BUSINESS IS HIGHLY COMPETITIVE AND WE MAY BE UNABLE TO COMPETE SUCCESSFULLY.

We compete for development opportunities and opportunities to purchase
healthcare facilities with, among others:

- private investors;

- healthcare providers, including physicians;

- other REITs;

- real estate partnerships;

- financial institutions; and

- local developers.

Many of these competitors have substantially greater financial and other
resources than we have and may have better relationships with lenders and
sellers. Competition for healthcare facilities from competitors, including other
REITs, may adversely affect our ability to acquire or develop healthcare
facilities and the prices we pay for those facilities. If we are unable to
acquire or develop facilities or if we pay too much for facilities, our revenue
and earnings growth and financial return could be materially adversely affected.
Certain of our facilities and additional facilities we may acquire or develop
will face competition from other nearby facilities that provide services
comparable to those offered at our facilities and additional facilities we may
acquire or develop. Some of those facilities are owned by governmental agencies
and supported by tax revenues, and others are owned by tax-exempt corporations
and may be supported to a large extent by endowments and charitable
contributions. Those types of support are not

available to our facilities and additional facilities we may acquire or develop.
In addition, competing healthcare facilities located in the areas served by our
facilities and additional facilities we may acquire or develop may provide
healthcare services that are not available at our facilities and additional
facilities we may acquire or develop. From time to time, referral sources,
including physicians and managed care organizations, may change the healthcare
facilities to which they refer patients, which could adversely affect our rental
revenues.

OUR USE OF DEBT FINANCING WILL SUBJECT US TO SIGNIFICANT RISKS, INCLUDING
REFINANCING RISK AND THE RISK OF INSUFFICIENT CASH AVAILABLE FOR DISTRIBUTION TO
OUR STOCKHOLDERS.

Our charter and other organizational documents do not limit the amount of
debt we may incur. We have targeted our debt level at up to approximately 60% of
our aggregate facility acquisition and development costs. However, we may modify
our target debt level at any time without stockholder or board of director
approval. We cannot assure you that our use of financial leverage will prove to
be beneficial. We borrowed $75 million from Merrill Lynch Capital under a loan
agreement. We have also entered into loan agreements with Colonial Bank for
construction loans in an aggregate amount of $43.4 million. As of March 31,
2005, we had $74.1 million of long-term debt outstanding. We have received a
term sheet from Merrill Lynch Capital for an up to $100.0 million senior secured
revolving credit facility with a term of four years, with one 12-month extension
option, to refinance the outstanding amount under our existing loan agreement
with Merrill Lynch Capital and for general corporate purposes. We will have the
right to increase the amount available under the facility by an amount up to
$75.0 million.

We may borrow from other lenders in the future, or we may issue corporate
debt securities in public or private offerings. The loans from Merrill Lynch
Capital and Colonial Bank are secured by the Vibra Facilities and our facilities
under construction in Houston, Texas, respectively. Some of our other borrowings
in the future may be secured by additional facilities we may acquire or develop.
In addition, in connection with debt financing from Merrill Lynch Capital and
Colonial Bank we are, and in connection with other debt financing in the future
we may be, subject to covenants that may restrict our operations. We cannot
assure you that we will be able to meet our debt payment obligations or
restrictive covenants and, to the extent that we cannot, we risk the loss of
some or all of our facilities to foreclosure. In addition, debt service
obligations will reduce the amount of cash available for distribution to our
stockholders.

We anticipate that much of our debt will be non-amortizing and payable in
balloon payments. Therefore, we will likely need to refinance at least a portion
of that debt as it matures. There is a risk that we may not be able to refinance
then-existing debt or that the terms of any refinancing will not be as favorable
as the terms of the then-existing debt. If principal payments due at maturity
cannot be refinanced, extended or repaid with proceeds from other sources, such
as new equity capital or sales of facilities, our cash flow may not be
sufficient to repay all maturing debt in years when significant balloon payments
come due. Additionally, we may incur significant penalties if we choose to
prepay the debt.

FAILURE TO HEDGE EFFECTIVELY AGAINST INTEREST RATE CHANGES MAY ADVERSELY AFFECT
OUR RESULTS OF OPERATIONS AND OUR ABILITY TO MAKE DISTRIBUTIONS TO OUR
STOCKHOLDERS.

Upon completion of this offering, we expect to have $ in variable
interest rate debt. We may seek to manage our exposure to interest rate
volatility by using interest rate hedging arrangements that involve risk,
including the risk that counterparties may fail to honor their obligations under
these arrangements, that these arrangements may not be effective in reducing our
exposure to interest rate changes and that these arrangements may result in
higher interest rates than we would otherwise have. Moreover, no hedging
activity can completely insulate us from the risks associated with changes in
interest rates. Failure to hedge effectively against interest rate changes may
materially adversely affect results of operations and our ability to make
distributions to our stockholders.

OUR CURRENT TENANTS HAVE, AND PROSPECTIVE TENANTS MAY HAVE, AN OPTION TO
PURCHASE THE FACILITIES WE LEASE TO THEM WHICH COULD DISRUPT OUR OPERATIONS.

Our current tenants have, and some prospective tenants will have, the
option to purchase the facilities we lease to them. At the expiration of each
Vibra lease, each tenant will have the option to purchase the facility at a
purchase price equal to the greater of (i) the appraised value of the facility,
determined assuming the lease is still in place, or (ii) the purchase price we
paid for the facility, including acquisition costs, increased by 2.5% per year
from the date of purchase. At any time after February 28, 2007, so long as DVH,
and its affiliates are not in default under any lease with us or any of the
leases with its subtenants, DVH will have the option, upon 90 days' prior
written notice, to purchase the Desert Valley Facility at a purchase price equal
to the sum of (i) the purchase price of the facility, and (ii) that amount
determined under a formula that would provide us an internal rate of return of
10% per year, increased by 2% of such percentage each year, taking into account
all payments of base rent received by us. If during the term of the lease we
receive from the previous owner or any of its affiliates, a written offer to
purchase the Desert Valley Facility and we are willing to accept the offer, so
long as DVH and its affiliates are not in default under any lease with us or any
of the subleases with its subtenants, we must first present the offer to DVH and
allow DVH the right to purchase the facility upon the same price, terms and
conditions as set forth in the offer; however, if the offer is made after
February 28, 2007, in lieu of exercising its right of first refusal, DVH may
exercise its option to purchase as provided above. After the first full 12 month
period after construction of the West Houston MOB and the West Houston Hospital,
respectively, as long as Stealth is not in default under either of its leases
with us or any of the leases with its physician subtenants, it has the right to
purchase the West Houston MOB or the West Houston Hospital at a price equal to
the greater of (i) that amount determined under a formula that would provide us
an internal rate of return of at least 18% and (ii) the appraised value based on
a 15 year lease in place. Upon written notice to us within 90 days of the
expiration of the applicable lease, as long as Stealth is not in default under
either of its leases with us or any of the leases with its physician subtenants,
Stealth will have the option to purchase the West Houston MOB or the West
Houston Hospital at a price equal to the greater of (i) the total development
costs (including any capital additions funded by us, but excluding any capital
additions funded by Stealth) increased by 2.5% per year, and (ii) the appraised
value based on a 15 year lease in place. The Stealth leases also provide that
under certain limited circumstances, Stealth will have the right to present us
with a choice of one out of three proposed exchange facilities to be substituted
for the leased facility.

All of our arrangements which provide or will provide tenants the option to
purchase the facilities we lease to them are subject to regulatory requirements
that such purchases be at fair market value. We cannot assure you that the
formulas we have developed for setting the purchase price will yield a fair
market value purchase price. Any purchase not at fair market value may present
risks of challenge from healthcare regulatory authorities.

In the event our tenants and prospective tenants determine to purchase the
facilities they lease either during the lease term or after their expiration,
the timing of those purchases will be outside of our control and we may not be
able to re-invest the capital on as favorable terms, or at all. Any of these
purchases would disrupt our cash flow by eliminating lease payments from these
tenants. Our inability to effectively manage the turn-over of our facilities
could materially adversely affect our ability to execute our business plan and
our results of operations.

PROPERTY OWNED IN LIMITED LIABILITY COMPANIES AND PARTNERSHIPS IN WHICH WE ARE
NOT THE SOLE EQUITY HOLDER MAY LIMIT OUR ABILITY TO ACT EXCLUSIVELY IN OUR
INTERESTS.

We own, and in the future expect to own, interests in our facilities
through wholly or majority owned subsidiaries of our operating partnership.
Stealth, L.P., the tenant of our West Houston Hospital, owns a 6% limited
partnership interest in MPT West Houston Hospital, L.P., which owns the West
Houston Hospital. We have sold limited partnership interests representing
approximately 24% of the aggregate equity interests in MPT West Houston MOB,
L.P., the entity that owns our West Houston MOB, to physicians and others
associated with our tenant or subtenants of the West Houston MOB. We may offer
limited liability company and limited partnership interests to tenants,
subtenants and physicians in the

future. Investments in partnerships, limited liability companies or other
entities with co-owners may, under certain circumstances, involve risks not
present were a co-owner not involved, including the possibility that partners or
other co-owners might become bankrupt or fail to fund their share of required
capital contributions. Partners or other co-owners may have economic or other
business interests or goals that are inconsistent with our business interests or
goals, and may be in a position to take actions contrary to our policies or
objectives. Such investments may also have potential risks pertaining to
healthcare regulatory compliance, particularly when partners or other co-owners
are physicians, and of impasses on major decisions, such as sales or mergers,
because neither we nor our partners or other co-owners would have full control
over the partnership, limited liability company or other entity. Disputes
between us and our partners or other co-owners may result in litigation or
arbitration that would increase our expenses and prevent our officers and
directors from focusing their time and effort on our business. Consequently,
actions by or disputes with our partners or other co-owners might result in
subjecting facilities owned by the partnership, limited liability company or
other entity to additional risk. In addition, we may in certain circumstances be
liable for the actions of our partners or other co-owners. The occurrence of any
of the foregoing events could have a material adverse effect on our results of
operations and our ability to make distributions to our stockholders.

TERRORIST ATTACKS, SUCH AS THE ATTACKS THAT OCCURRED IN NEW YORK AND WASHINGTON,
D.C. ON SEPTEMBER 11, 2001, U.S. MILITARY ACTION AND THE PUBLIC'S REACTION TO
THE THREAT OF TERRORISM OR MILITARY ACTION COULD ADVERSELY AFFECT OUR RESULTS OF
OPERATIONS AND THE MARKET ON WHICH OUR COMMON STOCK WILL TRADE.

There may be future terrorist threats or attacks against the United States
or U.S. businesses. These attacks may directly impact the value of our
facilities through damage, destruction, loss or increased security costs. Losses
due to wars or terrorist attacks may be uninsurable, or insurance may not be
available at a reasonable price. More generally, any of these events could cause
consumer confidence and spending to decrease or result in increased volatility
in the United States and worldwide financial markets and economies.

RISKS RELATING TO REAL ESTATE INVESTMENTS

OUR REAL ESTATE INVESTMENTS WILL BE CONCENTRATED IN NET-LEASED HEALTHCARE
FACILITIES, MAKING US MORE VULNERABLE ECONOMICALLY THAN IF OUR INVESTMENTS WERE
MORE DIVERSIFIED.

We have acquired and are developing and expect to continue acquiring and
developing net-leased healthcare facilities. We are subject to risks inherent in
concentrating investments in real estate. The risks resulting from a lack of
diversification become even greater as a result of our business strategy to
invest in net-leased healthcare facilities. A downturn in the real estate
industry could materially adversely affect the value of our facilities. A
downturn in the healthcare industry could negatively affect our tenants' ability
to make lease or loan payments to us and, consequently, our ability to meet debt
service obligations or make distributions to our stockholders. These adverse
effects could be more pronounced than if we diversified our investments outside
of real estate or outside of healthcare facilities.

OUR NET-LEASED FACILITIES AND TARGETED NET-LEASED FACILITIES MAY NOT HAVE
EFFICIENT ALTERNATIVE USES, WHICH COULD IMPEDE OUR ABILITY TO FIND REPLACEMENT
TENANTS IN THE EVENT OF TERMINATION OR DEFAULT UNDER OUR LEASES.

All of the facilities in our current portfolio are and all of the
facilities we acquire or develop in the future will be net-leased healthcare
facilities. If we or our tenants terminate the leases for these facilities or if
these tenants lose their regulatory authority to operate these facilities, we
may not be able to locate suitable replacement tenants to lease the facilities
for their specialized uses. Alternatively, we may be required to spend
substantial amounts to adapt the facilities to other uses. Any loss of revenues
or additional capital expenditures occurring as a result could have a material
adverse effect on our financial

condition and results of operations and could hinder our ability to meet debt
service obligations or make distributions to our stockholders.

ILLIQUIDITY OF REAL ESTATE INVESTMENTS COULD SIGNIFICANTLY IMPEDE OUR ABILITY TO
RESPOND TO ADVERSE CHANGES IN THE PERFORMANCE OF OUR FACILITIES AND HARM OUR
FINANCIAL CONDITION.

Real estate investments are relatively illiquid. Our ability to quickly
sell or exchange any of our facilities in response to changes in economic and
other conditions will be limited. No assurances can be given that we will
recognize full value for any facility that we are required to sell for liquidity
reasons. Our inability to respond rapidly to changes in the performance of our
investments could adversely affect our financial condition and results of
operations.

DEVELOPMENT AND CONSTRUCTION RISKS COULD ADVERSELY AFFECT OUR ABILITY TO MAKE
DISTRIBUTIONS TO OUR STOCKHOLDERS.

We are developing a community hospital and an adjacent medical office
building in Houston, Texas which we expect to complete in 2005. We have entered
into letters of commitment and contracts to develop properties in the future.
Our development and related construction activities may subject us to the
following risks:

- we may have to compete for suitable development sites;

- our ability to complete construction is dependent on there being no
title, environmental or other legal proceedings arising during
construction;

- we may be subject to delays due to weather conditions, strikes and other
contingencies beyond our control;

- we may be unable to obtain, or suffer delays in obtaining, necessary
zoning, land-use, building, occupancy healthcare regulatory and other
required governmental permits and authorizations, which could result in
increased costs, delays in construction, or our abandonment of these
projects;

- we may incur construction costs for a facility which exceed our original
estimates due to increased costs for materials or labor or other costs
that we did not anticipate; and

- we may not be able to obtain financing on favorable terms, which may
render us unable to proceed with our development activities.

We expect the net proceeds of this offering allocated to development
projects to be applied to these projects over time. Additionally, the time frame
required for development and construction of these facilities means that we may
have to wait years for a significant cash return. Because we are required to
make cash distributions to our stockholders, if the cash flow from operations or
refinancings is not sufficient, we may be forced to borrow additional money to
fund distributions. We cannot assure you that we will complete our current
construction projects on time or within budget or that future development
projects will not be subject to delays and cost overruns. Risks associated with
our development projects may reduce anticipated rental revenue which could
affect the timing of, and our ability to make, distributions to our
stockholders.

OUR FACILITIES MAY NOT ACHIEVE EXPECTED RESULTS OR WE MAY BE LIMITED IN OUR
ABILITY TO FINANCE FUTURE ACQUISITIONS, WHICH MAY HARM OUR FINANCIAL CONDITION
AND OPERATING RESULTS AND OUR ABILITY TO MAKE THE DISTRIBUTIONS TO OUR
STOCKHOLDERS REQUIRED TO MAINTAIN OUR REIT STATUS.

Acquisitions and developments entail risks that investments will fail to
perform in accordance with expectations and that estimates of the costs of
improvements necessary to acquire and develop facilities will prove inaccurate,
as well as general investment risks associated with any new real estate
investment. We anticipate that future acquisitions and developments will largely
be financed through externally generated funds such as borrowings under credit
facilities and other secured and unsecured debt financing and from issuances of
equity securities. Because we must distribute at least 90% of our REIT taxable
24

income, excluding net capital gain, each year to maintain our qualification as a
REIT, our ability to rely upon income from operations or cash flow from
operations to finance our growth and acquisition activities will be limited.
Accordingly, if we are unable to obtain funds from borrowings or the capital
markets to finance our acquisition and development activities, our ability to
grow would likely be curtailed, amounts available for distribution to
stockholders could be adversely affected and we could be required to reduce
distributions, thereby jeopardizing our ability to maintain our status as a
REIT.

Newly-developed or newly-renovated facilities do not have the operating
history that would allow our management to make objective pricing decisions in
acquiring these facilities (including facilities that may be acquired from
certain of our executive officers, directors and their affiliates). The purchase
prices of these facilities will be based in part upon projections by management
as to the expected operating results of the facilities, subjecting us to risks
that these facilities may not achieve anticipated operating results or may not
achieve these results within anticipated time frames.

IF WE SUFFER LOSSES THAT ARE NOT COVERED BY INSURANCE OR THAT ARE IN EXCESS OF
OUR INSURANCE COVERAGE LIMITS, WE COULD LOSE INVESTMENT CAPITAL AND ANTICIPATED
PROFITS.

We have purchased general liability insurance (lessor's risk) that provides
coverage for bodily injury and property damage to third parties resulting from
our ownership of the healthcare facilities that are leased to and occupied by
our tenants. Our leases require our tenants to carry general liability,
professional liability, loss of earnings, all risk, and extended coverage
insurance in amounts sufficient to permit the replacement of the facility in the
event of a total loss, subject to applicable deductibles. However, there are
certain types of losses, generally of a catastrophic nature, such as
earthquakes, floods, hurricanes and acts of terrorism, that may be uninsurable
or not insurable at a price we or our tenants can afford. Inflation, changes in
building codes and ordinances, environmental considerations and other factors
also might make it impracticable to use insurance proceeds to replace a facility
after it has been damaged or destroyed. Under such circumstances, the insurance
proceeds we receive might not be adequate to restore our economic position with
respect to the affected facility. If any of these or similar events occur, it
may reduce our return from the facility and the value of our investment.

CAPITAL EXPENDITURES FOR FACILITY RENOVATION MAY BE GREATER THAN ANTICIPATED AND
MAY ADVERSELY IMPACT RENT PAYMENTS BY OUR TENANTS AND OUR ABILITY TO MAKE
DISTRIBUTIONS TO STOCKHOLDERS.

Facilities, particularly those that consist of older structures, have an
ongoing need for renovations and other capital improvements, including periodic
replacement of furniture, fixtures and equipment. Although our leases require
our tenants to be primarily responsible for the cost of such expenditures,
renovation of facilities involves certain risks, including the possibility of
environmental problems, construction cost overruns and delays, uncertainties as
to market demand or deterioration in market demand after commencement of
renovation and the emergence of unanticipated competition from other facilities.
All of these factors could adversely impact rent and loan payments by our
tenants, could have a material adverse effect on our financial condition and
results of operations and could adversely effect our ability to make
distributions to our stockholders.

ALL OF OUR HEALTHCARE FACILITIES ARE SUBJECT TO PROPERTY TAXES THAT MAY INCREASE
IN THE FUTURE AND ADVERSELY AFFECT OUR BUSINESS.

Our facilities are subject to real and personal property taxes that may
increase as property tax rates change and as the facilities are assessed or
reassessed by taxing authorities. Our leases generally provide that the property
taxes are charged to our tenants as an expense related to the facilities that
they occupy. As the owner of the facilities, however, we are ultimately
responsible for payment of the taxes to the government. If property taxes
increase, our tenants may be unable to make the required tax payments,
ultimately requiring us to pay the taxes. If we incur these tax liabilities, our
ability to make expected distributions to our stockholders could be adversely
affected.

OUR PERFORMANCE AND THE PRICE OF OUR COMMON STOCK WILL BE AFFECTED BY RISKS
ASSOCIATED WITH THE REAL ESTATE INDUSTRY.

Factors that may adversely affect the economic performance and price of our
common stock include:

- changes in the national, regional and local economic climate, including
but not limited to changes in interest rates;

- local conditions such as an oversupply of, or a reduction in demand for,
rehabilitation hospitals, long-term acute care hospitals, ambulatory
surgery centers, medical office buildings, specialty hospitals and
treatment centers;

- attractiveness of our facilities to healthcare providers and other types
of tenants; and

- competition from other rehabilitation hospitals, long-term acute care
facilities, medical office buildings, outpatient treatment facilities,
ambulatory surgery centers and specialty hospitals and treatment centers.

AS THE OWNER AND LESSOR OF REAL ESTATE, WE ARE SUBJECT TO RISKS UNDER
ENVIRONMENTAL LAWS, THE COST OF COMPLIANCE WITH WHICH AND ANY VIOLATION OF WHICH
COULD MATERIALLY ADVERSELY AFFECT US.

Our operating expenses could be higher than anticipated due to the cost of
complying with existing and future environmental and occupational health and
safety laws and regulations. Various environmental laws may impose liability on
a current or prior owner or operator of real property for removal or remediation
of hazardous or toxic substances. Current or prior owners or operators may also
be liable for government fines and damages for injuries to persons, natural
resources and adjacent property. These environmental laws often impose liability
whether or not the owner or operator knew of, or was responsible for, the
presence or disposal of the hazardous or toxic substances. The cost of complying
with environmental laws could materially adversely affect amounts available for
distribution to our stockholders and could exceed the value of all of our
facilities. In addition, the presence of hazardous or toxic substances, or the
failure of our tenants to properly dispose of or remediate such substances,
including medical waste generated by physicians and our other healthcare
tenants, may adversely affect our tenants or our ability to use, sell or rent
such property or to borrow using such property as collateral which, in turn,
could reduce our revenue and our financing ability. We have obtained on all
facilities we have acquired and are developing and intend to obtain on all
future facilities we acquire Phase I environmental assessments. However, even if
the Phase I environmental assessment reports do not reveal any material
environmental contamination, it is possible that material environmental
liabilities may exist of which we are unaware.

In April 2003, Stealth, which then owned the property on which the West
Houston Facilities are being constructed, arranged for a Phase I environmental
assessment to be performed. The assessor recommended further investigation based
on field screening of soil samples collected during a geotechnical
investigation. Accordingly, the tenant arranged for a Phase II environmental
soil sampling to be performed in June 2003 to assess shallow soils for the
presence of petroleum hydrocarbons and volatile organic compounds. Based on the
findings of this sampling, the tenant was advised that no further tests were
warranted and that the property was suitable for the proposed development.

In April 2005, we arranged for a Phase I environmental assessment to be
performed at the Denham Springs, Louisiana property. The assessor recommended
further soil and groundwater sampling due to the property's previous use as a
hospital that involved X-ray and photochemical developing activities.
Accordingly, we arranged for a Phase II environmental soil and groundwater
sampling. On May 19, 2005, we received a Phase II report which concluded that
one groundwater sample was at or exceeded Louisiana Department of Environmental
Quality (LDEQ) Numerical Acute and Chronic Criteria standards for several
metals. Concentrations of metals in the soil samples were either below
quantification limits or below LDEQ regulatory guidelines. Based on this
sampling, we were advised to present the findings to LDEQ for review and
determination. We were also advised that additional action or investigation may
be required by the agency. We cannot predict the action, if any, that may be
taken by state or federal

regulatory enforcement agencies with respect to these findings or the exposure
to us for costs of clean-up or fines.

Although the leases for our facilities generally require our tenants to
comply with laws and regulations governing their operations, including the
disposal of medical waste, and to indemnify us for certain environmental
liabilities, the scope of their obligations may be limited. We cannot assure you
that our tenants would be able to fulfill their indemnification obligations and,
therefore, any violation of environmental laws could have a material adverse
affect on us. In addition, environmental and occupational health and safety laws
constantly are evolving, and changes in laws, regulations or policies, or
changes in interpretations of the foregoing, could create liabilities where none
exists today.

COSTS ASSOCIATED WITH COMPLYING WITH THE AMERICANS WITH DISABILITIES ACT OF 1993
MAY ADVERSELY AFFECT OUR FINANCIAL CONDITION AND OPERATING RESULTS.

Under the Americans with Disabilities Act of 1993, all public
accommodations are required to meet certain federal requirements related to
access and use by disabled persons. While our facilities are generally in
compliance with these requirements, a determination that we are not in
compliance with the Americans with Disabilities Act of 1993 could result in
imposition of fines or an award of damages to private litigants. In addition,
changes in governmental rules and regulations or enforcement policies affecting
the use and operation of the facilities, including changes to building codes and
fire and life-safety codes, may occur. If we are required to make substantial
modifications at our facilities to comply with the Americans with Disabilities
Act of 1993 or other changes in governmental rules and regulations, this may
have a material adverse effect on our financial condition and results of
operations and could adversely affect our ability to make distributions to our
stockholders.

OUR FACILITIES MAY CONTAIN OR DEVELOP HARMFUL MOLD OR SUFFER FROM OTHER AIR
QUALITY ISSUES, WHICH COULD LEAD TO LIABILITY FOR ADVERSE HEALTH EFFECTS AND
COSTS OF REMEDIATING THE PROBLEM.

When excessive moisture accumulates in buildings or on building materials,
mold growth may occur, particularly if the moisture problem remains undiscovered
or is not addressed over a period of time. Some molds may produce airborne
toxins or irritants. Indoor air quality issues can also stem from inadequate
ventilation, chemical contamination from indoor or outdoor sources and other
biological contaminants such as pollen, viruses and bacteria. Indoor exposure to
airborne toxins or irritants above certain levels can be alleged to cause a
variety of adverse health effects and symptoms, including allergic or other
reactions. As a result, the presence of significant mold or other airborne
contaminants at any of our facilities could require us to undertake a costly
remediation program to contain or remove the mold or other airborne contaminants
from the affected facilities or increase indoor ventilation. In addition, the
presence of significant mold or other airborne contaminants could expose us to
liability from our tenants, employees of our tenants and others if property
damage or health concerns arise.

OUR INTERESTS IN FACILITIES THROUGH GROUND LEASES EXPOSE US TO THE LOSS OF THE
FACILITY UPON BREACH OR TERMINATION OF THE GROUND LEASE AND MAY LIMIT OUR USE OF
THE FACILITY.

We have acquired our interest in one of our facilities by acquiring a
leasehold interest in the land on which the facility is located rather than an
ownership interest in the facility, and we may acquire additional facilities in
the future through ground leases. As lessee under ground leases, we are exposed
to the possibility of losing the property upon termination, or an earlier breach
by us, of the ground lease. Ground leases may also restrict our use of
facilities. Our current ground lease in Marlton, New Jersey limits our use of
the property to operation of a 76 bed rehabilitation hospital. This restriction
and any similar future restrictions in ground leases will limit our flexibility
in renting the facility and may impede our ability to sell the property.

RISKS RELATING TO THE HEALTHCARE INDUSTRY

REDUCTIONS IN REIMBURSEMENT FROM THIRD-PARTY PAYORS, INCLUDING MEDICARE AND
MEDICAID, COULD ADVERSELY AFFECT THE PROFITABILITY OF OUR TENANTS AND HINDER
THEIR ABILITY TO MAKE RENT PAYMENTS TO US.

Sources of revenue for our tenants and operators may include the federal
Medicare program, state Medicaid programs, private insurance carriers and health
maintenance organizations, among others. Efforts by such payors to reduce
healthcare costs will likely continue, which may result in reductions or slower
growth in reimbursement for certain services provided by some of our tenants. In
addition, the failure of any of our tenants to comply with various laws and
regulations could jeopardize their ability to continue participating in
Medicare, Medicaid and other government-sponsored payment programs.

The healthcare industry continues to face various challenges, including
increased government and private payor pressure on healthcare providers to
control or reduce costs. We believe that our tenants will continue to experience
a shift in payor mix away from fee-for-service payors, resulting in an increase
in the percentage of revenues attributable to managed care payors, government
payors and general industry trends that include pressures to control healthcare
costs. Pressures to control healthcare costs and a shift away from traditional
health insurance reimbursement have resulted in an increase in the number of
patients whose healthcare coverage is provided under managed care plans, such as
health maintenance organizations and preferred provider organizations. In
addition, due to the aging of the population and the expansion of governmental
payor programs, we anticipate that there will be a marked increase in the number
of patients reliant on healthcare coverage provided by governmental payors.
These changes could have a material adverse effect on the financial condition of
some or all of our tenants, which could have a material adverse effect on our
financial condition and results of operations and could negatively affect our
ability to make distributions to our stockholders.

THE HEALTHCARE INDUSTRY IS HEAVILY REGULATED AND EXISTING AND NEW LAWS OR
REGULATIONS, CHANGES TO EXISTING LAWS OR REGULATIONS, LOSS OF LICENSURE OR
CERTIFICATION OR FAILURE TO OBTAIN LICENSURE OR CERTIFICATION COULD RESULT IN
THE INABILITY OF OUR TENANTS TO MAKE LEASE PAYMENTS TO US.

The healthcare industry is highly regulated by federal, state and local
laws, and is directly affected by federal conditions of participation, state
licensing requirements, facility inspections, state and federal reimbursement
policies, regulations concerning capital and other expenditures, certification
requirements and other such laws, regulations and rules. In addition,
establishment of healthcare facilities and transfers of operations of healthcare
facilities are subject to regulatory approvals not required for establishment of
or transfers of other types of commercial operations and real estate. Sanctions
for failure to comply with these regulations and laws include, but are not
limited to, loss of or inability to obtain licensure, fines and loss of or
inability to obtain certification to participate in the Medicare and Medicaid
programs, as well as potential criminal penalties. The failure of any tenant to
comply with such laws, requirements and regulations could affect its ability to
establish or continue its operation of the facility or facilities and could
adversely affect the tenant's ability to make lease payments to us which could
have a material adverse effect on our financial condition and results of
operations and could negatively affect our ability to make distributions to our
stockholders. In addition, restrictions and delays in transferring the
operations of healthcare facilities, in obtaining new third-party payor
contracts including Medicare and Medicaid provider agreements, and in receiving
licensure and certification approval from appropriate state and federal agencies
by new tenants may affect our ability to terminate lease agreements, remove
tenants that violate lease terms, and replace existing tenants with new tenants.
Furthermore, these matters may affect new tenants ability to obtain
reimbursement for services rendered, which could adversely affect their ability
to pay rent to us and to pay principal and interest on their loans from us.

ADVERSE TRENDS IN HEALTHCARE PROVIDER OPERATIONS MAY NEGATIVELY AFFECT OUR LEASE
REVENUES AND OUR ABILITY TO MAKE DISTRIBUTIONS TO OUR STOCKHOLDERS.

We believe that the healthcare industry is currently experiencing:

- changes in the demand for and methods of delivering healthcare services;

- changes in third-party reimbursement policies;
28

- significant unused capacity in certain areas, which has created
substantial competition for patients among healthcare providers in those
areas;

- continuing pressure by private and governmental payors to reduce payments
to providers of services; and

- increased scrutiny by federal and state authorities of billing, referral
and other practices.

These factors may adversely affect the economic performance of some or all
of our tenants and, in turn, our revenues. Accordingly, these factors could have
a material adverse effect on our financial condition and results of operations
and could negatively affect our ability to make distributions to our
stockholders.

OUR TENANTS ARE SUBJECT TO FRAUD AND ABUSE LAWS, THE VIOLATION OF WHICH BY A
TENANT MAY JEOPARDIZE THE TENANT'S ABILITY TO MAKE LEASE AND LOAN PAYMENTS TO
US.

The federal government and numerous state governments have passed laws and
regulations that attempt to eliminate healthcare fraud and abuse by prohibiting
business arrangements that induce patient referrals or the ordering of specific
ancillary services. In addition, the Balanced Budget Act of 1997 strengthened
the federal anti-fraud and abuse laws to provide for stiffer penalties for
violations. Violations of these laws may result in the imposition of criminal
and civil penalties, including possible exclusion from federal and state
healthcare programs. Imposition of any of these penalties upon any of our
tenants could jeopardize any tenant's ability to operate a facility or to make
lease and loan payments, thereby potentially adversely affecting us.

In the past several years, federal and state governments have significantly
increased investigation and enforcement activity to detect and eliminate fraud
and abuse in the Medicare and Medicaid programs. In addition, legislation has
been adopted at both state and federal levels which severely restricts the
ability of physicians to refer patients to entities in which they have a
financial interest. It is anticipated that the trend toward increased
investigation and enforcement activity in the area of fraud and abuse, as well
as self-referrals, will continue in future years and could adversely affect our
prospective tenants and their operations, and in turn their ability to make
lease and loan payments to us.

We cannot assure you that we will meet all the conditions for the safe
harbor for space rental in structuring lease arrangements involving facilities
in which local physicians are investors and tenants, and it is unlikely that we
will meet all conditions for the safe harbor in those instances in which
percentage rent is contemplated and we have physician investors. In addition,
federal regulations require that our tenants with purchase options pay fair
market value purchase prices for facilities in which we have physician
investment. We cannot assure you that all of our purchase options will be at
fair market value. Any purchase not at fair market value may present risks of
challenge from healthcare regulatory authorities.

Vibra has accepted, and prospective tenants may accept, an assignment of
the previous operator's Medicare provider agreement. Vibra and other
new-operator tenants that take assignment of Medicare provider agreements might
be subject to federal or state regulatory, civil and criminal investigations of
the previous owner's operations and claims submissions. While we conduct due
diligence in connection with the acquisition of such facilities, these types of
issues may not be discovered prior to purchase. Adverse decisions, fines or
recoupments might negatively impact our tenants' financial condition.

CERTAIN OF OUR LEASE ARRANGEMENTS MAY BE SUBJECT TO FRAUD AND ABUSE OR PHYSICIAN
SELF-REFERRAL LAWS.

Local physician investment in our operating partnership or our subsidiaries
that own our facilities could subject our lease arrangements to scrutiny under
fraud and abuse and physician self-referral laws. Under the federal Ethics in
Patient Referrals Act of 1989, or Stark Law, and regulations adopted thereunder,
if our lease arrangements do not satisfy the requirements of an applicable
exception, that noncompliance could adversely affect the ability of our tenants
to bill for services provided to Medicare beneficiaries pursuant to referrals
from physician investors and subject us and our tenants to fines, which could
impact their ability to make lease and loan payments to us. On March 26, 2004
CMS issued Phase II final rules under the Stark Law, which, together with the
2001 Phase I final rules, set forth CMS' current interpretation and application
of the Stark Law prohibition on referrals of designated health
29

services, or DHS. These rules provide us additional guidance on application of
the Stark Law through the implementation of "bright-line" tests, including
additional regulations regarding the indirect compensation exception, but do not
eliminate the risk that our lease arrangements and business strategy of
physician investment may violate the Stark Law. Finally, the Phase II rules
implemented an 18-month moratorium on physician investment in specialty
hospitals imposed by the Medicare Prescription Drug, Improvement and
Modernization Act. We intend to use our good faith efforts to structure our
lease arrangements to comply with these laws; however, if we are unable to do
so, this failure may restrict our ability to permit physician investment or,
where such physicians do participate, may restrict the types of lease
arrangements into which we may enter, including our ability to enter into
percentage rent arrangements.

STATE CERTIFICATE OF NEED LAWS MAY ADVERSELY AFFECT OUR DEVELOPMENT OF
FACILITIES AND THE OPERATIONS OF OUR TENANTS.

Certain healthcare facilities in which we invest may also be subject to
state laws which require regulatory approval in the form of a certificate of
need prior to initiation of certain projects, including, but not limited to, the
establishment of new or replacement facilities, the addition of beds, the
addition or expansion of services and certain capital expenditures. State
certificate of need laws are not uniform throughout the United States and are
subject to change. We cannot predict the impact of state certificate of need
laws on our development of facilities or the operations of our tenants.

In addition, certificate of need laws often materially impact the ability
of competitors to enter into the marketplace of our facilities. Finally, in
limited circumstances, loss of state licensure or certification or closure of a
facility could ultimately result in loss of authority to operate the facility
and require re-licensure or new certificate of need authorization to
re-institute operations. As a result, a portion of the value of the facility may
be related to the limitation on new competitors. In the event of a change in the
certificate of need laws, this value may markedly decrease.

RISKS RELATING TO OUR ORGANIZATION AND STRUCTURE

PROVISIONS OF MARYLAND LAW, OUR CHARTER AND OUR BYLAWS MAY PREVENT OR DETER
CHANGES IN MANAGEMENT AND THIRD-PARTY ACQUISITION PROPOSALS THAT YOU MAY BELIEVE
TO BE IN YOUR BEST INTEREST, DEPRESS OUR STOCK PRICE OR CAUSE DILUTION.

Our charter contains ownership limitations that may restrict business
combination opportunities, inhibit change of control transactions and reduce the
value of our stock. To qualify as a REIT under the Code, no more than 50% in
value of our outstanding stock, after taking into account options to acquire
stock, may be owned, directly or indirectly, by five or fewer persons during the
last half of each taxable year, other than our first REIT taxable year. Our
charter generally prohibits direct or indirect ownership by any person of more
than 9.8% in value or in number, whichever is more restrictive, of outstanding
shares of any class or series of our securities, including our common stock.
Generally, common stock owned by affiliated owners will be aggregated for
purposes of the ownership limitation. Any transfer of our common stock that
would violate the ownership limitation will be null and void, and the intended
transferee will acquire no rights in such stock. Instead, such common stock will
be designated as "shares-in-trust" and transferred automatically to a trust
effective on the day before the purported transfer of such stock. The
beneficiary of that trust will be one or more charitable organizations named by
us. The ownership limitation could have the effect of delaying, deterring or
preventing a change in control or other transaction in which holders of common
stock might receive a premium for their common stock over the then-current
market price or which such holders otherwise might believe to be in their best
interests. The ownership limitation provisions also may make our common stock an
unsuitable investment vehicle for any person seeking to obtain, either alone or
with others as a group, ownership of more than 9.8% of either the value or
number of the outstanding shares of our common stock. Our board of directors, in
its sole discretion, may waive or modify, subject to limitations, the ownership
limit with respect to one or more stockholders if it is satisfied that ownership
in excess of their limit will not jeopardize our status as a REIT. See
"Description of Capital Stock -- Restrictions on Ownership and Transfer."

Certain provisions of Maryland law may limit the ability of a third party
to acquire control of our company. Certain provisions of the Maryland General
Corporation Law, or the MGCL, could have the effect of inhibiting a third party
from making a proposal to acquire us or of impeding a change of control under
circumstances that otherwise could provide the holders of shares of our common
stock with the opportunity to realize a premium over the then-prevailing market
price of such shares, including:

- "business combination" provisions that, subject to limitations, prohibit
certain business combinations between us and an "interested stockholder"
(defined generally as a person who beneficially owns 10% or more of the
voting power of our shares or an affiliate thereof) for five years after
the most recent date on which the stockholder becomes an interested
stockholder, and thereafter imposes special appraisal rights and special
stockholder voting requirements on these combinations; and

- "control share" provisions that provide that "control shares" of our
company (defined as shares which, when aggregated with other shares
controlled by the stockholder, entitle the stockholder to exercise one of
three increasing ranges of voting power in electing directors) acquired
in a "control share acquisition" (defined as the direct or indirect
acquisition of ownership or control of "control shares") have no voting
rights except to the extent approved by our stockholders by the
affirmative vote of the holders of at least two-thirds of all the votes
entitled to be cast on the matter, excluding all interested shares.

We have opted out of these provisions of the MGCL pursuant to provisions in
our charter. However, we may, by amendment to our charter with approval of our
stockholders, opt in to the business combination and control share provisions of
the MGCL in the future.

Additionally, Title 8, Subtitle 3 of the MGCL permits our board of
directors, without stockholder approval and regardless of what is currently
provided in our charter and our amended and restated bylaws, or bylaws, to
implement takeover defenses, some of which (for example, a classified board) we
do not presently have. These provisions may have the effect of inhibiting a
third party from making an acquisition proposal for our company or of delaying,
deferring or preventing a change of control of our company under circumstances
that otherwise could provide the holders of our common stock with the
opportunity to realize a premium over the then-current market price of our
common stock.

Maryland law does not impose heightened standards on directors in takeover
situations. The MGCL provides that an act of a director relating to or affecting
an acquisition or potential acquisition of control of a corporation may not be
subject to a higher duty or greater scrutiny than is applied to any other act of
a director. Therefore, directors of a Maryland corporation are not required to
act in the same manner as directors of a Delaware corporation in takeover
situations.

Our charter and bylaws contain provisions that may impede third-party
acquisition proposals that may be in your best interests. Our charter and
bylaws also provide that our directors may only be removed by the affirmative
vote of the holders of two-thirds of our stock, that stockholders are required
to give us advance notice of director nominations and new business to be
conducted at our annual meetings of stockholders and that special meetings of
stockholders can only be called by our president, our board of directors or the
holders of at least 25% of stock entitled to vote at the meetings. These and
other charter and bylaw provisions may delay or prevent a change of control or
other transaction in which holders of our common stock might receive a premium
for their common stock over the then-current market price or which such holders
otherwise might believe to be in their best interests.

Our board of directors may issue additional shares that may cause dilution
and could deter change of control transactions that you may believe to be in
your best interest. Our charter authorizes our board, without stockholder
approval, to:

- issue up to 10,000,000 shares of preferred stock, having preferences,
conversion or other rights, voting powers, restrictions, limitations as
to distribution, qualifications, or terms or conditions of redemption as
determined by the board;

- amend the charter to increase or decrease the aggregate number of shares
of capital stock or the number of shares of stock of any class or series
that we have the authority to issue;
31

- cause us to issue additional authorized but unissued shares of common
stock or preferred stock; and

- classify or reclassify any unissued shares of common or preferred stock
by setting or changing in any one or more respects, from time to time
before the issuance of such shares, the preferences, conversion or other
rights and other terms of such classified or reclassified shares,
including the issuance of additional shares of common stock or preferred
stock that have preference rights over the common stock with respect to
dividends, liquidation, voting and other matters.

WE DEPEND ON KEY PERSONNEL, THE LOSS OF ANY ONE OF WHOM MAY THREATEN OUR ABILITY
TO OPERATE OUR BUSINESS SUCCESSFULLY.

We depend on the services of Edward K. Aldag, Jr., William G. McKenzie,
Emmett E. McLean, R. Steven Hamner and Michael G. Stewart to carry out our
business and investment strategy. If we were to lose any of these executive
officers, it may be more difficult for us to locate attractive acquisition
targets, complete our acquisitions and manage the facilities that we have
acquired or are developing. Additionally, as we expand, we will continue to need
to attract and retain additional qualified officers and employees. The loss of
the services of any of our executive officers, or our inability to recruit and
retain qualified personnel in the future, could have a material adverse effect
on our business and financial results.

WE MAY EXPERIENCE CONFLICTS OF INTEREST WITH OUR OFFICERS AND DIRECTORS, WHICH
COULD RESULT IN OUR OFFICERS AND DIRECTORS ACTING OTHER THAN IN OUR BEST
INTEREST.

As described below, our officers and directors may have conflicts of
interest in connection with their duties to us and the limited partners of our
operating partnership and with allocation of their time between our business and
affairs and their other business interests. In addition, from time to time, we
may acquire or develop facilities in transactions involving prospective tenants
in which our directors or officers have an interest. In transactions of this
nature, there will be conflicts between our interests and the interests of the
director or officer involved, and that director or officer may be in a position
to influence the terms of those transactions.

In the event we purchase properties from executive officers or directors in
exchange for units of limited partnership in our operating partnership, the
interests of those persons with the interests of the company may conflict. Where
a unitholder has unrealized gains associated with his limited partnership
interests in our operating partnership, these holders may incur adverse tax
consequences in the event of a sale or refinancing of those properties.
Therefore the interest of these executive officers or directors of our company
could be different from the interests of the company in connection with the
disposition or refinancing of a property. Conflicts of interest with our
officers and directors could result in our officers and directors acting other
than in our best interest.

OUR EXECUTIVE OFFICERS HAVE AGREEMENTS THAT PROVIDE THEM WITH BENEFITS IN THE
EVENT THEIR EMPLOYMENT IS TERMINATED BY US WITHOUT CAUSE, BY THE EXECUTIVE FOR
GOOD REASON, OR UNDER CERTAIN CIRCUMSTANCES FOLLOWING A CHANGE OF CONTROL
TRANSACTION THAT YOU MAY BELIEVE TO BE IN YOUR BEST INTEREST.

We have entered into agreements with certain of our executive officers that
provide them with severance benefits if their employment is terminated by us
without cause, by them for good reason (which includes, among other reasons,
failure to be elected to the board for Mr. Aldag and failure to have their
agreements automatically renewed for Messrs. Aldag, McLean, Hamner, McKenzie and
Stewart), or under certain circumstances following a change of control of our
company. Certain of these benefits and the related tax indemnity could prevent
or deter a change of control of our company that might involve a premium price
for our common stock or otherwise be in the best interests of our stockholders.

THE VICE CHAIRMAN OF OUR BOARD OF DIRECTORS, WILLIAM G. MCKENZIE, HAS OTHER
BUSINESS INTERESTS THAT MAY HINDER HIS ABILITY TO ALLOCATE SUFFICIENT TIME TO
THE MANAGEMENT OF OUR OPERATIONS, WHICH COULD JEOPARDIZE OUR ABILITY TO EXECUTE
OUR BUSINESS PLAN.

Our employment agreement with the vice chairman of our board of directors,
Mr. McKenzie, permits him to continue to own, operate and control facilities
that he owned as of the date of his employment agreement and requires that he
only provide a limited amount of his time per month to our company. In

addition, the terms of Mr. McKenzie's employment agreement permit him to compete
against us with respect to these previously owned healthcare facilities.

ALL MANAGEMENT RIGHTS ARE VESTED IN OUR BOARD OF DIRECTORS AND OUR STOCKHOLDERS
HAVE LIMITED RIGHTS.

Our board of directors is responsible for our management and strategic
business direction, and management is responsible for our day-to-day operations.
Our major policies, including our policies with respect to REIT qualification,
acquisitions and developments, leasing, financing, growth, operations, debt
limitation and distributions, are determined by our board of directors. Our
board of directors may amend or revise these and other policies from time to
time without a vote of our stockholders. Investment and operational policy
changes could adversely affect the market price of our common stock and our
ability to make distributions to our stockholders.

THE ABILITY OF OUR BOARD OF DIRECTORS TO REVOKE OUR REIT STATUS WITHOUT
STOCKHOLDER APPROVAL MAY CAUSE ADVERSE CONSEQUENCES TO OUR STOCKHOLDERS.

Our charter provides that our board of directors may revoke or otherwise
terminate our REIT election, without the approval of our stockholders, if it
determines that it is no longer in our best interest to continue to qualify as a
REIT. If we cease to be a REIT, we would become subject to federal income tax on
our taxable income and would no longer be required to distribute most of our
taxable income to our stockholders, which may have adverse consequences on total
return to our stockholders.

OUR RIGHTS AND THE RIGHTS OF OUR STOCKHOLDERS TO TAKE ACTION AGAINST OUR
DIRECTORS AND OFFICERS ARE LIMITED.

Maryland law provides that a director or officer has no liability in that
capacity if he or she performs his or her duties in good faith, in a manner he
or she reasonably believes to be in our best interests and with the care that an
ordinarily prudent person in a like position would use under similar
circumstances. In addition, our charter eliminates our directors' and officers'
liability to us and our stockholders for money damages except for liability
resulting from actual receipt of an improper benefit in money, property or
services or active and deliberate dishonesty established by a final judgment and
which is material to the cause of action. Our bylaws and indemnification
agreements require us to indemnify our directors and officers for liability
resulting from actions taken by them in those capacities to the maximum extent
permitted by Maryland law. As a result, we and our stockholders may have more
limited rights against our directors and officers than might otherwise exist
under common law. In addition, we may be obligated to fund the defense costs
incurred by our directors and officers. See "Certain Provisions of Maryland Law
and of Our Charter and Bylaws -- Indemnification and Limitation of Directors'
and Officers' Liability." Directors may be removed with or without cause by the
affirmative vote of the holders of two-thirds of the votes entitled to be cast
in the election of directors.

OUR UPREIT STRUCTURE MAY RESULT IN CONFLICTS OF INTEREST BETWEEN OUR
STOCKHOLDERS AND THE HOLDERS OF OUR OPERATING PARTNERSHIP UNITS.

We are organized as an UPREIT, which means that we hold our assets and
conduct substantially all of our operations through an operating limited
partnership, and may in the future issue limited partnership units to third
parties. Persons holding operating partnership units would have the right to
vote on certain amendments to the partnership agreement of our operating
partnership, as well as on certain other matters. Persons holding these voting
rights may exercise them in a manner that conflicts with the interests of our
stockholders. Circumstances may arise in the future, such as the sale or
refinancing of one of our facilities, when the interests of limited partners in
our operating partnership conflict with the interests of our stockholders. As
the general partner of our operating partnership, we have fiduciary duties to
the limited partners of our operating partnership that may conflict with
fiduciary duties our officers and directors owe to our stockholders. These
conflicts may result in decisions that are not in your best interest.

THROUGH WHOLLY-OWNED SUBSIDIARIES, WE ARE THE GENERAL PARTNER OF OUR OPERATING
PARTNERSHIP AND OUR OPERATING PARTNERSHIP, THROUGH WHOLLY-OWNED SUBSIDIARIES, IS
THE GENERAL PARTNER OF OTHER SUBSIDIARIES WHICH OWN OUR FACILITIES AND, SHOULD
ANY OF THESE WHOLLY-OWNED GENERAL PARTNERS BE DISREGARDED, THEN WE OR OUR
OPERATING PARTNERSHIP COULD BECOME LIABLE FOR THE DEBTS AND OTHER OBLIGATIONS OF
OUR SUBSIDIARIES BEYOND THE AMOUNT OF OUR INVESTMENT.

Through our wholly-owned subsidiary, Medical Properties Trust, LLC, we are
the sole general partner of our operating partnership, and also currently own
100% of the limited partnership interests in the operating partnership. In
addition, our operating partnership, through other wholly-owned subsidiaries, is
the general partner of other subsidiaries which own our facilities. If any of
our wholly-owned subsidiaries which act as general partner were disregarded, we
would be liable for the debts and other obligations of the subsidiaries that own
our facilities. In such event, if any of these subsidiaries were unable to pay
their debts and other obligations, we would be liable for such debts and other
obligations beyond the amount of our investment in these subsidiaries. These
obligations could include unforeseen contingent liabilities.

TAX RISKS ASSOCIATED WITH OUR STATUS AS A REIT

FAILURE TO ATTAIN OR LOSS OF OUR TAX STATUS AS A REIT WOULD HAVE SIGNIFICANT
ADVERSE CONSEQUENCES TO US AND THE VALUE OF OUR COMMON STOCK.

We expect to qualify as a REIT for federal income tax purposes and will
elect to be taxed as a REIT under the federal income tax laws commencing with
our taxable year that began on April 6, 2004 and ended on December 31, 2004. Our
qualification as a REIT will depend on our ability to meet various requirements
concerning, among other things, the ownership of our outstanding common stock,
the nature of our assets, the sources of our income and the amount of our
distributions to our stockholders. The REIT qualification requirements are
extremely complex, and interpretations of the federal income tax laws governing
qualification as a REIT are limited. Accordingly, there is no assurance that we
will be successful in operating so as to qualify as a REIT. At any time, new
laws, regulations, interpretations or court decisions may change the federal tax
laws relating to, or the federal income tax consequences of, qualification as a
REIT. It is possible that future economic, market, legal, tax or other
considerations may cause our board of directors to revoke the REIT election,
which it may do without stockholder approval.

If we fail to achieve, lose or revoke our REIT status, we will face serious
tax consequences that will substantially reduce the funds available for
distribution because:

- we would not be allowed a deduction for distributions to stockholders in
computing our taxable income; therefore we would be subject to federal
income tax at regular corporate rates and we might need to borrow money
or sell assets in order to pay any such tax;

- we also could be subject to the federal alternative minimum tax and
possibly increased state and local taxes; and

- unless we are entitled to relief under statutory provisions, we also
would be disqualified from taxation as a REIT for the four taxable years
following the year during which we ceased to qualify.

As a result of all these factors, a failure to achieve or a loss or
revocation of our REIT status could have a material adverse effect on our
financial condition and results of operations and would adversely affect the
value of our common stock.

FAILURE TO MAKE REQUIRED DISTRIBUTIONS WOULD SUBJECT US TO TAX.

In order to qualify as a REIT, each year we must distribute to our
stockholders at least 90% of our REIT taxable income, excluding net capital
gain. To the extent that we satisfy the distribution requirement, but distribute
less than 100% of our taxable income, we will be subject to federal corporate
income tax on our undistributed income. In addition, we will incur a 4%
nondeductible excise tax on the amount, if any, by which our distributions in
any year are less than the sum of:

- 85% of our ordinary income for that year;

- 95% of our capital gain net income for that year; and

- 100% of our undistributed taxable income from prior years.

We intend to pay out our income to our stockholders in a manner that
satisfies the distribution requirement and avoids corporate income tax and the
4% excise tax. We may be required to make distributions to stockholders at
disadvantageous times or when we do not have funds readily available for
distribution. Differences in timing between the recognition of income and the
related cash receipts or the effect of required debt amortization payments could
require us to borrow money or sell assets to pay out enough of our taxable
income to satisfy the distribution requirement and to avoid corporate income tax
and the 4% excise tax in a particular year. In the future, we may borrow to pay
distributions to our stockholders and the limited partners of our operating
partnership. Any funds that we borrow would subject us to interest rate and
other market risks.

WE WILL PAY SOME TAXES AND THEREFORE MAY HAVE LESS CASH AVAILABLE FOR
DISTRIBUTION TO OUR STOCKHOLDERS.

Even if we qualify as a REIT for U.S. federal income tax purposes, we will
be required to pay some U.S. federal, state and local taxes on the income from
the operations of our taxable REIT subsidiary, MPT Development Services, Inc. A
taxable REIT subsidiary is a fully taxable corporation and may be limited in its
ability to deduct interest payments made to us. In addition, we will be subject
to a 100% penalty tax on certain amounts if the economic arrangements among our
tenants, our taxable REIT subsidiary and us are not comparable to similar
arrangements among unrelated parties. To the extent that we are or our taxable
REIT subsidiary is required to pay U.S. federal, state or local taxes, we will
have less cash available for distribution to stockholders.

COMPLYING WITH REIT REQUIREMENTS MAY CAUSE US TO FOREGO OTHERWISE ATTRACTIVE
OPPORTUNITIES.

To qualify as a REIT for federal income tax purposes, we must continually
satisfy tests concerning, among other things, the sources of our income, the
nature and diversification of our assets, the amounts we distribute to our
stockholders and the ownership of our stock. In order to meet these tests, we
may be required to forego attractive business or investment opportunities.
Overall, no more than 20% of the value of our assets may consist of securities
of one or more taxable REIT subsidiaries, and no more than 25% of the value of
our assets may consist of securities that are not qualifying assets under the
test requiring that 75% of a REIT's assets consist of real estate and other
related assets. Further, a taxable REIT subsidiary may not directly or
indirectly operate or manage a healthcare facility. For purposes of this
definition a "healthcare facility" means a hospital, nursing facility, assisted
living facility, congregate care facility, qualified continuing care facility,
or other licensed facility which extends medical or nursing or ancillary
services to patients and which is operated by a service provider that is
eligible for participation in the Medicare program under Title XVIII of the
Social Security Act with respect to the facility. Thus, compliance with the REIT
requirements may limit our flexibility in executing our business plan.

OUR LOAN TO VIBRA COULD BE RECHARACTERIZED AS EQUITY, IN WHICH CASE OUR RENTAL
INCOME FROM VIBRA WOULD NOT BE QUALIFYING INCOME UNDER THE REIT RULES AND WE
COULD LOSE OUR REIT STATUS.

In connection with the acquisition of the Vibra Facilities, our taxable
REIT subsidiary made a loan to Vibra in an aggregate amount of approximately
$41.4 million to acquire the operations at the Vibra Facilities. Our taxable
REIT subsidiary also made a loan of approximately $6.2 million to Vibra and its
subsidiaries for working capital purposes, which has been paid in full. The
acquisition loan bears interest at an annual rate of 10.25%. Our operating
partnership loaned the funds to our taxable REIT subsidiary to make these loans.
The loan from our operating partnership to our taxable REIT subsidiary bears
interest at an annual rate of 9.25%.

The Internal Revenue Service, or IRS, may take the position that the loans
to Vibra should be treated as equity interests in Vibra rather than debt, and
that our rental income from Vibra should not be treated as qualifying income for
purposes of the REIT gross income tests. If the IRS were to successfully treat
the loans to Vibra as equity interests in Vibra, Vibra would be a "related party
tenant" with respect to our company and the rent that we receive from Vibra
would not be qualifying income for purposes of the REIT gross income tests. As a
result, we could lose our REIT status. In addition, if the IRS were to
35

successfully treat the loans to Vibra as interests held by our operating
partnership rather than by our taxable REIT subsidiary and to treat the loans as
other than straight debt, we would fail the 10% asset test with respect to such
interests and, as a result, could lose our REIT status, which would subject us
to corporate level income tax and adversely affect our ability to make
distributions to our stockholders.

RISKS RELATING TO THIS OFFERING

THERE IS CURRENTLY NO PUBLIC MARKET FOR OUR COMMON STOCK, AND AN ACTIVE TRADING
MARKET FOR OUR COMMON STOCK MAY NEVER DEVELOP FOLLOWING THIS OFFERING.

There has not been any public market for our common stock prior to this
offering. We have applied to list our common stock on the NYSE in connection
with this offering, but even if our shares are approved for listing, an active
trading market for our common stock may never develop or be sustained. The last
trade of our common stock on The Portal(SM) Market, a subsidiary of The Nasdaq
Stock Market, Inc. which permits secondary sales of eligible securities to
qualified institutional buyers in accordance with Rule 144A under the Securities
Act, occurred on May 25, 2005 at a price of $10.05 per share, which may not be
indicative of the prices at which our shares of common stock will trade after
this offering.

THE MARKET PRICE AND TRADING VOLUME OF OUR COMMON STOCK MAY BE VOLATILE
FOLLOWING THIS OFFERING.

Even if an active trading market develops for our common stock after this
offering, the market price of our common stock may be highly volatile and be
subject to wide fluctuations. In addition, the trading volume in our common
stock may fluctuate and cause significant price variations to occur. If the
market price of our common stock declines significantly, you may be unable to
resell your shares at or above the initial public offering price.

We cannot assure you that the market price of our common stock will not
fluctuate or decline significantly in the future. Some of the factors that could
negatively affect our share price or result in fluctuations in the price or
trading volume of our common stock include:

- actual or anticipated variations in our quarterly operating results or
distributions;

- changes in our funds from operations or earnings estimates or publication
of research reports about us or the real estate industry;

- increases in market interest rates that lead purchasers of our shares of
common stock to demand a higher yield;

- changes in market valuations of similar companies;

- adverse market reaction to any increased indebtedness we incur in the
future;

- additions or departures of key management personnel;

- actions by institutional stockholders;

- speculation in the press or investment community; and

- general market and economic conditions.

BROAD MARKET FLUCTUATIONS COULD NEGATIVELY IMPACT THE MARKET PRICE OF OUR COMMON
STOCK.

In addition, the stock market has experienced extreme price and volume
fluctuations that have affected the market price of many companies in industries
similar or related to ours and that have been unrelated to these companies'
operating performances. These broad market fluctuations could reduce the market
price of our common stock. Furthermore, our operating results and prospects may
be below the expectations of public market analysts and investors or may be
lower than those of companies with comparable market capitalizations, which
could lead to a material decline in the market price of our common stock.

COMMON STOCK ELIGIBLE FOR FUTURE SALE MAY HAVE ADVERSE EFFECTS ON OUR STOCK
PRICE.

We cannot predict the effect, if any, of future sales of common stock, or
the availability of shares for future sales, on the market price of our common
stock. Sales of substantial amounts of common stock, or the perception that
these sales could occur, may adversely affect prevailing market prices for our
common stock. In addition, under a registration rights agreement, we have
granted holders of the 25,300,000 shares of our common stock issued in our April
2004 private placement the right to have their shares registered for resale
under the Securities Act. If any or all of these holders sell a large number of
securities in the public market, the sale could reduce the trading price of our
common stock and could impede our ability to raise future capital. We also may
issue from time to time additional common stock or units of our operating
partnership in connection with the acquisition of facilities and we may grant
additional demand or piggyback registration rights in connection with these
issuances. Sales of substantial amounts of common stock or the perception that
these sales could occur may adversely effect the prevailing market price for our
common stock. In addition, the sale of these shares could impair our ability to
raise capital through a sale of additional equity securities.

YOU SHOULD NOT RELY ON THE UNDERWRITERS' LOCK-UP AGREEMENTS TO LIMIT THE NUMBER
OF SHARES OF COMMON STOCK SOLD INTO THE MARKET.

All of our directors and executive officers, subject to limited exceptions,
have agreed to be bound by lock-up agreements that prohibit these holders from
selling or otherwise disposing of any of our common stock or securities
convertible into our common stock that they own or acquire for 180 days after
the date of this prospectus. In addition, the underwriters will require that all
of our stockholders other than our executive officers and directors not sell or
otherwise dispose of any of the shares of our common stock or securities
convertible into our common stock that they have acquired prior to the date of
this prospectus and are not selling in this offering until 60 days after the
date of this prospectus, subject to limited exceptions. Friedman, Billings,
Ramsey & Co., Inc., on behalf of the underwriters, may, in its discretion,
release all or any portion of the common stock subject to the lock-up agreements
with our directors and executive officers, at any time and without notice or
stockholder approval, in which case our other stockholders would also be
released from the restrictions under the registration rights agreement. There
are no present agreements between the underwriters and us or any of our
executive officers, directors or stockholders releasing them or us from these
lock-up agreements. However, we cannot predict the circumstances or timing under
which Friedman, Billings, Ramsey & Co., Inc. may waive these restrictions.

If the restrictions under the lock-up agreements and the registration
rights agreement are waived or terminated, up to approximately shares
of common stock will be available for sale into the market, subject only to
applicable securities rules and regulations, which could reduce the market price
for our common stock.

AN INCREASE IN MARKET INTEREST RATES MAY HAVE AN ADVERSE EFFECT ON THE MARKET
PRICE OF OUR SECURITIES.

One of the factors that investors may consider in deciding whether to buy
or sell our securities is our distribution rate as a percentage of our price per
share of common stock, relative to market interest rates. If market interest
rates increase, prospective investors may desire a higher distribution or
interest rate on our securities or seek securities paying higher distributions
or interest. The market price of our common stock likely will be based primarily
on the earnings that we derive from rental income with respect to our facilities
and our related distributions to stockholders, and not from the underlying
appraised value of the facilities themselves. As a result, interest rate
fluctuations and capital market conditions can affect the market price of our
common stock. In addition, rising interest rates would result in increased
interest expense on our variable-rate debt, thereby adversely affecting cash
flow and our ability to service our indebtedness and make distributions.

IF YOU PURCHASE COMMON STOCK IN THIS OFFERING, YOU WILL EXPERIENCE IMMEDIATE
DILUTION.

We expect the initial public offering price of our common stock to be
higher than the book value per share of our outstanding common stock. Assuming
that the common stock sold in this offering is sold at $11.00 per share, if you
purchase common stock in this offering, you will experience immediate dilution
of

approximately $2.04 in net tangible book value per share. This means that
investors who purchase our common stock in this offering:

- will likely pay a price per share that exceeds the book value of our
assets after subtracting our liabilities; and

- will have contributed, in the aggregate, approximately 32.9% of our
funding since inception but will own only 30.1% of our fully diluted
equity interests.

OUR ENGAGEMENT AGREEMENT WITH FRIEDMAN, BILLINGS, RAMSEY & CO., INC. MAY
PRECLUDE US FROM ENGAGING INVESTMENT BANKING FIRMS OTHER THAN FRIEDMAN,
BILLINGS, RAMSEY & CO., INC. UNTIL APRIL 7, 2006 FOR FUTURE FINANCING AND OTHER
STRATEGIC TRANSACTIONS, AND FRIEDMAN, BILLINGS, RAMSEY & CO., INC. HAS INTERESTS
IN THIS OFFERING OTHER THAN UNDERWRITING DISCOUNTS AND COMMISSIONS.

Friedman, Billings, Ramsey & Co., Inc. has an interest in the successful
completion of this offering beyond the underwriting discounts and commissions it
will receive. Friedman, Billings, Ramsey Group, Inc., an affiliate of Friedman,
Billings, Ramsey & Co., Inc., is currently our largest stockholder, owning
approximately 10.9% of our common stock outstanding prior to completion of this
offering. In addition, on November 13, 2003, we entered into an engagement
letter agreement with Friedman, Billings, Ramsey & Co., Inc. The engagement
letter gives Friedman, Billings, Ramsey & Co., Inc., the right to serve in the
following capacities until April 7, 2006:

- as our financial advisor with respect to any future mergers, acquisitions
or other business combinations;

- as the sole book running and lead underwriter or sole placement agent in
connection with any public or private offering of equity or any public
offering of debt securities; and

- as our agent in connection with the exercise of our warrants or options,
other than warrants or options held by management or by Friedman,
Billings, Ramsey & Co., Inc.

Our engagement letter with Friedman, Billings, Ramsey & Co., Inc. may
preclude us until April 7, 2006 from using competing investment banks or
financial advisors for many financial and strategic transactions. Accordingly,
in planning and completing some transactions, including public offerings of our
stock, we may not be able to utilize the services of competitors of Friedman,
Billings, Ramsey & Co., Inc. and thereby obtain pricing, distribution and other
benefits that we otherwise could and we may be dependent on the ability of
Friedman, Billings, Ramsey & Co., Inc. to execute certain financing and other
strategic transactions on our behalf. As a result of Friedman, Billings, Ramsey
Group, Inc.'s position as a large holder of our common stock, Friedman, Billings
Ramsey & Co., Inc. will have an interest in the successful completion of this
offering beyond underwriting discounts and commissions it will receive. Although
not required under the Conduct Rules of the National Association of Securities
Dealers, Inc., this offering is being made using a "qualified independent
underwriter" as contemplated by Rule 2720(b)(15) of the Conduct Rules of the
National Association of Securities Dealers, Inc. J.P. Morgan Securities Inc. has
assumed the responsibilities of acting as a qualified independent underwriter.
In this role, J.P. Morgan Securities Inc. performed a due diligence
investigation of us and participated in the preparation of this prospectus and
the registration statement of which this prospectus is a part. The initial
public offering price of the shares of common stock will be no higher than the
price recommended by J.P. Morgan Securities Inc.

A WARNING ABOUT FORWARD LOOKING STATEMENTS

We make forward-looking statements in this prospectus that are subject to
risks and uncertainties. These forward-looking statements include information
about possible or assumed future results of our business, financial condition,
liquidity, results of operations, plans and objectives. Statements regarding the
following subjects, among others, are forward-looking by their nature:

- our business strategy;

- our projected operating results;

- our ability to acquire or develop net-leased facilities;

- availability of suitable facilities to acquire or develop;

- our ability to enter into, and the terms of, our prospective leases;

- our ability to use effectively the proceeds of this offering;

- our ability to obtain future financing arrangements;

- estimates relating to, and our ability to pay, future distributions;

- our ability to compete in the marketplace;

- market trends;

- projected capital expenditures; and

- the impact of technology on our facilities, operations and business.

The forward-looking statements are based on our beliefs, assumptions and
expectations of our future performance, taking into account all information
currently available to us. These beliefs, assumptions and expectations can
change as a result of many possible events or factors, not all of which are
known to us. If a change occurs, our business, financial condition, liquidity
and results of operations may vary materially from those expressed in our
forward-looking statements. You should carefully consider these risks before you
make an investment decision with respect to our common stock, along with, among
others, the following factors that could cause actual results to vary from our
forward-looking statements:

- the factors referenced in this prospectus, including those set forth
under the sections captioned "Risk Factors," "Management's Discussion and
Analysis of Financial Condition and Results of Operations;" "Our
Business" and "Our Portfolio;"

- general volatility of the capital markets and the market price of our
common stock;

- changes in our business strategy;

- changes in healthcare laws and regulations;

- availability, terms and development of capital;

- availability of qualified personnel;

- changes in our industry, interest rates or the general economy; and

- the degree and nature of our competition.

When we use the words "believe," "expect," "may," "potential,"
"anticipate," "estimate," "plan," "will," "could," "intend" or similar
expressions, we are identifying forward-looking statements. You should not place
undue reliance on these forward-looking statements. We are not obligated to
publicly update or revise any forward-looking statements, whether as a result of
new information, future events or otherwise.

The safe harbor protections provided by the Private Securities Litigation
Reform Act of 1995 and Section 27A of the Securities Act do not apply to the
forward-looking statements contained in this prospectus.
39

USE OF PROCEEDS

We expect to receive net proceeds from the sale of the shares of common
stock offered by this prospectus, after deducting the underwriting discount and
estimated offering expenses payable by us, of approximately $115.0. If the
underwriters exercise their over-allotment option in full, we expect to receive
net proceeds of approximately $132.3 million. We expect to use the net proceeds
as follows:

- approximately $51.0 million to fund the development of a community
hospital in Houston, Texas that we have under letter of commitment;

- approximately $38.0 million to fund the development of a women's
hospital and integrated medical office building in Bensalem,
Pennsylvania that we have under contract;

- approximately $18.0 million to fund a portion of the development costs
of a community hospital in Bloomington, Indiana that we have under
letter of commitment; and

- approximately $8.0 million to lend to Hammond Properties pursuant to a
mortgage loan we have entered into a letter of commitment to provide.

Net proceeds of the offering that we allocate to our pending development
facilities will be applied over time according to the terms of development
agreements we expect to enter into as described in this prospectus. We cannot
assure you that we will complete these transactions on the terms described or at
all. See "Our Portfolio -- Our Pending Acquisitions and Developments" for a
discussion of the conditions with respect to these transactions. Pending these
uses, we intend to invest the net offering proceeds in interest-bearing,
short-term marketable investment grade securities or money-market accounts that
are consistent with our intention to qualify as a REIT. These investments may
include, for example, government and government agency securities, certificates
of deposit, interest-bearing bank deposits and mortgage loan participations.

CAPITALIZATION

The following table sets forth:

- our actual capitalization as of March 31, 2005; and

- our pro forma capitalization, as adjusted to give effect to the sale of
shares of common stock in this offering at an assumed public offering
price of $11.00 per share and our declaration of a distribution of $0.16
per share of common stock on May 19, 2005, which is payable on July 14,
2005.

AS OF
MARCH 31, 2005
---------------------------
PRO FORMA,
HISTORICAL AS ADJUSTED
------------ ------------

LONG TERM DEBT.............................................. $ 74,141,667 $ 74,141,667
MINORITY INTERESTS.......................................... 1,762,500 1,762,500
STOCKHOLDERS' EQUITY:
Preferred stock, $0.001 par value. 10,000,000 shares
authorized; no shares issued and outstanding........... -- --
Common stock, $0.001 par value, 100,000,000 shares
authorized; 26,082,862 shares issued and outstanding at
March 31, 2005; 37,635,862 shares issued and
outstanding, as adjusted............................... 26,083 37,636(1)
Additional paid in capital............................. 233,701,690 350,771,937
Accumulated deficit.................................... (1,233,510) (7,487,888)
------------ ------------
Total stockholders' equity........................... 232,494,263 343,321,685
------------ ------------
Total capitalization................................. $308,398,430 $419,225,852
============ ============

- ---------------

(1) Includes 106,000 shares of restricted common stock to be awarded upon
completion of this offering and 82,000 shares of restricted common stock
awarded to our employees in April 2005 under our equity incentive plan.
Excludes (i) 1,704,750 shares of common stock that may be issued by us upon
exercise of the underwriters' overallotment option; (ii) 100,000 shares of
common stock issuable upon the exercise of stock options granted to our
independent directors under our equity incentive plan, one-third of which
are vested; (iii) 35,000 shares of common stock issuable upon the exercise
of a vested warrant granted to an unaffiliated third party; (iv) 5,000
shares of common stock issuable in October 2007 and 7,500 shares of common
stock issuable in March 2008 pursuant to deferred stock units awarded under
our equity incentive plan to our independent directors and (v) 490,680
shares of common stock available for future awards under our equity
incentive plan.

DILUTION

NET TANGIBLE BOOK VALUE

As of March 31, 2005, we had a net tangible book value of approximately
$222.3 million, or approximately $8.52 per share. Net tangible book value per
share represents the amount of our total tangible assets less our total
liabilities and total minority interests, divided by the number of shares of our
common stock outstanding.

DILUTION AFTER THIS OFFERING

Dilution in net tangible book value per share represents the difference
between the amount per share paid by purchasers of common stock in this offering
and the net tangible book value per share of common stock immediately after this
offering and the application of the estimated net offering proceeds. After
giving effect to:

- the sale of the common stock offered by us under this prospectus at an
assumed initial public offering price of $11.00 per share, and our
receipt of approximately $115.0 million in net proceeds from this
offering, after deducting the underwriting discount and estimated
offering expenses payable by us;

- the issuance of 82,000 shares of restricted common stock to our employees
in April 2005;

- the issuance of 106,000 shares of restricted stock to our senior
management team upon completion of this offering;

- the issuance of 100,000 shares of common stock issuable upon the exercise
of outstanding stock options granted to our independent directors and
35,000 shares of common stock issuable upon the exercise of a warrant
granted to an unaffiliated third party; and

- the issuance of 12,500 shares of common stock underlying deferred stock
units awarded to our independent directors,

our pro forma net tangible book value as of March 31, 2005 would have been
approximately $338.6 million (includes the proceeds to be received from the
exercise of options for common stock), or $8.96 per share of common stock. This
amount represents an immediate increase in net tangible book value of $.49 per
share to existing stockholders prior to this offering and an immediate dilution
in pro forma net tangible book value of $2.04 per share to investors in this
offering. The following table illustrates this per share dilution:

Assumed initial public offering price per share............. $11.00
Net tangible book value per share as of March 31,
2005(1)................................................ 8.52
Increase in pro forma net tangible book value per share to
existing stockholders attributable to this
offering(2)............................................ .49
Decrease in pro forma net tangible book value per share to
existing stockholders attributable to the issuance of
restricted stock....................................... (.05)
Change in pro forma net tangible book value per share to
existing stockholders attributable to the exercise of
stock options, deferred stock units and warrant........ .00
-----
Pro forma net tangible book value per share after this
offering(3)............................................... 8.96
------
Dilution in pro forma net tangible book value per share to
new investors(4).......................................... $ 2.04
======

- ---------------

(1) Net tangible book value per share of common stock is determined by dividing
net tangible book value as of March 31, 2005 (net book value of the tangible
assets consisting of total assets less accrued rental income, intangible
assets, and deferred costs) by the number of shares of common stock
outstanding prior to the offering.

(2) After deducting the underwriting discount and other expenses of this
offering.

(3) Based on pro forma net tangible book value attributable to common
stockholders of approximately $338.6 million divided by the sum of
37,447,862 shares of our common stock to be outstanding, the issuance of
106,000 shares of restricted stock, the issuance of 135,000 shares of common
stock issuable upon the exercise of outstanding stock options and warrants,
the issuance of 12,500 shares of common stock underlying deferred stock
units awarded to our independent directors and the issuance of 82,000 shares
of restricted common stock awarded to our employees.

(4) Dilution is determined by subtracting (i) pro forma net tangible book value
per share of our common stock after giving effect to this offering and the
application of the net proceeds therefrom from (ii) the initial public
offering price per share paid by a new investor in this offering.

DIFFERENCES BETWEEN NEW AND EXISTING STOCKHOLDERS IN NUMBER OF SHARES AND AMOUNT
PAID

The table below summarizes, as of March 31, 2005, on the pro forma basis
discussed above but excluding options and warrants to purchase 135,000 shares of
common stock that will be outstanding upon completion of this offering, the
differences between the number of shares of common stock purchased from us, the
total consideration paid and the average price per share paid by existing
stockholders and by the new investors purchasing common stock in this offering.
The options and warrants described in the preceding sentence are exercisable at
a weighted average exercise price of $9.82 per share and will remain outstanding
upon the completion of this offering. To the extent that these outstanding
options are exercised in the future, there will be further dilution to new
investors. We used an assumed initial public offering price of $11.00 per share,
and we have not deducted estimated underwriting discounts and commissions and
estimated offering expenses in our calculations.

SHARES ISSUED TOTAL CONSIDERATION
------------------------ -------------------------------------
NUMBER PERCENTAGE AMOUNT PERCENTAGE PER SHARE
----------- ---------- ------------ ---------- ---------

Existing stockholders...... 26,082,862 70% $251,870,968 67% $ 9.56
New investors in the
offering................. 11,365,000 30% 125,015,000 33% $11.00
Total...................... 37,447,862 100% $376,885,968 100%

DISTRIBUTION POLICY

We intend to make regular quarterly distributions to our stockholders so
that we distribute each year all or substantially all of our REIT taxable
income, if any, so as to avoid paying corporate level income tax and excise tax
on our REIT income and to qualify for the tax benefits accorded to REITs under
the Code. In order to qualify as a REIT, we must distribute to our stockholders
an amount at least equal to 90% of our REIT taxable income, excluding net
capital gain. See "United States Federal Income Tax Considerations." The
distributions will be authorized by our board of directors and declared by us
based upon a number of factors, including:

- our actual results of operations;

- the rent received from our tenants;

- the ability of our tenants to meet their other obligations under their
leases and their obligations under their loans from us;

- debt service requirements;

- capital expenditure requirements for our facilities;

- our taxable income;

- the annual distribution requirement under the REIT provisions of the
Code; and

- other factors that our board of directors may deem relevant.

To the extent not inconsistent with maintaining our REIT status, we may
retain accumulated earnings of our taxable REIT subsidiaries in those
subsidiaries. Our ability to make distributions to our stockholders will depend
on our receipt of distributions from our operating partnership.

The table below is a summary of our distributions. We cannot assure you
that we will have cash available for future quarterly distributions at these
levels, or at all. See "Risk Factors."

DISTRIBUTION PER SHARE
DECLARATION DATE RECORD DATE DATE OF DISTRIBUTION OF COMMON STOCK
- ---------------- ----------- -------------------- ----------------------

SELECTED FINANCIAL INFORMATION

The following table sets forth our selected financial and operating data on
an historical and pro forma basis. Our selected historical balance sheet
information as of December 31, 2004, and the historical statement of operations
and other data for the year ended December 31, 2004, have been derived from our
historical financial statements audited by KPMG LLP, independent registered
public accounting firm, whose report with respect thereto is included elsewhere
in this prospectus. The historical balance sheet information as of March 31,
2005 and the historical statement of operations and other data for the three
months ended March 31, 2005 have been derived from our unaudited historical
balance sheet as of March 31, 2005 and from our unaudited statement of
operations for the three months ended March 31, 2005 included elsewhere in this
prospectus. The unaudited historical financial statements include all
adjustments, consisting of normal recurring adjustments, that we consider
necessary for a fair presentation of our financial condition and results of
operations as of such dates and for such periods under accounting principles
generally accepted in the U.S.

The unaudited pro forma consolidated balance sheet data as of March 31,
2005, are presented as if completion of this offering and completion of our
probable acquisitions had occurred on March 31, 2005.

The unaudited pro forma consolidated statement of operations and other data
for the three months ended March 31, 2005 are presented as if our acquisition of
the Desert Valley Facility, completion of this offering and completion of our
probable acquisitions had occurred on January 1, 2005, and our December 31, 2004
unaudited pro forma consolidated statement of operations are presented as if our
acquisition of the current portfolio of facilities (the six Vibra Facilities and
the Desert Valley Facility), our making of the Vibra loans, completion of this
offering and completion of our probable acquisitions had occurred on January 1,
2004. The pro forma information does not give effect to any of our facilities
under development or probable development transactions. The pro forma
information is not necessarily indicative of what our actual financial position
or results of operations would have been as of the dates or for the periods
indicated, nor does it purport to represent our future financial position or
results of operations.

FOR THE THREE MONTHS ENDED FOR THE YEAR ENDED
MARCH 31, 2005 DECEMBER 31, 2004
-------------------------- -------------------------
PRO FORMA HISTORICAL PRO FORMA HISTORICAL
----------- ----------- ----------- -----------

OPERATING INFORMATION:
Revenues
Rent income.............................. $ 6,669,856 $ 5,268,490 $25,101,257 $ 8,611,344
Interest income from loans............... 1,212,038 1,212,038 5,037,049 2,282,115
----------- ----------- ----------- -----------
Total revenues........................... 7,881,894 6,480,528 30,138,306 10,893,459
Operating expenses
Depreciation and amortization............ 1,130,162 842,407 4,520,645 1,478,470
General and administrative............... 1,698,249 1,698,249 5,057,284 5,057,284
Total operating expenses................. 2,880,972 2,593,217 10,350,278 7,214,601
Operating income......................... 5,000,922 3,887,311 19,788,028 3,678,858
Net other income (expense)............... (327,377) (327,377) 897,491 897,491
Net income................................. 4,673,545 3,559,934 20,685,519 4,576,349
Net income per share, basic and diluted.... 0.12 0.14 0.67 0.24
Weighted average shares
outstanding -- basic..................... 37,652,195 26,099,195 30,863,833 19,310,833
Weighted average shares
outstanding -- diluted................... 37,656,259 26,103,259 30,865,634 19,312,634

AS OF
AS OF MARCH 31, 2005 DECEMBER 31, 2004
--------------------------- -----------------
PRO FORMA HISTORICAL HISTORICAL
------------ ------------ -----------------

BALANCE SHEET INFORMATION:
Gross investment in real estate assets............ $219,914,624 $192,129,624 $151,690,293
Net investment in real estate..................... 217,593,747 189,808,747 150,211,823
Construction in progress.......................... 36,757,429 36,757,429 24,318,098
Cash and cash equivalents......................... 162,226,562 82,053,255 97,543,677
Loans receivable.................................. 42,498,111 42,498,111 50,224,069(1)
Total assets...................................... 434,262,386 326,304,079 306,506,063
Total debt........................................ 74,141,667 74,141,667 56,000,000
Total liabilities................................. 89,178,201 92,047,316 73,777,619
Total stockholders' equity........................ 343,321,685 232,494,263 231,728,444
Total liabilities and stockholders' equity........ 434,262,386 326,304,079 306,506,063

OTHER INFORMATION:
Funds from operations(2)............... $5,803,707 $ 4,402,341 $25,206,164 $ 6,054,819
Cash Flows:
Provided by operating activities..... 1,643,836 9,918,898
Used for investing activities........ (32,729,071) (195,600,642)
Provided by financing activities..... 15,594,813 283,125,421

- ---------------

(1) Includes $1.5 million in commitment fees payable to us by Vibra.

The following table presents a reconciliation of FFO to net income for the
three months ended March 31, 2005 and for the year ended December 31, 2004 on
an actual and pro forma basis.

FOR THE THREE MONTHS ENDED FOR THE YEAR ENDED
MARCH 31, 2005 DECEMBER 31, 2004
--------------------------- ------------------------
PRO FORMA HISTORICAL PRO FORMA HISTORICAL
----------- ----------- ----------- ----------

FUNDS FROM OPERATIONS:
Net income............................................ $4,673,545 $3,559,934 $20,685,519 $4,576,349
Depreciation and amortization......................... 1,130,162 842,407 4,520,645 1,478,470
---------- ---------- ----------- ----------
Funds from operations................................. $5,803,707 $4,402,341 $25,206,164 $6,054,819
========== ========== =========== ==========

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS

We were recently formed and did not commence revenue generating operations
until June 2004. Please see "Risk Factors -- Risks Relating to Our Business and
Growth Strategy" for a discussion of risks relating to our limited operating
history. The following discussion should be read in conjunction with our audited
financial statements and the related notes thereto included elsewhere in this
prospectus.

OVERVIEW

We were incorporated under Maryland law on August 27, 2003 primarily for
the purpose of investing in and owning net-leased healthcare facilities. Our
existing tenants are, and our prospective tenants will generally be, hospital
operating companies and other healthcare providers that use substantial real
estate assets in their operations. We offer financing for these operators' real
estate through 100% lease financing and generally seek lease terms of at least
10 years with a series of shorter renewal terms at the option of our tenants; we
also intend to include annual contractual rental rate increases that in the
current market range from 1.5% to 3.0%. Our existing portfolio escalators range
from 2.0% to 2.5%. In addition to the base rent, our leases generally require
our tenants to pay all operating costs and expenses associated with the
facility.

We conduct substantially all of our operations through our operating
partnership. We own all of the membership interests in the sole general partner
of our operating partnership and thereby control the operating partnership. At
present, we also own 100% of the limited partnership interests, although we may
issue units of limited partnership in exchange for interests in healthcare
facilities from time to time in the future. Sellers of healthcare facilities who
receive limited partnership units of our operating partnership in exchange for
interests in their facilities may be able to defer recognition of any gain that
would be recognized in a cash sale until such time that they redeem the
operating partnership units. Upon their election to redeem their units, we may
redeem them either for cash or shares of our common stock on a one-for-one
basis. In addition, we may sell equity interests in subsidiaries of our
operating partnership in connection with the acquisition or development of
facilities.

Whenever we issue shares of our common stock for cash, we are obligated to
contribute any net proceeds we receive from the sale of the stock to our
operating partnership and our operating partnership is, in turn, obligated to
issue an equivalent number of limited partnership units to us. Our operating
partnership distributes the income it generates from its operations to us. In
turn, we expect to distribute a substantial majority of the amounts we receive
from our operating partnership to our stockholders in the form of quarterly cash
distributions. We intend to qualify as a REIT for federal tax purposes, thereby
generally avoiding federal and state corporate income taxes on most of the
earnings that we distribute to our stockholders.

We conduct business operations in one segment. We acquire and develop
healthcare facilities and lease the facilities to healthcare operating companies
under long-term net leases. At December 31, 2004 our real estate and loan assets
comprised approximately 49% and 16%, respectively, of our total assets. We do
not expect our loan assets to exceed this level in the future. Our lending
business is important to our overall business strategy for two primary reasons:
(1) it provides opportunities to make income-earning investments that yield
attractive risk-adjusted returns in an industry in which our management has
expertise, and (2) by making debt capital available to certain qualified
operators, we believe we create for our company a competitive advantage over
other buyers of, and financing sources for, healthcare facilities.

We currently own four rehabilitation hospitals and two long-term acute care
hospitals that are leased to a single operating company and one community
hospital with an integrated medical office building leased to another operating
company and we are developing a community hospital and an adjacent medical
office building that are leased to a separate operating company. We have also
made and in the future may make loans to our tenants to facilitate the
acquisition of healthcare businesses and for working capital and from time to
time may make mortgage loans to facility owners.

Our revenues are derived from rents we earn pursuant to the lease
agreements we have with our tenants and from interest income from loans we make
to our tenants and other facility owners. Our tenants operate in the healthcare
industry, generally providing medical, surgical and rehabilitative care to
patients. The capacity of our tenants to pay our rents and interest is dependent
upon their ability to conduct their operations at profitable levels. We believe
that the business environment of the industry segments in which our tenants
operate in is generally positive for efficient operators. However, our tenants'
operations are subject to economic, regulatory and market conditions that may
affect their profitability. Accordingly, we monitor certain key factors, changes
to which we believe may provide early indications of conditions that may affect
the level of risk in our lease and loan portfolio.

Key factors that we consider in underwriting prospective tenants and in
monitoring the performance of existing tenants include the following:

- the historical and prospective operating margins (measured by a tenant's
earnings before interest, taxes, depreciation, amortization and facility
rent) of each tenant and at each facility;

- the ratio of our tenants' operating earnings to facility rent and to
facility rent plus other fixed costs, including debt costs;

- trends in the source of our tenants' revenue, including the relative mix
of Medicare, Medicaid/MediCal, commercial insurance, and private pay
patients;

- the effect of evolving healthcare regulations on our tenants'
profitability

Certain business factors, in addition to those described above that
directly affect our tenants, will likely materially influence our future results
of operations. These factors include:

- trends in the cost and availability of capital, including market interest
rates, that our prospective tenants may use for their real estate assets
instead financing their real estate assets through lease structures;

- unforeseen changes in healthcare regulations that may limit the
opportunities for physicians to participate in the ownership of
healthcare providers and healthcare real estate;

- reductions in reimbursements from Medicare, state healthcare programs and
commercial insurance providers that may reduce our tenants' profitability
and our lease rates; and

- competition from other financing sources.

CRITICAL ACCOUNTING POLICIES

In order to prepare financial statements in conformity with accounting
principles generally accepted in the United States, we must make estimates about
certain types of transactions and account balances. We believe that our
estimates of the amount and timing of lease revenues, credit losses, fair values
and periodic depreciation of our real estate assets, stock compensation expense,
and the effects of any derivative and hedging activities will have significant
effects on our financial statements. Each of these items involves estimates that
require us to make judgments that are subjective in nature. We intend to rely on
our experience, collect historical data and current market data, and develop
relevant assumptions in order to arrive at what we believe to be reasonable
estimates. Under different conditions or assumptions, materially different
amounts could be reported related to the accounting policies described below. In
addition, application of these accounting policies involves the exercise of
judgments on the use of assumptions as to future uncertainties and, as a result,
actual results could materially differ from these estimates. Our accounting
estimates will include the following:

Revenue Recognition. Our revenues, which are comprised largely of rental
income, include rents that each tenant pays in accordance with the terms of its
respective lease reported on a straight-line basis over the initial term of the
lease. Since some of our leases provide for rental increases at specified
intervals, straight-line basis accounting requires us to record as an asset, and
include in revenues, unbilled rent that we will only receive if the tenant makes
all rent payments required through the expiration of the term of the lease.
Accordingly, our management must determine, in its judgment, to what extent the
unbilled rent

receivable applicable to each specific tenant is collectible. We will review
each tenant's unbilled rent receivable on a quarterly basis and take into
consideration the tenant's payment history, the financial condition of the
tenant, business conditions in the industry in which the tenant operates and
economic conditions in the area in which the facility is located. In the event
that the collectibility of unbilled rent with respect to any given tenant is in
doubt, we are required to record an increase in our allowance for uncollectible
accounts or record a direct write-off of the specific rent receivable, which
would have an adverse effect on our net income for the year in which the reserve
is increased or the direct write-off is recorded and would decrease our total
assets and stockholders' equity.

We make loans to our tenants and from time to time may make mortgage loans
to facility owners. We recognize interest income on loans as earned based upon
the principal amount outstanding. These loans are generally secured by interests
in real estate, receivables, equity interests of a tenant or corporate and
individual guarantees. As with unbilled rent receivables, our management must
also periodically evaluate loans to determine what amounts may not be
collectible. Accordingly, a provision for losses on loans receivable is recorded
when it becomes probable that the loan will not be collected in full. The
provision is an amount which reduces the loan to its estimated net receivable
value based on a determination of the eventual amounts to be collected either
from the debtor or from the collateral, if any. At that time, we discontinue
recording interest income on the loan to the tenant.

Investments in Real Estate. We record investments in real estate at cost,
and capitalize improvements and replacements when they extend the useful life or
improve the efficiency of the asset. To the extent that we incur costs of
repairs and maintenance, we expense those costs as incurred. We compute
depreciation using the straight-line method over the estimated useful life of 40
years for buildings and improvements, five to seven years for equipment and
fixtures and the shorter of the useful life or the remaining lease term for
tenant improvements and leasehold interests.

We are required to make subjective assessments as to the useful lives of
our facilities for purposes of determining the amount of depreciation expense to
record on an annual basis with respect to our investments in real estate
improvements. These assessments have a direct impact on our net income because,
if we were to shorten the expected useful lives of our investments in real
estate improvements, we would depreciate these investments over fewer years,
resulting in more depreciation expense and lower net income on an annual basis.

We have adopted Statement of Financial Accounting Standards (SFAS) No. 144,
Accounting for the Impairment or Disposal of Long-Lived Assets, which
establishes a single accounting model for the impairment or disposal of
long-lived assets including discontinued operations. SFAS No. 144 requires that
the operations related to facilities that have been sold or that we intend to
sell be presented as discontinued operations in the statement of operations for
all periods presented, and facilities we intend to sell be designated as "held
for sale" on our balance sheet.

When circumstances such as adverse market conditions indicate a possible
impairment of the value of a facility, we will review the recoverability of the
facility's carrying value. The review of recoverability will be based on our
estimate of the future undiscounted cash flows, excluding interest charges,
expected to result from the facility's use and eventual disposition. Our
forecast of these cash flows will consider factors such as expected future
operating income, market and other applicable trends and residual value, as well
as the effects of leasing demand, competition and other factors. If impairment
exists due to the inability to recover the carrying value of a facility, an
impairment loss will be recorded to the extent that the carrying value exceeds
the estimated fair value of the facility. We will be required to make subjective
assessments as to whether there are impairments in the values of our investments
in real estate.

Purchase Price Allocation. We record above-market and below-market
in-place lease values, if any, for the facilities we own which are based on the
present value (using an interest rate which reflects the risks associated with
the leases acquired) of the difference between (i) the contractual amounts to be
paid pursuant to the in-place leases and (ii) management's estimate of fair
market lease rates for the corresponding in-place leases, measured over a period
equal to the remaining non-cancelable term of the lease. We amortize any
resulting capitalized above-market lease values as a reduction of rental income

over the remaining non-cancelable terms of the respective leases. We amortize
any resulting capitalized below-market lease values (presented in the
accompanying balance sheet as value of assumed lease obligations) as an increase
to rental income over the initial term and any fixed-rate renewal periods in the
respective leases. Because our strategy to a large degree involves the
origination of long term lease arrangements at market rates, we do not expect
the above-market and below-market in-place lease values to be significant for
many of our anticipated transactions.

We measure the aggregate value of other intangible assets to be acquired
based on the difference between (i) the property valued with existing in-place
leases adjusted to market rental rates and (ii) the property valued as if
vacant. Management's estimates of value are expected to be made using methods
similar to those used by independent appraisers (e.g., discounted cash flow
analysis). Factors considered by management in its analysis include an estimate
of carrying costs during hypothetical expected lease-up periods considering
current market conditions, and costs to execute similar leases. We also consider
information obtained about each targeted facility as a result of our
pre-acquisition due diligence, marketing and leasing activities in estimating
the fair value of the tangible and intangible assets acquired. In estimating
carrying costs, management also includes real estate taxes, insurance and other
operating expenses and estimates of lost rentals at market rates during the
expected lease-up periods, which we expect to range primarily from six to 18
months, depending on specific local market conditions. Management also estimates
costs to execute similar leases including leasing commissions, legal and other
related expenses to the extent that such costs are not already incurred in
connection with a new lease origination as part of the transaction.

The total amount of other intangible assets to be acquired, if any, is
further allocated to in-place lease values and customer relationship intangible
values based on management's evaluation of the specific characteristics of each
prospective tenant's lease and our overall relationship with that tenant.
Characteristics to be considered by management in allocating these values
include the nature and extent of our existing business relationships with the
tenant, growth prospects for developing new business with the tenant, the
tenant's credit quality and expectations of lease renewals, including those
existing under the terms of the lease agreement, among other factors.

We expect to amortize the value of in-place leases, if any, to expense over
the initial term of the respective leases, which we expect to range primarily
from 10 to 15 years. The value of customer relationship intangibles is amortized
to expense over the initial term and any renewal periods in the respective
leases, but in no event will the amortization period for intangible assets
exceed the remaining depreciable life of the building. Should a tenant terminate
its lease, the unamortized portion of the in-place lease value and customer
relationship intangibles would be charged to expense.

Accounting for Derivative Financial Investments and Hedging Activities. We
expect to account for our derivative and hedging activities, if any, using SFAS
No. 133, Accounting for Derivative Instruments and Hedging Activities, as
amended by SFAS No. 137 and SFAS No. 149, which requires all derivative
instruments to be carried at fair value on the balance sheet.

Derivative instruments designated in a hedge relationship to mitigate
exposure to variability in expected future cash flows, or other types of
forecasted transactions, are considered cash flow hedges. We expect to formally
document all relationships between hedging instruments and hedged items, as well
as our risk-management objective and strategy for undertaking each hedge
transaction. We plan to review periodically the effectiveness of each hedging
transaction, which involves estimating future cash flows. Cash flow hedges, if
any, will be accounted for by recording the fair value of the derivative
instrument on the balance sheet as either an asset or liability, with a
corresponding amount recorded in other comprehensive income within stockholders'
equity. Amounts will be reclassified from other comprehensive income to the
income statement in the period or periods the hedged forecasted transaction
affects earnings. Derivative instruments designated in a hedge relationship to
mitigate exposure to changes in the fair value of an asset, liability, or firm
commitment attributable to a particular risk, such as interest rate risk, are
considered fair value hedges under SFAS No. 133. We are not currently a party to
any derivatives contracts.

Variable Interest Entities. In January 2003, the FASB issued FASB
Interpretation No. 46 (FIN 46), Consolidation of Variable Interest Entities. In
December 2003, the FASB issued a revision to FIN 46, which is termed FIN 46R.
FIN 46R clarifies the application of Accounting Research Bulletin No. 51,
Consolidated Financial Statements and provides guidance on the identification of
entities for which control is achieved through means other than through voting
rights and how to determine when and which business enterprise should
consolidate such an entity. This model for consolidation applies to an entity in
which either (1) the equity investors (if any) do not have a controlling
financial interest or (2) the equity investment at risk is insufficient to
finance that entity's activities without receiving additional subordinated
financial support from other parties. We periodically evaluate the terms of our
relationships with our tenants and borrowers to determine whether we are
required to consolidate any tenants or borrowers.

Stock Based Compensation. We currently apply the intrinsic value method to
account for the issuance of stock options under our equity incentive plan in
accordance with APB Opinion No. 25, Accounting for Stock Issued to Employees. In
this regard, we anticipate that a substantial portion of our options will be
granted to individuals who are our officers or directors. Accordingly, because
the grants are expected to be at exercise prices that represent fair value of
the stock at the date of grant, we do not currently record any expense related
to the issuance of these options under the intrinsic value method. If the actual
terms vary from the expected, the impact to our compensation expense could
differ.

In December 2004, the FASB issued SFAS No. 123(R), "Share-Based Payment,"
which is a revision of SFAS No. 123, "Accounting for Stock Based Compensation."
SFAS No. 123(R) establishes standards for the accounting for transactions in
which an entity exchanges it equity instruments for goods or services. The
Statement focuses primarily on accounting for transactions in which an entity
obtains employee services in share-based payment transactions. SFAS No. 123(R)
requires that the fair value of such equity instruments be recognized as expense
in the historical financial statements as services are performed. Prior to SFAS
No. 123(R), only certain pro forma disclosures of fair value were required. SFAS
No. 123(R) becomes effective for public companies with their first annual
reporting period that begins after June 15, 2005. For non-public companies, the
standard becomes effective for their first fiscal year beginning after December
15, 2005. We are currently evaluating the impact of SFAS No. 123(R) on our
financial position and results of operations. However, we do not expect that
SFAS No. 123(R) will have a material effect on our financial position and
results of operations. Our existing equity incentive plan allows for stock-based
awards to be in the form of options, restricted stock, restricted stock units
and deferred stock units. The impact of SFAS No. 123(R) will also be affected by
the types of stock-based awards that our board of directors chooses to grant.

DISCLOSURE OF CONTRACTUAL OBLIGATIONS

The following table summarizes known material contractual obligations
associated with investing and financing activities as of March 31, 2005:

LESS THAN 2-3 4-5 AFTER
CONTRACTUAL OBLIGATIONS 1 YEAR YEARS YEARS 5 YEARS TOTAL
- ----------------------- ----------- ----------- -------- ---------- ------------

Construction contracts...................... $26,998,993 $ -- $ -- $ -- $ 26,998,993
Operating lease commitments................. 306,045 689,022 715,374 2,041,936 3,752,377
Long-term debt.............................. 3,750,000 70,391,667 -- -- 74,141,667
----------- ----------- -------- ---------- ------------
Total:.................................... $31,055,038 $71,080,689 $715,374 $2,041,936 $104,893,037
=========== =========== ======== ========== ============

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

Investors and analysts following the real estate industry utilize funds
from operations, or FFO, as a supplemental performance measure. While we believe
net income available to common stockholders as defined by GAAP is the most
appropriate measure, our management considers FFO an appropriate supplemental
measure given its wide use by and relevance to investors and analysts. FFO,
reflecting the assumption that real estate asset values rise or fall with market
conditions, principally adjusts for the effects of GAAP depreciation and
amortization of real estate assets, which assume that the value of real estate
diminishes predictably over time.

As defined by the National Association of Real Estate Investment Trusts, or
NAREIT, FFO represents net income (loss) (computed in accordance with GAAP),
excluding gains (losses) on sales of real estate, plus real estate related
depreciation and amortization and after adjustments for unconsolidated
partnerships and joint ventures. We compute FFO in accordance with the NAREIT
definition. FFO should not be viewed as a substitute measure of our company's
operating performance since it does not reflect either depreciation and
amortization costs or the level of capital expenditures and leasing costs
necessary to maintain the operating performance of our properties, which are
significant economic costs that could materially impact our results of
operations.

The following table presents a reconciliation of FFO to net income for the
three months ended March 31, 2005 and for the year ended December 31, 2004 on an
actual and pro forma basis.

FOR THE THREE MONTHS ENDED FOR THE YEAR ENDED
MARCH 31, 2005 DECEMBER 31, 2004
--------------------------- ------------------------
PRO FORMA HISTORICAL PRO FORMA HISTORICAL
------------ ------------ ----------- ----------

Funds from operations:
Net income....................... $4,673,545 $3,559,934 $20,685,519 $4,576,349
Depreciation and amortization.... 1,130,162 842,407 4,520,645 1,478,470
---------- ---------- ----------- ----------
Funds from operations............ $5,803,747 $4,402,341 $25,206,164 $6,054,819
========== ========== =========== ==========

RESULTS OF OPERATIONS

THREE MONTHS ENDED MARCH 31, 2005 AND MARCH 31, 2004

Net income for the three months ended March 31, 2005 was $3,559,934
compared to a net loss of $493,726 for the three months ended March 31, 2004.

Three Months Ended March 31, 2005: Revenue of $6,480,528 was comprised of
rents (81%) and interest from loans (19%). During this quarter, we received
percentage rents from Vibra of approximately $395,000. These percentage rents
occurred due to an increase in patient census at the Vibra Facilities from the
three months ended December 31, 2004 to the three months ended March 31, 2005.
The higher census figures at the Vibra Facilities produced increased revenue
which exceeded the thresholds on which percentage rent are based. Also, we
acquired the Desert Valley Facility during the quarter, which added to our rent
revenue. Interest income from loans decreased due to Vibra repaying one of its
loans from us.

Depreciation and amortization during the first quarter of 2005 are
primarily attributable to the Vibra Facilities. The Desert Valley Facility
contributed one month of depreciation and amortization during the quarter.

Property expenses are comprised primarily of a ground lease payment on our
rehabilitation hospital located in Marlton, New Jersey.

General and administrative expenses during the quarter, which totaled
$1,698,249, were comprised primarily of executive compensation of approximately
$1.0 million, with the balance made up primarily of legal, office and other
administrative expenses. During the three months ended March 31, 2005, we had 16
full-time employees and one part-time employee.

Other income of $383,772 consisted of interest and dividends, primarily
from the temporary investment of the net proceeds of our April 2004 private
placement and borrowings from Merrill Lynch Capital in mutual funds and other
interest-bearing accounts.

Interest expense from the borrowings under our Merrill Lynch Capital loan
during the three months ended March 31, 2005 totaled $711,149. Capitalized
interest of approximately $395,000 was recorded in the three months ended March
31, 2005 for the construction of the West Houston Facilities.

Three Months Ended March 31, 2004: The loss in 2004 preceded our April
2004 private placement and covered a period during which we incurred
administrative costs consisting primarily of executive compensation expenses. At
March 31, 2004, we had five employees, four of whom were executive officers.

We had no operating properties and no development properties. Our activities in
the first quarter of 2004 were concentrated in evaluating potential acquisitions
and planning for the April 2004, private placement. Due to the lack of
operations in the first quarter of 2004, there is limited comparability to the
results for the same period in 2005.

YEAR ENDED DECEMBER 31, 2004

Net income for the year ended December 31, 2004 was $4,576,349. Revenue,
which was $10,893,459, was comprised primarily of rents (79%) and interest from
loans (21%). Interest and dividends, primarily from the temporary investment of
the net proceeds of our April 2004 private placement, totaled $930,260. We
completed our private placement of common stock in April 2004 and received
proceeds, net of offering costs and fees, of approximately $233.5 million.
Expenses during the year, which totalled $7,214,601, were comprised primarily of
compensation of $3,700,442, depreciation and amortization of $1,517,530, other
general and administrative expenses of $1,336,897 and approximately $585,345 of
costs associated with unsuccessful acquisitions. These costs, which consisted
primarily of legal fees, costs of third party reports and travel, related to a
portfolio of five facilities that were subject to a letter of intent with a
prospective operator. During the second quarter of 2004, we declined to pursue
the acquisition.

INCEPTION (AUGUST 27, 2003) THROUGH DECEMBER 31, 2003

Our net loss for the period from inception (August 27, 2003) through
December 31, 2003 was $1,023,276. Included in this loss is approximately
$423,000 in accrued expenses that were incurred by Medical Properties Trust, LLC
prior to August 27, 2003 and assumed by us in connection with our formation.
These constitute all of the expenses of this company. We had no revenues during
this period and substantially all of the expenses that comprised our net loss
from inception through December 31, 2003 are related to start-up activities,
including business development, identification of acquisition possibilities,
legal, accounting, and consulting. We do not consider the results of our
operations in this period to be meaningful with respect to an analysis of our
expected operations.

LIQUIDITY AND CAPITAL RESOURCES

Our long-term liquidity requirements consist primarily of funds to pay the
costs of acquiring and developing facilities and making distributions to our
stockholders. We believe that our existing cash and cash equivalents, together
with the net proceeds from this offering, cash flow from operations and
borrowings under our Merrill Lynch and Colonial Bank loans, will be sufficient
to acquire the Pending Acquisition and Development Facilities and to fund our
cash requirements during the next 12 months. Our current portfolio of
facilities, other than the Desert Valley Facility, serves as collateral for our
current indebtedness.

We received approximately $233.5 million, net of offering costs and fees,
from our April 2004 private placement. We have acquired and committed to develop
healthcare facilities with an aggregate estimated cost of $387.3 million and
have provided approximately $41.4 million in acquisition financing to one of our
tenants. As of March 31, 2005, we had stockholders' equity of approximately
$232.5 million, including approximately $82.0 million in cash and cash
equivalents.

Our sources of funds for future acquisitions and developments will
primarily be our uncommitted cash balances, the net proceeds of this offering,
operating cash flows and borrowings. We intend to use these cash resources in
the acquisition and development of our Pending Acquisition and Development
Facilities and to pay our operating expenses for the foreseeable future. To
maintain our status as a REIT under the Code, we must distribute annually at
least 90% of our taxable income. These distribution requirements limit our
ability to retain earnings and thereby replenish or increase capital for
acquisitions, developments and operations. However, we believe that our current
access to financings will provide us with financial flexibility at levels
sufficient to meet current and anticipated capital requirements, including
funding new acquisition and development opportunities.

We intend to utilize various types of debt to finance a portion of the
costs to complete our proposed development facilities and acquire and develop
additional facilities. We expect this debt will include long-term, fixed-rate
mortgage loans, variable-rate term loans, secured revolving lines of credit and
construction financing facilities. We believe we will be able generally to
finance up to approximately 60% of the cost of our healthcare facilities;
however, there is no assurance that we will be able to obtain or maintain this
level of debt on our portfolio of real estate assets on favorable terms in the
future.

We borrowed $75 million from Merrill Lynch under a loan agreement with a
term of three years for acquisition and development of additional facilities and
other working capital needs. The loan bears interest at one month LIBOR (3.15%
at June 2, 2005) plus 300 basis points. There was $74.1 million outstanding
under this loan as of March 31, 2005. The term loan is secured by our interests
in the Vibra Facilities and requires us to comply with certain financial
covenants.

We have accepted a term sheet from Merrill Lynch Capital for an up to $100
million senior secured revolving credit facility with a term of four years, with
one 12-month extension option, to refinance the outstanding amount under our
existing loan agreement with Merrill Lynch Capital and for general corporate
purposes. During the term of the loan, we will have the right to increase the
amount available under the facility by an amount up to $75.0 million, subject to
no event of default continuing or occurring at the time of such increase. The
facility will initially be secured by our interests in the Vibra Facilities, or
the borrowing base properties. The maximum availability under the facility will
be equal to 65% of the collateral value of the borrowing base properties. The
facility will bear interest at one month LIBOR plus up to 275 basis points
depending on the amount of the facility leveraged. We expect the facility with
Merrill Lynch to include financial covenants requiring us to maintain a maximum
total leverage ratio (ratio of consolidated indebtedness to gross asset value)
of 65%, a minimum consolidated fixed charge coverage ratio of 1.65 to 1 and to
maintain minimum tangible net worth equal to $200 million plus 75% of net
proceeds from any additional equity issuances. Execution of this credit facility
is subject to Merrill Lynch's underwriting and credit approval and completion of
acceptable legal documentation.

We have also entered into construction loan agreements in an aggregate
amount of $43.4 million with Colonial Bank to fund construction costs for our
West Houston Facilities. Each construction loan has a term of 18 months and an
option on the part of the borrower to convert the loan to a 30-month term loan
upon completion of construction of the West Houston Facility securing that loan.
The construction loans are secured by mortgages on the West Houston Facilities,
as well as assignments of rents and leases on those facilities. The terms of the
construction loan agreements require us to comply with a financial ratio
relating to debt coverage. The construction loans bear interest at one month
LIBOR plus 225 basis points, during the construction period and one month LIBOR
plus 250 basis points, thereafter. The Colonial Bank loans are cross-defaulted.
As of the date of this prospectus, we have made no borrowings under the Colonial
Bank loans.

Any other indebtedness we incur will likely be subject to continuing
covenants, and we will likely be required to make continuing representations and
warranties in connection with that debt. Moreover, some or all of our debt may
be secured by some or all of our assets. If we default in the payment of
interest or principal on any of our debt, breach any representation or warranty
in connection with any borrowing or violate any covenant in any loan document,
the lender may accelerate the maturity of the debt requiring us to immediately
repay all outstanding principal and accrued interest. If we are unable to make
the payment, our lender could foreclose on our assets that are pledged as
collateral to the lender. The lender could also sue us or force us into
bankruptcy. Any of these events would likely have a material adverse effect on
the value of an investment in our common stock.

Our real estate investments, like most commercial real estate investments,
are relatively illiquid and our ability to sell one or more of our properties
quickly and on favorable terms may be limited by a variety of factors beyond our
control, including current market conditions, the cost and availability of debt
financing, zoning and regulatory changes, and the need for capital improvements.
Moreover, the length of our lease agreements, the specialized nature of our
tenants' operations and the resulting design of our facilities and the risk that
the nature and profitability of our tenants' operations may be affected by
healthcare regulations may further impact the liquidity of our facilities.

DISTRIBUTION POLICY

We expect to qualify as a REIT for federal income tax purposes and will
elect to be taxed as a REIT commencing with our taxable year that began on April
6, 2004 and ended on December 31, 2004. To qualify as a REIT, we must meet a
number of organizational and operational requirements, including a requirement
that we distribute at least 90% of our REIT taxable income, excluding net
capital gain, to our stockholders. It is our current intention to comply with
these requirements, elect REIT status and maintain such status going forward.
See "United States Federal Income Tax Considerations."

The table below is a summary of our distributions.

DECLARATION DATE RECORD DATE DATE OF DISTRIBUTION DISTRIBUTION PER SHARE
- ---------------- ----------- -------------------- ----------------------

We intend to pay to our stockholders, within the time periods prescribed by
the Code, all or substantially all of our annual taxable income, including
taxable gains from the sale of real estate and recognized gains on the sale of
securities. It is our policy to make sufficient cash distributions to
stockholders in order for us to maintain our status as a REIT under the Code and
to avoid corporate income and excise tax on undistributed income.

INFLATION

Our leases contain provisions designed to mitigate the adverse impact of
inflation. These provisions generally increase rental rates during the terms of
the leases either at fixed rates or indexed escalations (based on the Consumer
Price Index or other measures). In addition, all of our existing leases, and we
intend that most of our new leases will, require the tenant to pay the operating
expenses of the facility, including common area maintenance costs, real estate
taxes and insurance. This may reduce our exposure to increases in costs and
operating expenses resulting from inflation. However, if inflation rates exceed
the contractual rental increases, our results of operations may be adversely
affected, and inflation may also adversely impact our revenue from any leases
that do not contain escalation provisions.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market risk includes risks that arise from changes in interest rates,
foreign currency exchange rates, commodity prices, equity prices and other
market changes that affect market sensitive instruments. In pursuing our
business plan, we expect that the primary market risk to which we will be
exposed is interest rate risk.

We may be exposed to the effects of interest rate changes primarily as a
result of long-term debt used to maintain liquidity and to fund expansion of our
portfolio and operations. Our interest rate risk-management objectives will be
to limit the impact of interest rate changes on earnings and cash flows and to
lower overall borrowing costs. To achieve our objectives, we will borrow
primarily at fixed rates or variable rates with the lowest margins available
and, in some cases, with the ability to convert variable rates to fixed rates.
We may also enter into derivative financial instruments such as interest rate
swaps and caps in order to mitigate our interest rate risk on a related
financial instrument. We do not intend to enter into derivative transactions for
speculative purposes.

In addition to changes in interest rates, the value of our facilities will
be subject to fluctuations based on changes in local and regional economic
conditions and changes in the ability of our tenants to generate profits, all of
which may affect our ability to refinance our debt if necessary.

OUR BUSINESS

OUR COMPANY

We are a self-advised real estate company that acquires, develops and
leases healthcare facilities providing state-of-the-art healthcare services. We
lease our facilities to healthcare operators pursuant to long-term net-leases,
which require the tenant to bear most of the costs associated with the property.
From time to time, we also make loans to our tenants. We believe that the United
States healthcare delivery system is becoming decentralized and is evolving away
from the traditional "one stop," large-scale acute care hospital. We believe
that this change is the result of a number of trends, including increasing
specialization and technological innovation and the desire of both physicians
and patients to utilize more convenient facilities. We also believe that
demographic trends in the United States, including in particular an aging
population, will result in continued growth in the demand for healthcare
services, which in turn will lead to an increasing need for a greater supply of
modern healthcare facilities. In response to these trends, we believe that
healthcare operators increasingly prefer to conserve their capital for
investment in operations and new technologies rather than investing in real
estate and, therefore, increasingly prefer to lease, rather than own, their
facilities. Given these trends and the size, scope and growth of this dynamic
industry, we believe there are significant opportunities to acquire and develop
net-leased healthcare facilities that are integral components of local
healthcare delivery systems.

Our strategy is to lease the facilities that we acquire or develop to
experienced healthcare operators pursuant to long-term net-leases. We focus on
acquiring and developing rehabilitation hospitals, long-term acute care
hospitals, ambulatory surgery centers, cancer hospitals, women's and children's
hospitals and regional and community hospitals, as well as other specialized
single-discipline facilities and ancillary facilities. We believe that these
types of facilities will capture an increasing share of expenditures for
healthcare services. We believe that our strategy for acquisition and
development of these types of net-leased facilities, which generally require a
physician's order for patient admission, distinguish us as a unique investment
alternative among REITs.

Our management team has extensive experience in acquiring, owning,
developing, managing and leasing healthcare facilities; managing investments in
healthcare facilities; acquiring healthcare companies; and managing real estate
companies. Our management team also has substantial experience in healthcare
operations and administration, which includes many years of service in executive
positions for hospitals and other healthcare providers, as well as in physician
practice management and hospital/physician relations. Therefore, in addition to
understanding investment characteristics and risk levels typically important to
real estate investors, our management understands the changing healthcare
delivery environment, including changes in healthcare regulations, reimbursement
methods and patient demographics, as well as the technological innovations and
other advances in healthcare delivery generally. We believe that this experience
gives us the specialized knowledge necessary to select attractively-located
net-leased facilities, underwrite our tenants, analyze facility-level operations
and understand the issues and potential problems that may affect the healthcare
industry generally and the tenant service area and facility in particular. We
believe that our management's experience in healthcare operations and real
estate management and finance will enable us to take advantage of numerous
attractive opportunities to acquire, develop and lease healthcare facilities.

We completed a private placement of our common stock in April 2004 in which
we raised net proceeds of approximately $233.5 million. Shortly after completion
of our private placement, we began to acquire our current portfolio of nine
facilities, consisting of seven facilities that are in operation and two
facilities that are under development. Four of the facilities that are in
operation are rehabilitation hospitals, two are long-term acute care hospitals
and one is a community hospital with an integrated medical office building. The
facilities under development are a community hospital and an adjacent medical
office building. With the net proceeds of this offering, along with our
available cash and cash equivalents, we intend to expand our portfolio of
facilities by acquiring or developing additional net-leased healthcare
facilities.

We employ leverage in our capital structure in amounts determined from time
to time by our board of directors. At present, we intend to limit our debt to
approximately 60% of the aggregate costs of our facilities, although we may
temporarily exceed that level from time to time. We expect our borrowings to be
a combination of long-term, fixed-rate, non-recourse mortgage loans,
variable-rate secured term and revolving credit facilities, and other fixed and
variable-rate short to medium-term loans.

We borrowed $75 million from Merrill Lynch under a loan agreement which has
a term of three years. We have used the loan proceeds for acquisition of our
current portfolio of facilities and plan to use the loan proceeds for
acquisition and development of additional facilities and other working capital
needs. The loan bears interest at one month LIBOR (3.15% at June 2, 2005) plus
300 basis points. There is $74.1 million outstanding under this loan as of March
31, 2005. The loan is secured by our interests in the Vibra Facilities. The loan
with Merrill Lynch includes financial covenants requiring us to meet an interest
coverage ratio (ratio of our earnings before interest, taxes, depreciation and
amortization to interest expense) of 2 to 1, a fixed charge coverage ratio
(ratio of earnings before interest, taxes, depreciation and amortization to the
sum of total debt service, assumed capital expenditures pertaining to the Vibra
Facilities, income taxes and preferred dividends) greater than 1.65 to 1, a net
debt to total asset valuation ratio (ratio of total net debt to the product of
nine and the sum of net income, interest expense, depreciation and amortization
minus management fees not exceeding 1% of net revenue and $300 per licensed bed
per annum) not greater than 70%, and, for each Vibra Facility, a base rent
coverage ratio (ratio of earnings of the applicable lessee of the Vibra Facility
before interest, taxes, depreciation, amortization, rent and management fees to
base rent payable by the lessee) equal to or greater than 1.25 to 1 and to
maintain minimum tangible net worth of at least $200 million. As of the date of
this prospectus, we are in compliance with all material financial covenants
under our loan with Merrill Lynch.

We have accepted a term sheet from Merrill Lynch Capital for an up to
$100.0 million senior secured revolving credit facility with a term of four
years, with one 12-month extension option, to refinance the outstanding amount
under our existing loan agreement with Merrill Lynch Capital and for general
corporate purposes. During the term of the loan, we will have the right to
increase the amount available under the facility by an amount up to $75.0
million, subject to no event of default continuing or occurring at the time of
such increase. Merrill Lynch will syndicate the that increase in the amount to
be available under the facility on a best efforts basis, and no lender will be
required to increase its commitment to facilitate the increase in the amount
available under the facility.

The facility will initially be secured by our interests in the Vibra
Facilities, or the borrowing base properties. The maximum availability under the
facility will be equal to 65% of the collateral value of the borrowing base
properties. The facility will bear interest at one month LIBOR plus up to 275
basis points depending on the amount of the facility leveraged. We expect the
facility with Merrill Lynch to include financial covenants requiring us to
maintain a maximum total leverage ratio (ratio of consolidated indebtedness to
gross asset value) of 65%, a minimum consolidated fixed charge coverage ratio of
1.65 to 1 and to maintain minimum tangible net worth equal to $200 million plus
75% of net proceeds from any additional equity issuances. Execution of this
credit facility is subject to Merrill Lynch's underwriting and credit approval
and completion of acceptable legal documentation.

We have also entered into construction loan agreements in an aggregate
amount of $43.4 million with Colonial Bank to fund construction costs for our
West Houston Facilities. Each construction loan has a term of 18 months and an
option on the part of the borrower to convert the loan to a 30-month term loan
upon completion of construction of the West Houston Facility securing that loan.
The construction loans are secured by mortgages on the West Houston Facilities,
as well as assignments of rents and leases on those facilities. The terms of the
construction loan agreements prevent us from allowing the net operating income
of the facility used as collateral for any calendar quarter to be less than 1.25
times the principal and interest payments then due and payable under the
promissory note for the designated period until the loan is paid in full. In the
event that our net operating income falls below the minimum debt service
requirement, we must prepay a portion of the principal balance of the promissory
note so that the debt service requirement is satisfied and maintained within 10
days of our non-compliance. The construction loans bear interest at the one
month LIBOR plus 225 basis points during the construction period and one

month LIBOR plus 250 basis points thereafter. The Colonial Bank loans are
cross-defaulted. As of the date of this prospectus, we have made no borrowings
under the Colonial Bank loans.

MARKET OPPORTUNITY

According to the United States Department of Commerce, Bureau of Economic
Analysis, healthcare is one of the largest industries in the United States, and
was responsible for approximately 15.3% of United States gross domestic product
in 2003. Healthcare spending has consistently grown at rates greater than
overall spending growth and inflation. As the chart below reflects, healthcare
expenditures are projected to increase by more than 7% in 2004 and 2005 to $1.8
trillion and $1.9 trillion, respectively, and are expected to reach $3.1
trillion by 2012.

(GRAPH)

We believe that the fundamental reasons for this growth in the demand for
healthcare services include the aging and growth of the United States
population, the advances in medical technology and treatments, and the increase
in life expectancy. As illustrated by the chart below, the projected compound
annual growth rate (or CAGR), from 2000 to 2030 of the population of senior
citizens is three times the rate projected for the total United States
population. This demographic trend is projected to result in an increase in the
percentage of United States citizens who are age 65 or older from 12.4% in 2000
to 19.6% in 2030.

(GRAPH)
Source: United States Bureau of the Census

To satisfy this growing demand for healthcare services, there is a
significant amount of new construction of healthcare facilities. In 2003 alone,
$24.5 billion was spent on the construction of healthcare facilities, according
to CMS. This represented more than a 9% increase over the $22.4 billion in
healthcare construction spending for 2002. The following chart reflects the
growth and expected growth in healthcare construction expenditures over the
period that began in 1990 and ends in 2012:

(GRAPH)

We believe that the United States healthcare delivery system is evolving
away from reliance on the traditional "one-stop," large-scale acute care
hospital to one that relies on specialty hospitals and healthcare facilities
that focus on single disciplines. We believe that there will be an increasing
demand for more accessible, specialized and technologically-advanced healthcare
delivery services as the population grows and ages. We own and have targeted for
acquisition and development net-leased healthcare facilities

providing state-of-the-art healthcare services because we believe these types of
facilities represent the future of healthcare delivery.

We believe that United States healthcare operators are in the early stages
of a long-term evolution from a model that favors ownership of healthcare
facilities to one that favors long-term net leasing of these facilities. We see
two primary reasons for this:

- First, in our experience, financial arrangements such as bond financing
gave non-profit healthcare providers access to inexpensive capital,
usually at 100% of the building cost. However, budget constraints on
local governments and tighter underwriting standards have greatly reduced
the availability of this very inexpensive capital.

- Second, in our experience, healthcare providers were reimbursed on
cost-based reimbursement plans (calculated in part by reference to a
provider's total cost in plant and equipment) which provided no incentive
for healthcare providers to make efficient use of their capital. With the
evolution of the prospective payment reimbursement system, which
reimburses healthcare providers for specific procedures or diagnoses and
thus rewards the most efficient providers, healthcare providers are no
longer assured of returns on investments in non-revenue producing assets
such as the real estate where they operate. Accordingly, in recent years,
healthcare providers have begun to convert their owned facilities to
long-term lease arrangements thereby accessing substantial amounts of
previously unproductive capital to invest in high margin operations and
assets.

In summary, the following market trends have shaped our investment
strategy:

- Decentralization: We believe that healthcare services are increasingly
delivered through smaller, more accessible facilities that are designed
for specific treatments and medical conditions and that are located near
physicians and their patients. Based upon our experience, more healthcare
services are delivered in specialized facilities than in acute care
hospitals.

- Specialization: In our experience, the percentage of physicians and
other healthcare professionals who practice in a recognized specialty or
subspecialty has been increasing for many years. We believe that this
creates opportunities for development of additional specialized
healthcare facilities as advances in technologies and recognition of new
practice specialties result in new treatments for difficult medical
conditions.

- Convenient Patient Care: We believe that healthcare service providers
are increasingly seeking to provide specific services in a single
location for the convenience of both patients and physicians. These
single-discipline centers are primarily located in suburban areas, near
patients and physicians, as opposed to the traditional urban hospital
setting.

- Aging Population: We believe that demographic trends in the United
States, including in particular an aging population, will result in
continued growth in the demand for healthcare services, which in turn
will lead to an increasing need for a greater supply of modern healthcare
facilities.

- Use of Capital: We believe that healthcare operators increasingly prefer
to conserve their capital for investment in their operations and for new
technologies rather than investing it in real estate.

OUR TARGET FACILITIES

The market for healthcare real estate is extensive and includes real estate
owned by a variety of healthcare operators. We focus on acquiring and developing
those net-leased facilities that are specifically designed to reflect the latest
trends in healthcare delivery methods. These facilities include:

- Regional and Community Hospitals: We define regional and community
hospitals as general medical/surgical hospitals whose practicing
physicians generally serve a market specific area, whether urban,
suburban or rural. We intend to limit our ownership of these facilities
to those with market, ownership, competitive and technological
characteristics that provide barriers to entry for potential competitors.

- Medical Office Buildings: Medical office buildings are office and clinic
facilities occupied and used by physicians and other healthcare providers
in the provision of outpatient healthcare services to their patients. The
medical office buildings that we target are or will be master-leased and
generally adjacent to our other targeted healthcare facilities.

UNDERWRITING PROCESS

Our real estate and loan underwriting process focuses on healthcare
operations and real estate investment. This process is described in a written
policy that requires, among other things, completion of specific elements of due
diligence at the appropriate stages, including appraisals, engineering
evaluations and environmental assessments, all provided by qualified and
independent third parties. All of our executive officers are involved in the
acquisition and due diligence process.

Our acquisition and development selection process includes a comprehensive
analysis of the targeted healthcare facility's profitability, financial trends
in revenues and expenses, barriers to competition, the need in the market for
the type of healthcare services provided by the facility, the strength of the
location and the underlying value of the facility, as well as the financial
strength and experience of the prospective tenant and the tenant's management
team. We also analyze the operating history of the specific facility, including
the facility's earnings, cash flow, occupancy and patient and payor mix, in
order to evaluate its financial and operating strength.

When we identify an attractive acquisition or development opportunity based
on historical operations and market conditions, we determine the financial value
of a potential long-term net-lease arrangement based on our target long-term
net-lease capitalization rates, which currently range from 9.5% to 11%, and
fixed charge coverage ratios. We compare that financial value to the replacement
costs that we estimate by consulting with major healthcare construction
contractors, engaging construction engineers or facility

assessment consultants as appropriate, and reviewing recent cost studies. In
addition, our due diligence process includes obtaining and evaluating title,
environmental and other customary third-party reports. In certain instances we
have acquired or may acquire a facility from a tenant or proposed tenant at a
purchase price in excess of what our tenant or proposed tenant recently paid or
expects to pay for that same facility. Our current policy requires the approval
of the investment committee of our board of directors for acquisitions or
developments of facilities that exceed $10.0 million.

We seek to build tenant relationships with healthcare operators that we
believe are positioned to prosper in the changing healthcare environment. We
seek tenant relationships with operators who, based on our financial and
operating analyses, have demonstrated the ability to manage in good and bad
economic conditions. In certain cases, we lend funds to prospective tenants to
assist them with their acquisition of the operations at the facilities that we
intend to acquire and lease to them and for initial working capital needs. See
"Our Portfolio -- Our Current Portfolio of Facilities." In these instances,
where feasible and in compliance with applicable healthcare laws and
regulations, we seek to obtain percentage rents based on the prospective
tenant's revenues in addition to our base rent. Through our detailed
underwriting of healthcare operations and real estate, we expect to deliver
attractive risk-adjusted returns to our stockholders.

ASSET MANAGEMENT

We actively monitor our facilities, including reviewing periodic financial
reporting and operating data, as well as visiting each facility and meeting with
the management of our tenants on a regular basis. Integral to our asset
management philosophy is our desire to build long-term relationships with the
tenants and, accordingly, we have developed a partnering approach which we
believe results in the tenant viewing us as a member of its team. We understand
that in order to maximize the value of our investments, our tenants must
prosper. Therefore, we expect to work closely with our tenants throughout the
terms of our leases in order to foster a long-term working relationship and to
maximize the possibility of new business opportunities. For example, we and our
prospective tenants typically conduct due diligence in a coordinated manner and
share with each other the results of our respective due diligence
investigations. During the lease term, we conduct joint evaluations of local
facility operations and participate in discussions about strategic plans that
may ultimately require our approval pursuant to the terms of our lease
agreements. Our chief executive officer, chief financial officer and chief
operating officer also communicate frequently with their counterparts at our
tenants in order to maintain knowledge about changing regulatory and business
conditions. We believe this knowledge equips us to anticipate changes in our
tenants' operations in sufficient time to strategically and financially plan
for, rather than react to, changing conditions.

In addition to our ongoing analyses of our tenants' operations, our
management team actively monitors and researches each healthcare segment in
which we own and lease facilities in order to help us recognize changing
economic, market and regulatory conditions. Our senior management is not only
involved in the underwriting of each asset upon acquisition or development, but
is also involved in the asset management process during the entire period in
which we own the facility.

OUR FORMATION TRANSACTIONS

The following is a summary of our formation transactions:

- We were formed as a Maryland corporation on August 27, 2003 to succeed to
the business of Medical Properties Trust, LLC, a Delaware limited
liability company, which was formed by certain of our founders in
December 2002. In connection with our formation, we issued our founders
1,630,435 shares of our common stock in exchange for nominal cash
consideration, the membership interests of Medical Properties Trust, LLC
were transferred to us and Medical Properties Trust, LLC became our
wholly-owned subsidiary. Upon its formation in September 2003, our
operating partnership assumed certain obligations of Medical Properties
Trust, LLC. Upon completion of our private placement in April 2004,
1,108,527 shares of the 1,630,435 shares of common stock held by our
founders were redeemed and they now collectively hold 557,908 shares of
our common stock, including shares purchased in our April 2004 private
placement. Our founders agreed to the

redemption of a portion of their shares of our common stock for nominal
consideration primarily in order to facilitate the completion of our
April 2004 private placement.

- Our operating partnership, MPT Operating Partnership, L.P., was formed in
September 2003. Through our wholly-owned subsidiary, Medical Properties
Trust, LLC, we are the sole general partner of our operating partnership.
We currently own all of the limited partnership interests in our
operating partnership.

- MPT Development Services, Inc., a Delaware corporation that we formed in
January 2004, operates as our wholly-owned taxable REIT subsidiary.

- In April 2004 we completed a private placement of 25,300,000 shares of
common stock at an offering price of $10.00 per share. Friedman,
Billings, Ramsey & Co., Inc. acted as the initial purchaser and sole
placement agent. The total net proceeds to us, after deducting fees and
expenses of the offering, were approximately $233.5 million. The net
proceeds of our private placement, together with borrowed funds, have
been or will be used to acquire our current portfolio of nine facilities,
consisting of seven facilities that are in operation and two that are
under development, repay debt, pay pre-offering operating expenses and
for working capital. Thus far we have utilized approximately $155.4
million to acquire our seven existing facilities, have loaned $47.6
million to Vibra to acquire the operations at the Vibra Facilities and
for working capital purposes, $6.2 million of which has been repaid, and
have funded $35.1 million of a projected total of $63.1 million of
development costs for the West Houston Facilities. There are
approximately 316 beneficial holders of our common stock as of the date
of this prospectus.

Edward K. Aldag, Jr., William G. McKenzie, Emmett E. McLean, R. Steven
Hamner and James P. Bennett may be considered our founders. Mr. Aldag is serving
as chairman of our board of directors and as our president and chief executive
officer. Mr. McKenzie is serving as our vice chairman of the board. Mr. McLean
is serving as our executive vice president, chief operating officer, treasurer
and assistant secretary. Mr. Hamner is serving as our executive vice president
and chief financial officer. Mr. Bennett formerly was an owner, officer,
director of and consultant to the company's predecessor, Medical Properties
Trust, LLC, but has not been affiliated with us since August 2003.

OUR OPERATING PARTNERSHIP

We own our facilities and conduct substantially all of our business through
our operating partnership, MPT Operating Partnership, L.P., and its
subsidiaries. MPT Operating Partnership, L.P. is a Delaware limited partnership
organized by us in September 2003. Our wholly-owned limited liability company,
Medical Properties Trust, LLC, serves as the sole general partner of, and holds
a 1% interest in, our operating partnership. We also currently own all of the
limited partnership interests in our operating partnership, constituting a 99%
partnership interest, but may issue limited partnership units from time to time
in connection with facility acquisitions and developments. Where permitted by
applicable law, we intend to sell equity interests in subsidiaries of our
operating partnership in connection with, or subsequent to, the acquisition and
development of facilities.

Holders of limited partnership units of our operating partnership, other
than us, would be entitled to redeem their partnership units for shares of our
common stock on a one-for-one basis, subject to adjustments for stock splits,
dividends, recapitalizations and similar events. At our option, in lieu of
issuing shares of common stock upon redemption of limited partnership units, we
may redeem the partnership units tendered for cash in an amount equal to the
then-current value of the shares of common stock. Holders of limited partnership
units would be entitled to receive distributions equivalent to the dividends we
pay to holders of our shares of common stock. As the sole owner of the general
partner of our operating partnership, we have the power to manage and conduct
our operating partnership's business, subject to the limitations described in
the first amended and restated agreement of limited partnership of our operating
partnership. See "Partnership Agreement."

MPT Operating Partnership, L.P. is a limited partner of MPT West Houston
MOB, L.P. and MPT West Houston Hospital, L.P., which respectively own the
Houston medical office building and the Houston community hospital in our
portfolio which are under development. MPT West Houston MOB,

LLC and MPT West Houston Hospital, LLC, our wholly-owned subsidiaries, are the
respective general partners of these entities. We have sold limited partnership
interests representing approximately 24% of the aggregate equity interests in
MPT West Houston MOB, L.P. to physicians and others associated with our tenant
or subtenants of the West Houston MOB. Stealth, L.P., the tenant of the Houston
community hospital under development and an entity majority-owned by physicians,
owns a 6% limited partnership interest in MPT West Houston Hospital, L.P.

In general, the management and control of the limited partnerships or
limited liability companies that own our properties, such as MPT West Houston
MOB, L.P. and MPT West Houston Hospital, L.P., rests with our operating
partnership or its subsidiaries. The limited partners or other minority owners
in these entities will not participate in the management or control of the
business of the partnership or other entity. Although the partnership agreements
or limited liability company agreements for future limited partnerships or
limited liability companies may vary, our current limited partnership agreements
require approval of the limited partners holding a majority of the units in the
partnership other than the general partner and its affiliates to:

- amend the partnership agreement in a manner that would:

- adversely affect the financial or other rights of the limited partners
who are not affiliates of the general partner or positively affect the
financial rights or other rights of the general partner or reduce the
general partner's obligations and responsibilities under the limited
partnership agreement;

- impose on the limited partners who are not affiliates of the general
partner any obligation to make additional capital contributions to the
partnership;

- adversely affect the rights of certain limited partners without
similarly affecting the rights of other limited partners;

- merge, consolidate or combine with another entity; or

- determine the terms and the amount of consideration payable for any
issuances of additional partnership units to our operating partnership,
the general partner or any of their respective affiliates.

In general, each partner or other equity owner will share in the
partnership's profits, losses and available cash flow pro rata based upon his
percentage interest in the partnership. We may hold properties we develop or
acquire in the future through structures similar to the structure through which
we hold the Houston facilities in our portfolio.

MPT DEVELOPMENT SERVICES, INC.

MPT Development Services, Inc., our taxable REIT subsidiary, was
incorporated in January 2004 as a Delaware corporation. MPT Development
Services, Inc. is authorized to provide third-party facility planning, project
management, medical equipment planning and implementation services, medical
office building management services, lending services, including but not limited
to acquisition and working capital loans to our tenants, and other services that
neither we nor our operating partnership can undertake directly under applicable
REIT tax rules. Overall, no more than 20% of the value of our assets may consist
of securities of one or more taxable REIT subsidiaries, and no more than 25% of
the value of our assets may consist of securities that are not qualifying assets
under the test requiring that 75% of a REIT's assets consist of real estate and
other related assets. Further, a taxable REIT subsidiary may not directly or
indirectly operate or manage a healthcare facility. For purposes of this
definition a "healthcare facility" means a hospital, nursing facility, assisted
living facility, congregate care facility, qualified continuing care facility,
or other licensed facility which extends medical or nursing or ancillary
services to patients and which is operated by a service provider that is
eligible for participation in the Medicare program under Title XVIII of the
Social Security Act with respect to the facility.

MPT Development Services, Inc. will pay federal, state and local income
taxes at regular corporate rates on its taxable income. MPT Development
Services, Inc. has made, and from time to time may make, loans to tenants or
prospective tenants to assist them with the acquisition of the operations at
facilities

leased or to be leased to them and for initial working capital needs. There are
currently approximately $41.4 million in such loans outstanding. See "Our
Portfolio -- Our Current Portfolio of Facilities."

DEPRECIATION

Generally, the federal tax basis for our facilities used to determine
depreciation for federal income tax purposes will be our acquisition costs for
such facilities. To the extent facilities are acquired with units of our
operating partnership or its subsidiaries, we will acquire a carryover basis in
the facilities. For federal income tax purposes, depreciation with respect to
the real property components of our facilities, other than land, generally will
be computed using the straight-line method over a useful life of 40 years, for a
depreciation rate of 2.50% per year.

OUR LEASES

The leases for our facilities are "net" leases with terms requiring the
tenant to pay all ongoing operating and maintenance expenses of the facility,
including property, casualty, general liability and other insurance coverages,
utilities and other charges incurred in the operation of the facilities, as well
as real estate taxes, ground lease rent and the costs of capital expenditures,
repairs and maintenance. Our leases also provide that our tenants will indemnify
us for environmental liabilities. Our current leases range from 11 to 16 years
and provide for annual rent escalation and, in the case of the Vibra Facilities,
percentage rent. Our leases require periodic reports and financial statements
from our tenants. In addition, our leases contain customary default,
termination, and subletting and assignment provisions. See "Our Portfolio -- Our
Current Portfolio of Facilities." We anticipate that our future leases will have
similar terms, including percentage rent where feasible and in compliance with
applicable healthcare laws and regulations.

ENVIRONMENTAL MATTERS

Under various federal, state and local environmental laws and regulations,
a current or previous owner, operator or tenant of real estate may be required
to investigate and clean up hazardous or toxic substances or petroleum product
releases or threats of releases at such property and may be held liable to a
government entity or to third parties for property damage and for investigation,
clean-up and monitoring costs incurred by such parties in connection with the
actual or threatened contamination, including substances currently unknown, that
may have been released on the real estate. These laws may impose clean-up
responsibility and liability without regard to fault, or whether or not the
owner, operator or tenant knew of or caused the presence of the contamination.
The liability under these laws may be joint and several for the full amount of
the investigation, clean-up and monitoring costs incurred or to be incurred or
actions to be undertaken, although a party held jointly and severally liable
might be able to obtain contributions from other identified, solvent,
responsible parties of their fair share toward these costs. Investigation,
clean-up and monitoring costs may be substantial and can exceed the value of the
property. The presence of contamination, or the failure to properly remediate
contamination, on a property may adversely affect the ability of the owner,
operator or tenant to sell or rent that property or to borrow funds using such
property as collateral and may adversely impact our investment in that property.
In addition, if hazardous substances are located on or released from our
properties, we could incur substantial liabilities through a private party
personal injury claim, a property damage claim by an adjacent property owner, or
claims by a governmental entity or others for other damages, such as natural
resource damages. This liability may be imposed under environmental laws or
common-law principles.

Federal regulations require building owners and those exercising control
over a building's management to identify and warn, via signs and labels, of
potential hazards posed by workplace exposure to installed asbestos-containing
materials and potentially asbestos-containing materials in their building. The
regulations also set forth employee training, record keeping and due diligence
requirements pertaining to asbestos-containing materials and potentially
asbestos-containing materials. Government entities can assess significant fines
for violation of these regulations. Building owners and those exercising control
over a building's management may be subject to an increased risk of personal
injury lawsuits by workers and others exposed to asbestos-containing materials
and potentially asbestos-containing materials as a result of these regulations.
The regulations may affect the value of a building containing
asbestos-containing materials and potentially asbestos-containing materials in
which we have invested. Federal, state and local

laws and regulations also govern the removal, encapsulation, disturbance,
handling and disposal of asbestos-containing materials and potentially
asbestos-containing materials when such materials are in poor condition or in
the event of construction, remodeling, renovation or demolition of a building.
Such laws and regulations may impose liability for improper handling or a
release to the environment of asbestos-containing materials and potentially
asbestos-containing materials and may provide for fines to, and for third
parties to seek recovery from, owners or operators of real property for personal
injury or improper work exposure associated with asbestos-containing materials
and potentially asbestos-containing materials.

Prior to closing any facility acquisition, we obtain Phase I environmental
assessments in order to attempt to identify potential environmental concerns at
the facilities. These assessments will be carried out in accordance with an
appropriate level of due diligence and will generally include a physical site
inspection, a review of relevant federal, state and local environmental and
health agency database records, one or more interviews with appropriate
site-related personnel, review of the property's chain of title and review of
historic aerial photographs and other information on past uses of the property.
We may also conduct limited subsurface investigations and test for substances of
concern where the results of the Phase I environmental assessments or other
information indicates possible contamination or where our consultants recommend
such procedures.

While we may purchase many of our facilities on an "as is" basis, we intend
for all of our purchase contracts to contain an environmental contingency
clause, which permits us to reject a facility because of any environmental
hazard at the facility.

COMPETITION

We compete in acquiring and developing facilities with financial
institutions, institutional pension funds, real estate developers, other REITs,
other public and private real estate companies and private real estate
investors. Among the factors adversely affecting our ability to compete are the
following:

- we may have less knowledge than our competitors of certain markets in
which we seek to purchase or develop facilities;

- many of our competitors have greater financial and operational resources
than we have; and

- our competitors or other entities may determine to pursue a strategy
similar to ours.

To the extent that we experience vacancies in our facilities, we will also
face competition in leasing those facilities to prospective tenants. The actual
competition for tenants varies depending on the characteristics of each local
market. Virtually all of our facilities operate in a competitive environment,
and patients and referral sources, including physicians, may change their
preferences for a healthcare facilities from time to time.

HEALTHCARE REGULATORY MATTERS

The following discussion describes certain material federal healthcare laws
and regulations that may affect our operations and those of our tenants.
However, the discussion does not address state healthcare laws and regulations,
except as otherwise indicated. These state laws and regulations, like the
federal healthcare laws and regulations, could affect our operations and those
of our tenants. Moreover, the discussion relating to reimbursement for
healthcare services addresses matters that are subject to frequent review and
revision by Congress and the agencies responsible for administering federal
payment programs. Consequently, predicting future reimbursement trends or
changes is inherently difficult.

Ownership and operation of hospitals and other healthcare facilities are
subject, directly and indirectly, to substantial federal, state and local
government healthcare laws and regulations. Our tenants' failure to comply with
these laws and regulations could adversely affect their ability to meet their
lease obligations. Physician investment in us or in our facilities also will be
subject to such laws and regulations. We intend for all of our business
activities and operations to conform in all material respects with all
applicable laws and regulations.

Anti-Kickback Statute. 42 U.S.C. sec.1320a-7b(b), or the Anti-Kickback
Statute, prohibits, among other things, the offer, payment, solicitation or
acceptance of remuneration directly or indirectly in return

for referring an individual to a provider of services for which payment may be
made in whole or in part under a federal healthcare program, including the
Medicare or Medicaid programs. Violation of the Anti-Kickback Statute is a crime
and is punishable by criminal fines of up to $25,000 per violation, five years
imprisonment or both. Violations may also result in civil sanctions, including
civil penalties of up to $50,000 per violation, exclusion from participation in
federal healthcare programs, including Medicare and Medicaid, and additional
monetary penalties in amounts treble to the underlying remuneration.

The Anti-Kickback Statute defines the term "remuneration" very broadly and,
accordingly, local physician investment in our facilities could trigger scrutiny
of our lease arrangements under the Anti-Kickback Statute. In addition to
certain statutory exceptions, the Office of Inspector General of the Department
of Health and Human Services, or OIG, has issued "Safe Harbor Regulations" that
describe practices that will not be considered violations of the Anti-Kickback
Statute. These include a safe harbor for space rental arrangements which
protects payments made by a tenant to a landlord under a lease arrangement
meeting certain conditions. We intend to use our commercially reasonable efforts
to structure lease arrangements involving facilities in which local physicians
are investors and tenants so as to satisfy, or meet as closely as possible, the
conditions for the safe harbor for space rental. We cannot assure you, however,
that we will meet all the conditions for the safe harbor, and it is unlikely
that we will meet all conditions for the safe harbor in those instances in which
percentage rent is contemplated and we have physician investors. In addition,
federal regulations require that our tenants with purchase options pay fair
market value purchase prices for facilities in which we have physician
investment. We intend our lease agreement purchase option prices to be fair
market value; however, we cannot assure you that all of our purchase options
will be at fair market value. Any purchase not at fair market value may present
risks of challenge from healthcare regulatory authorities. The fact that a
particular arrangement does not fall within a statutory exception or safe harbor
does not mean that the arrangement violates the Anti-Kickback Statute. The
statutory exception and Safe Harbor Regulations simply provide a guaranty that
qualifying arrangements will not be prosecuted under the Anti-Kickback Statute.
The implication of the Anti-Kickback Statute could limit our ability to include
local physicians as investors or tenants or restrict the types of leases into
which we may enter if we wish to include such physicians as investors having
direct or indirect ownership interests in our facilities.

Federal Physician Self-Referral Statute. Any physicians investing in our
company or its subsidiary entities could also be subject to the Ethics in
Patient Referrals Act of 1989, or the Stark Law (codified at 42 U.S.C.
sec. 1395nn). Unless subject to an exception, the Stark Law prohibits a
physician from making a referral to an "entity" furnishing "designated health
services" paid by Medicare or Medicaid if the physician or a member of his
immediate family has a "financial relationship" with that entity. A reciprocal
prohibition bars the entity from billing Medicare or Medicaid for any services
furnished pursuant to a prohibited referral. Financial relationships are defined
very broadly to include relationships between a physician and an entity in which
the physician or the physician's family member has (i) a direct or indirect
ownership or investment interest that exists in the entity through equity, debt
or other means and includes an interest in an entity that holds a direct or
indirect ownership or investment interest in any entity providing designated
health services; or (ii) a direct or indirect compensation arrangement with the
entity.

The Stark Law as originally enacted in 1989 only applied to referrals for
clinical laboratory tests reimbursable by Medicare. However, the law was amended
in 1993 and 1994 and, effective January 1, 1995, became applicable to referrals
for an expanded list of designated health services reimbursable under Medicare
or Medicaid.

The Stark Law specifies a number of substantial sanctions that may be
imposed upon violators. Payment is to be denied for Medicare claims related to
designated health services referred in violation of the Stark Law. Further, any
amounts collected from individual patients or third-party payors for such
designated health services must be refunded on a timely basis. A person who
presents or causes to be presented a claim to the Medicare program in violation
of the Stark Law is also subject to civil monetary penalties of up to $15,000
per claim, civil money penalties of up to $100,000 per arrangement and possibly
even exclusion from participation in the Medicare and Medicaid programs.

Final regulations applicable only to physician referrals for clinical
laboratory services were published in August 1995. A proposed rule applicable to
physician referrals for all designated health services was published in January
1998. In January 2001, CMS published the "Phase I" final rule, which finalized a
significant portion of the 1998 proposed rule. On March 26, 2004, CMS issued the
second phase of its final regulations addressing physician referrals to entities
with which they have a financial relationship (the "Phase II" rule). The Phase
II rule addresses and interprets a number of exceptions for ownership and
compensation arrangements involving physicians, including the exceptions for
space and equipment rentals and the exception for indirect compensation
arrangements. The Phase II rule also includes exceptions for physician ownership
and investment, including physician ownership of rural providers and hospitals.
The new regulation revises the hospital ownership exception to reflect the
18-month moratorium that began December 8, 2003 on physician ownership of
specialty hospitals, which was enacted in Section 507 of the Medicare
Prescription Drug, Improvement, and Modernization Act of 2003. The Phase II rule
became effective on July 26, 2004.

In those cases where physicians invest in us or our facilities, we intend
to fashion our lease arrangements with healthcare providers to meet the
applicable indirect compensation exceptions under the Stark Law, however, no
assurance can be given that our leases will satisfy these Stark Law exception
requirements. Unlike the Anti-kickback Statute Safe Harbor Regulations, a
financial arrangement which implicates the Stark Law must meet the requirements
of an applicable exception to avoid a violation of the Stark Law. This may lead
to obstacles in permitting local physicians to invest in our facilities or
restrict the types of lease arrangements we may enter into if we wish to include
such physicians as investors.

State Self-Referral Laws. In addition to the Anti-Kickback Statute and the
Stark Law, state physician self-referral laws could limit physician investment
in our company or restrict the types of leases we may enter into if such
physician investment is permitted.

Recent Regulatory and Legislative Developments. On August 1, 2003, CMS
published the fiscal year 2004 Final Rule for inpatient rehabilitation
facilities, or IRFs. Under the Final Rule, all IRFs have received an increase in
their prospective payment system rate for fiscal year 2004 due to an across the
board 3.2% IRF market basket increase. On July 30, 2004, CMS published the
fiscal year 2005 Final Rule which updated the prospective payment rates for IRFs
for fiscal year 2005. In updating the fiscal year 2005 payment rates, CMS
applied an increase factor to the fiscal year 2004 IRF prospective payment
system rates that is equal to the IRF market basket. According to CMS, the
projected fiscal year 2005 IRF market basket increase factor is 3.1%.
Additionally, the Final Rule calculates the labor-related share for fiscal year
2005. These increases benefit those tenants of ours who operate IRFs.

On May 7, 2004, CMS issued a Final Rule to revise the classification
criterion, commonly known as the "75 percent rule," used to classify a hospital
or hospital unit as an IRF. The compliance threshold is used to distinguish an
IRF from an acute care hospital for purposes of payment under the Medicare IRF
prospective payment system. The Final Rule implements a three-year period to
analyze claims and patient assessment data to determine whether CMS will
continue to use a compliance threshold that is lower than 75% or not. For cost
reporting periods beginning on or after July 1, 2004, and before July 1, 2005,
the compliance threshold will be 50% of the IRF's total patient population. The
compliance threshold will increase to 60% of the IRF's total patient population
for cost reporting periods beginning on or after July 1, 2005 and before July 1,
2006, to 65% for cost reporting periods beginning on or after July 1, 2006 and
before July 1, 2007, and to 75% for cost reporting periods after July 1, 2007.

On December 8, 2003, President Bush signed into law the Medicare
Prescription Drug and Modernization Act of 2003, or the Act, which contains
sweeping changes to the federal health insurance program for the elderly and
disabled. The Act includes provisions affecting program payment for inpatient
and outpatient hospital services. In total, the Congressional Budget Office
estimates that hospitals will receive $24.8 billion over ten years in additional
funding due to the Act.

Rural hospitals, which may include regional or community hospitals, one of
our targeted types of facilities, will benefit most from the reimbursement
changes in the Act. Some examples of these reimbursement changes include (i)
providing that payment for all hospitals, regardless of geographic
68

location, will be based on the same, higher standardized amount which was
previously available only for hospitals located in large urban areas, (ii)
reducing the labor share of the standardized amount from 71% to 62% for
hospitals with an applicable wage index of less than 1.0, (iii) giving hospitals
the ability to seek a higher wage index based on the number of hospital
employees who take employment out of the county in which the hospital is located
with an employer in a neighboring county with a higher wage index, and (iv)
improving critical access hospital program conditions of participation
requirements and reimbursement. Medicare disproportionate share hospital, or
DSH, payment adjustments for hospitals that are not large urban or large rural
hospitals will be calculated using the DSH formula for large urban hospitals, up
to a 12% cap in 2004 for all hospitals other than rural referral centers, which
are not subject to the cap. The Act provides that sole community hospitals, as
defined in 42 U.S.C. sec. 1395 ww(d)(5)(D)(iii), located in rural areas, rural
hospitals with 100 or fewer beds, and certain cancer and children's hospitals
shall receive Transitional Outpatient Payments, or TOPs, such that these
facilities will be paid as much under the Medicare outpatient prospective
payment system, or OPPS, as they were paid prior to implementation of OPPS. As
of January 1, 2004 all TOPs for community mental health centers and all other
hospitals were otherwise discontinued. The "hold harmless" TOPs provided for
under the Act will continue for qualifying rural hospitals for services
furnished through December 31, 2005 and for sole community hospitals for cost
reporting periods beginning on or after January 1, 2004 and ending on December
31, 2005. Hold harmless TOPs payments continue permanently for cancer and
children's hospitals.

The Act also requires CMS to provide supplemental payments to acute care
hospitals that are located more than 25 road miles from another acute care
hospital and have low inpatient volumes, defined to include fewer than 800
discharges per fiscal year, effective on or after October 1, 2004. Total
supplemental payments may not exceed 25 percent of the otherwise applicable
prospective payment rate.

Finally, the Act assures inpatient hospitals that submit certain quality
measure data a full inflation update equal to the hospital market basket
percentage increase for fiscal years 2005 through 2007. The market basket
percentage increase refers to the anticipated rate of inflation for goods and
services used by hospitals in providing services to Medicare patients. For
fiscal year 2005, the market basket percentage increase for hospitals paid under
the inpatient prospective payment system is 3.3 percent. For those inpatient
hospitals that do not submit such quality data, the Act provides for an update
of market basket minus 0.4 percentage points.

The Act also imposes an 18 month moratorium limiting the availability of
the "whole hospital exception," or Whole Hospital Exception, under the Stark Law
for specialty hospitals. The moratorium began upon enactment of the Act and will
continue until June 8, 2005. Prior to the moratorium's expiration, Congress will
reevaluate this provision to determine whether it should sunset, be extended or
be made permanent. On January 12, 2005, as part of its mandated report on
specialty hospitals, the Medicare Payment Advisory Committee, or MedPAC,
recommended that Congress extend the 18 month moratorium for an additional
period until January 1, 2007. Under the Whole Hospital Exception, the Stark Law
currently permits a physician to refer a Medicare or Medicaid patient to a
hospital in which the physician has an ownership or investment interest so long
as the physician maintains staff privileges at the hospital and the physician's
ownership or investment interest is in the hospital as a whole, rather than a
subdivision of the facility.

Specialty hospitals are defined to mean a hospital subject to the inpatient
prospective payment system that is located outside of Puerto Rico, which was
neither in operation nor under development as of November 18, 2003, and is
primarily or exclusively engaged in treating patients with cardiac or orthopedic
conditions, undergoing surgery or receiving any other specialized category of
services that the Secretary designates. If a specialty hospital that was in
operation or under development as of November 18, 2003 increases the number of
physician investors, adds certain new clinical services, augments its bed
capacity or violates other requirements to be designated by the Secretary it
will become subject to the moratorium. The Act also prohibits physicians from
investing in rural specialty hospitals from invoking the alternative Stark Law
exception for physician ownership in rural providers.

Any acquisition or development of specialty hospitals must comply with the
current application and interpretation of the Stark Law. CMS may clarify or
modify its definition of specialty hospital, which may result in physicians who
own interests in our tenants being forced to divest their ownership. Although
the specialty hospital moratorium limits physician ownership or investment in
"specialty hospitals" as defined by CMS, it does not limit a physician's ability
to hold an ownership or investment interest in facilities which may be leased to
hospital operators or other healthcare providers, assuming the lease arrangement
conforms to the requirements of an applicable exception under the Stark Law. We
intend to structure all of our leases, including leases containing percentage
rent arrangements, to comply with applicable exceptions under the Stark Law and
to comply with the Anti-kickback Statute. We believe that strong arguments can
be made that percentage rent arrangements, when structured properly, should be
permissible under the Stark Law and the Anti-kickback law; however, these laws
are subject to continued regulatory interpretation and there can be no assurance
that such arrangements will continue to be permissible. Accordingly, although we
do not currently have any percentage rent arrangements where physicians own an
interest in our facilities, we may be prohibited from entering into percentage
rent arrangements in the future where physicians own an interest in our
facilities. In the event we enter into such arrangements at some point in the
future and later find the arrangements no longer comply with the Stark Law or
Anti-Kickback Statute, we or our tenants may be subject to penalties under the
statutes.

The California Department of Health Services recently adopted regulations,
codified as Sections 70217, 70225 and 70455 of Title 22 of the California Code
of Regulations, or CCR, which establish minimum, specific, numerical licensed
nurse-to-patient ratios for specified units of general acute care hospitals.
These regulations are effective January 1, 2004. The minimum staffing ratios set
forth in 22 CCR 70217(a) co-exist with existing regulations requiring that
hospitals have a patient classification system in place. 22 CCR, 70053.2 and
70217. The licensed nurse-to-patient ratios constitute the minimum number of
registered nurses, licensed vocational nurses, and, in the case of psychiatric
units, licensed psychiatric technicians, who shall be assigned to direct patient
care and represent the maximum number of patients that can be assigned to one
licensed nurse at any one time. Over the past several years many hospitals have,
in response to managed care reimbursement contracts, cut costs by reducing their
licensed nursing staff. The California Legislature responded to this trend by
requiring a minimum number of licensed nurses at the bedside. Due to this new
regulatory requirement, any acute care facilities we target for acquisition or
development in California may be required to increase their licensed nursing
staff or decrease their admittance rates as a result.

On May 7, 2004, CMS issued a final rule to update the annual payment rates
for the Medicare prospective payment system for services provided by long term
care hospitals. The rule increases the Medicare payment rate for long-term care
hospitals by 3.1% starting July 1, 2004. Medicare expects aggregate payment to
these hospitals to increase to $2.96 billion during the 2005 long-term care
hospital rate year. Long-term care hospitals, one of the types of facilities we
are targeting, are defined generally as hospitals that have an average Medicare
inpatient length of stay greater than 25 days. CMS issued a proposed rule on
February 3, 2005 which contains the proposed annual payment rate updates under
the prospective payment system for long-term care hospitals. The proposed rule
contains the 2006 long-term care hospital prospective payment system rate for
the year July 1, 2005 through June 30, 2006. According to CMS, the proposed
standard federal rate for the 2006 long-term care hospital prospective payment
system rate year would increase 3.1% compared to the 2005 long-term care
hospital prospective payment system rate year standard federal rate due to the
proposed update to the long-term care hospital prospective payment system
federal rate. In addition, the proposed rule contains policy changes including
the adoption of new labor market area definitions for long-term care hospitals
which are based on the new Core-Based Statistical Areas announced by the OMB
late in 2000.

In addition to the extension of the specialty hospital moratorium discussed
above, at its January 12, 2005 meeting, MedPAC made extensive recommendations to
Congress and the Secretary of HHS including proposing revisions to DRG payments
to more fully capture differences in severity of illnesses in an attempt to more
equally pay for care provided at general acute care hospitals as compared to
specialty hospitals. Furthermore, MedPAC made significant recommendations
regarding paying healthcare providers relative to their performance and to the
outcomes of the care they provided. MedPAC recommendations
70

have historically provided strong indications regarding future directions of
both the regulatory and legislative process.

INSURANCE

EMPLOYEES

We employ 15 full-time employees and one part-time employee as of the date
of this prospectus. We anticipate hiring approximately five to 10 additional
full-time employees during the next 12 months, commensurate with our growth. We
believe that our relations with our employees are good. None of our employees is
a member of any union.

LEGAL PROCEEDINGS

We are not involved in any material litigation nor, to our knowledge, is
any material litigation pending or threatened against us.

OUR PORTFOLIO

OUR CURRENT PORTFOLIO

Our current portfolio of facilities consists of nine healthcare facilities,
seven of which are in operation and two of which are under development. The
Vibra Facilities consist of four rehabilitation hospitals and two long-term
acute care hospitals. The Desert Valley Facility is a community hospital with an
integrated medical office building. The facilities under development are the
West Houston Hospital and the adjacent West Houston MOB that is master-leased by
the tenant of the hospital. All of the leases for the hospitals currently in
operation have initial terms of 15 years. The initial lease term for the West
Houston Hospital began when construction commenced in July 2004 and will end 15
years after completion of construction. The initial lease term for the West
Houston MOB began when construction commenced in July 2004 and will end 10 years
after completion of construction. Construction of the West Houston MOB is
projected to be completed in August 2005 and construction of the West Houston
Hospital is projected to be completed in October 2005. The leases for all of the
facilities in our current portfolio provide for contractual base rent and an
annual rent escalator. The leases for the Vibra Facilities also provide for
percentage rent based on an agreed percentage of the tenants' gross revenue. The
following tables set forth information, as of March 31, 2005, regarding our
current portfolio of facilities:

Operating Facilities
GROSS
PURCHASE LEASE
LOCATION PRICE(3) EXPIRATION
- -------- ------------ ---------------

Bowling Green,
Kentucky...............

$ 38,211,658 July 2019
Marlton, New
Jersey(5)..............

32,267,622 July 2019
Victorville,
California(7)..........
28,000,000 February 2020

New Bedford,
Massachusetts..........

22,077,847 August 2019
Fresno, California......

18,681,255 July 2019

Thornton, Colorado...... Rehabilitation Vibra
hospital Healthcare,
LLC(4) 117 870,377 933,200 1,064,471
Kentfield, California... Long-term Vibra
acute care Healthcare,
hospital LLC(4) 60 783,339 858,998 958,024
--- ----------- ----------- -----------
TOTAL................... -- -- 548 $13,150,010 $16,684,639 $18,938,462
=== =========== =========== ===========

Operating Facilities
GROSS
PURCHASE LEASE
LOCATION PRICE(3) EXPIRATION
- -------- ------------ ---------------

Thornton, Colorado......
8,491,481 August 2019
Kentfield, California...
7,642,332 July 2019
------------
TOTAL................... $155,372,195 --
============

- ---------------

(1) Based on the number of licensed beds.

(2) Based on leases in place as of the date of this prospectus.

(3) Includes acquisition costs.

(4) The tenant in each case is a separate, wholly-owned subsidiary of Vibra
Healthcare, LLC.

(6) Thirty of the 76 beds are pediatric rehabilitation beds operated by HBA
Management, Inc.

Facilities Under
Development

Houston, Texas.......... Community
hospital(4) Stealth, L.P. 105(5) $ -- $ 772,196 $4,749,005
Houston, Texas.......... Medical office
building(7) Stealth, L.P. n/a -- 670,840 2,052,769
--- ----------- ---------- ----------
TOTAL................... -- -- 105 $ -- $1,443,036 $6,801,774
=== =========== ========== ==========

PROJECTED
DEVELOPMENT LEASE
LOCATION COST(3) EXPIRATION
- -------- ----------- ---------------

Houston, Texas..........
$43,099,310 October 2020(6)
Houston, Texas..........
20,855,119 August 2015(8)
-----------
TOTAL................... $63,954,429 --
===========

- ---------------

(1) Based on the number of licensed beds.

(3) Includes acquisition costs.

(4) Expected to be completed in October 2005.

(5) Seventy-one of the 105 beds will be acute care beds operated by Stealth,
L.P. and the remaining 34 beds will be long-term acute care beds operated by
Triumph Southwest, L.P.

(7) Expected to be completed in August 2005.

VIBRA FACILITIES AND LOANS

General. We own or ground lease the six Vibra Facilities located in
Bowling Green, Kentucky; Marlton, New Jersey; Fresno, California; Kentfield,
California; Thornton, Colorado; and New Bedford, Massachusetts. We acquired
these facilities from Care Ventures, Inc., an unaffiliated third party, in July
and August 2004 for an aggregate purchase price of approximately $127.4 million,
including acquisition costs. The purchase price was arrived at through
arms-length negotiations with Care Ventures, Inc., based upon our analysis of
various factors. These factors included the demographics of the area in which
the facility is located, the capabilities of the tenant to operate the facility,
healthcare spending trends in the geographic area, the structural integrity of
the facility, governmental regulatory trends which may impact the services
provided by the tenant, and the financial and economic returns which we require
for making an investment. The Vibra Facilities are leased to subsidiaries of
Vibra. Our leases of the Vibra Facilities require the tenant to carry customary
insurance which is adequate to satisfy our underwriting standards.

Vibra is an affiliate of Senior Real Estate Holdings, LLC, D/B/A The
Hollinger Group, or The Hollinger Group. Vibra has been recently formed and had
engaged in no meaningful operations prior to

entering into the leases for the Vibra Facilities in July and August 2004. The
principals of The Hollinger Group have extensive experience in developing,
acquiring, managing and operating specialty healthcare facilities and senior
care facilities. Mr. Hollinger, the principal owner of Vibra and the founder and
chief executive officer of The Hollinger Group, has 18 years experience in all
phases of senior care and healthcare activities. For financial information
respecting Vibra and its subsidiaries, see the audited financial statements
included elsewhere in this prospectus.

Vibra Loans and Fees Receivable. At the time we acquired the Vibra
Facilities, MPT Development Services, Inc., our taxable REIT subsidiary, made a
loan of approximately $41.4 million to Vibra to acquire the operations at these
locations. We refer to this loans as the acquisition loan. The acquisition loan
accrues interest at the rate of 10.25% per year and are to be repaid over 15
years with interest only for the first three years and the principal balance
amortizing over the remaining 12 year period. The acquisition loan may be
prepaid at any time without penalty. In connection with the Vibra transactions,
Vibra agreed to pay us commitment fees of approximately $1.5 million. MPT
Development Services, Inc. also made secured loans totaling approximately $6.2
million to Vibra and its subsidiaries for working capital purposes. The
commitment fees were paid, and the working capital loans were repaid, on
February 9, 2005.

As security for the acquisition loan, Vibra has pledged to us all of its
interests in each of the tenants, and Mr. Hollinger has pledged to us his entire
interest in Vibra. In addition, Mr. Hollinger, The Hollinger Group and Vibra
Management, LLC, another affiliate of Mr. Hollinger, have guaranteed the
repayment of the acquisition loan; however, The Hollinger Group and Vibra
Management, LLC do not have substantial assets and the liability of Mr.
Hollinger under his guaranty is limited to $5.0 million. See "-- Lease
Guaranties and Security."

Vibra has entered into a $14.0 million credit facility with Merrill Lynch,
and that loan is secured by an interest in Vibra's receivables. There was
approximately $11.0 million outstanding under the facility on March 31, 2005.
Our loan to Vibra is subordinate to Merrill Lynch with respect to Vibra's
receivables. At March 31, 2005, Vibra was not in compliance with a facility rent
coverage covenant under its Merrill Lynch credit facility. The Merrill Lynch
credit facility documents were subsequently amended to retroactively change the
rent coverage covenant from a by facility rent coverage to a consolidated rent
coverage calculation, such that Vibra was in compliance with the amended
covenant at March 31, 2005.

Leases. Each Vibra lease provides that, so long as the acquisition loan is
outstanding, after January 1, 2005, and beginning with the calendar month after
the month in which aggregate gross revenues for the Vibra Facilities exceed a
revenue threshold, the tenant will pay, in addition to base rent, percentage
rent in an amount equal to 2% of revenues for the preceding month. Each calendar
month thereafter during the term of each lease, the percentage rent will be
decreased pro rata based on the amount of the principal reduction of the
acquisition loan during the previous calendar month; however, the percentage
rent will not be decreased below 1% of revenues.

On March 31, 2005, the leases for the Vibra Facilities were amended to
provide (i) that the testing of certain financial covenants will be deferred
until the quarter beginning July 1, 2006 and ending September 30, 2006, (ii)
that these same financial covenants will be tested on a consolidated basis for
all of the Vibra Facilities, (iii) that the reduction in the rate of percentage
rent will be made on a monthly rather than annual basis and (iv) that Vibra will
escrow insurance premiums and taxes at our request. Prior to execution of this
amendment, Vibra did not meet the fixed charge coverage ratios required by the
lease agreements. One covenant required that each Vibra Facility maintain a
ratio of earnings before interest expense, income tax expense, depreciation
expense, amortization expense and base rent (EBITDAR) to total debt payments
plus base rent, measured at the end of each quarter, in excess of 125%. The
second covenant required that each Vibra Facility maintain a ratio of EBITDAR to
base rent, measured at the end of each quarter, in excess of 150%. In the event
that either ratio for any Vibra Facility was below the required level for two
consecutive fiscal quarters, an event of default would have occurred.

Capital Improvements. The tenant under each Vibra lease is responsible for
all capital expenditures required to keep the facility in compliance with
applicable laws and regulations. Beginning on July 1, 2005, each tenant will
make quarterly deposits into a capital improvement reserve account for the
particular facility in the amount of $1,500 per bed per year, except that the
first deposit will be pro-rated based on one-half of a year. On each January 1
thereafter, the payment of $1,500 per bed per year into the capital improvement
reserve will be increased by 2.5%. All capital expenditures made in each year
during the term of the lease will be funded first from the capital improvement
reserve, and the tenant will pay into its respective capital improvement reserve
such funds as necessary for all replacements and repairs.

Lease and Loan Guaranties and Security. We have obtained guaranty
agreements from Mr. Hollinger, Vibra, Vibra Management, LLC and The Hollinger
Group that obligate them to make lease and loan payments in the event that Vibra
or its tenants fail to do so. We believe that these agreements are important
elements of our underwriting of newly-formed healthcare operating companies
because they create incentives for their owners and managements to successfully
operate our tenants. However, we do not believe that these parties have
sufficient financial resources to satisfy a material portion of the total lease
or loan obligations. Mr. Hollinger's guaranty is limited to $5.0 million, Vibra
Management, LLC and The Hollinger Group do not have substantial assets and
Vibra's assets are substantially comprised of the Vibra Facilities.

Each Vibra lease is cross-defaulted with the other leases for the Vibra
Facilities. In addition, Vibra has pledged to us all of its interests in each of
the tenants, and Mr. Hollinger has pledged to us his interest in Vibra. As
security for the leases, each of the Vibra tenants has granted us a security
interest in all personal property, other than receivables, located at the Vibra
Facilities. The management fees that the Vibra tenants pay to Vibra Management,
LLC are subordinated to the rents payable to us under the Vibra leases.

We have included the audited and unaudited consolidated financial
statements for Vibra Healthcare, LLC as of and for the year ended December 31,
2004 and as of and for the three months ended March 31, 2005. We believe that
the financial statements of Vibra Healthcare, LLC are the most meaningful
financial information respecting the ability of Vibra to make the lease and loan
payments which it is obligated to make to us. We do not believe that historical
financial information on the facilities prior to our acquisition of those
facilities would be meaningful because the facilities had three different owners
in the year prior to our acquisition. Also during that time, the owners did not
lease those facilities to lessees but operated the facilities themselves, and
the facilities were not operated in the same manner as they are currently being
operated. We also believe that the financial statements of the guarantors
provide limited financial information due to the limited resources which those
guarantors possess. We do not believe the financial statements of the Vibra
guarantors other than Vibra would be helpful to prospective investors.
Therefore, we have provided the financial statements of Vibra Healthcare, LLC,
which includes consolidated financial information on the actual lessees of the
Vibra Facilities and the parent entity, which is one of the guarantors and the
borrower under the Vibra loans.

Purchase Option. At the expiration of each Vibra lease, each tenant will
have the option to purchase the facility at a purchase price equal to the
greater of (i) the appraised value of the facility, determined assuming the
lease is still in place, or (ii) the purchase price we paid for the facility,
including acquisition costs, increased by 2.5% per annum from the date of
purchase.

Depreciation and Real Estate Taxes. The following table sets forth
information, as of March 31, 2005, regarding the depreciation and real estate
taxes for the Vibra Facilities:

DEPRECIATION
FEDERAL TAX BASIS -------------------------------------- 2005 REAL ESTATE
------------------------ ANNUAL -----------------
LAND BUILDINGS RATE METHOD LIFE IN YEARS TAXES RATE
---------- ----------- ------ ------------- ------------- --------- -----

Bowling Green, KY...... $3,070,000 $35,141,658 2.5% Straight-line 40 $ 27,062 0.07%
Thornton, CO........... 2,130,000 6,361,481 2.5% Straight-line 40 197,902 2.33%
Fresno, CA............. 1,550,000 17,131,255 2.5% Straight-line 40 113,512 0.61%
Kentfield, CA.......... 2,520,000 5,122,332 2.5% Straight-line 40 92,243 1.21%
Marlton, NJ............ -- 32,267,622 2.5% Straight-line 40 334,122 1.04%
New Bedford, NJ........ 1,400,000 20,677,847 2.5% Straight-line 40 284,535 1.29%

BOWLING GREEN, KENTUCKY

General. This facility, licensed for 60 beds, is an approximately 62,500
gross square foot rehabilitation hospital located in Bowling Green, Kentucky,
which is approximately 60 miles from Nashville, Tennessee. Construction of the
facility was completed in 1992. We acquired a fee simple interest in this
facility on July 1, 2004 for a purchase price of approximately $38.2 million
including acquisition costs.

Lease. This facility is 100% leased to 1300 Campbell Lane Operating
Company, LLC, a wholly-owned subsidiary of Vibra, pursuant to a 15-year
net-lease with the tenant responsible for all costs of the facility, including,
but not limited to, taxes, utilities, insurance and maintenance. The tenant has
three options to renew for five years each. Beginning on July 1, 2005, the per
annum base rent will be equal to 12.23% of the purchase price, including
acquisition costs. On January 1, 2006 and on each January 1 thereafter, the base
rent will be increased by 2.5%.

MARLTON, NEW JERSEY

General. This facility, licensed for 76 beds, is an approximately 89,139
gross square foot rehabilitation hospital located in Marlton, New Jersey, which
is approximately 15 miles from Philadelphia, Pennsylvania. Construction of the
facility was completed in 1994. We acquired a ground lease interest in this
facility on July 1, 2004 for a purchase price of approximately $32.3 million
including acquisition costs. We ground lease the property on which the facility
is located from Virtua West Jersey Health System, a New Jersey non-profit
corporation, pursuant to a ground lease dated July 15, 1993. The initial term of
the ground lease expires in 2030. We have the right to renew the ground lease
for an additional term of 35 years upon the satisfaction of certain conditions
as set forth in the ground lease.

Lease. This facility is 100% leased to 92 Brick Road Operating Company,
LLC, a wholly-owned subsidiary of Vibra, pursuant to a 15 year net-lease with
the tenant responsible for all costs of the facility, including, but not limited
to, taxes, utilities, insurance and maintenance. The tenant has three options to
renew for five years each. Beginning on July 1, 2005, the per annum base rent
will be equal to 12.23% of the purchase price, including acquisition costs. On
January 1, 2006 and on each January 1 thereafter, the base rent will be
increased by 2.5%.

HBA Management, Inc., or HBA, has subleased the entire third floor of the
hospital facility, approximately 26,896 square feet, for the operation of a
30-bed pediatric comprehensive rehabilitation unit and related office use,
together with certain fixtures, furnishings and equipment located in the
subleased premises. The current term of the sublease expires on August 31, 2013.
HBA has the option to extend the sublease term for two additional terms of five
years each. Base annual rent due under the sublease through September 30, 2005
is approximately $1,112,980 per annum, with adjustments annually thereafter. In
addition to base annual rent, HBA is required to pay its proportionate share of
all reimbursable expenses.

FRESNO, CALIFORNIA

General. This facility, licensed for 62 beds, is an approximately 78,258
gross square foot rehabilitation hospital located in Fresno, California.
Construction of the facility was completed in 1990. We acquired a fee simple
interest in this facility on July 1, 2004 for approximately $18.7 million
including acquisition costs.

Lease. This facility is 100% leased to 7173 North Sharon Avenue Operating
Company, LLC, a wholly-owned subsidiary of Vibra, pursuant to a 15 year
net-lease with the tenant responsible for all costs of the facility, including,
but not limited to, taxes, utilities, insurance and maintenance. The tenant has
three options to renew for five years each. Beginning on July 1, 2005, the per
annum base rent will be equal to 12.23% of the purchase price, including
acquisition costs. On January 1, 2006 and on each January 1 thereafter, the base
rent will be increased by 2.5%.

THORNTON, COLORADO

General. This facility, licensed for 117 beds, is an approximately 141,388
gross square foot rehabilitation hospital located in Thornton, Colorado, which
is approximately 10 miles from Denver, Colorado. Of the 117 beds, 70 are
rehabilitation beds, 23 are psychiatric beds and 24 are skilled nursing care
beds. Construction of the original facility was completed in 1962 with additions
completed as recently as 1975. We acquired a fee simple interest in this
facility on August 17, 2004 for a purchase price of approximately $8.5 million
including acquisition costs.

Lease. This facility is 100% leased to 8451 Pearl Street Operating
Company, LLC, a wholly-owned subsidiary of Vibra, pursuant to a 15 year
net-lease with the tenant responsible for all costs of the facility, including,
but not limited to, taxes, utilities, insurance and maintenance. The tenant has
three options to renew for five years each. Beginning on August 17, 2005, the
per annum base rent will be equal to 12.23% of the purchase price, including
acquisition costs. On January 1, 2006 and on each January 1 thereafter, the base
rent will be increased by 2.5%.

NEW BEDFORD, MASSACHUSETTS

General. This facility, licensed for 90 beds, is an approximately 70,657
gross square foot long-term acute care hospital located in New Bedford,
Massachusetts, which is approximately 45 miles from Boston, Massachusetts.
Construction of the original facility was completed in 1942 with additions
completed as recently as 1995. We acquired a fee simple interest in this
facility on August 17, 2004 for a purchase price of approximately $22.0 million
including acquisition costs.

Lease. This facility is 100% leased to 4499 Acushnet Avenue Operating
Company, LLC, a wholly-owned subsidiary of Vibra, pursuant to a 15 year
net-lease with the tenant responsible for all costs of the facility, including,
but not limited to, taxes, utilities, insurance and maintenance. The tenant has
three options to renew for five years each. Beginning on August 17, 2005, the
per annum base rent will be equal to 12.23% of the purchase price, including
acquisition costs. On January 1, 2006 and on each January 1 thereafter, the base
rent will be increased by 2.5%.

KENTFIELD, CALIFORNIA

General. This facility, licensed for 60 beds, is an approximately 43,500
gross square foot long-term acute care hospital located in Kentfield,
California, which is approximately 15 miles from San Francisco, California.
Construction of the facility was completed in 1963 with the last renovations in
1988. We acquired a fee simple interest in this facility on July 1, 2004 for a
purchase price of approximately $7.6 million including acquisition costs.

Lease. This facility is 100% leased to 1125 Sir Francis Drake Boulevard
Operating Company, LLC, a wholly-owned subsidiary of Vibra, pursuant to a 15
year net-lease with the tenant responsible for all costs of the facility,
including, but not limited to, taxes, utilities, insurance and maintenance. The
tenant has three options to renew for five years each. Beginning on July 1,
2005, the per annum base rent will be
76

equal to 12.23% of the purchase price, including acquisition costs. On January
1, 2006 and on each January 1 thereafter, the base rent will be increased by
2.5%.

DESERT VALLEY FACILITY

General. On February 28, 2005, we acquired a fee simple interest in the
Desert Valley Facility located in Victorville, California, which is
approximately 75 miles from Los Angeles, California. The approximately 122,140
square foot community hospital facility, built in 1994, is licensed for 83 beds
and has an integrated medical office building comprising approximately 50,000
square feet. We acquired the facility from Prime A Investments, LLC, an
unaffiliated third party, for a purchase price of approximately $28.0 million.
The purchase price was determined through arms-length negotiations with Prime A
Investments, LLC based upon our analysis of various factors. These factors
included the demographics of the area in which the facility is located, the
capability of the tenant to operate the facility, healthcare spending trends in
the geographic area, the structural integrity of the facility, governmental
regulatory trends which may impact the services provided by the tenant, and the
financial and economic returns which we require for making an investment.

Lease. This facility is 100% leased to DVH, an affiliate of Prime A
Investments, LLC. The principals of DVH have experience in developing,
acquiring, managing and operating acute care hospital facilities. The lease is a
15-year net-lease with the tenant responsible for all costs of the facility,
including, but not limited to, taxes, utilities, insurance and maintenance. DVH
has three options to renew for five years each. Currently, the annual base rent
is equal to 10% of the purchase price, or the annual rate of $2.8 million. On
January 1, 2006, and on each January 1 thereafter, the base rent will be
increased by an amount equal to the greater of (i) 2% per year of the prior
year's base rent or (ii) the percentage by which the CPI as published by the
United States Department of Labor, Bureau of Labor Statistics on January 1 shall
have increased over the CPI figure in effect on the immediately preceding
January 1, annualized based on the highest annual rate effective during the
preceding year if the previous year's base rent is for a partial year. The lease
requires DVH to carry customary insurance which is adequate to satisfy our
underwriting standards.

DVH has subleased approximately 40,110 square feet of space in the medical
office portion of the facility to its affiliate, Desert Valley Medical Group,
Inc., or DVMG, for office use. The DVMG lease requires DVMG to pay rent of
$50,137.50 per month, to be adjusted commencing on January 1, 2006 by the CPI.
The DVMG sublease expires on December 31, 2011. DVH has also subleased
approximately 500 square feet of space in the facility to Network
Pharmaceuticals, Inc. for the operation of a pharmacy. The pharmacy sublease
requires the tenant to pay rent of $2,000 per month. The pharmacy sublease
currently expires on May 15, 2007, subject to the pharmacy's option to renew for
a term of 10 years.

Lease Guaranties and Security. The Desert Valley lease is guaranteed by
Prime A Investments, L.L.C., Desert Valley Health System, Inc. and Desert Valley
Medical Group, Inc. The guaranty is an absolute and irrevocable guaranty. The
lease is cross-defaulted with any other leases between us or any of our
affiliates and DVH, any guarantor and any of their affiliates. In addition, as
security for the lease, DVH has granted us a security interest in all personal
property, other than receivables, located at the Desert Valley Facility, subject
to purchase money liens on equipment. Desert Valley Hospital, Inc. has provided
to us unaudited financial statements reflecting that, as of March 31, 2005, it
had tangible assets of approximately $21.6 million, liabilities of approximately
$17.6 million and stockholders' equity of approximately $4.0 million, and for
the three months ended March 31, 2005, had net income of approximately $4.0
million.

Desert Valley Health Systems, the parent of DVH and a guarantor of the
lease, has provided to us unaudited financial statements showing that, as of
December 31, 2004, it had consolidated tangible assets of approximately $40.5
million, consolidated liabilities of approximately $31.4 million, and
consolidated tangible net worth of approximately $9.1 million and for the year
ended December 31, 2004, had consolidated net income of approximately $3.9
million.

Reserve for Extraordinary Repairs. DVH is responsible for all maintenance
and repairs and all extraordinary repairs required to keep the facility in
compliance with all applicable laws and regulations and as required under the
lease. DVH is required to make quarterly deposits into a reserve account in the
amount of $2,500 per bed per year. Beginning on January 1, 2006 and on each
January 1 thereafter, the payment of $2,500 per bed per year into the
improvement reserve will be increased by 2%. All extraordinary repair
expenditures made in each year during the term of the lease are to be funded
first from the reserve, and DVH is to pay into the reserve such funds as
necessary for all extraordinary repairs.

Purchase Options. At any time after February 28, 2007, so long as DVH and
its affiliates are not in default under any lease with us or any of the leases
with its subtenants, DVH will have the option, upon 90 days' prior written
notice, to purchase the facility at a purchase price equal to the sum of (i) the
purchase price of the facility, and (ii) that amount determined under a formula
that would provide us an internal rate of return of 10% per year, increased by
2% of such percentage each year, taking into account all payments of base rent
received by us. If during the term of the lease we receive from the previous
owner or any of its affiliates a written offer to purchase the Desert Valley
Facility and we are willing to accept the offer, so long as DVH and its
affiliates are not in default under any lease with us or any of the subleases
with its subtenants, we must first present the offer to DVH and allow DVH the
right to purchase the facility upon the same price, terms and conditions as set
forth in the offer; however, if the offer is made after February 28, 2007, in
lieu of exercising its right of first refusal, DVH may exercise its option to
purchase as provided above.

Depreciation and Real Estate Taxes. The following table sets forth
information, as of December 31, 2004, regarding the depreciation and real estate
taxes for the Desert Valley Facility:

FEDERAL TAX BASIS DEPRECIATION 2004 REAL ESTATE
------------------------ --------------------------- LIFE -----------------
LAND BUILDINGS ANNUAL RATE METHOD IN YEARS TAXES RATE
---------- ----------- ----------- ------------- -------- --------- -----

Victorville,
California........... $2,000,000 $26,000,000 2.5% Straight-line 40 $289,905 1.07%

Facility Expansion. We have also entered into a letter agreement with DVH
pursuant to which, subject to certain conditions, we have agreed to fund up to
$20.0 million for the purpose of expanding our Desert Valley Facility. Subject
to DVH providing us a development agreement, which it is not obligated to do, we
have agreed to begin funding and DVH has agreed to begin drawing funds before
February 28, 2006, in accordance with a disbursement schedule to be provided in
the development agreement at the time of the first draw. Upon receipt and
approval of the development agreement, DVH is obligated to pay us a fee in cash
equal to 0.5% of the maximum amount that can be funded. This fee will be
adjusted following the full and final funding of the expansion to a sum equal to
0.5% of the actual amount funded. Except for any adjustments to the fee that may
result from funding less than the maximum amount, the fee is non-refundable. If
DVH fails to provide a development agreement to us by February 28, 2006, we will
have no further liability or obligation to provide the funding. The $20.0
million expansion amount will be treated as a capital addition under the lease
and, accordingly, as such expansion costs are funded, the annual rent payable
under the lease will increase by an amount equal to the then-current lease rate
multiplied by the amount of expansion cost incurred. Such additional rent will
continue to be payable for the remaining term of the lease. For purposes of the
repurchase options contained in the lease, the purchase price will be increased
by the total cost of the addition. DVH is not obligated to present us with a
development agreement, and, if it does not, we have no obligation to provide
funding to DVH for the expansion. We will not generate any revenues from this
transaction unless and until we and DVH execute a definitive development
agreement and DVH begins drawing the committed funds.

WEST HOUSTON FACILITIES

General. In June 2004, we entered into agreements with Stealth and GPMV to
develop the West Houston Hospital and the adjacent West Houston MOB in Houston,
Texas. We have engaged GPMV to develop the 105 bed, 121,884 gross square foot
West Houston Hospital. Seventy-one beds will be acute care beds to be operated
by Stealth and 34 will be long-term acute care beds to be operated by Triumph
Southwest, L.P., or Triumph, a tenant of Stealth. We have engaged a third-party
developer to develop the

adjacent 120,000 gross square foot West Houston MOB on the property. Pursuant to
the agreements with Stealth and GPMV, we have formed two Delaware limited
partnerships, MPT West Houston Hospital, L.P., or the hospital limited
partnership, which will own the West Houston Hospital, and MPT West Houston MOB,
L.P., or the MOB limited partnership, which will own the adjoining West Houston
MOB. Stealth will be required to maintain insurance that is adequate to satisfy
our underwriting standards.

West Houston GP, L.P., an affiliate of GPMV, holds a 25% general
partnership interest in Stealth. The limited partners of Stealth, which
currently hold a 75% interest, consist of 85 physicians. The sole business of
Stealth is the operation of the West Houston Hospital offering multi-specialty
services and the West Houston MOB. Because those facilities are still in the
construction phase, Stealth has had no meaningful operations to date. Our
operating partnership owns an approximate 93% limited partnership interest in
the hospital limited partnership and Stealth owns an approximate 6% limited
partnership interest. MPT West Houston Hospital, LLC, a wholly-owned limited
liability company of our operating partnership, owns the 1% general partnership
interest in the hospital limited partnership. Currently, our operating
partnership owns all of the limited partnership interests in the MOB limited
partnership and MPT West Houston MOB, LLC, a wholly-owned subsidiary of our
operating partnership, owns the 1% general partnership interest. We have sold
limited partnership interests representing approximately 24% of the aggregate
equity interests in the MOB limited partnership to physicians and others
associated with our tenant or subtenants of the West Houston MOB.

The hospital limited partnership and MOB limited partnership each own a fee
simple interest in the undeveloped land on which the facilities are being
constructed, as well as adjacent undeveloped land. In addition, Stealth has an
option throughout the term of the lease to reacquire approximately 14.5 acres of
land owned by the hospital limited partnership, which land is located adjacent
to the land on which the facilities are being constructed. The option price for
this parcel is equal to the original cost to us. Stealth also has a right of
first offer throughout the term of the lease to purchase this parcel should we
determine to sell it to a third party.

In connection with the development of the West Houston Facilities, we are
entitled to a commitment fee of approximately $932,125. This fee is to be paid
15 years from the date of completion of the hospital facility, with interest
thereon at the rate of 10.75% per year, and is unsecured but is cross-defaulted
with the leases we have with Stealth at the West Houston Facilities. Stealth is
to commence making monthly interest payments beginning the first month after
completion of the West Houston Hospital.

In addition, MPT Development Services, Inc., our taxable REIT subsidiary,
has agreed to make a working capital loan to Stealth in an amount up to $1.62
million. To date, no funds have been drawn by Stealth. This loan is to be repaid
15 years from the date of completion of the West Houston Hospital, with interest
at the rate of 10.75% per year, and is unsecured but cross-defaulted with the
leases we have with Stealth at the West Houston Facilities. The loans are not
guaranteed. The leases contain certain debt coverage ratio and other financial
covenants, the default of which would constitute a default under the loans.
Stealth is obligated to commence making monthly interest payments beginning the
first month after completion of the West Houston Hospital. Either the fee or the
working capital loan may be prepaid at any time without penalty, except that a
minimum prepayment of $500,000 is required for the working capital loan.

If either we or Stealth determine in good faith, after consultation with
healthcare counsel, that healthcare law prohibitions or restrictions require the
physician-limited partners to divest their ownership interests in Stealth, we
have agreed to issue up to $6 million of limited partnership interests in the
hospital limited partnership to Stealth to be used as part of the consideration
to completely redeem the physician-limited partners' ownership interests in
Stealth. We have agreed to lend Stealth the $6 million to purchase the limited
partnership interests in the hospital limited partnership, which loan would
accrue interest at the rate of not less than 10.75% per year, and would be paid
over 10 years. If this transaction is necessary, we do not expect it to occur
prior to the end of the second quarter of 2005.

Development Agreements. The hospital limited partnership has agreed to pay
GPMV a development fee of approximately $700,000, a construction management fee
not to exceed $200,000, and a contingent
79

funds fee of approximately $450,000. The MOB limited partnership has agreed to
pay the developer of the West Houston MOB a development fee of approximately
$550,000, a construction management fee of $300,000, and a contingent funds fee
of approximately $350,000. Upon the completion of the development of the
facilities, we will obtain independent as-built appraisals of the facilities.

Stealth is obligated to pay MPT Development Services, Inc., our taxable
REIT subsidiary, a project inspection fee for construction coordination services
of $100,000 in the case of the West Houston Hospital and $50,000 in the case of
the adjacent West Houston MOB. These fees are to be paid, with interest at the
rate of 10.75% per year, over a 15 year period beginning on the date that the
West Houston Hospital is completed. The total development costs for the
facilities, including acquisition cost, development services fee, commitment
fee, project management fee, and construction costs, are estimated to be $42.6
million for the hospital facility and $20.5 million for the medical office
building. Construction, which commenced in July 2004, is expected to be
completed in October 2005 for the West Houston Hospital and in August 2005 for
the adjacent West Houston MOB. During the construction period, we will advance
funds pursuant to requests made in accordance with the terms of the development
agreements between us and the developers. We have agreed to fund 100% of the
total development costs for the West Houston Hospital and the adjacent West
Houston MOB. Our agreement with Stealth provides that $17,006,803 of this
funding will be in the form of an equity contribution for the West Houston
Hospital, with the remaining funding being in the form of debt, and for the
adjoining West Houston MOB, our agreement with Stealth provides that $5.0
million of the funding will be in the form of an equity contribution or
subordinated debt, with the remaining funding being in the form of debt. If we
obtain third-party construction financing, the debt portion of the development
costs will be provided by the third-party lender.

Leases. We are leasing the facilities to Stealth during the construction
phase with rent accruing until the completion dates and the accrued rent to be
paid over the remaining lease term once the facilities are completed. Following
the completion dates, the lease term will extend for a period of 15 years for
the West Houston Hospital and 10 years for the West Houston MOB. Stealth will
have three options to renew each lease for a period of five years each. On
January 1, 2006 and on each January 1 thereafter, the base rent for the West
Houston Hospital will increase 2.5% and the base rent for the West Houston MOB
will increase 2.0%. The leases are net-leases with Stealth responsible for all
costs and expenses associated with the operation, maintenance and repair of the
facilities. Triumph has subleased an entire floor of the West Houston Hospital
in order to operate 34 long-term acute care beds. The sublease is for a term of
180 months following the completion of the construction of the West Houston
Hospital. The sublease grants to Triumph options to extend the term of the
sublease for three additional periods of five years each. The sublease requires
Triumph to pay rent in an amount equal to 12% of all rent and other charges
payable by Stealth to us under our lease with Stealth, with certain exclusions.
The sublease provides that Stealth's obligations under the sublease are
conditioned upon the execution of a guaranty by Triumph HealthCare of Texas,
L.L.C. and Triumph HealthCare, L.L.P. The sublease grants Stealth the right to
relocate Triumph to a new facility to be constructed adjacent to and attached to
the West Houston Hospital. In order to exercise the relocation right, Stealth
must give Triumph at least 270 days' notice prior to the date of such
relocation. Triumph must vacate the subleased premises on or before the
relocation date specified in the notice from Stealth, which cannot be earlier
than 270 days after the date of the relocation notice.

Triumph has subleased 9,726 square feet of net rentable area in the West
Houston MOB for use as a medical office exclusively for the practice of
medicine, the operation of a medical office and the provision of related
administrative services, or medical related use. The sublease is for a term of
120 months following the earlier of the date of final completion of the
leasehold improvements, or the date on which Triumph commences business in the
subleased premises. The sublease grants to Triumph options to extend the term of
the sublease for four additional periods of five years each. The sublease
requires Triumph to pay annual base rent for years one through ten calculated at
$20 per net rentable square foot. Beginning on the first anniversary of the
lease and on each anniversary date thereafter, base rent is increased to an
amount equal to 1.02 times or 102% of the base rent payable in the previous
year. The lease also requires

Triumph to pay its pro rata share of annual operating expenses, taxes and
insurance relating to the West Houston MOB. The sublease provides that Stealth's
obligations under the sublease are conditioned upon the execution of a guaranty
by Triumph HealthCare of Texas, L.L.C. and Triumph HealthCare, L.L.P. The West
Houston MOB sublease with Triumph also runs concurrently with Stealth's lease
with us. In the event our lease with Stealth is terminated, the sublease on the
hospital with Triumph is also terminated.

Purchase Option. After the first full 12 month period after construction
of each of the West Houston Facilities is completed, as long as Stealth is not
in default under either of its leases with us or any of the leases with its
physician subtenants, Stealth has the right to purchase the West Houston MOB and
the West Houston Hospital at a purchase price equal to the greater of (i) that
amount determined under a formula that would provide us an internal rate of
return of at least 18% or (ii) the appraised value based on a 15 year lease in
place. To arrive at the appraised value, each of the parties chooses an
appraiser. If the appraisals obtained are not materially different, (meaning a
10% or more variance), 50% of the sum of each appraised value is used as the
option price. If the two appraisals are materially different, then the two
appraisers appoint a third appraiser and the appraiser's valuation which differs
greatest from the other two appraisers is excluded and 50% of the sum of the two
remaining determinations is used as the option price. The costs of the appraisal
process are borne equally by the parties. Upon written notice to us within 90
days of the expiration of the applicable lease, as long as Stealth is not in
default under either of its leases with us or any of the leases with its
physician subtenants, Stealth will have the option to purchase the West Houston
MOB or the West Houston Hospital at a price equal to the greater of (i) the
total development costs (including any capital additions funded by us, but
excluding any capital additions funded by Stealth) increased by 2.5% per year,
or (ii) the appraised value based on a 15 year lease in place. To arrive at the
appraised value, each of the parties chooses an appraiser. If the appraisals
obtained are not materially different, (meaning a 10% or more variance), 50% of
the sum of each appraised value is used as the option price. If the two
appraisals are materially different, then the two appraisers appoint a third
appraiser and the appraiser's valuation which differs greatest from the other
two appraisers is excluded and 50% of the sum of the two remaining
determinations is used as the option price. The costs of the appraisal process
are borne equally by the parties.

The leases also provide that under certain limited circumstances, the
tenant will have the right to present us with a choice of one out of three
proposed exchange facilities to be substituted for the leased facility. The
tenant will have the right to propose substitute facilities, if not in default,
at any time prior to the expiration of the term, if (i) in the good faith
judgment of the tenant the facility becomes uneconomic or unsuitable for its
primary intended use, (ii) there is an eviction or interference caused by any
claim of paramount title, or (iii) if for other prudent business reasons, the
tenant desires to terminate the lease. The tenant will have the obligation to
substitute facilities if it has discontinued use of the facility for a period in
excess of one year, and we have not exercised our right to terminate the lease.
Each proposed substitution facility must: (i) provide us with an annual return
on our equity in such facility, or yield, substantially equivalent to our yield
from the original facility (ii) provide us with rent with a substantially
equivalent yield taking into account any cash adjustment paid or received by us
and any other relevant factors, and (iii) have a fair market value in an amount
equal to the fair market value of the original facility, taking into account any
cash adjustment paid or received by us. If we elect to consummate the exchange,
the existing lease would terminate and the parties would enter into a new lease
for the substituted facility. If we elect not to proceed with the exchange, the
tenant would have the right to terminate the lease and purchase the leased
facility for appraised value, determined assuming the lease is still in place.

Right of First Offer to Purchase. At any time during the term of the
applicable lease for either of the West Houston Facilities, as long as Stealth
is not in default under either of its leases with us or any of the leases with
its physician subtenants, we are required to notify Stealth if we intend to sell
either facility to a third party. If Stealth wishes to offer to purchase the
facility, it must notify us in writing within 15 days, setting forth the terms
and conditions of the proposed purchase. If we accept Stealth's offer, Stealth
must close the purchase within 45 days of the date of our acceptance.

Security. The leases for the West Houston Facilities are cross-defaulted
and are guaranteed by West Houston G.P., L.P. and West Houston Joint Ventures,
Inc., affiliates of Stealth. To secure its performance

of its lease obligations under the West Houston Hospital lease, Stealth has
obtained a certificate of deposit in the amount of $1,905,234, of which we are
the beneficiary. The sublease between Stealth and Triumph requires Triumph to
obtain a certificate of deposit in the amount of $400,000 to secure the
performance of its obligations under its sublease with Stealth. However, subject
to execution of definitive agreements, we, Stealth and Triumph have agreed that
Triumph shall obtain and deliver to us a $400,000 letter of credit, in lieu of
the certificate of deposit, to be held by us. The sublease has been assigned to
us as collateral security for Stealth's performance under its lease. Under the
lease and the sublease, each of Stealth and Triumph, respectively, are required
to give us a security interest in these certificates of deposit and to enter
into control agreements with us and the issuing banks which provide that the
banks will follow our instructions regarding the certificates of deposit. Once
the West Houston Hospital commences operations, Stealth is required to
substitute a letter of credit in the amount of $1,905,234 in place of the
$1,905,234 certificate of deposit; and on May 1, 2005, the sublease requires
that Triumph substitute a letter of credit in the amount of $1,000,000 in place
of the $400,000 certificate of deposit. The lease further provides that the
Stealth letter of credit may be released in two increments of 50% of the total
amount of the letter of credit over a 2 year period following the date on which
Stealth generates a total rent (excluding additional charges) coverage from
EBITDAR of at least 200% for 12 consecutive months.

Stealth has provided to us unaudited financial statements reflecting that,
as of March 31, 2005, it had tangible assets of approximately $5.8 million,
including cash of approximately $4.4 million, liabilities of approximately
$269,000 and owners' equity of approximately $5.5 million. Neither of the
guarantors has any substantial assets, other than its interest in Stealth.

Capital Improvements. Stealth is responsible for all capital expenditures
required to keep the West Houston Facilities in compliance with applicable laws
and regulations. Beginning on January 1, 2005, Stealth will make monthly
deposits into a capital improvement reserve in the amount of $3,000 per year in
the case of the West Houston MOB and $2,500 per bed per annum in the case of the
West Houston Hospital. On each January 1 thereafter, the payment into the
capital improvement reserve will be increased by 2.0% in the case of the West
Houston MOB and by 2.25% in the case of the West Houston Hospital. All capital
expenditures made in each year during the term of the lease will be funded first
from the capital improvement reserve, and the tenant will pay into its
respective capital improvement reserve such funds as necessary for all
replacements and repairs.

Depreciation and Real Estate Taxes. The following table sets forth
information, as of December 31, 2004, regarding the estimated depreciation and
real estate taxes for the Houston Facilities:

ESTIMATED DEPRECIATION ESTIMATED
FEDERAL TAX BASIS -------------------------------------- 2005 REAL ESTATE
------------------------ ANNUAL -----------------
LAND BUILDINGS RATE METHOD LIFE IN YEARS TAXES RATE
---------- ----------- ------ ------------- ------------- ---------- ----

West Houston
Hospital............. $8,400,000 $34,200,000 2.5% Straight-line 40 $1,324,860 3.11%
West Houston MOB....... 1,800,000 18,700,000 2.5 Straight-line 40 637,550 3.11

OUR PENDING ACQUISITIONS AND DEVELOPMENTS

We intend to use the net proceeds of this offering and a portion of our
available cash and cash equivalents to expand our portfolio by acquiring or
developing our Pending Acquisition and Development Facilities, which we consider
to be probable acquisitions or developments as of the date of this prospectus,
under the terms of the contacts or letters of commitment relating to these
facilities. The leases for each of these facilities will provide for contractual
base rent and an annual rent escalator. The letters of commitment constitute
agreements of the parties to consummate the acquisition or development
transactions and enter into leases on the terms set forth in the letters of
commitment subject to the satisfaction of certain conditions, including the
execution of mutually-acceptable definitive agreements. The following tables
contain information regarding our Pending Acquisition and Development Facilities
as of the date of this prospectus:

Operating Facilities -- Acquisitions

ANNUAL
YEAR ONE MINIMUM GROSS
NUMBER OF CONTRACTUAL INCREASE IN PURCHASE LEASE
LOCATION TYPE TENANT BEDS(1) BASE RENT RENT PRICE EXPIRATION
- -------- ---- -------------------- --------- ----------- ----------- ----------- ----------

Covington, Louisiana*........ Long-term Gulf States 58 $1,170,750(2) 2.5%(3) $11,5 00,000 June 2020(4)
acute Long Term Acute Care
care of Covington, L.L.C.
hospital
Denham Springs, Louisiana*... Long-term Gulf States 59 630,000(2) 2.5%(3) 6,000,000 June 2020(4)
acute Long Term Acute Care
care of Denham Springs,
hospital L.L.C.
---- ---------- -----------
TOTAL........................ 117 $1,800,750 $17,500,000 --
--------- -------------------- ---- ---------- ----------- ---------

- ---------------

* Under letter of commitment.
(1) Based on the number of licensed beds.

(2) Year One is the 12 month period commencing on an expected closing date in
June 2005.

(3) The annual rent increase is the greater of 2.5% and any change in the CPI.

(4) The lease expiration is based upon a 15 year term commencing on an expected
closing date in June 2005.

Operating Facility -- Loan with Purchase Option

YEAR ONE
NUMBER OF CONTRACTUAL LOAN LEASE
LOCATION TYPE TENANT BEDS(1) INTEREST AMOUNT EXPIRATION
- -------- --------- ------------- --------- ----------- ---------- ----------

Hammond, Louisiana*(2)............................. Long-term Hammond 40 $840,000(3) $8,000,000 June 2021
acute Rehabilitation
care Hospital, LLC
hospital

- ---------------

Development Facilities

ANNUAL
MINIMUM PROJECTED
NUMBER OF INCREASE IN DEVELOPMENT LEASE
LOCATION TYPE TENANT BEDS(1) RENT COST EXPIRATION
- -------- ---- --------------- ----------- ----------- ------------ ----------

Bensalem, Pennsylvania**..................... Women's Bucks County 30 2.5%(2) 38,000,000 (3)
hospital/ Oncoplastic
medical Institute, LLC
office
building
Bloomington, Indiana*........................ Community Monroe 32 2.5%(2) $ 28,000,000 (3)
hospital Hospital, LLC
Houston, Texas*.............................. Community North Cypress 64 2.5%(2) 51,000,000 (3)
hospital Medical Center
Operating
Company, Ltd.
---- ------------
TOTAL........................................ -- -- 126 $117,000,000 --
---- ============

- ---------------

* Under letter of commitment.
** Under contract.
(1) Based on the number of licensed beds.
(2) The annual rent increase is the greater of 2.5% and any change in the CPI.
(3) We expect that each of these leases will have a 15 year term commencing on
the date that construction of the facility is completed.

COVINGTON AND DENHAM SPRINGS, LOUISIANA

General. On March 14, 2005, we entered into a letter of commitment with
Covington Healthcare Properties, L.L.C., or Covington, and Denham Springs
Healthcare Properties, L.L.C., or Denham Springs, both unaffiliated third
parties, to purchase two long-term acute care hospital facilities. One facility,
which we refer to as the Covington Facility, is located in Covington, Louisiana,
which is approximately 35 miles from New Orleans, Louisiana. The Covington
Facility contains approximately 43,250 square feet of space and is licensed for
58 beds. The letter of commitment provides that our purchase price for the
Covington Facility will be approximately $11,150,000; however, the parties are
negotiating an increase of the purchase price to $11.5 million. The other
facility, which we refer to as the Denham Springs Facility, is located in Denham
Springs, Louisiana, which is approximately 10 miles from Baton Rouge, Louisiana.
The Denham Springs Facility contains approximately 36,000 square feet of space
and is licensed for 59 beds. The letter of commitment provides that our purchase
price for the Denham Springs Facility will be approximately $6.0 million. We
expect these transactions to close by mid-June 2005 and to use a portion of our
available cash and cash equivalents to fund the purchase prices for these
facilities.

The purchase price for each of the Covington Facility and the Denham
Springs Facility was arrived at through arms-length negotiations based upon our
analysis of various factors. These factors included the demographics of the area
in which the facility is located, the capability of the tenant to operate the
facility, healthcare spending trends in the geographic area, the structural
integrity of the facility, governmental regulatory trends which may impact the
services provided by the tenant, and the financial and economic returns which we
require for making an investment.

We intend to form a Delaware limited liability company, MPT of Covington,
LLC, which will own the Covington Facility, and a Delaware limited liability
company, MPT of Denham Springs, LLC, which will own the Denham Springs Facility.
Initially, our operating partnership will own all of the membership interests in
each of these limited liability companies; however, at some point following
closing, we have agreed to offer up to 30% of the interests in each of these
limited liability companies to local physicians.

Lease. The letter of commitment provides that at the time we purchase the
Covington Facility, we will lease 100% of the facility to Gulf States Long Term
Acute Care of Covington, L.L.C. or its affiliate for a 15-year term, with 3
options to renew for 5 years each. At the time we purchase the Denham Springs
Facility, we will lease 100% of the facility to Gulf States Long Term Acute Care
of Denham Springs, L.L.C. or its affiliate for a 15-year term, with 3 options to
renew for 5 years each. The letter of commitment provides that each lease will
be a net-lease with the tenant responsible for all costs of the facility,
including, but not limited to, taxes, utilities, insurance, maintenance and
capital improvements. The letter of commitment provides that each lease will
require the tenant to pay base rent in an amount equal to 10.5% per annum of the
purchase price plus any costs and charges that may be capitalized. The

letter of commitment provides that on each January 1, the base rent will be
increased by an amount equal to the greater of (A) 2.5% per annum of the prior
year's base rent, or (B) the percentage by which the CPI on January 1 shall have
increased over the CPI figure in effect on the then just previous January 1;
provided, however, on January 1, 2006, the adjustment shall be prorated. The
letter of commitment provides that each lease will also require the tenant to
carry customary insurance which is adequate to satisfy our underwriting
standards.

Repair and Replacement Reserve. The letter of commitment provides that
each lease will require the tenant, commencing on the date we purchase the
facility, to make annual deposits into a reserve account. We expect that each
lease will provide that on each January 1 following the date we purchase the
facility, the payment into the reserve account will be increased, and that all
extraordinary repair expenditures made in each year during the term of the lease
will be funded first from the reserve, and the tenant will pay into the reserve
such funds as necessary for all extraordinary repairs.

Security. The letter of commitment provides that, as security for each
lease, the tenant will grant us a security interest in all personal property,
other than receivables, located and to be located at the respective facility.
The letter of commitment provides that each lease will also require the tenant
to obtain and deliver to us an unconditional and irrevocable letter of credit
from a bank acceptable to us, naming us beneficiary thereunder, in an amount
equal to six months' base rent under the lease, and will provide that at such
time as the operations in the facility have generated EBITDAR coverage of at
least two times the base rent for eight consecutive fiscal quarters, the letter
of credit may be reduced to an amount equal to three months of the base rent
then in effect. If, however, after satisfying the conditions necessary to reduce
the letter of credit to three months' base rent, EBITDAR coverage subsequently
drops below two times base rent for two consecutive fiscal quarters, the letter
of credit will be increased to six months' base rent. The letter of commitment
provides that the leases will be cross-defaulted with any other lease or
agreement between the parties. Gulf States Health Services, Inc. has provided to
us unaudited financial statements reflecting that, as of December 31, 2004, it
had tangible assets of approximately $11.1 million, liabilities of approximately
$9.3 million and stockholders' equity of approximately $1.8 million, and for the
year ended December 31, 2004 had net income of approximately $2.0 million. Team
Rehab, L.L.C., which is one of the guarantors of the leases, has provided to us
unaudited financial statements reflecting that, as of December 31, 2004, it had
tangible assets of approximately $21.3 million, liabilities of approximately
$9.2 million and owner's equity of approximately $12.1 million, and for the year
ended December 31, 2004 had net income of approximately $1.7 million.

The letter of commitment provides that the lease for the Covington Facility
will require that, as of the commencement date of the lease and at all times
during the lease term, the tenant and its affiliates, Team Rehab, LLC, Gulf
States Health Services, Inc. and Jamestown Healthcare Properties, LLC, maintain
an aggregate tangible net worth in an amount to be mutually agreed upon with us.
The letter of commitment provides that the lease for the Denham Springs Facility
will require that, as of the commencement date of the lease and at all times
during the lease, the tenant and its affiliates, Team Rehab, L.L.C., Gulf States
Health Services, Inc. and Jamestown Healthcare Properties, LLC, maintain an
aggregate tangible net worth in an amount to be mutually agreed upon.

Purchase Options. The letter of commitment provides that each lease will
provide that so long as the tenant is not in default, and no event has occurred
which with the giving of notice or the passage of time or both would constitute
a default under its (and its affiliates) leases with us or any of our affiliates
or any of the leases with its subtenants, the tenant will have the option to
purchase the facility (i) at the expiration of the initial term and each
extension term of the lease, to be exercised by 90 days' written notice prior to
the expiration of the initial term and each extension term, and (ii) within 90
days of written notification from us exercising our right to terminate the
engagement of the tenant's or its affiliate's management company as the
management company for the facility as a result of an event of default under the
lease. The letter of commitment provides that each lease will provide that the
purchase price shall be equal to the greater of (i) the appraised value of the
facility, assuming the lease remains in effect for 15 years and not taking into
account any purchase options contained therein, or (ii) the purchase price

paid by us for the facility, increased annually by an amount equal to the
greater of (A) 2.5% per annum from the date of the lease, or (B) the rate of
increase in the CPI on each January 1.

Commitment Fee. We will be entitled to a commitment fee at the closing of
the purchase of the Covington Facility equal to 1% of the purchase price,
$16,250 of which has already been paid. The letter of commitment provides that
we will be entitled to a commitment fee at the closing of the purchase of the
Denham Springs Facility equal to 1% of the purchase price, $8,750 of which has
already been paid.

HAMMOND, LOUISIANA

General. On April 1, 2005, we entered into a letter of commitment with
Hammond Healthcare Properties, LLC, the current owner of the property, or
Hammond Properties, and Hammond Rehabilitation Hospital, LLC, the current tenant
of the property, or Hammond Hospital, both unaffiliated third parties, to
provide a mortgage loan to Hammond Properties and enter into a put-call option
arrangement relating to our purchase of the facility from Hammond Properties and
our leaseback of the facility to Hammond Hospital or its affiliates.

The facility is a long-term acute care hospital located in Hammond,
Louisiana, which is approximately 45 miles from New Orleans, Louisiana. The
facility contains approximately 23,835 square feet of space and is licensed for
40 beds.

The letter of commitment provides that, under the mortgage loan
transaction, we will lend to Hammond Properties the sum of $8.0 million, which
will bear interest at the rate of 10.5% per year and be payable interest only on
a monthly basis with a balloon payment due and payable at the expiration of the
put-call option period described below or, if the put-call option is exercised,
at closing of our purchase of the facility. The letter of commitment provides
that the loan will be secured by a first mortgage on the facility and by the
other collateral and guaranteed as described below.

The letter of commitment provides that, at the time of the mortgage loan
closing, we will enter into a put-call option agreement with Hammond Properties
providing that either party will have the option, exercisable within 90 days
following the one year anniversary of the loan closing, to cause the purchase
and sale of the facility, subject to applicable conditions, for a purchase price
of the greater of (i) $10,285,714 or (ii) the quotient determined by dividing
the annual rental payments by .105 (but not to exceed $11 million). The purchase
price was arrived at through arm's-length negotiations based upon our analysis
of various factors, including the demographics of the area in which the facility
is located, the capability of the tenant to operate the facility, healthcare
spending in the geographic area, the structural integrity of the facility,
governmental regulatory trends which may impact the services provided by the
facility, and the financial and economic returns which we require for making an
investment.

If the put-call option is exercised, we will form a Delaware limited
liability company, MPT of Hammond, LLC, which will own the facility. Initially,
our operating partnership will own all of the membership interests in this
limited liability company; however, the letter of commitment provides that, at
some point following closing, we have agreed to offer up to 30% of the interests
in this limited liability company to local physicians.

Lease. The letter of commitment provides that, if the put-call option is
exercised, we will lease 100% of the facility to Hammond Hospital or its
affiliate for a 15-year term, with three options to renew for five years each.
The letter of commitment provides that the lease will be a net-lease with the
tenant responsible for all costs of the facility, including, but not limited to,
taxes, utilities, insurance, maintenance and capital improvements. The letter of
commitment provides that the lease will require the tenant to pay base rent in
an amount equal to 10.50% per annum of the purchase price plus any costs and
charges that may be capitalized, which base rent will be payable in monthly
installments. The letter of commitment provides that, on each January 1
beginning January 1, 2007, the base rent will be increased by an amount equal to
the greater of (A) 2.5% per annum of the prior year's base rent, or (B) the
percentage by which the CPI on January 1 shall have increased over the CPI
figure in effect on the then just previous January 1. The letter of commitment
provides that the lease will require the tenant to carry customary insurance
which is adequate to satisfy our underwriting standards.

Repair and Replacement Reserve. The letter of commitment provides that the
tenant, commencing on the date we purchase the facility, will make annual
deposits into a reserve account. We expect that the lease will provide that on
each January 1 following the date we purchase the facility, the payment into the
reserve account will be increased, and that all extraordinary repair
expenditures made in each year during the term of the lease will be funded first
from the reserve, and the tenant will pay into the reserve such funds as
necessary for all extraordinary repairs.

Security. The letter of commitment provides that, as security for the
mortgage loan and the lease, Hammond Properties or the tenant, as the case may
be, will grant us a security interest in all personal property, other than
receivables, located and to be located at the facility. The letter of commitment
requires Hammond Properties and the tenant to obtain and deliver to us an
unconditional and irrevocable letter of credit from a bank acceptable to us,
naming us beneficiary thereunder, in an amount equal to six months' debt service
or base rent under the lease, as the case may be, and that at such time as the
operations in the facility have generated EBITDAR coverage of at least two times
the base rent for eight consecutive fiscal quarters, the letter of credit may be
reduced to an amount equal to three months of the base rent then in effect. If,
however, after satisfying the conditions necessary to reduce the letter of
credit to three months' base rent, EBITDAR coverage subsequently drops below two
times base rent for two consecutive fiscal quarters, the letter of credit will
be increased to six months' base rent. The letter of commitment provides that
the lease will be cross-defaulted with any other lease or agreement between the
parties. The letter of commitment provides that the loan and lease will be
jointly and severally guaranteed by Hammond Properties, certain affiliates of
Hammond Properties and Gulf States Health Services, Inc. For information about
the financial condition of Gulf States Health Services, Inc., see the
description of the Covington and Denham Springs facilities above.

Purchase Options. The letter of commitment provides that the lease will
provide that so long as the tenant is not in default, and no event has occurred
which with the giving of notice or the passage of time or both would constitute
a default under its (and its affiliates) leases with us or any of our affiliates
or any of the leases with its subtenants, the tenant will have the option to
purchase the facility at the expiration of the initial term and each extension
term of the lease. The letter of commitment provides that the purchase price
shall be equal to the greater of (i) the appraised value of the facility,
assuming the lease remains in effect for 15 years and not taking into account
any purchase options contained therein, or (ii) the purchase price paid by us
for the facility, increased annually by an amount equal to the greater of (A)
2.5% per annum from the date of the lease, or (B) the rate of increase in the
CPI on each January 1. The parties will agree upon the notice and closing
periods applicable to these purchase options.

Net Worth Covenant. The letter of commitment provides that the loan and
lease documents will require that, as of the loan closing and throughout the
loan and lease terms, Hammond Properties, Hammond Hospital and Gulf States
Health Services, Inc. must maintain an aggregate tangible net worth in an amount
to be mutually agreed upon with us.

Commitment Fee. The letter of commitment provides that we will be entitled
to a commitment fee at the closing of the loan equal to $80,000, $25,000 of
which has already been paid. The letter of commitment further provides that we
will be entitled to a commitment fee at the closing of the sale transaction
equal to 1% of the purchase price, less the amount of all commitment fees
previously paid.

BENSALEM, PENNSYLVANIA

General. On March 3, 2005, we entered into a purchase and sales agreement
with Bucks County Oncoplastic Institute, LLC, or BCO, Jerome S. Tannenbaum,
M.D., M. Stephen Harrison and DSI Facility Development, LLC, or the developer,
all unaffiliated third parties, to purchase land and develop a women's hospital
facility with an integrated medical office building in Bucks County,
Pennsylvania, which is approximately 15 miles from Philadelphia, Pennsylvania.
The purchase and sale agreement was amended on April 29, 2005 to extend the
closing date to June 30, 2005, add G. Patrick Maxwell, M.D. as a party and to
increase the amount of pre-closing development costs we have agreed to advance
to approximately $2.0 million. BCO has entered into a contract with the owner of
the land upon which the facility will be constructed for the purchase of the
land.

We intend to enter into a development agreement with the developer to
develop the facility. The total development costs to develop the facility,
including the cost of the land, are estimated at approximately $38.0 million. We
will make a construction loan, secured by the improvements, to BCO for the
amount necessary for construction of the improvements with interest at 10.75%
per annum for a term ending upon completion of construction. We will ground
lease the land during the construction period and, subject to certain
conditions, purchase from and lease to BCO the improvements upon their
completion. In the event we do not exercise our right to purchase the
improvements upon completion of construction, we expect that the ground lease
will continue for a term of 15 years with three five year renewal options and
that the construction loan will be converted to a 15 year term loan with
interest at 10.75% per annum, secured by a mortgage on the improvements. If we
purchase the improvements, the ground lease will terminate and be replaced with
a lease for both the land and the improvements, which we refer to as the
facility lease.

We have agreed to advance up to approximately $2.0 million of development
costs prior to closing, which advances bear interest at the rate of 10.75% and
are guaranteed to the extent of $1.3 million by Dr. Tannenbaum, $300,000 by Mr.
Harrison and $385,000 by Dr. Maxwell.

Lease. We have formed a Delaware limited partnership, MPT of Bucks County
Hospital, L.P., to own the facility. At the time we purchase the land, we intend
to ground lease back 100% of the land to BCO for the construction period. If we
purchase the improvements at the end of the construction term, the ground lease
will terminate and be replaced by the facility lease, which would continue for a
term of 15 years with three options to renew for five years each. In the case of
the ground lease or the facility lease, each of which we refer to as the lease,
the lease is to be a net-lease with BCO responsible for all costs of the
facility, including, but not limited to, taxes, utilities, insurance and
maintenance. The lease will require BCO to pay monthly rent in a per annum
amount equal to 10.75% multiplied by the purchase price of the land in the case
of the ground lease or by the total amount of the funds disbursed under the
development agreement in the case of the facility lease. The lease will provide
that on January 1, 2006, and on each January 1 thereafter, the base rent will be
increased by an amount equal to the greater of (A) 2.5% per annum of the prior
year's base rent, or (B) the percentage by which the CPI, has increased over the
CPI figure in effect on the previous January 1. The lease will also require BCO
to carry customary insurance which is adequate to satisfy our underwriting
standards. The lease will require BCO to pay us on the commencement date of the
lease an amount equal to $7,500 to cover the cost of the physical inspections of
the facility, which fee will, beginning on January 1, 2006, and continuing on
each January 1 thereafter, be increased by 2.5% per annum. In addition to the
inspection fee, the total development costs will also include a fee equal to
$75,000 to cover our inspection of the facility during the construction period.

Capital Improvement Reserve. The lease will require BCO to be responsible
for all maintenance and repairs and all extraordinary repairs required to keep
the facility in compliance with all applicable laws and regulations and as
required under the lease. The lease will also require BCO, beginning on the
completion of construction of the facility, to make annual deposits into a
reserve account in the amount of $2,500 per bed per year. The lease will provide
that beginning on the first January 1 after the completion of construction, the
payment of $2,500 per bed per year into the improvement reserve will be
increased by 2.5%. We expect the lease to provide that all extraordinary repair
expenditures made in each year during the term of the lease will be funded first
from the reserve, and BCO will pay into the reserve such funds as necessary for
all extraordinary repairs.

Security. As security for the lease, BCO will grant us a security interest
in all personal property, other than receivables, located and to be located at
the facility, which security interest will be subject to any lien of any
purchase money lender. The lease will require BCO to obtain and deliver to us an
unconditional and irrevocable letter of credit from a bank acceptable to us,
naming us beneficiary thereunder, in an amount equal to one year's base rent
under the lease. As a condition to closing and as a continuing covenant under
the lease, BCO will be required to maintain a tangible net worth of $5 million
or access to a working capital line of at least $5 million guaranteed by Dr.
Tannenbaum, Dr. Maxwell and

other approved guarantors. The lease will be cross-defaulted to any other lease
or agreement between the parties. BCO is newly formed and has had no significant
operations to date.

Purchase Options. The lease will provide that so long as BCO is not in
default under any lease with us or any of the leases with its subtenants, at the
expiration of the lease BCO will have the option, upon 60 days prior written
notice, to purchase the facility at a purchase price equal to the greater of (i)
the appraised value of the facility, which assumes the lease remains in effect
for 15 years, or (ii) the total development costs, including any capital
additions funded by us, as increased by an amount equal to the greater of (A)
2.5% per annum from the date of the lease, or (B) the rate of increase in the
CPI on each January 1.

Commitment Fee. We are to receive at closing a commitment fee equal to 1%
of the commitment amount, $15,000 of which has already been paid.

BLOOMINGTON, INDIANA

General. On February 28, 2005, we entered into a letter of commitment with
Monroe Hospital Operating Company, or Monroe Hospital, to develop a community
hospital in Bloomington, Indiana, which is approximately 50 miles from
Indianapolis, Indiana. The letter of commitment provides that we will enter into
a contract with Monroe Hospital to, among other things, purchase the land. We
intend to enter into a development agreement with an affiliate of Monroe
Hospital to develop the facility. The total development costs to develop the
facility, including the cost of the land, will be approximately $28.0 million.
Alternatively, and subject to the approval of Monroe Hospital, we may make a
construction loan, secured by the improvements, to Monroe Hospital for the
amount necessary for construction of the improvements with interest at 10.50%
per annum for a term ending upon completion of construction. We will ground
lease the land during the construction period. Subject to certain conditions, we
will purchase from and lease to Monroe Hospital the improvements upon their
completion. In the event we do not exercise our right to purchase the
improvements upon completion of construction, we expect that the ground lease
will continue for a term of 15 years with three five year renewal options and
that the construction loan will be converted to a 15 year term loan with
interest at 10.50% per annum, secured by a mortgage on the improvements. If we
purchase the improvements, the ground lease will terminate and be replaced with
a lease for both the land and the improvements, which we refer to as the
facility lease.

Lease. We have formed a Delaware limited liability company, MPT of
Bloomington, LLC, which will own the facility. The letter of commitment provides
that, at the time we purchase the land, we will ground lease 100% of the land
and all improvements to be constructed thereon to Monroe Hospital for the
construction period. If we purchase the improvements at the end of the
construction term, the ground lease will terminate and be replaced by the
facility lease which would continue for a term of 15 years with three options to
renew for five years each. In the case of the ground lease or the facility
lease, each of which we refer to as the lease, the letter of commitment provides
that the lease will be a net-lease with the tenant responsible for all costs of
the facility, including, but not limited to, taxes, utilities, insurance,
maintenance and capital improvements. The letter of commitment provides that the
lease will require the tenant to pay monthly rent in a per annum amount equal to
10.50% multiplied by the purchase price of the land in the case of the ground
lease or by the total amount of the funds disbursed under the development
agreement in the case of the facility lease. The letter of commitment also
provides that on January 1, 2006, and on each January 1 thereafter, the base
rent will be increased by an amount equal to the greater of (A) 2.5% per annum
of the prior year's base rent, or (B) the percentage by which the CPI on January
1 shall have increased over the CPI figure in effect on the then just previous
January 1. The letter of commitment provides that the lease will also require
the tenant to carry customary insurance which is adequate to satisfy our
underwriting standards, and require the tenant to pay us on the commencement
date of the lease an amount equal to $5,000 to cover the cost of the physical
inspections of the facility, which fee will, beginning on January 1, 2006, and
continuing on each January 1 thereafter, be increased by 2.5% per annum. The
letter of commitment provides that the lease will be cross-defaulted with any
other lease between us and the tenant or its affiliates.

Repair and Replacement Reserve. The letter of commitment provides that the
lease will require the tenant, beginning on the completion of construction of
the facility, to make annual deposits into a reserve account in the amount of
$2,500 per bed per year. The letter of commitment also provides that the lease
will require that beginning on the first January 1 after the completion of
construction, the payment of $2,500 per bed per year into the improvement
reserve will be increased by 2.5%. We expect the lease to require that all
extraordinary repair expenditures made in each year during the term of the lease
will be funded first from the reserve, and the tenant will pay into the reserve
such funds as necessary for all extraordinary repairs.

Security. The letter of commitment provides that, as security for the
lease, the tenant will grant us a security interest in all personal property,
other than receivables, located and to be located at the facility. The letter of
commitment requires the tenant to obtain and deliver to us an unconditional and
irrevocable letter of credit from a bank acceptable to us, naming us beneficiary
thereunder, in an amount equal to one year's base rent under the lease, and
provide that at such time as the operations in the facility generated EBITDAR
coverage of at least two times the base rent for two consecutive fiscal years,
the letter of credit may be reduced to an amount equal to six months of the base
rent then in effect. The letter of commitment provides that the lease will be
cross-defaulted to any other lease or agreement between the parties.

Monroe Hospital is newly formed and has had no significant operations date.
The development transaction is conditioned upon Monroe Hospital receiving equity
contributions of at least $6.0 million and maintaining sufficient tangible net
worth to absorb reasonable costs and expenses, including our lease payments,
during the start-up period. Monroe Hospital has executed a contract with an
experienced hospital management company to manage the day-to-day operations of
the hospital, including staffing, scheduling, billing and collections,
governmental compliance and relations, and other functions. The management
company intends to make a substantial equity investment in Monroe Hospital. The
letter of commitment provides that we will have the right to require Monroe
Hospital to replace the management company under certain conditions.

Purchase Options. The letter of commitment provides that the lease will
provide that so long as Monroe Hospital is not in default under any lease with
us or any of the leases with its subtenants, at the expiration of the lease
Monroe Hospital will have the option, upon 60 days prior written notice, to
purchase the facility at a purchase price equal to the greater of (i) the
appraised value of the facility, which assumes the lease remains in effect for
15 years, or (ii) the total development costs, including any capital additions
funded by us, as increased by an amount equal to the greater of (A) 2.5% per
annum from the date of the lease, or (B) the rate of increase in the CPI on each
January 1.

Commitment Fee. The letter of commitment provides that we are entitled to
a commitment fee at closing equal to 0.5% of $28.0 million if closing occurs
before June 1, 2005, less the sum of $100,000 which we have already received as
a commitment fee. We may increase the commitment fee if closing occurs after May
31, 2005. We will also be entitled to receive at closing the sum of $50,000 as a
construction fee.

HOUSTON, TEXAS

General. On March 16, 2005, we entered into a letter of commitment with
North Cypress Medical Center Operating Company, Ltd., or North Cypress, an
unaffiliated third party, to develop a community hospital in Houston, Texas. We
expect to enter into a ground lease with the current owner of the land, with an
option for us to purchase the land and then sublease the land to North Cypress.
We intend to enter into a development agreement with an affiliate of North
Cypress to develop the facility. The letter of commitment provides that the
total development costs to develop the facility are estimated to be
approximately $51.0 million. Alternatively, and subject to the approval of North
Cypress, we will make a construction loan, secured by the improvements, to North
Cypress for the amount necessary for construction of the improvements with
interest at 10.50% per annum for a term ending upon completion of construction.
We will ground sublease the land during the construction period and, subject to
certain conditions, purchase from and lease to North Cypress the improvements
upon their completion. In the

event we do not exercise our right to purchase the improvements upon completion
of construction, we expect that the ground sublease will continue for a term of
15 years with three five year renewal options and that the construction loan
will be converted to a 15 year term loan with interest at 10.50% per annum,
secured by a mortgage on the improvements. If we purchase the improvements, the
ground sublease will terminate and be replaced with a lease for both the land
and the improvements which we refer to as the facility lease. We have ordered an
independent appraisal in connection with the lease of the land and the
development of the facility and expect that the appraised value will not be less
than the total development costs.

Commitment Fee. The letter of commitment provides that, in connection with
the acquisition of the leasehold and development of the facility, North Cypress
has agreed to pay us a commitment fee equal to 1% of the total development
costs, which shall be due and paid to us at the time the lease is signed;
provided, however, $100,000 of the total 1% commitment fee was paid to us at the
time the letter of commitment was executed.

Sublease. We intend to form a Delaware limited partnership, MPT of North
Cypress, LP, which will enter into the ground lease with the current owner. The
letter of commitment provides that, at the time we enter into the ground lease,
we will ground sublease 100% of the land to North Cypress for the construction
period. If we purchase the improvements at the end of the construction term, the
ground sublease will terminate and be replaced by the facility lease which would
continue for a term of 15 years with three options to renew for five years each.
The ground sublease or the facility lease will be a net-lease with the tenant
responsible for all costs of the facility, including, but not limited to, all
rent and other costs and expenses due and payable under the ground lease, taxes,
utilities, insurance, maintenance and capital improvements. The facility lease
will require the tenant to pay monthly rent in a per annum amount equal to
10.50% multiplied by the total amount of the funds disbursed under the
development agreement plus the sum of all rents paid pursuant to the ground
lease. The letter of commitment also provides that on January 1, 2006, and on
each January 1 thereafter, the base rent will be increased by an amount equal to
the greater of (A) 2.5% per year of the prior year's base rent, or (B) the
percentage by which the CPI on January 1 shall have increased over the CPI
figure in effect on the then just previous January 1. The letter of commitment
provides that the facility lease will require the tenant to carry customary
insurance which is adequate to satisfy our underwriting standards. The letter of
commitment provides that the facility lease will require the tenant to pay us,
commencing on January 1, 2006, an amount equal to $7,500 to cover the cost of
the physical inspections of the facility, which fee will, on each January 1, be
increased by 2.5% per annum. In addition to the inspection fee, the total
development costs will include $75,000 to cover our inspection of the facility
during the construction period.

Capital Improvement Reserve. The letter of commitment provides that the
sublease will require the tenant, beginning on the date that construction of the
facility has been completed, to make annual deposits into a reserve account in
the amount of $2,500 per bed per year. The letter of commitment also provides
that on each January 1 thereafter, the payment of $2,500 per bed per year into
the improvement reserve will be increased by 2.5%. We expect the lease to
require that all extraordinary repair expenditures made in each year during the
term of the sublease will be funded first from the reserve, and the tenant will
pay into the reserve such funds as necessary for all extraordinary repairs.

Capital Contributions and Net Worth Covenant. The letter of commitment
provides that the sublease will require that, as of the commencement date of the
sublease, tenant shall have received from its equity owners at least $15.0
million in cash equity which we expect to be used for operating expenses and not
be distributed to its equity owners. Those contributions will include the letter
of credit as described below. We expect the lease to provide that upon our
request tenant will provide to us evidence that such cash equity is in place and
has not been distributed to tenant's equity owners. The letter of commitment
provides that the sublease will require that North Cypress maintain at all times
during the sublease a tangible net worth, the amount of which shall be
negotiated prior to closing and execution of the sublease.

Security. The letter of commitment provides that as security for the
sublease, the tenant will grant us a security interest in all personal property,
other than receivables, located and to be located at the

facility. The letter of commitment provides that the sublease will be
cross-defaulted with any other sublease between North Cypress, or its
affiliates, and us, or our affiliates. The letter of commitment provides that
the sublease will also require the tenant to obtain and deliver to us an
unconditional and irrevocable letter of credit from a bank acceptable to us,
naming us beneficiary thereunder, in an amount equal to one year's base rent
under the sublease, and that at such time as the operations in the facility have
for two consecutive fiscal years generated EBITDAR coverage of at least two
times the base rent, the letter of credit may be reduced to an amount equal to
six months of the base rent then in effect.

North Cypress is newly formed and has had no significant operations date.
The development transaction is conditioned upon North Cypress receiving equity
contributions of at least $15.0 million and maintaining sufficient tangible net
worth to absorb reasonable costs and expenses, including our lease payments,
during the start-up period. North Cypress has executed a contract with an
experienced hospital management company to manage the day-to-day operations of
the hospital, including staffing, scheduling, billing and collections,
governmental compliance and relations, and other functions. The management
company intends to make a substantial equity investment in North Cypress. The
letter of commitment provides that we will have the right to require North
Cypress to replace the management company under certain conditions.

Purchase Options. The letter of commitment provides that so long as we
have the corresponding rights under the ground lease, the sublease will provide
that so long as the tenant is not in default, and no event has occurred which
with the giving of notice or the passage of time or both would constitute a
default under its, and its affiliates, leases and subleases with us or any of
our affiliates or any of the leases and subleases with its subtenants, at the
expiration of the sublease, and at the expiration of each extension term, the
tenant will have the option to purchase the facility at a purchase price equal
to the greater of (i) the appraised value of the facility, or (ii) the total
development costs, including any capital additions funded by us, as increased by
an amount equal to the greater of (A) 2.5% per annum from the date of the
sublease, or (B) the rate of increase in the CPI on each January 1.

Sale Proceeds Distributions or Syndication. The letter of commitment
provides that at the time we enter into the lease with the tenant, we will also
enter into an agreement with the tenant granting the tenant the right to choose
between two options relating to the facility. The first option is based on a
sale of the facility and, after we receive from the sales proceeds an amount
equal to the total development costs plus an internal rate of return equal to
15% any proceeds above that amount will be distributed to the tenant and us on
an equal basis. Under the other option, subject to applicable healthcare
regulatory requirements, if requested by tenant, we will offer the tenant or its
physician partners opportunities to purchase up to 49% of the limited
partnership equity interest in the limited partnership entity that will hold the
title to the facility. The valuation of the limited partnership's equity
interest will be based on the historical cost of the limited partnership's
assets. To the extent that we elect to place debt on the facility, such debt
will be non-recourse to the limited partners. Such offering will occur six to
nine months following the occupancy of the facility. If tenant chooses this
option, tenant and/or its physician partners will invest on an equal basis with
us.

We cannot assure you that we will acquire or develop any of the Pending
Acquisition and Development Facilities on the terms described in this prospectus
or at all, because each of these transactions is subject to a variety of
conditions, including, in the case of the Pending Acquisition and Development
Facility under contract, our satisfactory completion of due diligence, receipt
of appraisals and other third party reports, obtaining of government and third
party approvals and consents, our proposed tenant's acquisition of the property
on which facilities are to be built, as well as other customary closing
conditions and, in the case of the transactions under letters of commitment,
negotiation and execution of mutually-acceptable definitive agreements, our
satisfactory completion of due diligence, receipt of appraisals that support the
purchase price set forth in the commitment letter and other third party reports,
obtaining of government and third party approvals and consents, approval by our
board of directors, and in certain cases the acquisition of the property on
which the facility is to be constructed from the current owner, as well as
satisfaction of customary closing conditions.

OUR ACQUISITION AND DEVELOPMENT PIPELINE

We have also entered into the following arrangements which, because of the
various contingencies that must be satisfied before these transactions can be
completed, we do not consider to be probable acquisitions or developments as of
the date of this prospectus.

DIVERSIFIED SPECIALTY INSTITUTES, INC. ACQUISITION AND DEVELOPMENT FUNDING

General. On March 3, 2005, we entered into a letter agreement with
Diversified Specialty Institutes, Inc., or DSI. An affiliate of DSI is the
proposed tenant of the women's hospital and medical office building in Bensalem,
Pennsylvania that we have contracted with to develop and leaseback. The letter
agreement provides that, subject to DSI identifying facilities for acquisition
or development, which it is not required to do, and subject to certain other
conditions set forth in the letter agreement, we have agreed to make available
to DSI or its affiliates acquisition and development funding in the total amount
of $50.0 million to be used to finance the potential future acquisition or
development of healthcare facilities, in each case subject to our due diligence
and approval. The arrangement will remain outstanding until March 2, 2006, and
be available to finance any acquisition facility or development facility that is
subject to definitive agreements as of March 2, 2006, notwithstanding that the
closing or completion of the acquisition facility or development facility may
not have occurred as of March 2, 2006. We agreed that the definitive documents
relating to the arrangement must close by April 30, 2005, unless a 30-day
extension is requested by DSI or us. We have extended the closing date to June
30, 2005.

DSI is not required to identify facilities for acquisition or development
and, if it does not, we have no obligation to provide funding to DSI. If funds
are drawn from the arrangement to fund an acquisition or development facility,
as applicable, we expect to enter into definitive documents with DSI. With
respect to any development facility, we expect to enter into a development
agreement with a developer, which may be an affiliate of DSI, to develop the
development facility.

Commitment Fee. The letter agreement provides that we are entitled to a
fee equal to 1% of the aggregate purchase price or development costs of any
facilities we acquire pursuant to this arrangement, $100,000 of which was paid
when the letter agreement was signed. The remainder of the fee will be due and
payable at the closing of future projects, with the fee on each project being
equal to 1% of that project's purchase price. We have agreed to give DSI a
credit on future payments of fees for the $100,000 paid at the execution of the
letter agreement.

Lease. We expect to form a Delaware limited liability company or a limited
partnership to own each facility acquired or developed pursuant to the
commitment. The letter of commitment provides that, at the time of our purchase
of any acquisition or development facility, we intend to lease back to the
applicable tenant 100% of the land and all improvements, including improvements
to be constructed in the case of a development facility, for a 15-year term,
with three options to renew for five years each, so long as the options are
exercised at least six months prior to the expiration of the lease or the
applicable extended term. The letter of commitment provides that each lease will
be a net-lease with the tenant responsible for all costs of the facility,
including, but not limited to, taxes, utilities, insurance and maintenance.

For each development facility, the letter agreement provides that the
tenant will pay monthly rent during the construction period in a per year amount
equal to 10.75% multiplied by the total amount of the funds disbursed under the
development agreement. The letter agreement also provides that the lease
relating to a development facility to require the tenant to pay, following the
completion of construction of the facility, base rent in an amount equal to
10.75% per year of the total development costs, payable in monthly installments.
For an acquisition facility, we expect the lease to require the tenant to pay us
base rent equal to 10.75% of the purchase price of the facility. The letter
agreement provides that each lease will provide that commencing on the first
January 1 following the commencement of the lease with respect to an acquisition
facility, and on the first January 1 following the construction completion date
with respect to a development facility, and on each January 1 thereafter, the
base rent will be increased by an amount equal to the greater of (A) 2.5% per
year of the prior year's base rent, or (B) the percentage by which the CPI on
January 1 has increased over the CPI figure in effect on the then just previous
January 1. The letter of commitment also provides that each lease for an
acquisition facility and a development facility

will require the tenant to carry customary insurance which is adequate to
satisfy our underwriting standards.

The letter agreement provides that each lease will require the tenant to
pay us on the commencement date of the lease an amount equal to $7,500 to cover
the cost of the physical inspections of the facility. The letter agreement also
provides that this inspection fee will increase at the rate of 2.5% per year
starting on the first January 1 following the commencement date of the lease, in
the case of an acquisition facility, or the completion date, in the case of a
development facility. In addition to the inspection fee, we also expect the
tenant to pay us a fee equal to $75,000 per development facility to cover our
inspection of the development facility during the construction period.

Capital Improvement Reserve. The letter agreement provides that each lease
will require, commencing on the date that construction has been completed with
respect to a development facility, or on the date of commencement of the lease
with respect to an acquisition facility, the tenant to make annual deposits into
a reserve account in the amount of $2,500 per bed per year. The letter agreement
also provides that each lease is expected to provide that on each January 1
thereafter, the payment of $2,500 per bed per year into the improvement reserve
will be increased by 2.5%. We expect that the lease will require all
extraordinary repair expenditures made in each year during the term of the lease
will be funded first from the reserve, and the tenant will pay into the reserve
such funds as necessary for all extraordinary repairs.

Security. The letter agreement provides that, as security for each lease,
the tenant will grant us a security interest in all personal property, other
than receivables, located and to be located at the facility. The letter
agreement provides that each lease will be cross-defaulted with any other leases
between the tenant, or its affiliates, and us, or our affiliates. The letter
agreement provides that each lease will require the tenant to obtain and deliver
to us an unconditional and irrevocable letter of credit from a bank acceptable
to us, naming us beneficiary thereunder, in an amount equal to one year's base
rent under the lease.

The letter agreement provides that each lease will require that, as of the
commencement date of the lease, the tenant to have a tangible net worth of no
less than $5 million in cash equity or shall have access to a working capital
line of no less than $5 million that is personally guaranteed by Dr. Tannenbaum
and such other persons as may be approved by us.

Purchase Options. The letter agreement provides that each lease will
provide that so long as tenant is not in default, and no event has occurred
which with the giving of notice or the passage of time or both would constitute
a default under its, and its affiliates, leases with us or any of our affiliates
or any of the leases with its subtenants, at the expiration of the initial term
of the lease, and at the expiration of each extended term thereafter, upon at
least 60 days' prior written notice, tenant will have the option to purchase the
facility at a purchase price equal to the greater of (i) the appraised value of
the facility, or, in the case of a development facility (ii) the total
development costs (including any capital additions funded by us), as increased
by an amount equal to the greater of (A) 2.5% per year from the date of the
lease, or (B) the rate of increase in the CPI on each January 1, or, in the case
of an acquisition facility, (ii) the amount of (A) the purchase price paid for
the facility, including costs of third party reports, legal fees and all other
acquisition costs.

OTHER ARRANGEMENTS

On May 9, 2005, we entered into an arrangement with Vibra to purchase a
hospital facility in California for a purchase price of $20.8 million, subject
to adjustment. The transaction is subject to Vibra's acquisition of the facility
and the operations of the facility from the current owner and a number of other
conditions. Vibra has entered into a non-binding letter of intent to acquire the
facility and operations at that facility, but we cannot assure you that it will
be able to acquire the facility. If we purchase the facility, we will lease it
back to an affiliate of Vibra for a term of 15 years with three renewal options
of five years each. The lease will require the tenant to pay base rent in an
amount equal to 10.5% of the purchase price which rent shall increase each year
by the greater of 2.5% or the increase in CPI from the prior year. We have been
paid a fee of $ as consideration for entering into this arrangement. The
lease

will be cross-defaulted with all other leases and other agreements between us or
our affiliates, on the one hand, and the tenant or its affiliates, on the other
hand.

On May 3, 2005 we entered into an arrangement with Prime Healthcare
Systems, LLC or Prime Healthcare, an affiliate of DVH, to purchase a hospital
facility in California for a purchase price of $25.0 million, subject to
adjustment based on an appraisal that we intend to obtain. The transaction is
subject to Prime Healthcare's acquisition of the facility from the current owner
and a number of other conditions. Prime Healthcare has not yet entered into an
agreement or letter of intent to purchase the facility from the current owner
and we cannot assure you that it will be able to acquire the facility. If we
purchase the facility from Prime Healthcare, we will lease it back to an
affiliate of Prime Healthcare for a term of 15 years with three renewal options
of five years each. The lease will require the tenant to pay base rent in an
amount equal to 10% of the purchase price, which rent shall increase each year
by the greater of 2.0% or the increase in CPI from the prior year. We have been
paid a fee of $ as consideration for entering into this arrangement. The
lease will be cross-defaulted with all other leases and other agreements between
us or our affiliates, on the one hand, and the tenant or its affiliates, on the
other hand.

We cannot assure you that we will acquire or develop any of the facilities
in our acquisition and development pipeline on the terms described in this
prospectus or at all, because each of these transactions is subject to a variety
of conditions, including negotiation and execution of mutually-acceptable
definitive agreements, our satisfactory completion of due diligence, receipt of
appraisals that support the purchase price set forth in the letter agreements
and other third party reports, obtaining of government and third party approvals
and consents, approval by our board of directors, and in certain cases our
proposed tenant's acquisition of the facility from the current owner, as well as
satisfaction of customary closing conditions.

MANAGEMENT

OUR DIRECTORS AND EXECUTIVE OFFICERS

Our business and affairs are managed under the direction of our board of
directors, which consists of eight members, three of whom are members of our
senior management team and five of whom our board of directors has determined to
be independent in accordance with the listing standards established by the New
York Stock Exchange, or NYSE. Each director is elected to serve until the next
annual meeting of stockholders and until his successor is elected and qualified.
The terms of our present directors will expire at our 2005 annual meeting of
stockholders. The following table sets forth certain information regarding our
executive officers and directors:

NAME AGE POSITION
- ---- --- --------

Edward K. Aldag, Jr. ..................... 41 Chairman of the Board, President and Chief
Executive Officer
R. Steven Hamner.......................... 48 Director, Executive Vice President and
Chief Financial Officer
William G. McKenzie....................... 46 Vice Chairman of the Board
Emmett E. McLean.......................... 50 Executive Vice President, Chief Operating
Officer, Treasurer and Assistant Secretary
Michael G. Stewart........................ 50 Executive Vice President, General Counsel
and Secretary
Virginia A. Clarke........................ 46 Director
G. Steven Dawson.......................... 47 Director
Bryan L. Goolsby.......................... 54 Director
Robert E. Holmes, Ph.D. .................. 63 Director*
L. Glenn Orr, Jr. ........................ 65 Director

- ------------------------

* Mr. Holmes has been designated as our lead independent director.

The following is a summary of certain biographical information concerning
our directors and executive officers:

Edward K. Aldag, Jr. is one of our founders and has served as our president
and chief executive officer since August 2003, and as chairman of the board
since March 2004. Mr. Aldag served as our vice chairman of the board from August
2003 until March 2004 and as our secretary from August 2003 until March 2005.
Prior to that, Mr. Aldag served as an executive officer and director with our
predecessor from its inception in August 2002 until August 2003. From 1986 to
2001, Mr. Aldag managed two private real estate companies, Guilford Capital
Corporation and Guilford Medical Properties, Inc., that had aggregate assets
valued at more than $500 million. Mr. Aldag played an integral role in the
formation of investor groups, structuring the financing, and closing the
transactions. Guilford Medical Properties, Inc. owned numerous rehabilitation
hospitals across the country and net-leased them to four different national
healthcare providers. Mr. Aldag served as president and a member of the board of
directors of Guilford Medical Properties, Inc. from its inception until selling
his interest in the company in 2001. Mr. Aldag was the president and a member of
the board of directors of Guilford Capital Corporation from 1998 to 2001 and
from 1990 to 1998 served as executive vice president, chief operating officer
and a member of the board of directors. Mr. Aldag received his B.S. in Commerce
& Business from the University of Alabama with a major in corporate finance.

R. Steven Hamner is one of our founders and has served as our executive
vice president and chief financial officer since September 2003 and as a
director since February 2005. In August and September 2003, Mr. Hamner served as
our executive vice president and chief accounting officer. From October 2001
through March 2004, he was the managing director of Transaction Analysis LLC, a
company that provided interim and project-oriented accounting and consulting
services to commercial real estate owners

and their advisors. From June 1998 to September 2001, he was vice president and
chief financial officer of United Investors Realty Trust, a publicly-traded
REIT. For the 10 years prior to becoming an officer of United Investors Realty
Trust, he was employed by the accounting and consulting firm of Ernst & Young
LLP and its predecessors. Mr. Hamner received a B.S. in Accounting from
Louisiana State University. Mr. Hamner is a certified public accountant.

William G. McKenzie is one of our founders and has served as the vice
chairman of our board of directors since September 2003. Mr. McKenzie has served
as a director since our formation and served as the executive chairman of our
board of directors in August and September 2003. From May 2003 to August 2003,
he was an executive officer and director of our predecessor. From 1998 to the
present, Mr. McKenzie has served as president, chief executive officer and a
board member of Gilliard Health Services, Inc., a privately-held owner and
operator of acute care hospitals. From 1996 to 1998, he was executive vice
president and chief operating officer of the Mississippi Hospital
Association/Diversified Services, Inc. and the Health Insurance Exchange, a
mutual company and HMO. From 1994 to 1996, Mr. McKenzie was senior vice
president of Managed Care and executive vice president of Physician Solutions,
Inc., a subsidiary of Vaughan HealthCare, a private healthcare company in
Alabama. From 1981 to 1994, Mr. McKenzie was hospital administrator and chief
financial officer and held other management positions with several private acute
care organizations. Mr. McKenzie received a Masters of Science in Health
Administration from the University of Colorado and a B.S. in Business
Administration from Troy State University. He has served in numerous capacities
with the Alabama Hospital Association.

Emmett E. McLean is one of our founders and has served as our executive
vice president, chief operating officer and treasurer since September 2003. Mr.
McLean has served as assistant secretary since April 2004. In August and
September 2003, Mr. McLean also served as our chief financial officer. Mr.
McLean was one of our directors from September 2003 until April 2004. From June
to September, 2003, Mr. McLean served as executive vice president, chief
financial officer, and treasurer and board member of our predecessor. From 2000
to 2003, Mr. McLean was a private investor and, for part of that period, served
as a consultant to a privately held company. From 1995 to 2000, Mr. McLean
served as senior vice president -- development, secretary, treasurer and a board
member of PsychPartners, L.L.C., a healthcare services and practice management
company. From 1992 to 1994, he was senior vice president, chief financial
officer and secretary of Diagnostic Health Corporation, a healthcare services
company. From 1984 to 1992, he worked for Dean Witter Reynolds, Inc., now Morgan
Stanley, and Smith Barney, now Citigroup, in the corporate finance departments
of their respective investment banking businesses. From 1977 to 1982, Mr. McLean
worked as a commercial banker for SunTrust Banks, Inc. Mr. McLean received an
MBA from the University of Virginia and a B.A. in Economics from The University
of North Carolina.

Michael G. Stewart has served as our general counsel since October 2004 and
as our executive vice president and secretary since March 2005. Prior to October
2004, Mr. Stewart worked as a private investor, healthcare consultant and
novelist. He advised physician and surgery groups on emerging healthcare issues
for four years before publishing three novels. From 1993 until 1995, he served
as vice president and general counsel of Complete Health Services, Inc., a
managed care company, and its successor corporation, United Healthcare of the
South, a division of United Healthcare, Inc. (NYSE: UNH). Mr. Stewart was
engaged in the private practice of law between 1988 and 1993. Mr. Stewart holds
a J.D. degree from Cumberland School of Law of Samford University and a B.S. in
Business Administration from Auburn University.

Virginia A. Clarke has served as a member of our board of directors since
February 2005. Ms. Clarke has been a search consultant in the global executive
search firm of Spencer Stuart & Associates since 1997. Ms. Clarke was with DHR
International, an executive search firm, during 1996. Prior to that, Ms. Clarke
spent 10 years in the real estate investment management business with La Salle
Partners and Prudential Real Estate Investors, where her activities included
asset management, portfolio management, capital raising and client service, and
two years with First National Bank of Chicago. Ms. Clarke is a member of the
Pension Real Estate Association. Ms. Clarke graduated from the University of
California at

Davis and received a master's degree in management from the J.L. Kellogg
Graduate School of Management at Northwestern University.

G. Steven Dawson has served as a member of our board of directors since
April 2004. He is currently a private investor and serves on the boards of five
other real estate investment trusts in addition to his service for us, as
follows: American Campus Communities (NYSE: ACC), AmREIT, Inc. (AMEX: AMY),
Desert Capital REIT (a non-listed public mortgage company), Sunset Financial
Resource, Inc. (NYSE: SFO), and Trustreet Properties, Inc. (NYSE: TSY). Mr.
Dawson is chairman of the audit committees for each of these companies except
Sunset Financial Resource, Inc. and Trustreet Properties, Inc. From July 1990 to
September 2003, he was chief financial officer and senior vice president-finance
of Camden Property Trust (NYSE: CPT) and its predecessors, a REIT engaged in the
development, ownership, management, financing and sale of multi-family
properties throughout the southern United States. Mr. Dawson is involved in
various charitable, non-profit and educational organizations, including serving
on the board of His Grace Foundation, a charity providing services to the
families of children in the Bone Marrow Transplant Unit of Texas Children's
Hospital, and as a member of the Real Estate Roundtable at the Mays Graduate
School of Business at Texas A&M University. Mr. Dawson received a degree in
business from Texas A&M University.

Bryan L. Goolsby has served as a member of our board of directors since
February 2005. Mr. Goolsby is the managing partner of the law firm Locke Liddell
& Sapp LLP. Mr. Goolsby is an associate board member of the Board of Governors
of the National Association of Real Estate Investment Trusts. He is also a
member of the National Multi-Family Housing Association and the Pension Real
Estate Association, and an associate board member of the Edwin L. Cox School of
Business at Southern Methodist University. He serves as a director of Desert
Capital REIT, Inc. and AmREIT, Inc. Mr. Goolsby received a J.D. degree from the
University of Texas, and is a Certified Public Accountant.

Robert E. Holmes, Ph.D., has served as a member of our board of directors
since April 2004. Mr. Holmes, our lead independent director, is the Dean and
Professor of Management of the School of Business at the University of Alabama
at Birmingham, positions he has held since 1999. From 1995 to 1999, he was Dean
of the Olin Graduate School of Business at Babson College in Wellesley,
Massachusetts. Prior to that, he was Dean of the James Madison University
College of Business in Harrisonburg, Virginia for 12 years. He is the author of
more than 20 scholarly publications, is past president of the Southern Business
Administration Association, and is actively involved in the International
Association for Management Education. Mr. Holmes received a bachelor's degree
from the University of Texas at Austin, an MBA from University of North Texas,
and received his Ph.D. from the University of Arkansas with an emphasis on
management strategy.

L. Glenn Orr, Jr. has served as a member of our board of directors since
February 2005. Mr. Orr has been president and chief executive officer of The Orr
Group, which provides investment banking and consulting services for
middle-market companies, since 1995. Prior to that, he was chairman of the board
of directors, president and chief executive officer of Southern National
Corporation from 1990 until its merger with Branch Banking & Trust in 1995. Mr.
Orr is member of the board of directors, chairman of the governance/compensation
committee and a member of the executive committee of Highwoods Properties, Inc.
(NYSE: HIW). He is also a member of the boards of directors of General Parts,
Inc., Village Tavern, Inc. and Broyhill Management Fund, Inc. Mr. Orr previously
served as president and chief executive officer of Forsyth Bank and Trust Co.,
president of Community Bank in Greenville, South Carolina and president of the
North Carolina Bankers Association. He is a trustee of Wake Forest University.

CORPORATE GOVERNANCE -- BOARD OF DIRECTORS AND COMMITTEES

Our board of directors has adopted a code of ethics and business conduct
relating to the conduct of our business by our employees, officers and
directors, and has also adopted corporate governance guidelines to assist the
board of directors in the administration of its duties. Our corporate governance
guidelines and the listing standards of the NYSE require that a majority of the
members of our board of directors be

independent. Board members are recommended for nomination by our ethics,
nominating and corporate governance committee. Nominations must satisfy the
standards established by that committee for membership on our board of
directors.

Our directors generally meet quarterly or more frequently if necessary. The
directors are regularly kept informed about our business at meetings of the
board of directors and its committees and through supplemental reports and
communications. Our independent directors meet regularly in executive sessions
without the presence of any corporate officers. Mr. Holmes has been selected by
the board of directors to serve as lead independent director and in that
capacity presides at meetings of the non-management directors, coordinates the
preparation for meetings of the board of directors with our chief executive
officer, and serves as the liaison between the board of directors and our chief
executive officer.

Our board of directors has established audit, compensation, ethics,
nominating and corporate governance and investment committees, the principal
functions and membership of which are briefly described below. The charters of
the audit, compensation and ethics, nominating and corporate governance
committees, along with our code of ethics and business conduct and our corporate
governance guidelines, will be available on our website upon completion of this
offering.

In February 2005, we expanded the size of our board of directors from seven
to 11 directors and elected four new directors, Messrs. Goolsby, Hamner and Orr
and Ms. Clarke. In connection with the election of these new directors, our
board reconstituted our audit, compensation and ethics, nominating and corporate
governance committees and established the investment committee of our board. On
April 6, 2005, three of our independent directors who had become members of our
board in April 2004 resigned as directors.

AUDIT COMMITTEE

Our board of directors has established an audit committee, which is
comprised of three independent directors, Messrs. Dawson and Orr and Ms. Clarke.
Mr. Dawson serves as the chairperson of the audit committee and also serves on
the audit committees of three other public companies. Our board of directors has
determined that Mr. Dawson's service on the audit committees of other public
companies does not impair his ability to serve on our audit committee. The audit
committee oversees (i) our accounting and financial reporting processes; (ii)
the integrity and audits of our financial statements; (iii) our compliance with
legal and regulatory requirements; (iv) the qualifications and independence of
our independent auditors; and (v) the performance of our internal and
independent auditors. The audit committee also:

- has sole authority to appoint or replace our independent auditors;

- has sole authority to approve in advance all audit and non-audit services
by our independent auditors;

- monitors compliance of our employees with our standards of business
conduct and conflict of interest policies; and

- meets at least quarterly with our senior executive officers, internal
audit staff and our independent auditors in separate executive sessions.

The specific functions and responsibilities of the audit committee are set
forth in the audit committee's charter. Our board of directors has determined
that each of the members of the audit committee is financially literate, as such
term is interpreted by our board of directors. In addition, our board of
directors has determined that Mr. Dawson qualifies as an "audit committee
financial expert" under the current SEC regulations. Our management has primary
responsibility for the financial statements and internal control over financial
reporting. The audit committee engages an independent registered public
accounting firm to conduct an annual audit of the Company's financial statements
in accordance with the standards of the Public Company Accounting Oversight
Board.

COMPENSATION COMMITTEE

Our board of directors has established a compensation committee, which is
comprised of three independent directors, Messrs. Dawson, Goolsby and Orr. Mr.
Orr serves as the chairperson of the compensation committee. The principal
functions of the compensation committee are to:

- evaluate the performance of our executive officers;

- review and approve the compensation for our executive officers;

- review and make recommendation to the board with respect to our incentive
compensation plans and equity-based plans; and

- administer our equity incentive plan.

The compensation committee also reviews and approves corporate goals and
objectives relevant to the chief executive officer's compensation, evaluates the
chief executive officer's performance in light of those goals and objectives,
and establishes the chief executive officer's compensation levels based on its
evaluation. The compensation committee has the authority to retain and terminate
any compensation consultant to be used to assist in the evaluation of the
compensation of the chief executive officer or any other executive officer or
director. In 2004, the compensation committee engaged a compensation consultant
to perform a comprehensive review and provide recommendations to the
compensation committee regarding the compensation of our officers and directors.
The specific functions and responsibilities of the compensation committee are
set forth in more detail in the compensation committee's charter.

ETHICS, NOMINATING AND CORPORATE GOVERNANCE COMMITTEE

Our board of directors has established an ethics, nominating and corporate
governance committee. Membership of the committee is comprised of three
independent directors, Messrs. Dawson, Goolsby and Holmes. Mr. Holmes serves as
the chairperson of this committee. The ethics, nominating and corporate
governance committee is responsible for, among other things, recommending the
nomination of qualified individuals to become directors, recommending the
composition of committees of our board, periodically reviewing the board's
performance and effectiveness as a body, recommending proposed changes to the
board of directors, and periodically reviewing our corporate governance
guidelines and policies. The specific functions and duties of the ethics,
nominating and corporate governance committee are set forth in the committee's
charter.

INVESTMENT COMMITTEE

Our board of directors has established an investment committee. Membership
of the committee is comprised of all of our current directors. Mr. Aldag serves
as the chairperson of this committee. The investment committee is responsible
for, among other things, considering and taking action with respect to all
acquisitions, developments and leasing of healthcare facilities in which our
aggregate investment will exceed $10 million.

VACANCIES ON OUR BOARD OF DIRECTORS

Any director may resign at any time and may be removed with or without
cause by the stockholders upon the affirmative vote of the holders of at least
two-thirds of all of our common stock outstanding and entitled to vote generally
for the election of directors. Unless filled by a vote of the stockholders in
the event a director is removed as permitted by Maryland law, a vacancy created
by death, resignation, removal, adjudicated incompetence or other incapacity of
a director may be filled by a vote of a majority of the remaining directors
although less than a quorum. Vacancies created by an increase in the number of
directors must be filled by a vote of majority of the entire board.

100

LIMITED LIABILITY AND INDEMNIFICATION

The MGCL permits a Maryland corporation to include in its charter a
provision limiting the liability of its directors and officers to the
corporation and its stockholder for money damages except for liability resulting
from actual receipt of an improper benefit or profit in money, property or
services or active and deliberate dishonesty established by a final judgment as
being material to the cause of action. Our charter limits the personal liability
of our directors and officers for money damages to the fullest extent permitted
under Maryland law.

The MGCL requires a corporation, unless its charter provides otherwise,
which our charter does not, to indemnify a director or officer who has been
successful on the merits or otherwise, in the defense of any proceeding to which
he or she is made a party by reason of his or her service in that capacity. See
"Certain Provisions of Maryland Law and of Our Charter and
Bylaws -- Indemnification and Limitation of Directors' and Officers' Liability."

We maintain a directors and officers liability insurance policy. We have
also entered into indemnification agreements with each of our directors and
executive officers, which we refer to in this context as indemnitees. The
indemnification agreements provide that we will, to the fullest extent permitted
by Maryland law, indemnify and defend each indemnitee against all losses and
expenses incurred as a result of his current or past service as our director or
officer, or incurred by reason of the fact that, while he was our director or
officer, he was serving at our request as a director, officer, partners,
trustee, employee or agent of a corporation, partnership, joint venture, trust,
other enterprise or employee benefit plan. We have agreed to pay expenses
incurred by an indemnitee before the final disposition of a claim provided that
he provides us with a written affirmation that he has met the standard of
conduct required for indemnification and a written undertaking to repay the
amount we pay or reimburse if it is ultimately determined that he has not met
the standard of conduct required for indemnification. We are to pay expenses
within 20 days of receiving the indemnitee's written request for such an
advance. Indemnitees are entitled to select counsel to defend against
indemnifiable claims.

The general effect to investors of any arrangement under which any person
who controls us or any of our directors, officers or agents is insured or
indemnified against liability is a potential reduction in distributions to our
stockholders resulting from our payment of premiums associated with liability
insurance and payment of indemnifiable expenses and losses.

The SEC takes the position that indemnification against liabilities arising
under the Securities Act is against public policy and unenforceable. As a
result, indemnification of our directors and officers may not be allowed for
liabilities arising from or out of a violation of state or federal securities
laws.

DIRECTOR COMPENSATION

As compensation for serving on our board of directors, each of our
independent directors receives an annual fee of $20,000 and an additional $1,000
for each board of directors meeting attended. In addition, each independent
director is paid $1,000 for attendance at each meeting of a committee on which
he serves. Committee chairmen receive an additional $5,000 per year except that
the audit committee chairman receives an additional $10,000 per year. In
addition, we reimburse our directors for their reasonable out-of-pocket expenses
incurred in attending board of directors and committee meetings. Directors who
are also officers or employees of our company receive no additional compensation
for their service as directors. At the time of each annual meeting of our
stockholders following his or her election to the board of directors, each
independent director will receive 2,000 shares of our common stock, restricted
as to transfer for three years, or a comparable number of deferred stock units.
Our compensation committee may change the compensation of our independent
directors in its discretion.

Upon joining our board of directors, each independent director received a
non-qualified option to purchase 20,000 shares of our common stock with an
exercise price of $10.00 per share. One-third of these options vested upon
grant. One-half of the remaining options will vest on each of the first and
second anniversaries of the date of grant. In addition to this option to
purchase stock, each of our independent

101

directors has been awarded 2,500 deferred stock units, which represent the right
to receive 2,500 shares of common stock at no cost in October 2007 for Messrs.
Dawson and Holmes and 2,500 shares of common stock at no cost in March 2008 for
Ms. Clarke and Messrs. Goolsby and Orr.

EXECUTIVE COMPENSATION

The following table sets forth the compensation paid or earned by our chief
executive officer and our other executive officers for 2003 and 2004:

RESTRICTED STOCK OTHER ANNUAL ALL OTHER
NAME AND POSITION YEAR SALARY BONUS AWARDS(1) COMPENSATION COMPENSATION
- ----------------- ---- -------- -------- ---------------- ------------ ------------

Edward K. Aldag, Jr. ............. 2004 $350,000 $350,000 43,500 $50,462(2) $30,769(3)
Chairman, Chief Executive 2003 145,833(4) 145,833 10,492(5) 9,249(6)
Officer and President
Emmett E. McLean.................. 2004 $250,000 $250,000 20,500 $24,385(7) $15,385(3)
Executive Vice President, 2003 104,167(4) 104,167 -- 10,896(8)
Chief Operating Officer,
Treasurer and Assistant
Secretary
R. Steven Hamner.................. 2004 $250,000 $250,000 27,000 $24,385(7) $15,385(3)
Executive Vice President 2003 104,167(4) 104,167 -- 5,918(9)
and Chief Financial Officer
William G. McKenzie............... 2004 $175,000 $175,000 15,000 $ -- $ --
Vice Chairman of the Board 2003 72,917(4) 72,917 -- --
Michael G. Stewart................ 2004 $ 43,527(10) $ 42,188 -- $ -- $ --
Executive Vice President, 2003 -- -- -- -- --
Secretary and General Counsel

- ---------------

(1) To be awarded upon completion of this offering under our equity incentive
plan. These restricted stock awards will vest at a rate of 8.33% per
quarter beginning on the last day of the first calendar quarter after
completion of this offering so long as each named executive officer remains
an employee of ours. Dividends will be paid on the shares of restricted
common stock.

(2) Represents a $12,000 automobile allowance and $25,000 payable to Mr. Aldag
to reimburse him for the cost of tax preparation and financial planning
services and $13,462 to reimburse Mr. Aldag for his tax liabilities
associated with such payment.

(3) Represents reimbursement for life insurance premiums of $20,000 for Mr.
Aldag and $10,000 for each of Messrs. McLean and Hamner and reimbursement
of $10,769 for Mr. Aldag and $5,385 for each of Messrs. McLean and Hamner
for tax liabilities associated with such premium reimbursements, but does
not include any matching contributions under the 401(k) plan that we expect
to adopt in 2004.

(4) For the partial year period from our inception in August 2003 until
December 31, 2003.

(5) Represents a $7,000 automobile allowance and $3,492 payable to Mr. Aldag to
reimburse him for the cost of tax preparation and financial planning
services.

(6) Represents reimbursement for life insurance premiums of $9,249.

(7) Represents a $9,000 automobile allowance and $10,000 for the named
executive officers to reimburse them for the cost of tax preparation
services and $5,385 for the named executive officers to reimburse them for
their tax liabilities associated with such tax preparation cost
reimbursement.

(8) Represents reimbursement for life insurance premiums of $10,896.

(9) Represents reimbursement for life insurance premiums of $5,918.

(10) For the partial year period from October 25, 2004, Mr. Stewart's date of
hire, to December 31, 2004. Had Mr. Stewart been employed for the full year
2004, he would have been entitled to a base salary of $225,000 during 2004.
Mr. Stewart's employment agreement was amended effective April 28, 2005.
The amended employment agreement provides for an annual base salary of
$250,000.

EMPLOYMENT AGREEMENTS

We have employment agreements with each of the named executive officers.
These employment agreements provide the following annual base salaries: Edward
K. Aldag, Jr., $350,000; Emmett E. McLean, $250,000; R. Steven Hamner, $250,000;
Michael G. Stewart, $250,000; and William G. McKenzie, $175,000. The base
salaries for Messrs. Aldag, McLean and Hamner were increased by 5% effective
January 1, 2005. On each January 1 hereafter, each of the executive officers is
to receive a minimum increase in his base salary equal to the increase in the
Consumer Price Index. These agreements provide that the executive officers,
other than Mr. McKenzie, agree to devote substantially all of their business
time to our operation. The employment agreement for each of the named executive
officers is for a three year term which is automatically extended at the end of
each year within such term for an additional one year period, unless either
party gives notice of non-renewal as provided in the agreement.

102

These employment agreements permit us to terminate each executive's employment
with appropriate notice for or without "cause." "Cause" is generally defined to
mean:

- conviction of, or the entry of a plea of guilty or nolo contendere to, a
felony (excluding any felony relating to the negligent operation of a
motor vehicle or a conviction or plea of guilty or nolo contendere
arising under a statutory provision imposing per se criminal liability
due to the position held by the executive with us, provided the act or
omission of the executive or officer with respect to such matter was not
taken or omitted to be taken in contravention of any applicable policy or
directive of the board of directors);

- a willful breach of the executive's duty of loyalty which is materially
detrimental to us;

- a willful failure to perform or adhere to explicitly stated duties that
are consistent with the executive's employment agreement, or the
reasonable and customary guidelines of employment or reasonable and
customary corporate governance guidelines or policies, including, without
limitation, the business code of ethics adopted by the board of
directors, or the failure to follow the lawful directives of the board of
directors provided such directives are consistent with the terms of the
executive's employment agreement, which continues for a period of 30 days
after written notice to the executive; and

- gross negligence or willful misconduct in the performance of the
executive's duties.

Each of the named executive officers has the right under his employment
agreement to resign for "good reason." The following constitute good reason
under the employment agreements: (i) the employment agreement is not
automatically renewed by the company; (ii) the termination of certain incentive
compensation programs; (iii) the termination or diminution of certain employee
benefit plans, programs or material fringe benefits (other than for Mr.
McKenzie); (iv) the relocation of our principal office outside of a 100 mile
radius of Birmingham, Alabama (in the case of Mr. Aldag); or (v) our breach of
the employment agreement which continues uncured for 30 days. In addition, in
the case of Mr. Aldag, the following constitute good reason: (i) his removal
from the board of directors without cause or his failure to be nominated or
elected to the board of directors; or (ii) any material reduction in duties,
responsibilities or reporting requirements, or the assignment of any duties,
responsibilities or reporting requirements that are inconsistent with his
positions with us.

The executive employment agreements provide a monthly car allowance of
$1,000 for Mr. Aldag and $750 for each of Messrs. McLean, Hamner and Stewart.
Messrs. Aldag, McLean, Hamner and Stewart are also reimbursed for the cost of
tax preparation and financial planning services, up to $25,000 annually for Mr.
Aldag and $10,000 annually for each of Messrs. McLean, Hamner and Stewart. We
also reimburse each executive for the income tax he incurs on the receipt of
these tax preparation and financial planning services. In addition, the
employment agreements provide for annual paid vacation of six weeks for Mr.
Aldag and three weeks for Messrs. McLean, Hamner and Stewart and various other
customary benefits. The employment agreements also provide that Mr. Aldag will
receive up to $20,000 per year in reimbursement for life insurance premiums,
which amount is to increase annually based on the increase in the Consumer Price
Index for such year, and that Messrs. McLean, Hamner and Stewart will receive up
to $10,000 per year in reimbursement for life insurance premiums which amount is
to increase annually based on the increase in the Consumer Price Index for such
year. We also reimburse each executive for the income tax he incurs on the
receipt of these premium reimbursements.

We have the right to obtain a key man life insurance policy for the benefit
of the company on the life of each of our executives with a death benefit equal
to the death benefit of such executive's whole life policy.

The employment agreements referred to above provide that the executive
officers are eligible to receive the same benefits, including medical insurance
coverage and retirement plan benefits in a 401(k) plan to the same extent as
other similarly situated employees, and such other benefits as are commensurate
with their position. Participation in employee benefit plans is subject to the
terms of said benefit plans as in effect from time to time.
103

If the named executive officer's employment ends for any reason, we will
pay accrued salary, bonuses and incentive payments already determined, and other
existing obligations. In addition, if we terminate the named executive officer's
employment without cause or if any of them terminates his employment for good
reason, we will be obligated to pay (i) a lump sum payment of severance equal to
the sum of (x) the product of three and the sum of the salary in effect at the
time of termination plus the average cash bonus (or the highest cash bonus, in
the case of Mr. Aldag) paid to such executive during the preceding three years,
grossed up for taxes in the case of Mr. Aldag, and (y) the incentive bonus
prorated for the year in which the termination occurred, (ii) other than for Mr.
McKenzie, the cost of the executive's continued participation in the company's
benefit and welfare plans (other than the 401(k) plan) for a three year period
(or for a five year period in the case of Mr. Aldag), and (iii) certain other
benefits as provided for in the employment agreement. Additionally, in the event
of a termination by us for any reason other than cause or by the executive for
good reason, all of the options and restricted stock granted to the executive
will become fully vested, and the executive will have whatever period remains
under the options in which to exercise all vested options.

In the event of a termination of the employment of our executives as a
result of death, then in addition to the accrued salary, bonus and incentive
payments due to them, they shall become fully vested in their options and
restricted stock, and their respective beneficiaries will have whatever period
remains under the options to exercise such options. In addition, the executives
would be entitled to their prorated incentive bonuses.

In the event the employment of our executives ends as a result of a
termination by us for cause or by the executives without good reason, then in
addition to the accrued salary, bonuses and incentive payments due to them, the
executives would be entitled to exercise their vested stock options pursuant to
the terms of the grant, but all other unvested options and restricted stock
would be forfeited.

Upon a change of control, the named executive officers will become fully
vested in their options and restricted stock and will have whatever period
remains under the option in which to exercise their options. In addition, if any
executive's employment is terminated by us for cause or by the executive without
good reason in connection with a change of control, the executive will be
entitled to receive an amount equal to the largest cash compensation paid to the
executive for any twelve month period during his tenure multiplied by three. In
general terms, a change of control occurs:

- if a person, entity or affiliated group (with certain exceptions)
acquires more than 50% of our then-outstanding voting securities;

- if we merge into or complete a share exchange, consolidation or other
business combination transaction with another entity unless the holders
of our voting stock immediately prior to the merger have at least 50% of
the combined voting power of the securities in the merged entity or its
parent; or

- upon the liquidation, dissolution, sale or disposition of all or
substantially all of our assets such that after that transaction the
holders of our voting stock immediately prior to the transaction own less
than 50% of the voting securities of the acquiror or its parent.

If payments become due as a result of a change in control and the excise
tax imposed by Code Section 4999 applies, the terms of the employment agreements
require us to gross up the amount payable to the executive by the amount of this
excise tax plus the amount of income and other taxes due as a result of the
gross up payment.

For an 18 month period after termination of an executive's employment for
any reason other than (i) termination by us without cause or (ii) termination by
the executive for good reason, each of the executives under these employment
agreements has agreed not to compete with us by working with or investing in,
subject to certain limited exceptions, any enterprise engaged in a business
substantially similar to our business as it was conducted during the period of
the executive's employment with us.

104

The employment agreements provide that these named executive officers are
eligible to participate in our equity incentive plan, as described in the
section below titled "Equity Incentive Plan." The employment agreements also
provide that the named executive officers are eligible to receive annual bonuses
under our bonus policy. See "Annual Incentive Bonus Policy."

BENEFIT PLANS

ANNUAL INCENTIVE BONUS POLICY

We expect our compensation committee to adopt an annual cash incentive
bonus policy. This policy will be subject to those provisions in our executive
officers' employment agreements that provide that the executives will receive
not less than 40% nor more than 100% of their base salaries under the policy.
Our compensation committee will reevaluate the annual incentive bonus policy for
our executive officers on an annual basis, subject to the maximum and minimum
limitations previously described. In addition, the compensation committee may
approve any additional bonus awards to any executive officer.

401(K) PLAN

Our board of directors has approved the adoption of a Section 401(k) plan
covering our eligible employees. The plan will be a safe harbor plan providing
that each participant must complete one year of service before becoming eligible
for profit sharing contributions, we will match each dollar, dollar for dollar
for the first 3%, then 50% for each dollar of the next 2%, of each participant's
salary and participants' elective contributions and safe harbor contributions
will be fully vested when made and profit sharing contributions will vest over
three years.

EQUITY INCENTIVE PLAN

We have adopted the Amended and Restated Medical Properties Trust, Inc.
2004 Equity Incentive Plan, or equity incentive plan, for the purpose of
attracting and retaining directors, executive officers and other key employees
and consultants, including officers and employees of our operating partnership.
The equity incentive plan provides that the aggregate number of shares of common
stock as to which awards can be made pursuant to the equity incentive plan is
791,180. On April 25, 2005, our compensation committee awarded 82,000 shares of
restricted stock to Mr. Stewart and certain non-management employees. These
shares will vest 20% per year over five years beginning on April 25, 2006. There
remain 490,680 shares available for awards under the equity incentive plan. We
intend to seek stockholder approval of an amendment to the equity incentive plan
at our 2005 annual meeting in order to increase the shares of common stock
available under the plan.

Awards. The equity incentive plan authorizes the issuance of options to
purchase shares of common stock, restricted stock awards, restricted stock
units, deferred stock units, stock appreciation rights and performance units.
The equity incentive plan contains an award limit on the maximum number of
shares of common stock that may be awarded to an individual in any fiscal year
of 300,000 shares.

Vesting. Our compensation committee will determine the vesting of options
and restricted stock and restricted stock units granted under the equity
incentive plan, subject to any different vesting provisions agreed upon in a
participant's employment agreement. In addition, our compensation committee will
establish a standard vesting schedule for options, restricted stock and
restricted stock units subject to any different vesting schedule which is agreed
upon in a participant's employment or award agreement.

Options. Each option granted pursuant to the equity incentive plan is
designated at the time of grant as either an option intended to qualify as an
incentive stock option under Section 422 of the Code, referred to as a qualified
incentive option, or as an option that is not intended to so qualify, referred
to as a non-qualified option. The equity incentive plan authorizes our
compensation committee to grant incentive stock options for common stock in an
amount and at an exercise price to be determined by it, provided that the price
cannot be less than 100% of the fair market value of the common stock on the
date on which the option is granted. If an incentive stock option is granted to
a 10% stockholder, additional requirements will

105

apply to the option. The exercise price of non-qualified options will be equal
to 100% of the fair market value of common stock on the date the option is
granted unless otherwise determined by our compensation committee. The exercise
price for any option is generally payable in cash or, in certain circumstances,
by the surrender, at the fair market value on the date on which the option is
exercised, of shares of our common stock having a value equal to the exercise
price. The equity incentive plan provides that exercise may be delayed or
prohibited if it would adversely affect our status as a REIT. In addition, the
equity incentive plan permits optionholders to exercise their options prior to
the date on which the options will vest, subject to Committee action. In such
case, the optionholder will, upon payment for the shares, receive restricted
stock having vesting terms on transferability that are identical to the vesting
terms under the original option and subject to repurchase by us while the
restrictions on vesting are in effect.

In connection with certain extraordinary events, the compensation committee
may make adjustments in the aggregate number and kind of shares of capital stock
reserved for issuance, the number and kind of shares of capital stock covered by
outstanding awards and the exercise prices specified therein as may be
determined to be appropriate.

Restricted Stock. The equity incentive plan also provides for the grant of
restricted stock awards. A restricted stock award is an award of shares of
common stock that is subject to restrictions on transferability and other
restrictions, if any, as our compensation committee may impose at the date of
grant. Shares of restricted common stock are subject to vesting as our
compensation committee may approve or as may otherwise be agreed upon in a
participant's employment or other award agreement. The restrictions may lapse
separately or in combination at the times and under the circumstances, including
without limitation, a specified period of employment or the satisfaction of
pre-established criteria, in installments or otherwise, as our compensation
committee may determine. Except to the extent restricted under the award
agreement, a participant granted shares of restricted stock will have all of the
rights of a stockholder, including, without limitation, the right to vote and
the right to receive dividends on the restricted stock.

Restricted Stock Units and Deferred Stock Units. Under the equity
incentive plan, the compensation committee may award restricted stock units and
deferred stock units, each for the duration that it determines in its
discretion. Each restricted stock unit and each deferred stock unit is
equivalent in value to one share of common stock and entitles the participant
receiving the award to receive one share of common stock for each restricted
stock unit at the end of the vesting period applicable to such restricted stock
unit and for each deferred stock unit at the end of the deferral period.
Participants are not required to pay any additional consideration in connection
with the settlement of restricted stock units or deferred stock units. A holder
of restricted stock units or deferred stock units has no voting rights, right to
receive cash distributions or other rights as a stockholder until shares of
common stock are issued to the holder in settlement of the stock units. However,
participants holding restricted stock units or deferred stock units will be
entitled to receive dividend equivalents with respect to any payment of cash
dividends on an equivalent number of shares of common stock. Such dividend
equivalents will be credited in the form of additional stock units.

Performance Units. The equity incentive plan also provides for the grant
of performance shares and performance units. Holders of performance units will
be entitled to receive payment in cash or shares of our common stock (or in some
combination of cash and shares) if the performance goals established by the
compensation committee are achieved or the awards otherwise vest. Each
performance unit will have an initial value established by the compensation
committee. The compensation committee will set performance objectives, and such
performance objectives may be based upon the achievement of company-wide,
divisional or individual goals.

Stock Appreciation Rights. The equity incentive plan also authorizes our
compensation committee to grant stock appreciation rights. Stock appreciation
rights are awards that give the recipient the right to receive an amount equal
to (1) the number of shares exercised under the right, multiplied by (2) the
amount by which our stock price exceeds the exercise price. Payment may be in
cash, in shares of our common stock with equivalent value, or in some
combination, as determined by the administrator. The

106

compensation committee will determine the exercise price, vesting schedule and
other terms and conditions of stock appreciation rights; however, stock
appreciation rights expire under the same rules that apply to stock options.

Administration of the Plan. The equity incentive plan is administered by
our compensation committee. Mr. Aldag is to make recommendations to the
compensation committee as to which consultants, employees, and executive
officers, other than himself, will be eligible to participate, subject to
compensation committee review and approval. The compensation committee, in its
absolute discretion, will determine the effect of an employee's termination on
unvested options, restricted common stock and restricted stock units, unless
otherwise provided in the equity incentive plan or the participant's employment
or award agreement.

COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION

There are no compensation committee interlocks and none of our employees
participates on the compensation committee.

INSTITUTIONAL TRADING OF OUR COMMON STOCK

The last sale of our common stock on the Portal(SM) Market occurred on May
25, 2005 at a price of $10.05 per share. The following table shows the high and
low sales prices for our common stock for each quarterly period since our common
stock became eligible for trading in the Portal(SM) Market:

HIGH SALES LOW SALES
PRICE PRICE
----------- -----------

April 6, 2004 to June 30, 2004.............................. $10.50 $10.00
July 1, 2004 to September 30, 2004.......................... 10.00 10.00
October 1, 2004 to December 31, 2004........................ 10.25 10.00
January 1, 2005 to March 31, 2005........................... 10.25 10.00
April 1, 2005 to May 25, 2005............................... 10.25 10.00

107

PRINCIPAL STOCKHOLDERS

The following table sets forth the beneficial ownership of our common stock
as of June 2, 2005 by (i) each of our directors, (ii) each of our executive
officers, (iii) all of our directors and executive officers as a group and (iv)
each person known to us who is the beneficial owner of more than 5% of our
common stock, as adjusted to give effect to the issuance of shares of restricted
common stock issuable upon completion of this offering. The SEC has defined
"beneficial" ownership of a security to mean the possession, directly or
indirectly, of voting power or investment power. A stockholder is also deemed to
be, as of any date, the beneficial owner of all securities that such stockholder
has the right to acquire within 60 days after that date through (a) the exercise
of any option, warrant or right, (b) the conversion of a security, (c) the power
to revoke a trust, discretionary account or similar arrangement, or (d) the
automatic termination of a trust, discretionary account or similar arrangement.
Each beneficial owner named in the table has the sole voting and investment
power with respect to all of the shares of our common stock shown as
beneficially owned by such person, except as otherwise set forth in the notes to
the table. Unless otherwise indicated, the address of each named beneficial
owner is Medical Properties Trust, Inc., 1000 Urban Center Drive, Suite 501,
Birmingham, Alabama, 35242.

PERCENTAGE OF
ALL COMMON PERCENTAGE OF ALL
NUMBER OF SHARES SHARES COMMON SHARES
NAME OF BENEFICIAL OWNER BENEFICIALLY OWNED (PRE-OFFERING)(1) (POST-OFFERING)(1)
- ------------------------ ------------------ ----------------- ------------------

Edward K. Aldag, Jr................... 282,217(2) 1.08%
R. Steven Hamner...................... 73,804(3) *
William G. McKenzie................... 97,680(4) *
Emmett E. McLean...................... 105,207(5) *
Michael G. Stewart.................... 30,000(6) *
Virginia A. Clarke.................... 6,666(7) *
G. Steven Dawson...................... 33,333(8) *
Bryan L. Goolsby...................... 6,666(7) *
Robert E. Holmes, Ph.D. .............. 14,333(8) *
L. Glenn Orr, Jr. .................... 6,666(7) *
All executive officers and directors
as a group (10 persons).......... 655,672(9) 2.50%
Friedman, Billings, Ramsey Group,
Inc................................. 2,843,023(10) 10.90%
1001 Nineteenth St. North
Arlington, Virginia 22209

- ---------------

* Represents less than 1% of the number of shares of common stock outstanding.

(1) Pre-offering calculations assume 26,164,862 shares of common stock
outstanding as of June 2, 2005. Post-offering calculations assume
shares of common stock outstanding. Shares of common stock that are deemed
to be beneficially owned by a stockholder within 60 days after June 2, 2005
are deemed outstanding for purposes of computing such stockholder's
percentage ownership but are not deemed outstanding for the purpose of
computing the percentage ownership of any other stockholder.

(2) Excludes 43,500 shares of restricted common stock to be awarded upon
completion of this offering.

(3) Excludes 27,000 shares of restricted common stock to be awarded upon
completion of this offering.

(4) Excludes 15,000 shares of restricted common stock to be awarded upon
completion of this offering.

(5) Excludes 20,500 shares of restricted common stock to be awarded upon
completion of this offering.

(6) These restricted shares of common stock will vest over five years, at a
rate of 20% per year, beginning on April 25, 2006.

(7) Includes 6,666 shares of common stock issuable upon exercise of a vested
stock option.

(8) Includes 13,333 shares of common stock issuable upon exercise of a vested
stock option.

(9) See notes (1)-(8) above.

(10) Includes 1,795,571 shares of common stock owned directly by Friedman,
Billings, Ramsey Group, Inc., the parent company of Friedman, Billings,
Ramsey & Co., Inc., 52,452 shares owned directly by Friedman, Billings,
Ramsey & Co., Inc. and 995,000 shares held by various investment funds over
which Friedman, Billings, Ramsey Group, Inc., through a wholly-owned
indirect subsidiary, exercises shared investment and voting power.

We and our founders have agreed that the 521,908 shares of our common stock
held by them that were issued in connection with our formation, which excludes
the 36,000 shares in the aggregate that they

108

purchased in our April 2004 private placement, will vest upon the effective date
of the registration statement of which this prospectus is a part. In addition, a
founder's unvested shares will become 100% vested if the founder's employment is
terminated by that founder with good reason or by us without cause, upon the
founder's death or disability or upon a change of control of the company prior
to completion of this offering. A founder's unvested shares will be forfeited if
the founder's employment with us is terminated by us for good cause or by the
founder without good reason prior to completion of this offering.

SELLING STOCKHOLDERS

The following table sets forth the beneficial ownership of shares of common
stock by the selling stockholders as of , 2005, the maximum number of
shares of common stock being offered by the selling stockholders under this
prospectus and the beneficial ownership of shares of common stock by the selling
stockholders on , 2005 as adjusted to give effect to the sale of
shares of common stock offered by this prospectus. The SEC has defined
"beneficial" ownership of a security to mean the possession, directly or
indirectly, of voting power or investment power. A stockholder is also deemed to
be, as of any date, the beneficial owner of all securities that such stockholder
has the right to acquire within 60 days after that date through (a) the exercise
of any option, warrant or right, (b) the conversion of a security, (c) the power
to revoke a trust, discretionary account or similar arrangement, or (d) the
automatic termination of a trust, discretionary account or similar arrangement.
Shares of common stock may also be sold by donees, pledges or other transferees
or successors in interest of the selling stockholder.

Pursuant to a registration rights agreement between us and our existing
stockholders, these stockholders have the right to sell in this offering all or
a portion of their shares of common stock. In accordance with notices that we
received pursuant to these registration rights, we are including
shares of common stock in this offering.

PERCENTAGE OF BENEFICIAL OWNERSHIP
NUMBER OF MAXIMUM ALL SHARES AFTER RESALE OF SHARES
SHARES NUMBER OF BENEFICIALLY -------------------------
BENEFICIALLY SHARES BEING OWNED BEFORE NUMBER OF
SELLING STOCKHOLDER OWNED OFFERED RESALE(1) SHARES PERCENTAGE(2)
- ------------------- ------------ ------------ ------------- --------- -------------

- ---------------

* Represents less than 1%.

(1) Assumes shares of common stock outstanding as of , 2005.

(2) Assumes shares of common stock outstanding as of , 2005,
including shares of common stock issued in this offering.

REGISTRATION RIGHTS AND LOCK-UP AGREEMENTS

REGISTRATION RIGHTS

The purchasers of our common stock in our April 2004 private placement are
entitled to the benefits of a registration rights agreement among the purchasers
of our stock in that offering, Friedman, Billings, Ramsey & Co., Inc. and us. In
accordance with the registration rights agreement, we have agreed to include
shares held by of these purchasers in this offering. At the request of us or
the underwriters, the holders of our outstanding common stock not being sold in
this offering will be prohibited from selling, contracting to sell or otherwise
disposing of or hedging their common stock for specified periods of time
following the date of this prospectus. These registration rights and lock-up
agreements are described in detail below. The summary of the registration rights
agreement is subject to and qualified in its entirety by reference to the
registration rights agreement, a copy of which is filed as an exhibit to the
registration statement of which this prospectus is a part. See "Where You Can
Find More Information."

109

Inclusion of Common Stock in this Offering. On or about November 12, 2004,
we sent to all of our stockholders notice that we have filed a registration
statement with the SEC for this offering. We sent this notice pursuant to the
registration rights agreement among our stockholders, Friedman, Billings, Ramsey
& Co., Inc. and us, under which the persons who purchased our common stock in
our private placement in April 2004 and their transferees have the right to sell
in this offering all or a portion of their common stock, subject to various
rights of the underwriters and other conditions referred to below.

Because this offering is underwritten, the registration rights agreement:

- requires the selling stockholders to enter into the underwriting
agreement for this offering;

- permits the underwriters, based on marketing factors, to limit the number
of shares a selling stockholder may sell in this offering; and

- conditions the selling stockholders' participation in this offering on
compliance with applicable provisions of the registration rights
agreement.

Resale Registration Statement. Pursuant to the registration rights
agreement, we also agreed for the benefit of the holders of shares of common
stock sold in our April 2004 private placement or issued to Friedman, Billings,
Ramsey & Co., Inc. in connection with our April 2004 private placement, that we
would, at our expense, file with the SEC, no later than nine months following
the closing of the offering, or January 6, 2005, a resale registration statement
permitting the public offering and sale of the registrable securities. The
resale registration statement was filed on January 6, 2005. Pursuant to a
registration rights agreement between us, Friedman, Billings, Ramsey & Co., Inc.
and certain holders of our common stock, we are required to pay most expenses in
connection with the registration of the shares of common stock purchased in the
April 2004 private placement. In addition, we will reimburse selling
stockholders in an aggregate amount of up to $50,000, for the fees and expenses
of one counsel and one accounting firm, as selected by Friedman, Billings,
Ramsey & Co., Inc. for the selling stockholders to review any registration
statement. Each selling stockholder participating in this offering will bear a
proportionate share based on the total number of shares of common stock sold in
this offering of all discounts and commissions payable to the underwriters, all
transfer taxes and transfer fees and any other expense of the selling
stockholders not allocated to us in the registration rights agreement.

In addition, we agreed to use our reasonable best efforts to cause the
resale registration statement to become effective under the Securities Act as
promptly as practicable after the filing and to maintain the resale registration
statement continuously effective under the Securities Act until the first to
occur of (1) such time as all of the shares of common stock covered by the
resale registration statement have been sold pursuant to the registration
statement or pursuant to Rule 144 (or any successor or analogous rule) under the
Securities Act, (2) such time as all of the common stock not held by affiliates
of us, and covered by the resale registration statement, are eligible for sale
pursuant to Rule 144(k) (or any successor or analogous rule) under the
Securities Act, (3) such time as the shares of common stock have been otherwise
transferred, new certificates for them not bearing a legend restricting further
transfer have been delivered by us and subsequent public distribution of such
shares does not require registration, or (4) the second annual anniversary of
the initial effective date of the resale registration statement.

Notwithstanding the foregoing, we will be permitted, under limited
circumstances, to suspend the use, from time to time, of the prospectus that is
part of the resale registration statement, and therefore suspend sales under the
registration statement, for certain periods, referred to as "blackout periods,"
if a majority of the independent directors of our board, in good faith,
determines that we are in compliance with the terms of the registration rights
agreement, that it is in our best interest to suspend the use of the
registration statement, and:

- that the offer or sale of any registrable shares would materially impede,
delay or interfere with any material proposed acquisition, merger, tender
offer, business combination, corporate reorganization, consolidation or
similar material transaction;

110

- after the advice of counsel, sale of the registrable shares would require
disclosure of non-public material information not otherwise required to
be disclosed under applicable law; and

- disclosure would have a material adverse effect on us or on our ability
to close the applicable transaction.

In addition, we may effect a blackout if a majority of independent
directors of our board, in good faith, determines that we are in compliance with
the terms of the registration rights agreement, that it is in our best interest
to suspend the use of the registration statement, and, after advice of counsel,
that it is required by law, rule or regulation to supplement the registration
statement or file a post-effective amendment for the purposes of:

- including in the registration statement any prospectus required under
Section 10(a)(3) of the Securities Act;

- reflecting any facts or events arising after the effective date of the
registration statement that represents a fundamental change in
information set forth therein; or

- including any material information with respect to the plan of
distribution or change to the plan of distribution not set forth therein.

The cumulative blackout periods in any 12 month period commencing on the
closing of the offering may not exceed an aggregate of 90 days and furthermore
may not exceed 60 days in any 90 day period. We may not institute a blackout
period more than three times in any 12 month period. Upon the occurrence of any
blackout period, we are to use our reasonable best efforts to take all action
necessary to promptly permit resumed use of the registration statement.

If, among other matters, we fail to file a resale registration statement
within nine months of the closing of the April 2004 private placement or fail to
maintain its effectiveness, or, if our board of directors suspends the
effectiveness of the resale registration statement in excess of the permitted
blackout periods described above, the holders of registrable shares (other than
our affiliates) will be entitled to receive liquidated damages from us for the
period during which such failures or excess suspensions are continuing. The
liquidated damages will accrue daily during the first 90 days of any such period
at a rate of $0.25 per registrable share per year and will escalate by $0.25 per
registrable share per year at the end of each 90 day period within any such
period up to a maximum rate of $1.00 per registrable share per year. The
liquidated damages will be payable quarterly, in arrears within ten days after
the end of each applicable quarter.

In connection with the registration of the shares sold in the April 2004
private placement, we agreed to use our reasonable best efforts to list our
common stock on the NYSE or the Nasdaq National Market and thereafter to
maintain the listing.

LOCK-UP AGREEMENTS

All of our directors and executive officers, subject to limited exceptions,
have agreed to be bound by lock-up agreements that prohibit these holders from
selling or otherwise disposing of any of our common stock or securities
convertible into our common stock that they own or acquire for 180 days after
the date of this prospectus. In addition, the underwriters will require that all
of our stockholders other than our executive officers and directors agree not to
sell or otherwise dispose of any of the shares of our common stock or securities
convertible into our common stock that they have acquired prior to the date of
this prospectus and are not selling in this offering until 60 days after the
date of this prospectus, subject to limited exceptions. Friedman, Billings,
Ramsey & Co., Inc., on behalf of the underwriters, may, in its discretion,
release all or any portion of the common stock subject to the lock-up agreements
with our directors and executive officers, at any time and without notice or
stockholder approval, in which case our other stockholders would also be
released from the restrictions under the registration rights agreement.

111

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

OUR FORMATION

We were formed as a Maryland corporation on August 27, 2003 to succeed to
the business of Medical Properties Trust, LLC, a Delaware limited liability
company, which was formed by certain of our founders in December 2002. In
connection with our formation, we issued our founders 1,630,435 shares of our
common stock in exchange for nominal cash consideration and the membership
interests of Medical Properties Trust, LLC. Upon completion of our private
placement in April 2004, 1,108,527 shares of the 1,630,435 shares of common
stock held by our founders were redeemed for nominal value and they now
collectively hold 557,908 shares of our common stock, including shares purchased
in our April 2004 private placement.

James P. Bennett was formerly an owner, officer, director and consultant of
the company's predecessor, Medical Properties Trust, LLC, but has not been
affiliated with us since August 2003. Our predecessor had a consulting agreement
with Mr. Bennett pursuant to which he was to be paid a monthly consulting fee,
certain fringe benefits and, under certain circumstances, a fee based upon the
completion of specified acquisition transactions. We believe we owe Mr. Bennett
$411,238. Mr. Bennett disputes this amount and has notified us that he believes
he is entitled to be paid consulting fees of approximately $1.6 million. We
intend to vigorously defend against this claim.

From time to time, we may acquire or develop facilities in transactions
involving prospective tenants in which our directors or executive officers have
an interest. In accordance with our written conflicts of interest policy, we do
not intend to engage in these transactions without the approval of a majority of
our disinterested directors.

OUR STRUCTURE

Conflicts of interest could arise in the future as a result of the
relationships between us and our affiliates, on the one hand, and our operating
partnership or any limited partner thereof, on the other. Our directors and
officers have duties to our company and our stockholders under applicable
Maryland law in connection with their management of our company. At the same
time, we, through our wholly owned subsidiary, have fiduciary duties, as a
general partner, to our operating partnership and to the limited partners under
Delaware law in connection with the management of our operating partnership. Our
duties, through our wholly owned subsidiary, as a general partner to our
operating partnership and its partners may come into conflict with the duties of
our directors and officers to our company and our stockholders. The partnership
agreement of our operating partnership requires us to resolve such conflicts in
favor of our stockholders.

Pursuant to Maryland law, a contract or other transaction between us and a
director or between us and any other corporation or other entity in which any of
our directors is a director or has a material financial interest is not void or
voidable solely on the grounds of such common directorship or interest, the
presence of such director at the meeting at which the contract or transaction is
authorized, approved or ratified or the counting of the director's vote in favor
thereof. However, such transaction will not be void or voidable only if:

- the material facts relating to the common directorship or interest and as
to the transaction are disclosed to our board of directors or a committee
of our board, and our board or committee authorizes, approves or ratifies
the transaction or contract by the affirmative vote of a majority of
disinterested directors, even if the disinterested directors constitute
less than a quorum;

- the material facts relating to the common directorship or interest and as
to the transaction are disclosed to our stockholders entitled to vote
thereon, and the transaction is authorized, approved or ratified by a
majority of the votes cast by the stockholders entitled to vote (other
than the votes of shares owned of record or beneficially by the
interested director); or

112

- the transaction or contract is fair and reasonable to us at the time it
is authorized, ratified or approved.

Furthermore, under Delaware law, where our operating partnership is formed,
we, acting through the general partner, have a fiduciary duty to our operating
partnership and, consequently, such transactions are also subject to the duties
of care and loyalty that we, as a general partner, owe to limited partners in
our operating partnership (to the extent such duties have not been eliminated
pursuant to the terms of the partnership agreement). Where appropriate, in the
judgment of the disinterested directors, our board of directors may obtain a
fairness opinion, or engage independent counsel to represent the interests of
non-affiliated security holders, although our board of directors will have no
obligation to do so.

RELATIONSHIP WITH ONE OF OUR UNDERWRITERS

On November 13, 2003, we entered into an engagement letter agreement with
Friedman, Billings, Ramsey & Co., Inc., one of the underwriters of this
offering. The engagement letter gives Friedman, Billings, Ramsey & Co., Inc. the
right to serve in the following capacities until April 2006:

- as our financial advisor with respect to any future mergers, acquisitions
or other business combinations;

- as the sole book running and lead underwriter or sole placement agent in
connection with any public or private offering of equity or any public
offering of debt securities; and

- as our agent in connection with the exercise of our warrants or options,
other than warrants or options held by management or by Friedman,
Billings, Ramsey & Co., Inc.

On March 31, 2004, we entered into a Purchase/Placement Agreement with
Friedman, Billings, Ramsey & Co., Inc., pursuant to which Friedman, Billings,
Ramsey & Co., Inc. acted as initial purchaser and sole placement agent for our
April 2004 private placement and received aggregate initial purchaser discounts
and placement fees of $17.7 million. In addition, we issued 260,954 shares of
our common stock to Friedman, Billings, Ramsey & Co., Inc. as payment for
financial advisory services. As of June 2, 2005, Friedman, Billing, Ramsey
Group, Inc., an affiliate of Friedman, Billings, Ramsey & Co., Inc.,
beneficially owned, directly or indirectly through affiliates, 2,843,023 shares
of our common stock or approximately 10.90% of our outstanding common stock. We
have an account with Friedman, Billings, Ramsey & Co., Inc. through which we
manage approximately $69.7 million of our cash and cash equivalents.

113

INVESTMENT POLICIES AND POLICIES
WITH RESPECT TO CERTAIN ACTIVITIES

The following is a discussion of our investment policies and our policies
with respect to certain other activities, including financing matters and
conflicts of interest. These policies may be amended or revised from time to
time at the discretion of our board of directors, without a vote of our
stockholders. Any change to any of these policies by our board of directors,
however, would be made only after a thorough review and analysis of that change,
in light of then-existing business and other circumstances, and then only if, in
the exercise of its business judgment, our board of directors believes that it
is advisable to do so in our and our stockholders' best interests. We cannot
assure you that our investment objectives will be attained.

INVESTMENTS IN REAL ESTATE OR INTERESTS IN REAL ESTATE

We conduct our investment activities through our operating partnership and
other subsidiaries. Our policy is to acquire or develop assets primarily for
current income generation. In general, our investment strategy consists of the
following elements:

- Integral Healthcare Real Estate: We acquire and develop net-leased
healthcare facilities providing state-of-the-art healthcare services. In
our experience, healthcare service providers, including physicians and
hospital operating companies, choose to remain in an established location
for relatively long periods since changing the location of their physical
facilities does not assure that other critical components of the
healthcare delivery system, such as laboratory support, access to
specialized equipment, patient referral sources, nursing and other
professional support, and patient convenience, will continue to be
available at the same level of quality and efficiency. Consequently, we
believe market conditions will remain favorable for long-term net-leased
healthcare facilities, and we do not presently expect high levels of
tenant turnover. Moreover, we believe that our partnering approach will
afford us the opportunity to play an integral role in the strategic
planning process for the financing of replacement facilities and the
development of alternative uses for existing facilities.

- Net-lease Strategy: Our healthcare facilities are leased to healthcare
operators pursuant to long-term net-lease agreements under which our
tenants are responsible for virtually all costs of occupancy, including
property taxes, utilities, insurance and maintenance. We believe an
important investment consideration is that our leases to healthcare
operators provide a means for us to participate in the anticipated growth
of the healthcare sector of the United States economy. Our leases
generally provide for either contractual annual rent increases ranging
from 1.0% to 3.0% and, where feasible and in compliance with applicable
healthcare laws and regulations, percentage rent. We expect that such
rental rate adjustments will provide us with significant internal growth.

- Diversified Investment Strategy: Our facilities and the Pending
Acquisition and Development Facilities are diversified geographically, by
service type within the healthcare industry and by types of operator. We
have invested and intend to invest in a portfolio of net-leased
healthcare facilities providing state-of-the-art healthcare services. Our
facilities and Pending Acquisition and Development Facilities include new
and established facilities, both small and large facilities, including
rehabilitation hospitals, long-term acute care hospitals, ambulatory
surgical centers, regional and community hospitals, medical office
buildings and specialized single-discipline facilities. Our facilities
are and we expect will continue to be located across the country. In
addition, our tenants and prospective tenants are diversified across many
healthcare service areas. Because of the expected diversity of our
facilities in terms of facility type, geographic location and tenant, we
believe that our financial performance is less likely to be materially
affected by changes in reimbursement or payment rates by private or
public insurers or by changes in local or regional economies.

- Financing Strategy: We intend to employ leverage in our capital
structure in amounts determined from time to time by our board of
directors. At present, we intend to limit our debt to
114

approximately 60% of the aggregate costs of our facilities, although we
may temporarily exceed that level from time to time. We expect our
borrowings to be a combination of long-term, fixed-rate, non-recourse
mortgage loans, variable-rate secured term and revolving credit
facilities, and other fixed and variable-rate short to medium-term loans.

There are no limitations on the amount or percentage of our total assets
that may be invested in any one facility. Additionally, no limits have been set
on the concentration of investments in any one location or facility type or with
any one tenant. Our current policy requires the approval of our board of
directors for acquisitions or developments of facilities which exceed $10
million.

We believe that adherence to the investment strategy outlined above will
allow us to achieve the following objectives:

- increase in our stock value through increases in the cash flows and
values of our facilities;

- achievement of long-term capital appreciation, and preservation and
protection of the value of our interest in our facilities; and

- providing regular cash distributions to our stockholders, a portion of
which may constitute a nontaxable return of capital because it will
exceed our current and accumulated earnings and profits, as well as
providing growth in distributions over time.

INVESTMENTS IN SECURITIES OF OR INTERESTS IN PERSONS PRIMARILY ENGAGED IN REAL
ESTATE ACTIVITIES AND OTHER ISSUERS

Generally speaking, we do not expect to engage in any significant
investment activities with other entities, although we may consider joint
venture investments with other investors or with healthcare service providers.
We may also invest in the securities of other issuers in connection with
acquisitions of indirect interests in facilities (normally general or limited
partnership interests in special purpose partnerships owning facilities). We may
in the future acquire some, all or substantially all of the securities or assets
of other REITs or similar entities where that investment would be consistent
with our investment policies and the REIT qualification requirements. There are
no limitations on the amount or percentage of our total assets that may be
invested in any one issuer, other than those imposed by the gross income and
asset tests that we must satisfy to qualify as a REIT. However, we do not
anticipate investing in other issuers of securities for the purpose of
exercising control or acquiring any investments primarily for sale in the
ordinary course of business or holding any investments with a view to making
short-term profits from their sale. In any event, we do not intend that our
investments in securities will require us to register as an "investment company"
under the Investment Company Act, and we intend to divest securities before any
registration would be required.

We do not intend to engage in trading, underwriting, agency distribution or
sales of securities of other issuers.

DISPOSITIONS

Although we have no current plans to dispose of any of our facilities, we
will consider doing so, subject to REIT qualification rules and prohibited
transaction tax, if our management determines that a sale of a facility would be
in our best interests based on the price being offered for the facility, the
operating performance of the facility, the tax consequences of the sale and
other factors and circumstances surrounding the proposed sale. In addition, our
tenants have, and we expect that some or all of our prospective tenants will
have, the option to acquire the facilities at the end of or, in some cases,
during the lease term.

FINANCING POLICIES

We intend to employ leverage in our capital structure in amounts we
determine from time to time. At present, we intend to limit our debt to
approximately 60% of the aggregate costs of our facilities, although

115

we may temporarily exceed that level from time to time. We expect our borrowings
to be a combination of long-term, fixed-rate, non-recourse mortgage loans,
variable-rate secured term and revolving credit facilities, and other fixed and
variable-rate short to medium-term loans. Our board of directors considers a
number of factors when evaluating our level of indebtedness and when making
decisions regarding the incurrence of indebtedness, including the purchase price
of facilities to be acquired, the estimated market value of our facilities and
the ability of particular facilities, and our company as a whole, to generate
cash flow to cover expected debt service.

Any of this indebtedness may be unsecured or may be secured by mortgages or
other interests in our facilities, and may be recourse, non-recourse or
cross-collateralized and, if recourse, that recourse may include our general
assets and, if non-recourse, may be limited to the particular facility to which
the indebtedness relates. In addition, we may invest in facilities subject to
existing loans secured by mortgages or similar liens on the facilities, or may
refinance facilities acquired on a leveraged basis. We may use the proceeds from
any borrowings for working capital, to purchase additional interests in
partnerships or joint ventures in which we participate, to refinance existing
indebtedness or to finance acquisitions, expansion, redevelopment of existing
facilities or development of new facilities. We may also incur indebtedness for
other purposes when, in the opinion of our board of directors, it is advisable
to do so. In addition, we may need to borrow to meet the taxable income
distribution requirements under the Code if we do not have sufficient cash
available to meet those distribution requirements.

LENDING POLICIES

We do not have a policy limiting our ability to make loans to persons other
than our executive officers. We may consider offering purchase money financing
in connection with the sale of facilities where the provision of that financing
will increase the value to be received by us for the facility sold. We may make
loans to joint ventures in which we may participate in the future. Although we
do not intend to engage in significant lending activities in the future, we have
and may in the future make acquisition and working capital loans to prospective
tenants as well as mortgage loans to other facility owners. See
"Summary -- Loans and Fees Receivable."

EQUITY CAPITAL POLICIES

Subject to applicable law, our board of directors has the authority,
without further stockholder approval, to issue additional shares of authorized
common stock and preferred stock or otherwise raise capital, including through
the issuance of senior securities, in any manner and on the terms and for the
consideration it deems appropriate, including in exchange for property. Existing
stockholders will have no preemptive right to additional shares issued in any
offering, and any offering might cause a dilution of investment. We may in the
future issue common stock in connection with acquisitions. We also may issue
limited partnership units in our operating partnership or equity interests in
other subsidiaries in connection with acquisitions of facilities or otherwise.

Our board of directors may authorize the issuance of preferred stock with
terms and conditions that could have the effect of delaying, deterring or
preventing a transaction or a change in control in us that might involve a
premium price for holders of our common stock or otherwise might be in their
best interests. Additionally, any shares of preferred stock could have dividend,
voting, liquidation and other rights and preferences that are senior to those of
our common stock.

We may, under certain circumstances, purchase our common stock in the open
market or in private transactions with our stockholders, if those purchases are
approved by our board of directors. Our board of directors has no present
intention of causing us to repurchase any shares, and any action would only be
taken in conformity with applicable federal and state laws and the applicable
requirements for qualifying as a REIT.

In the future we may institute a dividend reinvestment plan, which would
allow our stockholders to acquire additional common stock by automatically
reinvesting their cash dividends. Shares would be acquired pursuant to the plan
at a price equal to the then prevailing market price, without payment of
116

brokerage commissions or service charges. Stockholders who do not participate in
the plan will continue to receive cash dividends as declared and paid.

CODE OF ETHICS AND CONFLICT OF INTEREST POLICY

We have adopted written policies that are intended to minimize actual or
potential conflicts of interest. However, we cannot assure you that these
policies will be successful in eliminating the influence of these conflicts. Our
code of ethics and business conduct, or code of ethics, requires our directors,
officers and employees to conduct themselves in a manner that avoids even the
appearance of a conflict of interest, and to discuss any transaction or
relationship that reasonably could be expected to give rise to a conflict of
interest with our code of ethics contact person. Our code of ethics also
addresses insider trading, company funds and property, corporate opportunities
and fair dealing.

In addition, we have adopted a policy that requires that all contracts and
transactions between us, our operating partnership or any of our subsidiaries,
on the one hand, and any of our directors or executive officers or any entity in
which such director or executive officer is a director or has a material
financial interest, on the other hand, must be approved by the affirmative vote
of a majority of our disinterested directors.

117

DESCRIPTION OF CAPITAL STOCK

The following summary of the material provisions of our capital stock is
subject to and qualified in its entirety by reference to the Maryland general
corporation law, or MGCL, and our charter and bylaws. Copies of our charter and
bylaws are filed as exhibits to the registration statement of which this
prospectus is a part. We recommend that you review these documents. See "Where
You Can Find More Information."

AUTHORIZED STOCK

Our charter authorizes us to issue up to 100,000,000 shares of common
stock, par value $.001 per share, and 10,000,000 shares of preferred stock, par
value $.001 per share. Upon completion of this offering, there will be
shares of common stock issued and outstanding and no shares of
preferred stock issued and outstanding. Our charter authorizes our board of
directors to increase the aggregate number of authorized shares or the number of
shares of any class or series without stockholder approval. Under Maryland law,
stockholders generally are not liable for the corporation's debts or
obligations.

COMMON STOCK

All shares of our common stock offered hereby will be duly authorized,
fully paid and nonassessable. Subject to the preferential rights of any other
class or series of stock and to the provisions of our charter regarding the
restrictions on transfer of stock, holders of shares of our common stock are
entitled to receive dividends on such stock when, as and if authorized by our
board of directors out of funds legally available therefor and declared by us
and to share ratably in the assets of our company legally available for
distribution to our stockholders in the event of our liquidation, dissolution or
winding up after payment of or adequate provision for all known debts and
liabilities of our company, including the preferential rights on dissolution of
any class or classes of preferred stock.

Subject to the provisions of our charter regarding the restrictions on
transfer of stock, each outstanding share of our common stock entitles the
holder to one vote on all matters submitted to a vote of stockholders, including
the election of directors and, except as provided with respect to any other
class or series of stock, the holders of such shares will possess the exclusive
voting power. There is no cumulative voting in the election of our board of
directors. Our directors are elected by a plurality of the votes cast at a
meeting of stockholders at which a quorum is present.

Holders of shares of our common stock have no preference, conversion,
exchange, sinking fund, redemption or appraisal rights and have no preemptive
rights to subscribe for any securities of our company. Subject to the provisions
of our charter regarding the restrictions on transfer of stock, shares of our
common stock will have equal dividend, liquidation and other rights.

Under the MGCL, a Maryland corporation generally cannot dissolve, amend its
charter, merge, consolidate, sell all or substantially all of its assets, engage
in a share exchange or engage in similar transactions outside the ordinary
course of business unless approved by the corporation's board of directors and
by the affirmative vote of stockholders holding at least two-thirds of the
shares entitled to vote on the matter unless a lesser percentage (but not less
than a majority of all of the votes entitled to be cast on the matter) is set
forth in the corporation's charter. Our charter does not provide for a lesser
percentage for these matters. However, Maryland law permits a corporation to
transfer all or substantially all of its assets without the approval of the
stockholders of the corporation to one or more persons if all of the equity
interests of the person or persons are owned, directly or indirectly, by the
corporation. Because operating assets may be held by a corporation's
subsidiaries, as in our situation, this may mean that a subsidiary of a
corporation can transfer all of its assets without a vote of the corporation's
stockholders.

Our charter authorizes our board of directors to reclassify any unissued
shares of our common stock into other classes or series of classes of stock and
to establish the number of shares in each class or series and to set the
preferences, conversion and other rights, voting powers, restrictions,
limitations as to dividends or other distributions, qualifications or terms or
conditions of redemption for each such class or series.

118

PREFERRED STOCK

Our charter authorizes our board of directors to classify any unissued
shares of preferred stock and to reclassify any previously classified but
unissued shares of any series. Prior to issuance of shares of each series, our
board of directors is required by the MGCL and our charter to set the terms,
preferences, conversion or other rights, voting powers, restrictions,
limitations as to dividends or other distributions, qualifications and terms and
conditions of redemption for each such series. Thus, our board of directors
could authorize the issuance of shares of preferred stock with terms and
conditions which could have the effect of delaying, deferring or preventing a
change of control transaction that might involve a premium price for holders of
our common stock or which holders might believe to otherwise be in their best
interest. As of the date hereof, no shares of preferred stock are outstanding,
and we have no current plans to issue any preferred stock.

WARRANT

On April 7, 2004, we granted an unregistered warrant for 35,000 shares of
common stock, with an exercise price of $9.30 per share, to an unaffiliated
third party. The warrant is fully vested, and may be exercised at any time until
the first to occur of a sale of all or substantially all of our assets or a
similar transaction, the closing of our initial public offering or April 7,
2009. We are required to give the warrantholder notice at least 10 days prior to
the closing of this offering.

POWER TO INCREASE AUTHORIZED STOCK AND ISSUE ADDITIONAL SHARES OF OUR COMMON
STOCK AND PREFERRED STOCK

We believe that the power of our board of directors, without stockholder
approval, to increase the number of authorized shares of stock, issue additional
authorized but unissued shares of our common stock or preferred stock and to
classify or reclassify unissued shares of our common stock or preferred stock
and thereafter to cause us to issue such classified or reclassified shares of
stock will provide us with flexibility in structuring possible future financings
and acquisitions and in meeting other needs which might arise. The additional
classes or series, as well as the common stock, will be available for issuance
without further action by our stockholders, unless stockholder consent is
required by applicable law or the rules of any national securities exchange or
automated quotation system on which our securities may be listed or traded.

RESTRICTIONS ON OWNERSHIP AND TRANSFER

In order for us to qualify as a REIT under the Code, not more than 50% of
the value of the outstanding shares of our stock may be owned, actually or
constructively, by five or fewer individuals (as defined in the Code to include
certain entities) during the last half of a taxable year (other than the first
year for which an election to be a REIT has been made by us). In addition, if
we, or one or more owners (actually or constructively) of 10% or more of our
stock, actually or constructively owns 10% or more of a tenant of ours (or a
tenant of any partnership in which we are a partner), the rent received by us
(either directly or through any such partnership) from such tenant will not be
qualifying income for purposes of the REIT gross income tests of the Code. Our
stock must also be beneficially owned by 100 or more persons during at least 335
days of a taxable year of 12 months or during a proportionate part of a shorter
taxable year (other than the first year for which an election to be a REIT has
been made by us).

Our charter contains restrictions on the ownership and transfer of our
capital stock that are intended to assist us in complying with these
requirements and continuing to qualify as a REIT. The relevant sections of our
charter provide that, effective upon completion of this offering and subject to
the exceptions described below, no person or persons acting as a group may own,
or be deemed to own by virtue of the attribution provisions of the Code, more
than (i) 9.8% of the number or value, whichever is more restrictive, of the
outstanding shares of our common stock or (ii) 9.8% of the number or value,
whichever is more restrictive, of the issued and outstanding preferred or other
shares of any class or series of our stock. We refer to this restriction as the
"ownership limit." The ownership limitation in our charter is more restrictive
than the restrictions on ownership of our common stock imposed by the Code.
119

The ownership attribution rules under the Code are complex and may cause
stock owned actually or constructively by a group of related individuals or
entities to be owned constructively by one individual or entity. As a result,
the acquisition of less than 9.8% of our common stock (or the acquisition of an
interest in an entity that owns, actually or constructively, our common stock)
by an individual or entity could nevertheless cause that individual or entity,
or another individual or entity, to own constructively in excess of 9.8% of our
outstanding common stock and thereby subject the common stock to the ownership
limit.

Our board of directors may, in its sole discretion, waive the ownership
limit with respect to one or more stockholders if it determines that such
ownership will not jeopardize our status as a REIT (for example, by causing any
tenant of ours to be considered a "related party tenant" for purposes of the
REIT qualification rules).

As a condition of our waiver, our board of directors may require an opinion
of counsel or IRS ruling satisfactory to our board of directors and
representations or undertakings from the applicant with respect to preserving
our REIT status.

In connection with the waiver of the ownership limit or at any other time,
our board of directors may decrease the ownership limit for all other persons
and entities; provided, however, that the decreased ownership limit will not be
effective for any person or entity whose percentage ownership in our capital
stock is in excess of such decreased ownership limit until such time as such
person or entity's percentage of our capital stock equals or falls below the
decreased ownership limit, but any further acquisition of our capital stock in
excess of such percentage ownership of our capital stock will be in violation of
the ownership limit. Additionally, the new ownership limit may not allow five or
fewer "individuals" (as defined for purposes of the REIT ownership restrictions
under the Code) to beneficially own more than 49.5% of the value of our
outstanding capital stock.

Our charter generally prohibits:

- any person from actually or constructively owning shares of our capital
stock that would result in us being "closely held" under Section 856(h)
of the Code; and

- any person from transferring shares of our capital stock if such transfer
would result in shares of our stock being beneficially owned by fewer
than 100 persons (determined without reference to any rules of
attribution).

Any person who acquires or attempts or intends to acquire beneficial or
constructive ownership of shares of our common stock that will or may violate
any of the foregoing restrictions on transferability and ownership will be
required to give notice immediately to us and provide us with such other
information as we may request in order to determine the effect of such transfer
on our status as a REIT. The foregoing provisions on transferability and
ownership will not apply if our board of directors determines that it is no
longer in our best interests to attempt to qualify, or to continue to qualify,
as a REIT.

Pursuant to our charter, if any purported transfer of our capital stock or
any other event would otherwise result in any person violating the ownership
limits or the other restrictions in our charter, then any such purported
transfer will be void and of no force or effect with respect to the purported
transferee or owner (collectively referred to hereinafter as the "purported
owner") as to that number of shares in excess of the ownership limit (rounded up
to the nearest whole share). The number of shares in excess of the ownership
limit will be automatically transferred to, and held by, a trust for the
exclusive benefit of one or more charitable organizations selected by us. The
trustee of the trust will be designated by us and must be unaffiliated with us
and with any purported owner. The automatic transfer will be effective as of the
close of business on the business day prior to the date of the violative
transfer or other event that results in a transfer to the trust. Any dividend or
other distribution paid to the purported owner, prior to our discovery that the
shares had been automatically transferred to a trust as described above, must be
repaid to the trustee upon demand for distribution to the beneficiary of the
trust and all dividends and other distributions paid by us with respect to such
"excess" shares prior to the sale by the trustee of such shares shall be paid to
the trustee for the beneficiary. If the transfer to the trust as described above
is not automatically effective, for any reason, to prevent violation of the
applicable ownership limit, then our
120

charter provides that the transfer of the excess shares will be void. Subject to
Maryland law, effective as of the date that such excess shares have been
transferred to the trust, the trustee shall have the authority (at the trustee's
sole discretion and subject to applicable law) (i) to rescind as void any vote
cast by a purported owner prior to our discovery that such shares have been
transferred to the trust and (ii) to recast such vote in accordance with the
desires of the trustee acting for the benefit of the beneficiary of the trust,
provided that if we have already taken irreversible action, then the trustee
shall not have the authority to rescind and recast such vote.

Shares of our capital stock transferred to the trustee are deemed offered
for sale to us, or our designee, at a price per share equal to the lesser of (i)
the price paid by the purported owner for the shares (or, if the event which
resulted in the transfer to the trust did not involve a purchase of such shares
of our capital stock at market price, the market price on the day of the event
which resulted in the transfer of such shares of our capital stock to the trust)
and (ii) the market price on the date we, or our designee, accepts such offer.
We have the right to accept such offer until the trustee has sold the shares of
our capital stock held in the trust pursuant to the provisions discussed below.
Upon a sale to us, the interest of the charitable beneficiary in the shares sold
terminates and the trustee must distribute the net proceeds of the sale to the
purported owner and any dividends or other distributions held by the trustee
with respect to such capital stock will be paid to the charitable beneficiary.

If we do not buy the shares, the trustee must, within 20 days of receiving
notice from us of the transfer of shares to the trust, sell the shares to a
person or entity designated by the trustee who could own the shares without
violating the ownership limits. After that, the trustee must distribute to the
purported owner an amount equal to the lesser of (i) the net price paid by the
purported owner for the shares (or, if the event which resulted in the transfer
to the trust did not involve a purchase of such shares at market price, the
market price on the day of the event which resulted in the transfer of such
shares of our capital stock to the trust) and (ii) the net sales proceeds
received by the trust for the shares. Any proceeds in excess of the amount
distributable to the purported owner will be distributed to the beneficiary.

All persons who own, directly or by virtue of the attribution provisions of
the Code, more than 5% (or such other percentage as provided in the regulations
promulgated under the Code) of the lesser of the number or value of the shares
of our outstanding capital stock must give written notice to us within 30 days
after the end of each calendar year. In addition, each stockholder will, upon
demand, be required to disclose to us in writing such information with respect
to the direct, indirect and constructive ownership of shares of our stock as our
board of directors deems reasonably necessary to comply with the provisions of
the Code applicable to a REIT, to comply with the requirements or any taxing
authority or governmental agency or to determine any such compliance.

All certificates representing shares of our capital stock will bear a
legend referring to the restrictions described above.

These ownership limits could delay, defer or prevent a transaction or a
change of control of our company that might involve a premium price over the
then prevailing market price for the holders of some, or a majority, of our
outstanding shares of common stock or which such holders might believe to be
otherwise in their best interest.

TRANSFER AGENT AND REGISTRAR

The transfer agent and registrar for our common stock is American Stock
Transfer and Trust Co.

121

MATERIAL PROVISIONS OF MARYLAND LAW AND OF
OUR CHARTER AND BYLAWS

The following is a summary of certain provisions of Maryland law and of our
charter and bylaws. For a complete description, we refer you to the applicable
Maryland laws and to our charter and bylaws, copies of which are exhibits to the
registration statement of which this prospectus is a part. See "Where You Can
Find More Information."

THE BOARD OF DIRECTORS

Our charter and bylaws provide that the number of our directors is to be
established by our board of directors but may not be fewer than one nor more
than 15. Currently, our board is comprised of seven directors. Any vacancy,
other than one resulting from an increase in the number of directors, may be
filled, at any regular meeting or at any special meeting called for that
purpose, by a majority of the remaining directors, though less than a quorum.
Any vacancy resulting from an increase in the number of our directors must be
filled by a majority of the entire board of directors. A director elected to
fill a vacancy shall be elected to serve until the next election of directors
and until his successor shall be elected and qualified.

Pursuant to our charter, each member of our board of directors is elected
until the next annual meeting of stockholders and until his successor is
elected, with the current members' terms expiring at the annual meeting of
stockholders to be held in 2005. Holders of shares of our common stock have no
right to cumulative voting in the election of directors. Consequently, at each
annual meeting of stockholders, all of the members of our board of directors
will stand for election and our directors will be elected by a plurality of
votes cast. Directors may be removed with or without cause by the affirmative
vote of two-thirds of the votes entitled to be cast in the election of
directors.

BUSINESS COMBINATIONS

Maryland law prohibits "business combinations" between a Maryland
corporation and an interested stockholder or an affiliate of an interested
stockholder for five years after the most recent date on which the interested
stockholder becomes an interested stockholder. These business combinations
include a merger, consolidation, share exchange, or, in circumstances specified
in the statute, certain transfers of assets, certain stock issuances and
reclassifications. Maryland law defines an interested stockholder as:

- any person who beneficially owns 10% or more of the voting power of the
corporation's voting stock; or

- an affiliate or associate of the corporation who, at any time within the
two-year period prior to the date in question, was the beneficial owner
of 10% or more of the voting power of the then-outstanding voting stock
of the corporation.

A person is not an interested stockholder if the board of directors
approves in advance the transaction by which the person otherwise would have
become an interested stockholder. However, in approving the transaction, the
board of directors may provide that its approval is subject to compliance, at or
after the time of approval, with any terms and conditions determined by the
board of directors.

After the five year prohibition, any business combination between a
corporation and an interested stockholder generally must be recommended by the
board of directors and approved by the affirmative vote of at least:

- 80% of the votes entitled to be cast by holders of the then outstanding
shares of voting stock; and

- two-thirds of the votes entitled to be cast by holders of the voting
stock other than shares held by the interested stockholder with whom or
with whose affiliate the business combination is to be effected or shares
held by an affiliate or associate of the interested stockholder.

122

These super-majority vote requirements do not apply if stockholders receive
a minimum price, as defined under Maryland law, for their shares in the form of
cash or other consideration in the same form as previously paid by the
interested stockholder for its shares.

The statute permits various exemptions from its provisions, including
business combinations that are approved by the board of directors before the
time that the interested stockholder becomes an interested stockholder.

As permitted by Maryland law, our charter includes a provision excluding
our company from these provisions of the MGCL and, consequently, the five-year
prohibition and the super-majority vote requirements will not apply to business
combinations between us and any interested stockholder of ours unless we later
amend our charter, with stockholder approval, to modify or eliminate this
exclusion provision. We believe that our ownership restrictions will
substantially reduce the risk that a stockholder would become an "interested
stockholder" within the meaning of the Maryland business combination statute.
There can be no assurance, however, that we will not opt into the business
combination provisions of the MGCL at a future date.

CONTROL SHARE ACQUISITIONS

The MGCL provides that "control shares" of a Maryland corporation acquired
in a "control share acquisition" have no voting rights except to the extent
approved at a special meeting by the affirmative vote of two-thirds of the votes
entitled to be cast on the matter. Shares owned by the acquiror or by officers
or directors who are our employees are excluded from shares entitled to vote on
the matter. "Control shares" are voting shares which, if aggregated with all
other shares previously acquired by the acquirer or in respect of which the
acquirer is able to exercise or direct the exercise of voting power except
solely by virtue of a revocable proxy, would entitle the acquirer to exercise
voting power in electing directors within one of the following ranges of voting
power: (i) one-tenth or more but less than one-third, (ii) one-third or more but
less than a majority, or (iii) a majority or more of all voting power. Control
shares do not include shares the acquiring person is then entitled to vote as a
result of having previously obtained stockholder approval. A "control share
acquisition" means the acquisition of control shares, subject to certain
exceptions.

A person who has made or proposes to make a control share acquisition, upon
satisfaction of certain conditions, including an undertaking to pay expenses,
may compel a corporation's board of directors to call a special meeting of
stockholders to be held within 50 days of demand to consider the voting rights
of the shares. If no request for a meeting is made, the corporation may itself
present the question at any stockholders meeting.

If voting rights are not approved at the meeting or if the acquiring person
does not deliver an acquiring person statement as required by Maryland law,
then, subject to certain conditions and limitations, the corporation may redeem
any or all of the control shares, except those for which voting rights have
previously been approved, for fair value determined, without regard to the
absence of voting rights for the control shares, as of the date of the last
control share acquisition by the acquirer or of any meeting of stockholders at
which the voting rights of such shares are considered and not approved. If
voting rights for control shares are approved at a stockholders meeting and the
acquirer becomes entitled to vote a majority of the shares entitled to vote,
then all other stockholders are entitled to demand and receive fair value for
their stock, or provided for in the "dissenters" rights provisions of the MGCL
may exercise appraisal rights. The fair value of the shares as determined for
purposes of such appraisal rights may not be less than the highest price per
share paid by the acquirer in the control share acquisition.

The control share acquisition statute does not apply (i) to shares acquired
in a merger, consolidation or share exchange if the corporation is a party to
the transaction or (ii) to acquisitions approved or exempted by the charter or
bylaws of the corporation.

123

Our charter contains a provision exempting from the control share
acquisition statute any and all acquisitions by any person of our stock. There
can be no assurance that we will not opt into the control share acquisition
provisions of the MGCL in the future.

MARYLAND UNSOLICITED TAKEOVERS ACT

Maryland law also permits Maryland corporations that are subject to the
Exchange Act and have at least three outside directors to elect by resolution of
the board of directors or by provision in its charter or bylaws to be subject to
some corporate governance provisions that may be inconsistent with the
corporation's charter and bylaws. Under the applicable statute, a board of
directors may classify itself without the vote of stockholders. A board of
directors classified in that manner cannot be altered by amendment to the
charter of the corporation. Further, the board of directors may, by electing
into applicable statutory provisions and notwithstanding the charter or bylaws:

- provide that a special meeting of the stockholders will be called only at
the request of stockholders entitled to cast at least a majority of the
votes entitled to be cast at the meeting;

- reserve for itself the right to fix the number of directors;

- provide that a director may be removed only by the vote of the holders of
two-thirds of the stock entitled to vote;

- retain for itself sole authority to fill vacancies created by the death,
removal or resignation of a director; and

- provide that all vacancies on the board of directors may be filled only
by the affirmative vote of a majority of the remaining directors, in
office, even if the remaining directors do not constitute a quorum for
the remainder of the full term of the class of directors in which the
vacancy occurred.

A board of directors may implement all or any of these provisions without
amending the charter or bylaws and without stockholder approval. A corporation
may be prohibited by its charter or by resolution of its board of directors from
electing any of the provisions of the statute. We are not prohibited from
implementing any or all of these provisions. While certain of these provisions
are already addressed by our charter and bylaws, the law would permit our board
of directors to override further changes to the charter or bylaws. If
implemented, these provisions could discourage offers to acquire our stock and
could increase the difficulty of completing an offer.

AMENDMENT TO OUR CHARTER

Our charter may be amended only if declared advisable by the board of
directors and approved by the affirmative vote of the holders of at least
two-thirds of all of the votes entitled to be cast on the matter except that
after June 1, 2005, our board of directors will be able, without stockholder
approval to amend our charter to change our corporate name or the name or
designation or par value of any class or series of stock.

DISSOLUTION OF OUR COMPANY

A voluntary dissolution of our company must be declared advisable by a
majority of the entire board of directors and approved by the affirmative vote
of the holders of at least two-thirds of all of the votes entitled to be cast on
the matter.

ADVANCE NOTICE OF DIRECTOR NOMINATIONS AND NEW BUSINESS

Our bylaws provide that:

- with respect to an annual meeting of stockholders, the only business to
be considered and the only proposals to be acted upon will be those
properly brought before the annual meeting:

- pursuant to our notice of the meeting;
124

- by, or at the direction of, a majority of our board of directors; or

- by a stockholder who is entitled to vote at the meeting and has complied
with the advance notice procedures set forth in our bylaws;

- with respect to special meetings of stockholders, only the business
specified in our company's notice of meeting may be brought before the
meeting of stockholders unless otherwise provided by law; and

- nominations of persons for election to our board of directors at any
annual or special meeting of stockholders may be made only:

- by, or at the direction of, our board of directors; or

- by a stockholder who is entitled to vote at the meeting and has complied
with the advance notice provisions set forth in our bylaws.

Generally, under our bylaws, a stockholder seeking to nominate a director
or bring other business before our annual meeting of stockholders must deliver a
notice to our secretary not later than the close of business on the 90th day nor
earlier than the close of business on the 120th day prior to the first
anniversary of the date of mailing of the notice to stockholders for the prior
year's annual meeting. For a stockholder seeking to nominate a candidate for our
board of directors, the notice must describe various matters regarding the
nominee, including name, address, occupation and number of shares of common
stock held, and other specified matters. For a stockholder seeking to propose
other business, the notice must include a description of the proposed business,
the reasons for the proposal and other specified matters.

INDEMNIFICATION AND LIMITATION OF DIRECTORS' AND OFFICERS' LIABILITY

The MGCL permits a Maryland corporation to include in its charter a
provision limiting the liability of its directors and officers to the
corporation and its stockholders for money damages except for liability
resulting from actual receipt of an improper benefit or profit in money,
property or services or active and deliberate dishonesty established by a final
judgment as being material to the cause of action. Our charter limits the
personal liability of our directors and officers for monetary damages to the
fullest extent permitted under current Maryland law, and our charter and bylaws
provide that a director or officer shall be indemnified to the fullest extent
required or permitted by Maryland law from and against any claim or liability to
which such director or officer may become subject by reason of his or her status
as a director or officer of our company. Maryland law allows directors and
officers to be indemnified against judgments, penalties, fines, settlements, and
expenses actually incurred in connection with any proceeding to which they may
be made a party by reason of their service on those or other capacities unless
the following can be established:

- the act or omission of the director or officer was material to the cause
of action adjudicated in the proceeding and was committed in bad faith or
was the result of active and deliberate dishonesty;

- the director or officer actually received an improper personal benefit in
money, property or services; or

- with respect to any criminal proceeding, the director or officer had
reasonable cause to believe his or her act or omission was unlawful.

The MGCL requires a corporation (unless its charter provides otherwise,
which our charter does not) to indemnify a director or officer who has been
successful on the merits or otherwise, in the defense of any claim to which he
or she is made a party by reason of his or her service in that capacity.

However, under the MGCL, a Maryland corporation may not indemnify for an
adverse judgment in a suit by or in the right of the corporation or for a
judgment of liability on the basis that personal benefit was improperly
received, unless in either case a court orders indemnification and then only for
expenses. In

125

addition, the MGCL permits a corporation to advance reasonable expenses to a
director or officer upon the corporation's receipt of:

- a written affirmation by the director or officer of his or her good faith
belief that he or she has met the standard of conduct necessary for
indemnification by the corporation; and

- a written undertaking by the director or on the director's behalf to
repay the amount paid or reimbursed by the corporation if it is
ultimately determined that the director did not meet the standard of
conduct.

Our charter authorizes us to obligate ourselves to indemnify and our bylaws
do obligate us, to the fullest extent permitted by Maryland law in effect from
time to time, to indemnify and, without requiring a preliminary determination of
the ultimate entitlement to indemnification, pay or reimburse reasonable
expenses in advance of final disposition of a proceeding to:

- any present or former director or officer who is made a party to the
proceeding by reason of his or her service in that capacity; or

- any individual who, while a director or officer of our company and at our
request, serves or has served another corporation, real estate investment
trust, partnership, joint venture, trust, employee benefit plan or any
other enterprise as a director, officer, partner or trustee of such
corporation, real estate investment trust, partnership, joint venture,
trust, employee benefit plan or other enterprise and who is made a party
to the proceeding by reason of his or her service in that capacity.

Our charter and bylaws also permit us to indemnify and advance expenses to
any person who served a predecessor of ours in any of the capacities described
above.

Our stockholders have no personal liability for indemnification payments or
other obligations under any indemnification agreements or arrangements. However,
indemnification could reduce the legal remedies available to us and our
stockholders against the indemnified individuals.

This provision for indemnification of our directors and officers does not
limit a stockholder's ability to obtain injunctive relief or other equitable
remedies for a violation of a director's or an officer's duties to us or to our
stockholders, although these equitable remedies may not be effective in some
circumstances.

In addition to any indemnification to which our directors and officers are
entitled pursuant to our charter and bylaws and the MGCL, our charter and bylaws
provide that, with the approval of our board of directors, we may indemnify
other employees and agents to the fullest extent permitted under Maryland law,
whether they are serving us or, at our request, any other entity.

We have entered into indemnification agreements with each of our directors
and executive officers, and we maintain a directors and officers liability
insurance policy. See "Management -- Limited Liability and Indemnification."

Insofar as the foregoing provisions permit indemnification of directors,
officers or persons controlling us for liability arising under the Securities
Act, we have been informed that, in the opinion of the SEC, this indemnification
is against public policy as expressed in the Securities Act and is therefore
unenforceable.

126

PARTNERSHIP AGREEMENT

The following is a summary of the material terms of the first amended and
restated agreement of limited partnership of our operating partnership. This
summary is subject to and qualified in its entirety by reference to the first
amended and restated agreement of limited partnership of our operating
partnership, a copy of which is an exhibit to the registration statement of
which this prospectus is a part. See "Where You Can Find More Information."

MANAGEMENT OF OUR OPERATING PARTNERSHIP

MPT Operating Partnership, L.P., our operating partnership, was organized
as a Delaware limited partnership on September 10, 2003. The initial partnership
agreement was entered into on that date and amended and restated on March 1,
2004. Pursuant to the partnership agreement, as the owner of the sole general
partner of the operating partnership, Medical Properties Trust, LLC, we have,
subject to certain protective rights of limited partners described below, full,
exclusive and complete responsibility and discretion in the management and
control of the operating partnership. We have the power to cause the operating
partnership to enter into certain major transactions, including acquisitions,
dispositions, refinancings and selection of tenants, and to cause changes in the
operating partnership's line of business and distribution policies. However, any
amendment to the partnership agreement that would affect the redemption rights
of the limited partners or otherwise adversely affect the rights of the limited
partners requires the consent of limited partners, other than us, holding more
than 50% of the units of our operating partnership held by such partners.

TRANSFERABILITY OF INTERESTS

We may not voluntarily withdraw from the operating partnership or transfer
or assign our interest in the operating partnership or engage in any merger,
consolidation or other combination, or sale of substantially all of our assets,
in a transaction which results in a change of control of our company unless:

- we receive the consent of limited partners holding more than 50% of the
partnership interests of the limited partners, other than those held by
our company or its subsidiaries;

- as a result of such transaction, all limited partners will have the right
to receive for each partnership unit an amount of cash, securities or
other property equal in value to the greatest amount of cash, securities
or other property paid in the transaction to a holder of one share of our
common stock, provided that if, in connection with the transaction, a
purchase, tender or exchange offer shall have been made to and accepted
by the holders of more than 50% of the outstanding shares of our common
stock, each holder of partnership units shall be given the option to
exchange its partnership units for the greatest amount of cash,
securities or other property that a limited partner would have received
had it (i) exercised its redemption right (described below) and (ii)
sold, tendered or exchanged pursuant to the offer shares of our common
stock received upon exercise of the redemption right immediately prior to
the expiration of the offer; or

- we are the surviving entity in the transaction and either (i) our
stockholders do not receive cash, securities or other property in the
transaction or (ii) all limited partners receive for each partnership
unit an amount of cash, securities or other property having a value that
is no less than the greatest amount of cash, securities or other property
received in the transaction by our stockholders.

We also may merge with or into or consolidate with another entity if
immediately after such merger or consolidation (i) substantially all of the
assets of the successor or surviving entity, other than partnership units held
by us, are contributed, directly or indirectly, to the partnership as a capital
contribution in exchange for partnership units with a fair market value equal to
the value of the assets so contributed as determined by the survivor in good
faith and (ii) the survivor expressly agrees to assume all of our obligations
under the partnership agreement and the partnership agreement shall be amended
after any such merger or consolidation so as to arrive at a new method of
calculating the amounts payable upon

127

exercise of the redemption right that approximates the existing method for such
calculation as closely as reasonably possible.

We also may (i) transfer all or any portion of our general partnership
interest to (A) a wholly-owned subsidiary or (B) a parent company, and following
such transfer may withdraw as general partner and (ii) engage in a transaction
required by law or by the rules of any national securities exchange or automated
quotation system on which our securities may be listed or traded.

CAPITAL CONTRIBUTION

We contributed to our operating partnership substantially all the net
proceeds of our April 2004 private placement as a capital contribution in
exchange for units of the operating partnership. The partnership agreement
provides that if the operating partnership requires additional funds at any time
in excess of funds available to the operating partnership from borrowing or
capital contributions, we may borrow such funds from a financial institution or
other lender and lend such funds to the operating partnership on the same terms
and conditions as are applicable to our borrowing of such funds. Under the
partnership agreement, we are obligated to contribute the proceeds of any
offering of shares of our company's stock as additional capital to the operating
partnership. We are authorized to cause the operating partnership to issue
partnership interests for less than fair market value if we have concluded in
good faith that such issuance is in both the operating partnership's and our
best interests. If we contribute additional capital to the operating
partnership, we will receive additional partnership units and our percentage
interest will be increased on a proportionate basis based upon the amount of
such additional capital contributions and the value of the operating partnership
at the time of such contributions. Conversely, the percentage interests of the
limited partners will be decreased on a proportionate basis in the event of
additional capital contributions by us. In addition, if we contribute additional
capital to the operating partnership, we will revalue the property of the
operating partnership to its fair market value, as determined by us, and the
capital accounts of the partners will be adjusted to reflect the manner in which
the unrealized gain or loss inherent in such property, that has not been
reflected in the capital accounts previously, would be allocated among the
partners under the terms of the partnership agreement if there were a taxable
disposition of such property for its fair market value, as determined by us, on
the date of the revaluation. The operating partnership may issue preferred
partnership interests, in connection with acquisitions of property or otherwise,
which could have priority over common partnership interests with respect to
distributions from the operating partnership, including the partnership
interests that our wholly-owned subsidiary owns as general partner.

REDEMPTION RIGHTS

Pursuant to Section 8.04 of the partnership agreement, the limited
partners, other than us, will receive redemption rights, which will enable them
to cause the operating partnership to redeem their limited partnership units in
exchange for cash or, at our option, shares of our common stock on a one-for-one
basis, subject to adjustment for stock splits, dividends, recapitalization and
similar events. Currently, we own 100% of the issued limited partnership units
of our operating partnership. Under Section 8.04 of our partnership agreement,
holders of limited partnership units will be prohibited from exercising their
redemption rights for 12 months after they are issued, unless this waiting
period is waived or shortened by our board of directors. Notwithstanding the
foregoing, a limited partner will not be entitled to exercise its redemption
rights if the delivery of common stock to the redeeming limited partner would:

- result in any person owning, directly or indirectly, common stock in
excess of the stock ownership limit in our charter;

- result in our shares of stock being owned by fewer than 100 persons
(determined without reference to any rules of attribution);

- result in our being "closely held" within the meaning of Section 856(h)
of the Code;

128

- cause us to own, actually or constructively, 10% or more of the ownership
interests in a tenant of our or the partnership's real property, within
the meaning of Section 856(d)(2)(B) of the Code; or

- cause the acquisition of common stock by such redeeming limited partner
to be "integrated" with any other distribution of common stock for
purposes of complying with the registration provisions of the Securities
Act.

We may, in our sole and absolute discretion, waive any of these
restrictions.

With respect to the partnership units issuable in connection with the
acquisition or development of our facilities, the redemption rights may be
exercised by the limited partners at any time after the first anniversary of our
acquisition of these facilities; provided, however, unless we otherwise agree:

- a limited partner may not exercise the redemption right for fewer than
1,000 partnership units or, if such limited partner holds fewer than
1,000 partnership units, the limited partner must redeem all of the
partnership units held by such limited partner;

- a limited partner may not exercise the redemption right for more than the
number of partnership units that would, upon redemption, result in such
limited partner or any other person owning, directly or indirectly,
common stock in excess of the ownership limitation in our charter; and

- a limited partner may not exercise the redemption right more than two
times annually.

We currently hold all the outstanding interests in our operating
partnership and, accordingly, there are currently no units of our operating
partnership subject to being redeemed in exchange for shares of our common
stock. The number of shares of common stock issuable upon exercise of the
redemption rights will be adjusted to account for stock splits, mergers,
consolidations or similar pro rata stock transactions.

The partnership agreement requires that the operating partnership be
operated in a manner that enables us to satisfy the requirements for being
classified as a REIT, to avoid any federal income or excise tax liability
imposed by the Code (other than any federal income tax liability associated with
our retained capital gains) and to ensure that the partnership will not be
classified as a "publicly traded partnership" taxable as a corporation under
Section 7704 of the Code.

In addition to the administrative and operating costs and expenses incurred
by the operating partnership, the operating partnership generally will pay all
of our administrative costs and expenses, including:

- all expenses relating to our continuity of existence;

- all expenses relating to offerings and registration of securities;

- all expenses associated with the preparation and filing of any of our
periodic reports under federal, state or local laws or regulations;

- all expenses associated with our compliance with laws, rules and
regulations promulgated by any regulatory body; and

- all of our other operating or administrative costs incurred in the
ordinary course of business on behalf of the operating partnership.

DISTRIBUTIONS

The partnership agreement provides that the operating partnership will
distribute cash from operations, including net sale or refinancing proceeds, but
excluding net proceeds from the sale of the operating partnership's property in
connection with the liquidation of the operating partnership, at such time and
in such amounts as determined by us in our sole discretion, to us and the
limited partners in accordance with their respective percentage interests in the
operating partnership.

Upon liquidation of the operating partnership, after payment of, or
adequate provision for, debts and obligations of the partnership, including any
partner loans, any remaining assets of the partnership will be
129

distributed to us and the limited partners with positive capital accounts in
accordance with their respective positive capital account balances.

ALLOCATIONS

Profits and losses of the partnership, including depreciation and
amortization deductions, for each fiscal year generally are allocated to us and
the limited partners in accordance with the respective percentage interests in
the partnership. All of the foregoing allocations are subject to compliance with
the provisions of Sections 704(b) and 704(c) of the Code and Treasury
regulations promulgated thereunder. The operating partnership expects to use the
"traditional method" under Section 704(c) of the Code for allocating items with
respect to contributed property acquired in connection with the offering for
which the fair market value differs from the adjusted tax basis at the time of
contribution.

TERM

The operating partnership will have perpetual existence, or until sooner
dissolved upon:

- our bankruptcy, dissolution, removal or withdrawal, unless the limited
partners elect to continue the partnership;

- the passage of 90 days after the sale or other disposition of all or
substantially all the assets of the partnership; or

- an election by us in our capacity as the owner of the sole general
partner of the operating partnership.

TAX MATTERS

Pursuant to the partnership agreement, the general partner is the tax
matters partner of the operating partnership. Accordingly, through our ownership
of the general partner of the operating partnership, we have authority to handle
tax audits and to make tax elections under the Code on behalf of the operating
partnership.

130

UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS

This section summarizes the current material federal income tax
consequences to our company and to our stockholders generally resulting from the
treatment of our company as a REIT. Because this section is a general summary,
it does not address all of the potential tax issues that may be relevant to you
in light of your particular circumstances. Baker, Donelson, Bearman, Caldwell &
Berkowitz, P.C., or Baker Donelson, has acted as our counsel, has reviewed this
summary, and is of the opinion that the discussion contained herein fairly
summarizes the federal income tax consequences that are material to a holder of
shares of our common stock. The discussion does not address all aspects of
taxation that may be relevant to particular stockholders in light of their
personal investment or tax circumstances, or to certain types of stockholders
that are subject to special treatment under the federal income tax laws, such as
insurance companies, tax-exempt organizations (except to the limited extent
discussed in "-- Taxation of Tax-Exempt Stockholders"), financial institutions
or broker-dealers, and non-United States individuals and foreign corporations
(except to the limited extent discussed in "-- Taxation of Non-United States
Stockholders").

The statements in this section and the opinion of Baker Donelson, referred
to as the Tax Opinion, are based on the current federal income tax laws
governing qualification as a REIT. We cannot assure you that new laws,
interpretations of law or court decisions, any of which may take effect
retroactively, will not cause any statement in this section to be inaccurate.
You should be aware that opinions of counsel are not binding on the IRS, and no
assurance can be given that the IRS will not challenge the conclusions set forth
in those opinions.

This section is not a substitute for careful tax planning. We urge you to
consult your own tax advisors regarding the specific federal state, local,
foreign and other tax consequences to you, in light of your own particular
circumstances, of the purchase, ownership and disposition of shares of our
common stock, our election to be taxed as a REIT and the effect of potential
changes in applicable tax laws.

TAXATION OF OUR COMPANY

We were previously taxed as a subchapter S corporation. We revoked our
subchapter S election on April 6, 2004 and we will elect to be taxed as a REIT
under Sections 856 through 860 of the Code, commencing with our taxable year
that began on April 6, 2004 and ended on December 31, 2004. Our counsel has
opined that, for federal income tax purposes, we are and have been organized in
conformity with the requirements for qualification to be taxed as a REIT under
the Code commencing with our initial short taxable year ended December 31, 2004,
and that our current and proposed method of operations as described in this
prospectus and as represented to our counsel by us satisfies currently, and will
enable us to continue to satisfy in the future, the requirements for such
qualification and taxation as a REIT under the Code for future taxable years.
This opinion, however, is based upon factual assumptions and representations
made by us.

We believe that our proposed future method of operation will enable us to
qualify as a REIT. However, no assurances can be given that our beliefs or
expectations will be fulfilled, as such qualification and taxation as a REIT
depend upon our ability to meet, for each taxable year, various tests imposed
under the Code as discussed below. Those qualification tests involve the
percentage of income that we earn from specified sources, the percentage of our
assets that falls within specified categories, the diversity of our stock
ownership, and the percentage of our earnings that we distribute. Baker Donelson
will not review our compliance with those tests on a continuing basis.
Accordingly, with respect to our current and future taxable years, no assurance
can be given that the actual results of our operation will satisfy such
requirements. For a discussion of the tax consequences of our failure to qualify
as a REIT. See "-- Failure to Qualify."

The sections of the Code relating to qualification and operation as a REIT,
and the federal income taxation of a REIT and its stockholders, are highly
technical and complex. The following discussion sets forth only the material
aspects of those sections. This summary is qualified in its entirety by the
applicable Code provisions and the related rules and regulations.
131

If we qualify as a REIT, we generally will not be subject to federal income
tax on the taxable income that we distribute to our stockholders. The benefit of
that tax treatment is that it avoids the "double taxation," or taxation at both
the corporate and stockholder levels, that generally results from owning stock
in a corporation. However, we will be subject to federal tax in the following
circumstances:

- We are subject to the corporate federal income tax on taxable income,
including net capital gain, that we do not distribute to stockholders
during, or within a specified time period after, the calendar year in
which the income is earned.

- We are subject to the corporate "alternative minimum tax" on any items of
tax preference that we do not distribute or allocate to stockholders.

- We are subject to tax, at the highest corporate rate, on:

- net income from the sale or other disposition of property acquired
through foreclosure ("foreclosure property") that we hold primarily
for sale to customers in the ordinary course of business, and

- other non-qualifying income from foreclosure property.

- We are subject to a 100% tax on net income from sales or other
dispositions of property, other than foreclosure property, that we hold
primarily for sale to customers in the ordinary course of business.

- If we fail to satisfy the 75% gross income test or the 95% gross income
test, as described below under "-- Requirements for
Qualification -- Gross Income Tests," but nonetheless continue to qualify
as a REIT because we meet other requirements, we will be subject to a
100% tax on:

- the greater of (i) the amount by which we fail the 75% test, or (ii)
the excess of 90% (95% for taxable years beginning on and after
January 1, 2005) of our gross income over the amount of gross income
attributable to sources that qualify under the 95% test, multiplied by

- a fraction intended to reflect our profitability.

- If we fail to distribute during a calendar year at least the sum of: (i)
85% of our REIT ordinary income for the year, (ii) 95% of our REIT
capital gain net income for the year, and (iii) any undistributed taxable
income from earlier periods, then we will be subject to a 4% excise tax
on the excess of the required distribution over the amount we actually
distributed.

- If we fail to satisfy one or more requirements for REIT qualification
during a taxable year beginning on or after January 1, 2005, other than a
gross income test or an asset test, we will be required to pay a penalty
of $50,000 for each such failure.

- We may elect to retain and pay income tax on our net long-term capital
gain. In that case, a United States stockholder would be taxed on its
proportionate share of our undistributed long-term capital gain (to the
extent that we make a timely designation of such gain to the stockholder)
and would receive a credit or refund for its proportionate share of the
tax we paid.

- We may be subject to a 100% excise tax on certain transactions with a
taxable REIT subsidiary that are not conducted at arm's-length.

- If we acquire any asset from a "C corporation" (that is, a corporation
generally subject to the full corporate-level tax) in a transaction in
which the basis of the asset in our hands is determined by reference to
the basis of the asset in the hands of the C corporation, and we
recognize gain on the disposition of the asset during the 10 year period
beginning on the date that we acquired the asset, then the asset's
"built-in" gain will be subject to tax at the highest regular corporate
rate.

132

REQUIREMENTS FOR QUALIFICATION

To qualify as a REIT, we must elect to be treated as a REIT, and we must
meet various (i) organizational requirements, (ii) gross income tests, (iii)
asset tests, and (iv) annual distribution requirements.

Organizational Requirements. A REIT is a corporation, trust or association
that meets each of the following requirements:

(1) it is managed by one or more trustees or directors;

(2) its beneficial ownership is evidenced by transferable stock, or by
transferable certificates of beneficial interest;

(3) it would be taxable as a domestic corporation, but for its
election to be taxed as a REIT under Sections 856 through 860 of the Code;

(4) it is neither a financial institution nor an insurance company
subject to special provisions of the federal income tax laws;

(5) at least 100 persons are beneficial owners of its stock or
ownership certificates (determined without reference to any rules of
attribution);

(6) not more than 50% in value of its outstanding stock or ownership
certificates is owned, directly or indirectly, by five or fewer
individuals, which the federal income tax laws define to include certain
entities, during the last half of any taxable year; and

(7) it elects to be a REIT, or has made such election for a previous
taxable year, and satisfies all relevant filing and other administrative
requirements established by the IRS that must be met to elect and maintain
REIT status.

We must meet requirements one through four during our entire taxable year
and must meet requirement five during at least 335 days of a taxable year of 12
months, or during a proportionate part of a taxable year of less than 12 months.
If we comply with all the requirements for ascertaining information concerning
the ownership of our outstanding stock in a taxable year and have no reason to
know that we violated requirement six, we will be deemed to have satisfied
requirement six for that taxable year. We do not have to satisfy requirements
five and six for our taxable year ending December 31, 2004. After the issuance
of common stock pursuant to our April 2004 private placement we had issued
common stock with enough diversity of ownership to satisfy requirements five and
six as set forth above. Our charter provides for restrictions regarding the
ownership and transfer of our shares of common stock so that we should continue
to satisfy these requirements. The provisions of our charter restricting the
ownership and transfer of our shares of common stock are described in
"Description of Capital Stock -- Restrictions on Ownership and Transfer."

For purposes of determining stock ownership under requirement six, an
"individual" generally includes a supplemental unemployment compensation
benefits plan, a private foundation, or a portion of a trust permanently set
aside or used exclusively for charitable purposes. An "individual," however,
generally does not include a trust that is a qualified employee pension or
profit sharing trust under the federal income tax laws, and beneficiaries of
such a trust will be treated as holding our shares in proportion to their
actuarial interests in the trust for purposes of requirement six.

A corporation that is a "qualified REIT subsidiary," or QRS, is not treated
as a corporation separate from its parent REIT. All assets, liabilities, and
items of income, deduction and credit of a QRS are treated as assets,
liabilities, and items of income, deduction and credit of the REIT. A QRS is a
corporation, all of the capital stock of which is owned by the REIT. Thus, in
applying the requirements described herein, any QRS that we own will be ignored,
and all assets, liabilities, and items of income, deduction and credit of such
subsidiary will be treated as our assets, liabilities, and items of income,
deduction and credit.

133

An unincorporated domestic entity, such as a partnership, that has a single
owner, generally is not treated as an entity separate from its parent for
federal income tax purposes. An unincorporated domestic entity with two or more
owners is generally treated as a partnership for federal income tax purposes. In
the case of a REIT that is a partner in a partnership that has other partners,
the REIT is treated as owning its proportionate share of the assets of the
partnership and as earning its allocable share of the gross income of the
partnership for purposes of the applicable REIT qualification tests. Thus, our
proportionate share of the assets, liabilities and items of income of our
operating partnership and any other partnership, joint venture, or limited
liability company that is treated as a partnership for federal income tax
purposes in which we acquire an interest, directly or indirectly, is treated as
our assets and gross income for purposes of applying the various REIT
qualification requirements.

A REIT is permitted to own up to 100% of the stock of one or more "taxable
REIT subsidiaries." A taxable REIT subsidiary is a fully taxable corporation
that may earn income that would not be qualifying income if earned directly by
the parent REIT. The subsidiary and the REIT must jointly file an election with
the IRS to treat the subsidiary as a taxable REIT subsidiary. A taxable REIT
subsidiary will pay income tax at regular corporate rates on any income that it
earns. In addition, the taxable REIT subsidiary rules limit the deductibility of
interest paid or accrued by a taxable REIT subsidiary to its parent REIT to
assure that the taxable REIT subsidiary is subject to an appropriate level of
corporate taxation. Further, the rules impose a 100% excise tax on certain types
of transactions between a taxable REIT subsidiary and its parent REIT or the
REIT's tenants that are not conducted on an arm's-length basis. We may engage in
activities indirectly through a taxable REIT subsidiary as necessary or
convenient to avoid obtaining the benefit of income or services that would
jeopardize our REIT status if we engaged in the activities directly. In
particular, we would likely engage in activities through a taxable REIT
subsidiary if we wished to provide services to unrelated parties which might
produce income that does not qualify under the gross income tests described
below. We might also dispose of an unwanted asset through a taxable REIT
subsidiary as necessary or convenient to avoid the 100% tax on income from
prohibited transactions. See description below under "Prohibited Transactions."
A taxable REIT subsidiary may not operate or manage a healthcare facility. For
purposes of this definition a "healthcare facility" means a hospital, nursing
facility, assisted living facility, congregate care facility, qualified
continuing care facility, or other licensed facility which extends medical or
nursing or ancillary services to patients and which is operated by a service
provider which is eligible for participation in the Medicare program under Title
XVIII of the Social Security Act with respect to such facility. We have formed
and made a taxable REIT subsidiary election with respect to MPT Development
Services, Inc., a Delaware corporation formed in January 2004. We may form or
acquire one or more additional taxable REIT subsidiaries in the future. See
"Federal Income Tax Considerations -- Income Taxation of the Partnerships and
the Partners -- Taxable REIT Subsidiaries."

Gross Income Tests. We must satisfy two gross income tests annually to
maintain our qualification as a REIT. First, at least 75% of our gross income
for each taxable year must consist of defined types of income that we derive,
directly or indirectly, from investments relating to real property or mortgages
on real property or qualified temporary investment income. Qualifying income for
purposes of that 75% gross income test generally includes:

- rents from real property;

- interest on debt secured by mortgages on real property, or on interests
in real property;

- dividends or other distributions on, and gain from the sale of, shares in
other REITs;

- gain from the sale of real estate assets;

- income derived from the temporary investment of new capital that is
attributable to the issuance of our shares of common stock or a public
offering of our debt with a maturity date of at least five years and that
we receive during the one year period beginning on the date on which we
received such new capital; and

- gross income from foreclosure property.
134

Second, in general, at least 95% of our gross income for each taxable year
must consist of income that is qualifying income for purposes of the 75% gross
income test, other types of interest and dividends, gain from the sale or
disposition of stock or securities, income from certain hedging instruments or
any combination of these. Gross income from our sale of property that we hold
primarily for sale to customers in the ordinary course of business is excluded
from both the numerator and the denominator in both income tests. In addition,
for taxable years beginning on and after January 1, 2005, income and gain from
"hedging transactions" that we enter into to hedge indebtedness incurred or to
be incurred to acquire or carry real estate assets and that are clearly and
timely identified as such also will be excluded from both the numerator and the
denominator for purposes of the 95% gross income test (but not the 75% gross
income test). The following paragraphs discuss the specific application of the
gross income tests to us.

Rents from Real Property. Rent that we receive from our real property will
qualify as "rents from real property," which is qualifying income for purposes
of the 75% and 95% gross income tests, only if the following conditions are met.

First, the rent must not be based in whole or in part on the income or
profits of any person. Participating rent, however, will qualify as "rents from
real property" if it is based on percentages of receipts or sales and the
percentages:

- are fixed at the time the leases are entered into;

- are not renegotiated during the term of the leases in a manner that has
the effect of basing rent on income or profits; and

- conform with normal business practice.

More generally, the rent will not qualify as "rents from real property" if,
considering the relevant lease and all the surrounding circumstances, the
arrangement does not conform with normal business practice, but is in reality
used as a means of basing the rent on income or profits. We have represented to
Baker Donelson that we intend to set and accept rents which are fixed dollar
amounts or a fixed percentage of gross revenue, and not determined to any extent
by reference to any person's income or profits, in compliance with the rules
above.

Second, we must not own, actually or constructively, 10% or more of the
stock or the assets or net profits of any tenant, referred to as a related party
tenant, other than a taxable REIT subsidiary. Failure to adhere to this
limitation would cause the rental income from the related party tenant to not be
treated as qualifying income for purposes of the REIT gross income tests. The
constructive ownership rules generally provide that, if 10% or more in value of
our stock is owned, directly or indirectly, by or for any person, we are
considered as owning the stock owned, directly or indirectly, by or for such
person. We do not own any stock or any assets or net profits of any tenant
directly. In addition, our charter prohibits transfers of our shares that would
cause us to own, actually or constructively, 10% or more of the ownership
interests in a tenant. We should not own, actually or constructively, 10% or
more of any tenant other than a taxable REIT subsidiary. We have represented to
counsel that we will not rent any facility to a related-party tenant. However,
because the constructive ownership rules are broad and it is not possible to
monitor continually direct and indirect transfers of our shares, no absolute
assurance can be given that such transfers or other events of which we have no
knowledge will not cause us to own constructively 10% or more of a tenant other
than a taxable REIT subsidiary at some future date. MPT Development Services,
Inc., our taxable REIT subsidiary, has made loans to Vibra Healthcare, LLC, the
parent entity of our tenants, in an aggregate amount of approximately $41.4
million to acquire the operations at certain facilities. MPT Development
Services, Inc. also made a loan of approximately $6.2 million to Vibra and its
subsidiaries for working capital purposes which was repaid in February 2005. We
believe that the loans to Vibra will be treated as debt rather than equity
interests in Vibra, and that our rental income from Vibra will be treated as
qualifying income for purposes of the REIT gross income tests. However, there
can be no assurance that the IRS will not take a contrary position. If the IRS
were to successfully treat the loans to Vibra as equity interests in Vibra,
Vibra would be a related party tenant with respect to our company, the rent that
we receive from Vibra would not be qualifying income for purposes of the REIT
gross

135

income tests, and we could lose our REIT status. However, as stated above, we
believe that the loans to Vibra will be treated as debt rather than equity
interests in Vibra.

As described above, we currently own 100% of the stock of MPT Development
Services, Inc., a taxable REIT subsidiary, and may in the future own up to 100%
of the stock of one or more additional taxable REIT subsidiaries. Under an
exception to the related-party tenant rule described in the preceding paragraph,
rent that we receive from a taxable REIT subsidiary will qualify as "rents from
real property" as long as (i) the taxable REIT subsidiary is a qualifying
taxable REIT subsidiary (among other things, it does not operate or manage a
healthcare facility), (ii) at least 90% of the leased space in the facility is
leased to persons other than taxable REIT subsidiaries and related party
tenants, and (iii) the amount paid by the taxable REIT subsidiary to rent space
at the facility is substantially comparable to rents paid by other tenants of
the facility for comparable space. If in the future we receive rent from a
taxable REIT subsidiary, we will seek to comply with this exception.

Third, the rent attributable to the personal property leased in connection
with a lease of real property must not be greater than 15% of the total rent
received under the lease. The rent attributable to personal property under a
lease is the amount that bears the same ratio to total rent under the lease for
the taxable year as the average of the fair market values of the leased personal
property at the beginning and at the end of the taxable year bears to the
average of the aggregate fair market values of both the real and personal
property covered by the lease at the beginning and at the end of such taxable
year (the "personal property ratio"). With respect to each of our leases, we
believe that the personal property ratio generally will be less than 15%. Where
that is not, or may in the future not be, the case, we believe that any income
attributable to personal property will not jeopardize our ability to qualify as
a REIT. There can be no assurance, however, that the IRS would not challenge our
calculation of a personal property ratio, or that a court would not uphold such
assertion. If such a challenge were successfully asserted, we could fail to
satisfy the 75% or 95% gross income test and thus lose our REIT status.

Fourth, we cannot furnish or render noncustomary services to the tenants of
our facilities, or manage or operate our facilities, other than through an
independent contractor who is adequately compensated and from whom we do not
derive or receive any income. However, we need not provide services through an
"independent contractor," but instead may provide services directly to our
tenants, if the services are "usually or customarily rendered" in connection
with the rental of space for occupancy only and are not considered to be
provided for the tenants' convenience. In addition, we may provide a minimal
amount of "noncustomary" services to the tenants of a facility, other than
through an independent contractor, as long as our income from the services does
not exceed 1% of our income from the related facility. Finally, we may own up to
100% of the stock of one or more taxable REIT subsidiaries, which may provide
noncustomary services to our tenants without tainting our rents from the related
facilities. We do not intend to perform any services other than customary ones
for our tenants, other than services provided through independent contractors or
taxable REIT subsidiaries. We have represented to Baker Donelson that we will
not perform noncustomary services which would jeopardize our REIT status.

Finally, in order for the rent payable under the leases of our properties
to constitute "rents from real property," the leases must be respected as true
leases for federal income tax purposes and not treated as service contracts,
joint ventures, financing arrangements, or another type of arrangement. We
generally treat our leases with respect to our properties as true leases for
federal income tax purposes. We believe that our lease of the Desert Valley
Facility is a true lease; however, because of the nature of the lessee's
purchase option thereunder, there can be no assurance that the IRS would not
consider this lease a financing arrangement instead of a true lease for federal
income tax purposes. In that case, our income from the lease of the Desert
Valley Facility would be interest income rather than rent and would be
qualifying income for purposes of the 75% gross income test to the extent that
our "loan" does not exceed the fair market value of the real estate assets
associated with the Desert Valley Facility. All of the interest income from our
loan would be qualifying income for purposes of the 95% gross income test. We
believe that the characterization of the Desert Valley Facility lease as a
financing arrangement would not adversely affect our ability to qualify as a
REIT.

136

If a portion of the rent we receive from a facility does not qualify as
"rents from real property" because the rent attributable to personal property
exceeds 15% of the total rent for a taxable year, the portion of the rent
attributable to personal property will not be qualifying income for purposes of
either the 75% or 95% gross income test. If rent attributable to personal
property, plus any other income that is nonqualifying income for purposes of the
95% gross income test, during a taxable year exceeds 5% of our gross income
during the year, we would lose our REIT status. By contrast, in the following
circumstances, none of the rent from a lease of a facility would qualify as
"rents from real property": (i) the rent is considered based on the income or
profits of the tenant; (ii) the tenant is a related party tenant or fails to
qualify for the exception to the related-party tenant rule for qualifying
taxable REIT subsidiaries; or (iii) we furnish more than a de minimis amount of
noncustomary services to the tenants of the facility, or manage or operate the
facility, other than through a qualifying independent contractor or a taxable
REIT subsidiary. In any of these circumstances, we could lose our REIT status
because we would be unable to satisfy either the 75% or 95% gross income test.

Tenants may be required to pay, besides base rent, reimbursements for
certain amounts we are obligated to pay to third parties (such as a tenant's
proportionate share of a facility's operational or capital expenses), penalties
for nonpayment or late payment of rent or additions to rent. These and other
similar payments should qualify as "rents from real property."

Interest. The term "interest" generally does not include any amount
received or accrued, directly or indirectly, if the determination of the amount
depends in whole or in part on the income or profits of any person. However, an
amount received or accrued generally will not be excluded from the term
"interest" solely because it is based on a fixed percentage or percentages of
receipts or sales. Furthermore, to the extent that interest from a loan that is
based upon the residual cash proceeds from the sale of the property securing the
loan constitutes a "shared appreciation provision," income attributable to such
participation feature will be treated as gain from the sale of the secured
property.

Fee Income. We may receive various fees in connection with our operations.
The fees will be qualifying income for purposes of both the 75% and 95% gross
income tests if they are received in consideration for entering into an
agreement to make a loan secured by real property and the fees are not
determined by income and profits. Other fees are not qualifying income for
purposes of either gross income test. Any fees earned by MPT Development
Services, Inc., our taxable REIT subsidiary, will not be included for proposes
of the gross income tests. We anticipate that MPT Development Services, Inc.
will receive most of the management fees, inspection fees, and construction fees
in connection with our operations.

Prohibited Transactions. A REIT will incur a 100% tax on the net income
derived from any sale or other disposition of property, other than foreclosure
property, that the REIT holds primarily for sale to customers in the ordinary
course of a trade or business. We believe that none of our assets will be held
primarily for sale to customers and that a sale of any of our assets will not be
in the ordinary course of our business. Whether a REIT holds an asset "primarily
for sale to customers in the ordinary course of a trade or business" depends,
however, on the facts and circumstances in effect from time to time, including
those related to a particular asset. Nevertheless, we will attempt to comply
with the terms of safe-harbor provisions in the federal income tax laws
prescribing when an asset sale will not be characterized as a prohibited
transaction. We cannot assure you, however, that we can comply with the
safe-harbor provisions or that we will avoid owning property that may be
characterized as property that we hold "primarily for sale to customers in the
ordinary course of a trade or business." We may form or acquire a taxable REIT
subsidiary to hold and dispose of those facilities we conclude may not fall
within the safe-harbor provisions.

Foreclosure Property. We will be subject to tax at the maximum corporate
rate on any income from foreclosure property, other than income that otherwise
would be qualifying income for purposes of the 75% gross income test, less
expenses directly connected with the production of that income. However, gross
income from foreclosure property will qualify under the 75% and 95% gross income
tests. Foreclosure property is any real property, including interests in real
property, and any personal property incident to

137

such real property acquired by a REIT as the result of the REIT's having bid on
the property at foreclosure, or having otherwise reduced such property to
ownership or possession by agreement or process of law after actual or imminent
default on a lease of the property or on indebtedness secured by the property,
or a "Repossession Action." Property acquired by a Repossession Action will not
be considered "foreclosure property" if (i) the REIT held or acquired the
property subject to a lease or securing indebtedness for sale to customers in
the ordinary course of business or (ii) the lease or loan was acquired or
entered into with intent to take Repossession Action or in circumstances where
the REIT had reason to know a default would occur. The determination of such
intent or reason to know must be based on all relevant facts and circumstances.
In no case will property be considered "foreclosure property" unless the REIT
makes a proper election to treat the property as foreclosure property.

Foreclosure property includes any qualified healthcare property acquired by
a REIT as a result of a termination of a lease of such property (other than a
termination by reason of a default, or the imminence of a default, on the
lease). A "qualified healthcare property" means any real property, including
interests in real property, and any personal property incident to such real
property which is a healthcare facility or is necessary or incidental to the use
of a healthcare facility. For this purpose, a healthcare facility means a
hospital, nursing facility, assisted living facility, congregate care facility,
qualified continuing care facility, or other licensed facility which extends
medical or nursing or ancillary services to patients and which, immediately
before the termination, expiration, default, or breach of the lease secured by
such facility, was operated by a provider of such services which was eligible
for participation in the Medicare program under Title XVIII of the Social
Security Act with respect to such facility.

However, a REIT will not be considered to have foreclosed on a property
where the REIT takes control of the property as a mortgagee-in-possession and
cannot receive any profit or sustain any loss except as a creditor of the
mortgagor. Property generally ceases to be foreclosure property at the end of
the third taxable year following the taxable year in which the REIT acquired the
property (or, in the case of a qualified healthcare property which becomes
foreclosure property because it is acquired by a REIT as a result of the
termination of a lease of such property, at the end of the second taxable year
following the taxable year in which the REIT acquired such property) or longer
if an extension is granted by the Secretary of the Treasury. This period (as
extended, if applicable) terminates, and foreclosure property ceases to be
foreclosure property on the first day:

- on which a lease is entered into for the property that, by its terms,
will give rise to income that does not qualify for purposes of the 75%
gross income test, or any amount is received or accrued, directly or
indirectly, pursuant to a lease entered into on or after such day that
will give rise to income that does not qualify for purposes of the 75%
gross income test;

- on which any construction takes place on the property, other than
completion of a building or any other improvement, where more than 10% of
the construction was completed before default became imminent; or

- which is more than 90 days after the day on which the REIT acquired the
property and the property is used in a trade or business which is
conducted by the REIT, other than through an independent contractor from
whom the REIT itself does not derive or receive any income. For this
purpose, in the case of a qualified healthcare property, income derived
or received from an independent contractor will be disregarded to the
extent such income is attributable to (i) a lease of property in effect
on the date the REIT acquired the qualified healthcare property (without
regard to its renewal after such date so long as such renewal is pursuant
to the terms of such lease as in effect on such date) or (ii) any lease
of property entered into after such date if, on such date, a lease of
such property from the REIT was in effect and, under the terms of the new
lease, the REIT receives a substantially similar or lesser benefit in
comparison to the prior lease.

Hedging Transactions. From time to time, we may enter into hedging
transactions with respect to one or more of our assets or liabilities. Our
hedging activities may include entering into interest rate swaps, caps, and
floors, options to purchase such items, and futures and forward contracts. For
taxable years beginning prior to January 1, 2005, any periodic income or gain
from the disposition of any financial
138

instrument for these or similar transactions to hedge indebtedness we incur to
acquire or carry "real estate assets" should be qualifying income for purposes
of the 95% gross income test, but not the 75% gross income test. For taxable
years beginning on and after January 1, 2005, income and gain from "hedging
transactions" will be excluded from gross income for purposes of the 95% gross
income test (but not the 75% gross income test). For those taxable years, a
"hedging transaction" will mean any transaction entered into in the normal
course of our trade or business primarily to manage the risk of interest rate or
price changes, or currency fluctuations with respect to borrowings made or to be
made, or ordinary obligations incurred or to be incurred, to acquire or carry
real estate assets. We will be required to clearly identify any such hedging
transaction before the close of the day on which it was acquired, originated, or
entered into. Since the financial markets continually introduce new and
innovative instruments related to risk-sharing or trading, it is not entirely
clear which such instruments will generate income which will be considered
qualifying income for purposes of the gross income tests. We intend to structure
any hedging or similar transactions so as not to jeopardize our status as a
REIT.

Failure to Satisfy Gross Income Tests. If we fail to satisfy one or both
of the gross income tests for our 2004 taxable year, we nevertheless may qualify
as a REIT for that year if we qualify for relief under certain provisions of the
federal income tax laws. Those relief provisions generally will be available if:

- our failure to meet these tests is due to reasonable cause and not to
willful neglect;

- we attach a schedule of the sources of our income to our tax return; and

- any incorrect information on the schedule is not due to fraud with intent
to evade tax.

For taxable years beginning on and after January 1, 2005, those relief
provisions will be available if:

- our failure to meet those tests is due to reasonable cause and not to
willful neglect, and

- following our identification of such failure for any taxable year, a
schedule of the sources of our income is filed in accordance with
regulations prescribed by the Secretary of the Treasury.

We cannot with certainty predict whether any failure to meet these tests
will qualify for the relief provisions. As discussed above in "-- Taxation of
Our Company," even if the relief provisions apply, we would incur a 100% tax on
the gross income attributable to the greater of the amounts by which we fail the
75% and 95% gross income tests, multiplied by a fraction intended to reflect our
profitability.

Asset Tests. To maintain our qualification as a REIT, we also must satisfy
the following asset tests at the end of each quarter of each taxable year.

First, at least 75% of the value of our total assets must consist of:

- cash or cash items, including certain receivables;

- government securities;

- real estate assets, which includes interest in real property, leaseholds,
options to acquire real property or leaseholds, interests in mortgages on
real property and shares (or transferable certificates of beneficial
interest) in other REITs;

- stock in other REITs; and

- investments in stock or debt instruments attributable to the temporary
investment (i.e., for a period not exceeding 12 months) of new capital
that we raise through equity offerings or offerings of debt with at least
a five year term.

With respect to investments not included in the 75% asset class, we may not hold
securities of any one issuer (other than a taxable REIT subsidiary) that exceed
5% of the value of our total assets; nor may we hold securities of any one
issuer (other than a taxable REIT subsidiary) that represent more than 10% of
the voting power of all outstanding voting securities of such issuer, or more
than 10% of the value of all outstanding securities of such issuer.

139

In addition, we may not hold securities of one or more taxable REIT
subsidiaries that represent in the aggregate more than 20% of the value of our
total assets, irrespective of whether such securities may also be included in
the 75% asset class (e.g., a mortgage loan issued to a taxable REIT subsidiary).
Furthermore, no more than 25% of our total assets may be represented by
securities that are not included in the 75% asset class, but this requirement
will necessarily be satisfied if the 75% asset class requirement is satisfied.

For purposes of the 5% and 10% asset tests, the term "securities" does not
include stock in another REIT, equity or debt securities of a qualified REIT
subsidiary or taxable REIT subsidiary, mortgage loans that constitute real
estate assets, or equity interests in a partnership. The term "securities,"
however, generally includes debt securities issued by a partnership or another
REIT, except that for purposes of the 10% value test, the term "securities" does
not include:

- "Straight debt," defined as a written unconditional promise to pay on
demand or on a specified date a sum certain in money if (i) the debt is
not convertible, directly or indirectly, into stock, and (ii) the
interest rate and interest payment dates are not contingent on profits,
the borrower's discretion, or similar factors. "Straight debt" securities
do not include any securities issued by a partnership or a corporation in
which we or any controlled TRS (i.e., a TRS in which we own directly or
indirectly more than 50% of the voting power or value of the stock) holds
non-"straight debt" securities that have an aggregate value of more than
1% of the issuer's outstanding securities. However, "straight debt"
securities include debt subject to the following contingencies:

- a contingency relating to the time of payment of interest or principal,
as long as either (i) there is no change to the effective yield of the
debt obligation, other than a change to the annual yield that does not
exceed the greater of 0.25% or 5% of the annual yield, or (ii) neither
the aggregate issue price nor the aggregate face amount of the issuer's
debt obligations held by us exceeds $1 million and no more than 12
months of unaccrued interest on the debt obligations can be required to
be prepaid; and

- a contingency relating to the time or amount of payment upon a default
or prepayment of a debt obligation, as long as the contingency is
consistent with customary commercial practice;

- Any loan to an individual or an estate;

- Any "section 467 rental agreement," other than an agreement with a
related party tenant;

- Any obligation to pay "rents from real property";

- Any security issued by a state or any political subdivision thereof, the
District of Columbia, a foreign government of any political subdivision
thereof, or the Commonwealth of Puerto Rico, but only if the
determination of any payment thereunder does not depend in whole or in
part on the profits of any entity not described in this paragraph or
payments on any obligation issued by an entity not described in this
paragraph;

- Any security issued by a REIT;

- Any debt instrument of an entity treated as a partnership for federal
income tax purposes to the extent of our interest as a partner in the
partnership;

- Any debt instrument of an entity treated as a partnership for federal
income tax purposes not described in the preceding bullet points if at
least 75% of the partnership's gross income, excluding income from
prohibited transactions, is qualifying income for purposes of the 75%
gross income test described above in "-- Requirements for
Qualification -- Income Tests."

For purposes of the 10% value test, our proportionate share of the assets of a
partnership is our proportionate interest in any securities issued by the
partnership, without regard to securities described in the last two bullet
points above.

140

In connection with the acquisition of the facilities in our current
portfolio, MPT Development Services, Inc., our taxable REIT subsidiary, has made
loans to Vibra Healthcare, LLC, the parent entity of our tenants, in an
aggregate amount of approximately $41.4 million to acquire the operations at
those facilities. MPT Development Services, Inc. also made a loan of
approximately $6.2 million to Vibra and its subsidiaries for working capital
purposes which was repaid in February 2005. Those loans bear interest at an
annual rate of 10.25%. Our operating partnership loaned the funds to MPT
Development Services, Inc. to make these loans. The loans from our operating
partnership to MPT Development Services, Inc. bear interest at an annual rate of
9.25%.

Baker Donelson is of the opinion that the loans to Vibra will be treated as
debt rather than equity interests in Vibra, and that our rental income from
Vibra will be treated as qualifying income for purposes of the REIT gross income
tests. However, there can be no assurance that the IRS will not take a contrary
position. If the IRS were to successfully treat the loans to Vibra as equity
interests in Vibra, Vibra would be a "related party tenant" with respect to our
company and the rent that we receive from Vibra would not be qualifying income
for purposes of the REIT gross income tests. As a result, we could lose our REIT
status. In addition, if the IRS were to successfully treat the loans to Vibra as
interests held by our operating partnership rather than by MPT Development
Services, Inc. and to treat the loans as other than straight debt, we would fail
the 10% asset test with respect to such interests and, as a result, could lose
our REIT status. Baker Donelson is of the opinion that the loans to Vibra will
be treated as straight debt for federal income tax purposes.

We will monitor the status of our assets for purposes of the various asset
tests and will manage our portfolio in order to comply at all times with such
tests. If we fail to satisfy the asset tests at the end of a calendar quarter,
we will not lose our REIT status if:

- we satisfied the asset tests at the end of the preceding calendar
quarter; and

- the discrepancy between the value of our assets and the asset test
requirements arose from changes in the market values of our assets and
was not wholly or partly caused by the acquisition of one or more
non-qualifying assets.

If we did not satisfy the condition described in the second item, above, we
still could avoid disqualification by eliminating any discrepancy within 30 days
after the close of the calendar quarter in which it arose.

In the event that, at the end of any calendar quarter in a taxable year
beginning on or after January 1, 2005, we violate the 5% or 10% test described
above, we will not lose our REIT status if (1) the failure is de minimis (up to
the lesser of 1% of our assets or $10 million) and (2) we dispose of assets or
otherwise comply with the asset tests within six months after the last day of
the quarter in which we identified the failure of the asset test. In the event
of a more than de minimis failure of the 5% or 10% tests, or a failure of the
other assets test, at the end of any calendar quarter in a taxable year
beginning on or after January 1, 2005, as long as the failure was due to
reasonable cause and not to willful neglect, we will not lose our REIT status if
we (1) dispose of assets or otherwise comply with the asset tests within six
months after the last day of the quarter in which we identified the failure of
the asset test and (2) pay a tax equal to the greater of $50,000 or 35% of the
net income from the nonqualifying assets during the period in which we failed to
satisfy the asset tests.

Distribution Requirements. Each taxable year, we must distribute
dividends, other than capital gain dividends and deemed distributions of
retained capital gain, to our stockholders in an aggregate amount not less than:

- the sum of:

- 90% of our "REIT taxable income," computed without regard to the
dividends-paid deduction or our net capital gain or loss, and

- 90% of our after-tax net income, if any, from foreclosure property,

141

- minus

- the sum of certain items of non-cash income.

We must pay such distributions in the taxable year to which they relate, or
in the following taxable year if we declare the distribution before we timely
file our federal income tax return for the year and pay the distribution on or
before the first regular dividend payment date after such declaration.

We will pay federal income tax on taxable income, including net capital
gain, that we do not distribute to stockholders. In addition, we will incur a 4%
nondeductible excise tax on the excess of a specified required distribution over
amounts we actually distribute if we distribute an amount less than the required
distribution during a calendar year, or by the end of January following the
calendar year in the case of distributions with declaration and record dates
falling in the last three months of the calendar year. The required distribution
must not be less than the sum of:

- 85% of our REIT ordinary income for the year;

- 95% of our REIT capital gain income for the year; and

- any undistributed taxable income from prior periods.

We may elect to retain and pay income tax on the net long-term capital gain
we receive in a taxable year. See " -- Taxation of Taxable United States
Stockholders." If we so elect, we will be treated as having distributed any such
retained amount for purposes of the 4% excise tax described above. We intend to
make timely distributions sufficient to satisfy the annual distribution
requirements and to avoid corporate income tax and the 4% excise tax.

It is possible that, from time to time, we may experience timing
differences between the actual receipt of income and actual payment of
deductible expenses and the inclusion of that income and deduction of such
expenses in arriving at our REIT taxable income. For example, we may not deduct
recognized capital losses from our "REIT taxable income." Further, it is
possible that, from time to time, we may be allocated a share of net capital
gain attributable to the sale of depreciated property that exceeds our allocable
share of cash attributable to that sale. As a result of the foregoing, we may
have less cash than is necessary to distribute all of our taxable income and
thereby avoid corporate income tax and the excise tax imposed on certain
undistributed income. In such a situation, we may need to borrow funds or issue
additional shares of common or preferred stock.

Under certain circumstances, we may be able to correct a failure to meet
the distribution requirement for a year by paying "deficiency dividends" to our
stockholders in a later year. We may include such deficiency dividends in our
deduction for dividends paid for the earlier year. Although we may be able to
avoid income tax on amounts distributed as deficiency dividends, we will be
required to pay interest based upon the amount of any deduction we take for
deficiency dividends.

Recordkeeping Requirements. We must maintain certain records in order to
qualify as a REIT. In addition, to avoid paying a penalty, we must request on an
annual basis information from our stockholders designed to disclose the actual
ownership of our shares of outstanding capital stock. We intend to comply with
these requirements.

Failure to Qualify. If we failed to qualify as a REIT in any taxable year
and no relief provision applied, we would have the following consequences. We
would be subject to federal income tax and any applicable alternative minimum
tax at rates applicable to regular C corporations on our taxable income,
determined without reduction for amounts distributed to stockholders. We would
not be required to make any distributions to stockholders, and any distributions
to stockholders would be taxable as ordinary income to the extent of our current
and accumulated earnings and profits. Corporate stockholders could be eligible
for a dividends-received deduction if certain conditions are satisfied. Unless
we qualified for relief under specific statutory provisions, we would not be
permitted to elect taxation as a REIT for the four taxable years following the
year during which we ceased to qualify as a REIT.

142

For taxable years beginning on and after January 1, 2005, if we fail to
satisfy one or more requirements for REIT qualification, other than the gross
income tests and the asset tests, we could avoid disqualification if the failure
is due to reasonable cause and not to willful neglect and we pay a penalty of
$50,000 for each such failure. In addition, there are relief provisions for a
failure of the gross income tests and asset tests, as described above in
"-- Income Tests" and "-- Asset Tests."

Taxation of Taxable United States Stockholders. As long as we qualify as a
REIT, a taxable "United States stockholder" will be required to take into
account as ordinary income distributions made out of our current or accumulated
earnings and profits that we do not designate as capital gain dividends or
retained long-term capital gain. A United States stockholder will not qualify
for the dividends-received deduction generally available to corporations. The
term "United States stockholder" means a holder of shares of common stock that,
for United States federal income tax purposes, is:

- a citizen or resident of the United States;

- a corporation or partnership (including an entity treated as a
corporation or partnership for United States federal income tax purposes)
created or organized under the laws of the United States or of a
political subdivision of the United States;

- an estate whose income is subject to United States federal income
taxation regardless of its source; or

- any trust if (i) a United States court is able to exercise primary
supervision over the administration of such trust and one or more United
States persons have the authority to control all substantial decisions of
the trust or (ii) it has a valid election in place to be treated as a
United States person.

Distributions paid to a United States stockholder generally will not
qualify for the new 15% tax rate for "qualified dividend income." The Jobs and
Growth Tax Relief Reconciliation Act of 2003 reduced the maximum tax rate for
qualified dividend income from 38.6% to 15% for tax years through 2008. Without
future congressional action, the maximum tax rate on qualified dividend income
will move to 35% in 2009 and 39.6% in 2011. Qualified dividend income generally
includes dividends paid by domestic C corporations and certain qualified foreign
corporations to most United States noncorporate stockholders. Because we are not
generally subject to federal income tax on the portion of our REIT taxable
income distributed to our stockholders, our dividends generally will not be
eligible for the new 15% rate on qualified dividend income. As a result, our
ordinary REIT dividends will continue to be taxed at the higher tax rate
applicable to ordinary income. Currently, the highest marginal individual income
tax rate on ordinary income is 35%. However, the 15% tax rate for qualified
dividend income will apply to our ordinary REIT dividends, if any, that are (i)
attributable to dividends received by us from non-REIT corporations, such as our
taxable REIT subsidiary, and (ii) attributable to income upon which we have paid
corporate income tax (e.g., to the extent that we distribute less than 100% of
our taxable income). In general, to qualify for the reduced tax rate on
qualified dividend income, a stockholder must hold our common stock for more
than 60 days during the 120-day period beginning on the date that is 60 days
before the date on which our common stock becomes ex-dividend.

Distributions to a United States stockholder which we designate as capital
gain dividends will generally be treated as long-term capital gain, without
regard to the period for which the United States stockholder has held its common
stock. We generally will designate our capital gain dividends as either 15%, 20%
or 25% rate distributions. A corporate United States stockholder, however, may
be required to treat up to 20% of certain capital gain dividends as ordinary
income.

We may elect to retain and pay income tax on the net long-term capital gain
that we receive in a taxable year. In that case, a United States stockholder
would be taxed on its proportionate share of our undistributed long-term capital
gain. The United States stockholder would receive a credit or refund for its
proportionate share of the tax we paid. The United States stockholder would
increase the basis in its shares of common stock by the amount of its
proportionate share of our undistributed long-term capital gain, minus its share
of the tax we paid.

143

A United States stockholder will not incur tax on a distribution in excess
of our current and accumulated earnings and profits if the distribution does not
exceed the adjusted basis of the United States stockholder's shares. Instead,
the distribution will reduce the adjusted basis of the shares, and any amount in
excess of both our current and accumulated earnings and profits and the adjusted
basis will be treated as capital gain, long-term if the shares have been held
for more than one year, provided the shares are a capital asset in the hands of
the United States stockholder. In addition, any distribution we declare in
October, November, or December of any year that is payable to a United States
stockholder of record on a specified date in any of those months will be treated
as paid by us and received by the United States stockholder on December 31 of
the year, provided we actually pay the distribution during January of the
following calendar year.

Stockholders may not include in their individual income tax returns any of
our net operating losses or capital losses. Instead, these losses are generally
carried over by us for potential offset against our future income. Taxable
distributions from us and gain from the disposition of shares of common stock
will not be treated as passive activity income; stockholders generally will not
be able to apply any "passive activity losses," such as losses from certain
types of limited partnerships in which the stockholder is a limited partner,
against such income. In addition, taxable distributions from us and gain from
the disposition of common stock generally will be treated as investment income
for purposes of the investment interest limitations. We will notify stockholders
after the close of our taxable year as to the portions of the distributions
attributable to that year that constitute ordinary income, return of capital,
and capital gain.

Taxation of United States Stockholders on the Disposition of Shares of
Common Stock. In general, a United States stockholder who is not a dealer in
securities must treat any gain or loss realized upon a taxable disposition of
our shares of common stock as long-term capital gain or loss if the United
States stockholder has held the stocks for more than one year, and otherwise as
short-term capital gain or loss. However, a United States stockholder must treat
any loss upon a sale or exchange of common stock held for six months or less as
a long-term capital loss to the extent of capital gain dividends and any other
actual or deemed distributions from us which the United States stockholder
treats as long-term capital gain. All or a portion of any loss that a United
States stockholder realizes upon a taxable disposition of common stock may be
disallowed if the United States stockholder purchases other shares of our common
stock within 30 days before or after the disposition.

Capital Gains and Losses. The tax-rate differential between capital gain
and ordinary income for non-corporate taxpayers may be significant. A taxpayer
generally must hold a capital asset for more than one year for gain or loss
derived from its sale or exchange to be treated as long-term capital gain or
loss. The highest marginal individual income tax rate is currently 35%. The
maximum tax rate on long-term capital gain applicable to individuals is 15% for
sales and exchanges of assets held for more than one year and occurring on or
after May 6, 2003 through December 31, 2008. The maximum tax rate on long-term
capital gain from the sale or exchange of "section 1250 property" (i.e.,
generally, depreciable real property) is 25% to the extent the gain would have
been treated as ordinary income if the property were "section 1245 property"
(i.e., generally, depreciable personal property). We generally may designate
whether a distribution we designate as capital gain dividends (and any retained
capital gain that we are deemed to distribute) is taxable to non-corporate
stockholders at a 15% or 25% rate.

The characterization of income as capital gain or ordinary income may
affect the deductibility of capital losses. A non-corporate taxpayer may deduct
capital losses not offset by capital gains against its ordinary income only up
to a maximum of $3,000 annually. A non-corporate taxpayer may carry unused
capital losses forward indefinitely. A corporate taxpayer must pay tax on its
net capital gain at corporate ordinary-income rates. A corporate taxpayer may
deduct capital losses only to the extent of capital gains, with unused losses
carried back three years and forward five years.

Information Reporting Requirements and Backup Withholding. We will report
to our stockholders and to the IRS the amount of distributions we pay during
each calendar year and the amount of tax we

144

withhold, if any. A stockholder may be subject to backup withholding at a rate
of up to 28% with respect to distributions unless the holder:

- is a corporation or comes within certain other exempt categories and when
required, demonstrates this fact; or

- provides a taxpayer identification number, certifies as to no loss of
exemption from backup withholding, and otherwise complies with the
applicable requirements of the backup withholding rules.

A stockholder who does not provide us with its correct taxpayer
identification number also may be subject to penalties imposed by the IRS. Any
amount paid as backup withholding will be creditable against the stockholder's
income tax liability. In addition, we may be required to withhold a portion of
capital gain distributions to any stockholders who fail to certify their
non-foreign status to us. For a discussion of the backup withholding rules as
applied to non-United States stockholders, see "Taxation of Non-United States
Stockholders."

Taxation of Tax-Exempt Stockholders. Tax-exempt entities, including
qualified employee pension and profit sharing trusts and individual retirement
accounts, referred to as pension trusts, generally are exempt from federal
income taxation. However, they are subject to taxation on their "unrelated
business taxable income." While many investments in real estate generate
unrelated business taxable income, the IRS has issued a ruling that dividend
distributions from a REIT to an exempt employee pension trust do not constitute
unrelated business taxable income so long as the exempt employee pension trust
does not otherwise use the shares of the REIT in an unrelated trade or business
of the pension trust. Based on that ruling, amounts we distribute to tax-exempt
stockholders generally should not constitute unrelated business taxable income.
However, if a tax-exempt stockholder were to finance its acquisition of common
stock with debt, a portion of the income it received from us would constitute
unrelated business taxable income pursuant to the "debt-financed property"
rules. Furthermore, social clubs, voluntary employee benefit associations,
supplemental unemployment benefit trusts and qualified group legal services
plans that are exempt from taxation under special provisions of the federal
income tax laws are subject to different unrelated business taxable income
rules, which generally will require them to characterize distributions they
receive from us as unrelated business taxable income. Finally, in certain
circumstances, a qualified employee pension or profit-sharing trust that owns
more than 10% of our shares of common stock must treat a percentage of the
dividends it receives from us as unrelated business taxable income. The
percentage is equal to the gross income we derive from an unrelated trade or
business, determined as if we were a pension trust, divided by our total gross
income for the year in which we pay the dividends. This rule applies to a
pension trust holding more than 10% of our shares only if:

- the percentage of our dividends which the tax-exempt trust must treat as
unrelated business taxable income is at least 5%;

- we qualify as a REIT by reason of the modification of the rule requiring
that no more than 50% of our shares of common stock be owned by five or
fewer individuals, which modification allows the beneficiaries of the
pension trust to be treated as holding shares in proportion to their
actual interests in the pension trust; and

- either of the following applies:

- one pension trust owns more than 25% of the value of our shares of
common stock; or

- a group of pension trusts individually holding more than 10% of the
value of our shares of common stock collectively owns more than 50% of
the value of our shares of common stock.

Taxation of Non-United States Stockholders. The rules governing United
States federal income taxation of nonresident alien individuals, foreign
corporations, foreign partnerships, and other foreign stockholders are complex.
This section is only a summary of such rules. We urge non-United States
stockholders to consult their own tax advisors to determine the impact of
federal, state, and local income tax laws on ownership of shares of common
stock, including any reporting requirements.
145

A non-United States stockholder that receives a distribution which (i) is
not attributable to gain from our sale or exchange of "United States real
property interests" (defined below) and (ii) we do not designate a capital gain
dividend (or retained capital gain) will recognize ordinary income to the extent
of our current or accumulated earnings and profits. A withholding tax equal to
30% of the gross amount of the distribution ordinarily will apply unless an
applicable tax treaty reduces or eliminates the tax. However, a non-United
States stockholder generally will be subject to federal income tax at graduated
rates on any distribution treated as effectively connected with the non-United
States stockholder's conduct of a United States trade or business, in the same
manner as United States stockholders are taxed on distributions. A corporate
non-United States stockholder may, in addition, be subject to the 30% branch
profits tax. We plan to withhold United States income tax at the rate of 30% on
the gross amount of any distribution paid to a non-United States stockholder
unless:

- a lower treaty rate applies and the non-United States stockholder files
an IRS Form W-8BEN evidencing eligibility for that reduced rate with us;
or

- the non-United States stockholder files an IRS Form W-8ECI with us
claiming that the distribution is effectively connected income.

A non-United States stockholder will not incur tax on a distribution in
excess of our current and accumulated earnings and profits if the excess portion
of the distribution does not exceed the adjusted basis of the stockholder's
shares of common stock. Instead, the excess portion of the distribution will
reduce the adjusted basis of the shares. A non-United States stockholder will be
subject to tax on a distribution that exceeds both our current and accumulated
earnings and profits and the adjusted basis of its shares, if the non-United
States stockholder otherwise would be subject to tax on gain from the sale or
disposition of shares of common stock, as described below. Because we generally
cannot determine at the time we make a distribution whether or not the
distribution will exceed our current and accumulated earnings and profits, we
normally will withhold tax on the entire amount of any distribution at the same
rate as we would withhold on a dividend. However, a non-United States
stockholder may obtain a refund of amounts we withhold if we later determine
that a distribution in fact exceeded our current and accumulated earnings and
profits.

We must withhold 10% of any distribution that exceeds our current and
accumulated earnings and profits. We will, therefore, withhold at a rate of 10%
on any portion of a distribution not subject to withholding at a rate of 30%.

For any year in which we qualify as a REIT, a non-United States stockholder
will incur tax on distributions attributable to gain from our sale or exchange
of "United States real property interests" under the "FIRPTA" provisions of the
Code. The term "United States real property interests" includes interests in
real property and stocks in corporations at least 50% of whose assets consist of
interests in real property. Under the FIRPTA rules, a non-United States
stockholder is taxed on distributions attributable to gain from sales of United
States real property interests as if the gain were effectively connected with
the conduct of a United States business of the non-United States stockholder. A
non-United States stockholder thus would be taxed on such a distribution at the
normal capital gain rates applicable to United States stockholders, subject to
applicable alternative minimum tax and a special alternative minimum tax in the
case of a nonresident alien individual. A non-United States corporate
stockholder not entitled to treaty relief or exemption also may be subject to
the 30% branch profits tax on such a distribution. We must withhold 35% of any
distribution that we could designate as a capital gain dividend. A non-United
States stockholder may receive a credit against our tax liability for the amount
we withhold.

For taxable years beginning on and after January 1, 2005, for non-U.S.
stockholders of our publicly-traded shares, capital gain distributions that are
attributable to our sale of real property will not be subject to FIRPTA and
therefore will be treated as ordinary dividends rather than as gain from the
sale of a United States real property interest, as long as the non-U.S.
stockholder did not own more than 5% of the class of our stock on which the
distributions are made during the taxable year. As a result, non-U.S.
stockholders generally would be subject to withholding tax on such capital gain
distributions in the same manner as they are subject to withholding tax on
ordinary dividends.
146

A non-United States stockholder generally will not incur tax under FIRPTA
with respect to gain on a sale of shares of common stock as long as, at all
times, non-United States persons hold, directly or indirectly, less than 50% in
value of the outstanding common stock. We cannot assure you that this test will
be met. In addition, a non-United States stockholder that owned, actually or
constructively, 5% or less of the outstanding common stock at all times during a
specified testing period will not incur tax under FIRPTA on gain from a sale of
common stock if the stock is "regularly traded" on an established securities
market. Any gain subject to tax under FIRPTA will be treated in the same manner
as it would be in the hands of United States stockholders subject to alternative
minimum tax, but under a special alternative minimum tax in the case of
nonresident alien individuals.

A non-United States stockholder generally will incur tax on gain from the
sale of common stock not subject to FIRPTA if:

- the gain is effectively connected with the conduct of the non-United
States stockholder's United States trade or business, in which case the
non-United States stockholder will be subject to the same treatment as
United States stockholders with respect to the gain; or

- the non-United States stockholder is a nonresident alien individual who
was present in the United States for 183 days or more during the taxable
year and has a "tax home" in the United States, in which case the
non-United States stockholder will incur a 30% tax on capital gains.

OTHER TAX CONSEQUENCES

Tax Aspects of Our Investments in the Operating Partnership. The following
discussion summarizes certain federal income tax considerations applicable to
our direct or indirect investment in our operating partnership and any
subsidiary partnerships or limited liability companies we form or acquire, each
individually referred to as a Partnership and, collectively, as Partnerships.
The following discussion does not cover state or local tax laws or any federal
tax laws other than income tax laws.

Classification as Partnerships. We are entitled to include in our income
our distributive share of each Partnership's income and to deduct our
distributive share of each Partnership's losses only if such Partnership is
classified for federal income tax purposes as a partnership (or an entity that
is disregarded for federal income tax purposes if the entity has only one owner
or member), rather than as a corporation or an association taxable as a
corporation. An organization with at least two owners or members will be
classified as a partnership, rather than as a corporation, for federal income
tax purposes if it:

- is treated as a partnership under the Treasury regulations relating to
entity classification (the "check-the-box regulations"); and

- is not a "publicly traded" partnership.

Under the check-the-box regulations, an unincorporated entity with at least
two owners or members may elect to be classified either as an association
taxable as a corporation or as a partnership. If such an entity does not make an
election, it generally will be treated as a partnership for federal income tax
purposes. We intend that each Partnership will be classified as a partnership
for federal income tax purposes (or else a disregarded entity where there are
not at least two separate beneficial owners).

A publicly traded partnership is a partnership whose interests are traded
on an established securities market or are readily tradable on a secondary
market (or a substantial equivalent). A publicly traded partnership is generally
treated as a corporation for federal income tax purposes, but will not be so
treated for any taxable year for which at least 90% of the partnership's gross
income consists of specified passive income, including real property rents,
gains from the sale or other disposition of real property, interest, and
dividends (the "90% passive income exception").

Treasury regulations, referred to as PTP regulations, provide limited safe
harbors from treatment as a publicly traded partnership. Pursuant to one of
those safe harbors, or private placement exclusion, interests in a partnership
will not be treated as readily tradable on a secondary market or the substantial
equivalent thereof if (i) all interests in the partnership were issued in a
transaction or transactions that were not required to be registered under the
Securities Act, and (ii) the partnership does not have more than 100
147

partners at any time during the partnership's taxable year. For the
determination of the number of partners in a partnership, a person owning an
interest in a partnership, grantor trust, or S corporation that owns an interest
in the partnership is treated as a partner in the partnership only if (i)
substantially all of the value of the owner's interest in the entity is
attributable to the entity's direct or indirect interest in the partnership and
(ii) a principal purpose of the use of the entity is to permit the partnership
to satisfy the 100-partner limitation. Each Partnership should qualify for the
private placement exclusion.

We have not requested, and do not intend to request, a ruling from the
Internal Revenue Service that the Partnerships will be classified as
partnerships for federal income tax purposes. If for any reason a Partnership
were taxable as a corporation, rather than as a partnership, for federal income
tax purposes, we likely would not be able to qualify as a REIT. See
"-- Requirements for Qualification -- Income Tests" and " -- Requirements for
Qualification -- Asset Tests." In addition, any change in a Partnership's status
for tax purposes might be treated as a taxable event, in which case we might
incur tax liability without any related cash distribution. See "-- Requirements
for Qualification -- Distribution Requirements." Further, items of income and
deduction of such Partnership would not pass through to its partners, and its
partners would be treated as stockholders for tax purposes. Consequently, such
Partnership would be required to pay income tax at corporate rates on its net
income, and distributions to its partners would constitute dividends that would
not be deductible in computing such Partnership's taxable income.

INCOME TAXATION OF THE PARTNERSHIPS AND THEIR PARTNERS

Partners, Not the Partnerships, Subject to Tax. A partnership is not a
taxable entity for federal income tax purposes. We will therefore take into
account our allocable share of each Partnership's income, gains, losses,
deductions, and credits for each taxable year of the Partnership ending with or
within our taxable year, even if we receive no distribution from the Partnership
for that year or a distribution less than our share of taxable income.
Similarly, even if we receive a distribution, it may not be taxable if the
distribution does not exceed our adjusted tax basis in our interest in the
Partnership.

Partnership Allocations. Although a partnership agreement generally will
determine the allocation of income and losses among partners, allocations will
be disregarded for tax purposes if they do not comply with the provisions of the
federal income tax laws governing partnership allocations. If an allocation is
not recognized for federal income tax purposes, the item subject to the
allocation will be reallocated in accordance with the partners' interests in the
partnership, which will be determined by taking into account all of the facts
and circumstances relating to the economic arrangement of the partners with
respect to such item. Each Partnership's allocations of taxable income, gain,
and loss are intended to comply with the requirements of the federal income tax
laws governing partnership allocations.

Tax Allocations With Respect to Contributed Properties. Income, gain,
loss, and deduction attributable to appreciated or depreciated property that is
contributed to a partnership in exchange for an interest in the partnership must
be allocated in a manner such that the contributing partner is charged with, or
benefits from, respectively, the unrealized gain or unrealized loss associated
with the property at the time of the contribution. Similar rules apply with
respect to property revalued on the books of a partnership. The amount of such
unrealized gain or unrealized loss, referred to as built-in gain or built-in
loss, is generally equal to the difference between the fair market value of the
contributed or revalued property at the time of contribution or revaluation and
the adjusted tax basis of such property at that time, referred to as a book-tax
difference. Such allocations are solely for federal income tax purposes and do
not affect the book capital accounts or other economic or legal arrangements
among the partners. The United States Treasury Department has issued regulations
requiring partnerships to use a "reasonable method" for allocating items with
respect to which there is a book-tax difference and outlining several reasonable
allocation methods. Our operating partnership generally intends to use the
traditional method for allocating items with respect to which there is a
book-tax difference.

Basis in Partnership Interest. Our adjusted tax basis in any partnership
interest we own generally will be:

- the amount of cash and the basis of any other property we contribute to
the partnership;

148

- increased by our allocable share of the partnership's income (including
tax-exempt income) and our allocable share of indebtedness of the
partnership; and

- reduced, but not below zero, by our allocable share of the partnership's
loss, the amount of cash and the basis of property distributed to us, and
constructive distributions resulting from a reduction in our share of
indebtedness of the partnership.

Loss allocated to us in excess of our basis in a partnership interest will
not be taken into account until we again have basis sufficient to absorb the
loss. A reduction of our share of partnership indebtedness will be treated as a
constructive cash distribution to us, and will reduce our adjusted tax basis.
Distributions, including constructive distributions, in excess of the basis of
our partnership interest will constitute taxable income to us. Such
distributions and constructive distributions normally will be characterized as
long-term capital gain.

Depreciation Deductions Available to Partnerships. The initial tax basis
of property is the amount of cash and the basis of property given as
consideration for the property. A partnership in which we are a partner
generally will depreciate property for federal income tax purposes under the
modified accelerated cost recovery system of depreciation, referred to as MACRS.
Under MACRS, the partnership generally will depreciate furnishings and equipment
over a seven year recovery period using a 200% declining balance method and a
half-year convention. If, however, the partnership places more than 40% of its
furnishings and equipment in service during the last three months of a taxable
year, a mid-quarter depreciation convention must be used for the furnishings and
equipment placed in service during that year. Under MACRS, the partnership
generally will depreciate buildings and improvements over a 39 year recovery
period using a straight line method and a mid-month convention. The operating
partnership's initial basis in properties acquired in exchange for units of the
operating partnership should be the same as the transferor's basis in such
properties on the date of acquisition by the partnership. Although the law is
not entirely clear, the partnership generally will depreciate such property for
federal income tax purposes over the same remaining useful lives and under the
same methods used by the transferors. The partnership's tax depreciation
deductions will be allocated among the partners in accordance with their
respective interests in the partnership, except to the extent that the
partnership is required under the federal income tax laws governing partnership
allocations to use a method for allocating tax depreciation deductions
attributable to contributed or revalued properties that results in our receiving
a disproportionate share of such deductions.

Under recently enacted legislation, a first-year bonus depreciation of 50%
may be available for certain tenant improvements. In addition, certain qualified
leasehold improvement property placed in service before January 1, 2006 will be
depreciated over a 15-year recovery period using a straight method and a
half-year convention.

Sale of a Partnership's Property. Generally, any gain realized by a
Partnership on the sale of property held for more than one year will be
long-term capital gain, except for any portion of the gain treated as
depreciation or cost recovery recapture. Any gain or loss recognized by a
Partnership on the disposition of contributed or revalued properties will be
allocated first to the partners who contributed the properties or who were
partners at the time of revaluation, to the extent of their built-in gain or
loss on those properties for federal income tax purposes. The partners' built-in
gain or loss on contributed or revalued properties is the difference between the
partners' proportionate share of the book value of those properties and the
partners' tax basis allocable to those properties at the time of the
contribution or revaluation. Any remaining gain or loss recognized by the
Partnership on the disposition of contributed or revalued properties, and any
gain or loss recognized by the Partnership on the disposition of other
properties, will be allocated among the partners in accordance with their
percentage interests in the Partnership.

Our share of any Partnership gain from the sale of inventory or other
property held primarily for sale to customers in the ordinary course of the
Partnership's trade or business will be treated as income from a prohibited
transaction subject to a 100% tax. Income from a prohibited transaction may have
an adverse effect on our ability to satisfy the gross income tests for REIT
status. See "-- Requirements for
149

Qualification -- Income Tests." We do not presently intend to acquire or hold,
or to allow any Partnership to acquire or hold, any property that is likely to
be treated as inventory or property held primarily for sale to customers in the
ordinary course of our, or the Partnership's, trade or business.

Taxable REIT Subsidiaries. As described above, we have formed and have
made a timely election to treat MPT Development Services, Inc. as a taxable REIT
subsidiary and may form or acquire additional taxable REIT subsidiaries in the
future. A taxable REIT subsidiary may provide services to our tenants and engage
in activities unrelated to our tenants, such as third-party management,
development, and other independent business activities.

We and any corporate subsidiary in which we own stock must make an election
for the subsidiary to be treated as a taxable REIT subsidiary. If a taxable REIT
subsidiary directly or indirectly owns shares of a corporation with more than
35% of the value or voting power of all outstanding shares of the corporation,
the corporation will automatically also be treated as a taxable REIT subsidiary.
Overall, no more than 20% of the value of our assets may consist of securities
of one or more taxable REIT subsidiaries, irrespective of whether such
securities may also qualify under the 75% assets test, and no more than 25% of
the value of our assets may consist of the securities that are not qualifying
assets under the 75% test, including, among other things, certain securities of
a taxable REIT subsidiary, such as stock or non-mortgage debt.

Rent we receive from our taxable REIT subsidiaries will qualify as "rents
from real property" as long as at least 90% of the leased space in the property
is leased to persons other than taxable REIT subsidiaries and related party
tenants, and the amount paid by the taxable REIT subsidiary to rent space at the
property is substantially comparable to rents paid by other tenants of the
property for comparable space. The taxable REIT subsidiary rules limit the
deductibility of interest paid or accrued by a taxable REIT subsidiary to us to
assure that the taxable REIT subsidiary is subject to an appropriate level of
corporate taxation. Further, the rules impose a 100% excise tax on certain types
of transactions between a taxable REIT subsidiary and us or our tenants that are
not conducted on an arm's-length basis.

A taxable REIT subsidiary may not directly or indirectly operate or manage
a healthcare facility. For purposes of this definition a "healthcare facility"
means a hospital, nursing facility, assisted living facility, congregate care
facility, qualified continuing care facility, or other licensed facility which
extends medical or nursing or ancillary services to patients and which is
operated by a service provider which is eligible for participation in the
Medicare program under Title XVIII of the Social Security Act with respect to
such facility.

State and Local Taxes. We and our stockholders may be subject to taxation
by various states and localities, including those in which we or a stockholder
transacts business, owns property or resides. The state and local tax treatment
may differ from the federal income tax treatment described above. Consequently,
stockholders should consult their own tax advisors regarding the effect of state
and local tax laws upon an investment in our common stock.

150

UNDERWRITING

Friedman, Billings, Ramsey & Co., Inc. is acting as representative of the
underwriters of this offering. Subject to the terms and conditions in the
underwriting agreement entered into in connection with the sale of our common
stock described in this prospectus, the underwriters named below have severally
agreed to purchase the number of shares of common stock set forth opposite their
respective names.

NUMBER OF SHARES
UNDERWRITER OF COMMON STOCK
- ----------- ----------------

Friedman, Billings, Ramsey & Co., Inc. .....................
J.P. Morgan Securities Inc. ................................
--------
TOTAL:......................................................
========

The underwriting agreement provides that the obligations of the
underwriters to purchase and accept delivery of the shares of common stock
offered by this prospectus are subject to approval by their counsel of legal
matters and to other conditions contained in the underwriting agreement
including, among other items, the receipt of legal opinions from counsel, the
receipt of comfort letters from our current auditors, the absence of any
material adverse changes affecting us or our business and the absence of any
objections from the National Association of Securities Dealers, Inc., or NASD,
with respect to the fairness and reasonableness of the underwriting terms. The
underwriters are obligated to purchase and accept delivery of all of the shares
of common stock offered by this prospectus, other than those covered by the
over-allotment option described below, if any shares are taken. If an
underwriter defaults, the underwriting agreement provides that the purchase
commitments of the non-defaulting underwriters may be increased or, in the event
that the purchase commitments of the defaulting underwriters represent more than
10% of the total number shares of common stock offered by this prospectus, the
underwriting agreement may be terminated.

The underwriters propose to offer the shares of common stock directly to
the public at the public offering price indicated on the cover page of this
prospectus and to various dealers at that price less a concession not to exceed
$ per share, of which $ may be reallowed to other dealers. After this
offering, the public offering price, concession and reallowance to dealers may
be reduced by the underwriters. No reduction shall change the amount of proceeds
to be received by us as indicated on the cover page of this prospectus. The
common stock is offered by the underwriters as stated in this prospectus,
subject to receipt and acceptance by them and subject to their right to reject
any order in whole or in part.

We have granted to the underwriters an option, exercisable within 30 days
after the date of this prospectus, to purchase from time to time up to an
aggregate of 1,704,750 additional shares of our common stock to cover
over-allotments, if any, at the public offering price less the underwriting
discount. If the underwriters exercise their over-allotment option to purchase
any of the additional 1,704,750 shares of common stock, each underwriter,
subject to certain conditions, will become obligated to purchase these
additional shares based on the underwriters' percentage purchase commitment in
the offering as indicated in the table above. If purchased, these additional
shares will be sold by the underwriters on the same terms as those on which the
shares offered by this prospectus are being sold. The underwriters may exercise
the over-allotment option to cover over-allotments made in connection with the
sale of the shares of common stock offered in this offering.

151

The following table summarizes the underwriting compensation to be paid to
the underwriters by us and the selling stockholders. These amounts assume both
no exercise and full exercise of the underwriters' over-allotment option to
purchase additional shares.

WITHOUT WITH
OVER-ALLOTMENT OVER-ALLOTMENT
-------------- --------------

By us:
Per share:..............................................
Total:..................................................
By the selling stockholders:
Per share:..............................................
Total:..................................................

We have agreed to reimburse Friedman, Billings, Ramsey & Co., Inc. for
certain of its reasonable out-of-pocket expenses in connection with this
offering, including any fees or disbursements of its counsel, not to exceed
$150,000.

Pursuant to a registration rights agreement between us, Friedman, Billings,
Ramsey & Co., Inc. and certain holders of our common stock, we are required to
pay substantially all of the expenses in connection with the registration of the
shares of common stock purchased in the April 2004 private placement. In
addition, we will reimburse selling stockholders in an aggregate amount of up to
$50,000, for the fees and expenses of one counsel and one accounting firm, as
selected by Friedman, Billings, Ramsey & Co., Inc. for the selling stockholders,
to review any registration statement. Each selling stockholder participating in
this offering will bear a proportionate share of the underwriting discounts
payable to the underwriters, all transfer taxes and transfer fees and any other
expense of the selling stockholders not allocated to us in the registration
rights agreement.

We estimate that the total expenses payable by us in connection with this
offering will be approximately $1.25 million.

Pursuant to an engagement letter dated November 13, 2003, we appointed
Friedman, Billings, Ramsey & Co., Inc. to act until April 7, 2006 as lead
underwriter or placement agent in connection with any public or private
offerings of our equity securities and to act as our financial advisor in
connection with any purchase or sale of stock, merger, corporate acquisition,
business combination or other strategic combination in which we may engage.
Other than with respect to this offering, the underwriters are not providing us
with any financial advisory services. Subject to the terms of that engagement
letter, the underwriters and their affiliates may from time to time engage in
future transactions with us and our affiliates and provide services to us and
our affiliates in the ordinary course of their business.

Friedman, Billings, Ramsey Group, Inc., an affiliate of Friedman, Billings,
Ramsey & Co., Inc. currently beneficially owns approximately 10.95% of our
outstanding common stock. Under the Conduct Rules of the NASD, when underwriters
or their affiliates beneficially own 10% or more of the common equity of a
company, they may be deemed to have a "conflict of interest" under Rule
2720(b)(7) of the rules and regulations of the NASD. When a NASD member with a
conflict of interest participates as an underwriter in a public offering, that
rule requires that the initial public offering price be no higher than that
recommended by a "qualified independent underwriter," as defined by the NASD,
which qualified independent underwriter shall also participate in the
preparation of the registration statement and the prospectus and exercise the
usual standards of "due diligence" in its participation. Although this rule does
not apply to REITs and therefore to this offering, J.P. Morgan Securities Inc.
has been engaged to act as a qualified independent underwriter. In this role,
J.P. Morgan Securities Inc. has performed a due diligence investigation of us
and participated in the preparation of this prospectus and the registration
statement. The initial public offering price of the shares of common stock will
be no higher than the price recommended by J.P. Morgan Securities Inc. We and
the selling stockholders have agreed to indemnify J.P. Morgan Securities Inc.
against liabilities incurred in connection with acting as a qualified
independent underwriter, including liabilities under the Securities Act.

152

We and the selling stockholders have also agreed to indemnify the
underwriters against various liabilities, including liabilities under the
Securities Act of 1933, or to contribute to payments the underwriters may be
required to make because of any of those liabilities.

We have applied to list our common stock on the New York Stock Exchange
upon the completion of this offering under the symbol "MPW." In connection with
the listing of our common stock on the New York Stock Exchange, the underwriters
will undertake to sell round lots of 100 shares or more to a minimum of 2,000
beneficial owners.

Prior to this offering, there has been no public market for our common
stock, other than limited trading on the Portal Market. The initial public
offering price has been determined through negotiations between the underwriters
and us. Among the factors considered in such determination were:

- prevailing market conditions;

- dividend yields and financial characteristics of publicly traded REITs
that we and the underwriters believe to be comparable to us;

- the present state of our financial and business operations;

- our management;

- estimates of our business and earnings potential; and

- the prospects for the industry in which we operate.

Each of our executive officers and directors has agreed, subject to
specified exceptions, not to:

- offer, sell, agree to offer or sell, solicit offers to purchase, grant
any call option or purchase any put option with respect to, pledge,
borrow or otherwise dispose of any shares of common stock, any of our or
our subsidiaries' other equity securities or any securities convertible
into or exercisable or exchangeable for shares of our common stock or any
such equity securities; or

- establish or increase any "put equivalent position" or liquidate or
decrease any "call equivalent position" or otherwise enter into any swap,
derivative or other transaction or arrangement that transfers to another,
in whole or in part, any of the economic consequences associated with the
ownership of any shares of our common stock or of our or our
subsidiaries' other equity securities (regardless of whether any of these
transactions are to be settled by the delivery of common stock, other
securities, cash or otherwise) for a period of 180 days after the date of
this prospectus without the prior written consent of Friedman, Billings,
Ramsey & Co., Inc. This restriction terminates after the close of trading
of the common stock on and including the 180th day after the date of this
prospectus. However, Friedman, Billings, Ramsey & Co., Inc. may, in its
sole discretion and at any time or from time to time before the
termination of the 180-day period, without notice, release all or any
portion of the securities subject to lock-up agreements. There are no
other existing agreements between the underwriters and any officer or
director who has executed a lock-up agreement providing consent to the
sale of shares prior to the expiration of the lock-up period.

In addition, we have agreed that, for 180 days after the date of this
prospectus, we will not, without the prior written consent of Friedman,
Billings, Ramsey & Co., Inc., issue, sell, contract to sell, or otherwise
dispose of, any shares of common stock, any options or warrants to purchase any
shares of common stock or any securities convertible into, exercisable for or
exchangeable for shares of common stock other than our sale of shares in this
offering, the issuance of options or shares of common stock upon the exercise of
outstanding options or warrants, the issuance of options or shares of common
stock under existing stock option and incentive plans, or the issuance of common
stock or other securities convertible into common stock issued in connection
with the acquisition of properties. We also have agreed that we will not consent
to the disposition of any shares held by officers or directors subject to
lock-up agreements prior to the expiration of their respective lock-up periods
unless pursuant to an exception to those agreements or with the consent of
Friedman, Billings, Ramsey & Co., Inc. The lockup provisions do not

153

prohibit us from filing a resale registration statement to register the shares
issued in our April 2004 private placement.

Our stockholders other than our executive officers and directors may not
sell or otherwise dispose of any of the shares of our common stock or securities
convertible into our common stock that they have acquired prior to the date of
this prospectus and are not selling in this offering until 60 days after the
date of this prospectus, subject to limited exceptions.

In connection with this offering, the underwriters may engage in activities
that stabilize, maintain or otherwise affect the price of our common stock,
including:

- short sales;

- syndicate covering transactions;

- imposition of penalty bids; and

- purchases to cover positions created by short sales.

Stabilizing transactions consist of bids or purchases made for the purpose
of preventing or retarding a decline in the market price of our common stock
while this offering is in progress. Stabilizing transactions may include making
short sales of our common stock, which involves the sale by the underwriters of
a greater number of shares of common stock than they are required to purchase in
this offering, and purchasing common stock from us or in the open market to
cover positions created by short sales. Short sales may be "covered" shorts,
which are short positions in an amount not greater than the underwriters'
over-allotment option referred to above, or may be "naked" shorts, which are
short positions in excess of that amount.

The underwriters may close out any covered short position either by
exercising their over-allotment option, in whole or in part, or by purchasing
shares in the open market. In making this determination, the underwriters will
consider, among other things, the price of shares available for purchase in the
open market compared to the price at which the underwriters may purchase shares
pursuant to the over-allotment option.

A naked short position is more likely to be created if the underwriters are
concerned that there may be downward pressure on the price of the common stock
in the open market that could adversely affect investors who purchased in this
offering. To the extent that the underwriters create a naked short position,
they will purchase shares in the open market to cover the position.

The representative also may impose a penalty bid on underwriters and
selling group members. This means that if the representative purchases shares in
the open market in stabilizing transactions or to cover short sales, the
representative can require the underwriters or selling group members that sold
those shares as part of this offering to repay underwriting discount or the
selling concession received by them.

As a result of these activities, the price of our common stock may be
higher than the price that otherwise might exist in the open market. If the
underwriters commence these activities, they may discontinue them at any time.
The underwriters may carry out these transactions on the New York Stock
Exchange, in the over-the-counter market or otherwise.

The underwriters do not expect sales to accounts over which they exercise
discretionary authority to exceed 5% of the total number of shares of common
stock offered by this prospectus.

At our request, the underwriters have reserved up to % of the common
stock being offered by this prospectus for sale to our directors, employees,
business associates and related persons at the public offering price. The sales
will be made by Friedman, Billings, Ramsey & Co., Inc. through a directed share
program. We do not know if these persons will choose to purchase all or any
portion of these reserved shares, but any purchases they do make will reduce the
number of shares available to the general public. These persons must commit to
purchase no later than the close of business on the day following the date of
this prospectus. Any directors, employees or other persons purchasing such
reserved shares will be prohibited from disposing of or hedging such shares for
a period of at least 180 days after the date of this

154

prospectus. The common stock issued in connection with the directed share
program will be issued as part of the underwritten public offering.

LEGAL MATTERS

The validity of the common stock and certain tax matters, including REIT
qualification and debt characterization, will be passed upon for us by Baker,
Donelson, Bearman, Caldwell & Berkowitz, P.C. The summary of legal matters
contained in the section of this prospectus under the heading "United States
Federal Income Tax Considerations" is based on the opinion of Baker Donelson.
Certain legal matters in connection with this offering will be passed upon for
the underwriters by Hunton & Williams LLP.

EXPERTS

Our consolidated financial statements and the accompanying financial
statement schedule as of December 31, 2004, and 2003, and for the year ended
December 31, 2004 and for the period from inception (August 27, 2003) through
December 31, 2003, included herein, have been audited by KPMG LLP, independent
registered public accounting firm, as stated in their report included herein.

The consolidated financial statements of Vibra as of December 31, 2004 and
for the period from inception (May 14, 2004) through December 31, 2004 included
herein have been audited by Parente Randolph, LLC, independent registered public
accounting firm, as stated in their report included herein.

The independent registered public accounting firms have not examined,
compiled or otherwise applied procedures to any financial forecast, projection
or anticipated results presented herein and, accordingly, do not express an
opinion or any other form of assurance on such.

WHERE YOU CAN FIND MORE INFORMATION

We have filed with the Securities and Exchange Commission a registration
statement on Form S-11, including exhibits, schedules and amendments filed with,
or incorporated by reference in, this registration statement, under the
Securities Act with respect to the shares of our common stock to be sold in this
offering. This prospectus does not contain all of the information set forth in
the registration statement and exhibits and schedules to the registration
statement. For further information with respect to our company and the shares of
our common stock to be sold in this offering, reference is made to the
registration statement, including the exhibits to the registration statement.
Statements contained in this prospectus as to the contents of any contract or
other document referred to in, or incorporated by reference in, this prospectus
are not necessarily complete and, where that contract is an exhibit to the
registration statement, each statement is qualified in all respects by the
exhibit to which the reference relates. Copies of the registration statement,
including the exhibits and schedules to the registration statement, may be
examined without charge at the public reference room of the Securities and
Exchange Commission, 450 Fifth Street, N.W. Room 1024, Washington, DC 20549.
Information about the operation of the public reference room may be obtained by
calling the Securities and Exchange Commission at 1-800-SEC-0300. Copies of all
or a portion of the registration statement can be obtained from the public
reference room of the Securities and Exchange Commission upon payment of
prescribed fees. Our Securities and Exchange Commission filings, including our
registration statement, are also available to you on the Securities and Exchange
Commission's website, www.sec.gov.

As a result of this offering, we will become subject to the information and
reporting requirements of the Securities Exchange Act, and will file periodic
reports, proxy statements and will make available to our stockholders annual
reports containing audited financial information for each year, and quarterly
reports for the first three quarters of each fiscal year containing unaudited
interim financial information.

155

INDEX TO FINANCIAL STATEMENTS

UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL INFORMATION
Medical Properties Trust, Inc. and Subsidiaries
Unaudited Pro Forma Consolidated Balance Sheet as of March
31, 2005............................................... F-3
Unaudited Pro Forma Consolidated Statement of Operations
for the Three Months Ended March 31, 2005.............. F-4
Unaudited Pro Forma Consolidated Statement of Operations
for the Year Ended December 31, 2004................... F-5
Notes to Unaudited Pro Forma Consolidated Financial
Statements............................................. F-6

HISTORICAL FINANCIAL INFORMATION
Medical Properties Trust, Inc. and Subsidiaries
Consolidated Balance Sheets as of March 31, 2005 and
December 31, 2004...................................... F-12
Consolidated Statements of Operations for the Three Months
Ended March 31, 2005 and March 31, 2004................ F-13
Consolidated Statements of Cash Flows for the Three Months
Ended March 31, 2005 and March 31, 2004................ F-14
Notes to Consolidated Financial Statements................ F-15
Report of Independent Registered Public Accounting Firm... F-18
Consolidated Balance Sheets as of December 31, 2004 and
December 31, 2003...................................... F-19
Consolidated Statements of Operations for the Year Ended
December 31, 2004 and for the Period from Inception
(August 27, 2003) through December 31, 2003............ F-20
Consolidated Statements of Cash Flows for the Year Ended
December 31, 2004 and for the Period from Inception
(August 27, 2003) through December 31, 2003............ F-21
Consolidated Statements of Stockholders' Equity (Deficit)
for the Year Ended December 31, 2004 and for the Period
from Inception (August 27, 2003) through December 31,
2003................................................... F-22
Notes to Consolidated Financial Statements................ F-23
Schedule III -- Real Estate and Accumulated Depreciation.... F-34
Vibra Healthcare, LLC (formerly Highmark Healthcare, LLC)
Consolidated Balance Sheet as of March 31, 2005 and
December 31, 2004...................................... F-35
Consolidated Statements of Operations and Changes in
Partners' Deficit for the Three Months Ended March 31,
2005................................................... F-36
Consolidated Statement of Cash Flows for the Three Months
Ended March 31, 2005................................... F-37
Notes to Consolidated Financial Statements................ F-38
Report of Independent Registered Public Accounting Firm... F-47
Consolidated Balance Sheet as of December 31, 2004........ F-48
Consolidated Statement of Operations and Changes in
Partner's Capital for the Period from Inception (May
14, 2004) through December 31, 2004.................... F-49
Consolidated Statement of Cash Flows for the Period from
Inception (May 14, 2004) through December 31, 2004..... F-50
Notes to Consolidated Financial Statements................ F-51

F-1

UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL INFORMATION

The following unaudited pro forma consolidated financial information sets
forth:

- the historical financial information derived from our audited
consolidated financial statements for the year ended December 31, 2004
and the three months ended March 31, 2005 as adjusted to:

- give effect to acquisition of our facilities acquired and leased to
Vibra and Desert Valley as if we owned them from the inception of each
period presented;

- give effect to our loans made to Vibra;

- give effect to our probable acquisitions;

- give effect to this offering; and

- our pro forma, as adjusted unaudited consolidated balance sheet as of
March 31, 2005, and the pro forma, as adjusted, unaudited consolidated
statement of operations for the year ended December 31, 2004, to give
effect to our initial portfolio, our probable acquisitions and this
offering.

This section contains forward-looking statements, which are projections of
future performance and the assumptions upon which the forward-looking statements
are based. Our actual results could differ materially from those expressed in
our forward-looking statements as a result of various risks, including those set
forth in "Risk Factors" and elsewhere in this prospectus. You should read the
information below along with all other financial information and analysis
presented in this prospectus, including the sections captioned "Management's
Discussion and Analysis of Financial Condition and Results of Operations" and
our historical financial statements and related notes.

The unaudited pro forma consolidated financial information is presented for
informational purposes only. We do not expect that this information will reflect
our future results of operations or financial position. The unaudited pro forma
adjustments and eliminations are based on available information and upon
assumptions that we believe are reasonable. The unaudited pro forma financial
information assumes that the above described transactions were completed as of
December 31, 2004, for purposes of the unaudited pro forma consolidated balance
sheets and as of the first day of the period presented for purposes of the
unaudited pro forma consolidated statements of operations.

F-2

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Unaudited Pro Forma Consolidated Balance Sheet
March 31, 2005

PROBABLE
ACQUISITION
PRO FORMA TRANSACTIONS
EFFECT OF EFFECT ------------
DIVIDENDS COMPLETED OF THIS GULF STATES
HISTORICAL DECLARED TRANSACTIONS OFFERING HEALTH
------------ ----------- ------------- ------------ ------------

ASSETS
Real estate assets
Land............................ $ 12,670,000 $ -- $ 12,670,000 $ -- $ 1,984,643(3)
Buildings and improvements...... 136,381,785 -- 136,381,785 -- 24,726,479(3)
Construction in progress........ 36,757,429 36,757,429 --
Intangible lease assets......... 6,320,410 -- 6,320,410 -- 1,073,878(3)
------------ ----------- ------------ ------------ ------------
Gross investment in real
estate assets............... 192,129,624 -- 192,129,624 -- 27,785,000
Accumulated depreciation and
amortization.................. (2,320,877) -- (2,320,877) -- --
------------ ----------- ------------ ------------ ------------
Net investment in real estate
assets...................... 189,808,747 -- 189,808,747 -- 27,785,000
Cash and cash equivalents......... 82,053,255 (7,055,493)(1) 74,997,762 115,013,800(4) (27,785,000)(3)
Interest and rent receivable...... 748,677 -- 748,677 -- --
Unbilled rent receivable.......... 5,177,925 -- 5,177,925 -- --
Loans............................. 42,498,111 -- 42,498,111 --
Other assets...................... 6,017,364 -- 6,017,364 -- --
------------ ----------- ------------ ------------ ------------
TOTAL ASSETS.................. $326,304,079 $(7,055,493) $319,248,586 $115,013,800 $ --
============ =========== ============ ============ ============
LIABILITIES AND STOCKHOLDERS'
EQUITY
Liabilities
Long-term debt.................. $ 74,141,667 $ -- $ 74,141,667 $ -- $ --
Accounts payable and accrued
expenses...................... 10,072,197 (2,869,115)(1) 7,203,082 -- --
Deferred revenue................ 4,518,896 -- 4,518,896 -- --
Lease deposits.................. 3,314,556 -- 3,314,556 -- --
------------ ----------- ------------ ------------ ------------
Total liabilities............. 92,047,316 (2,869,115) 89,178,201 -- --
Minority interest................. 1,762,500 -- 1,762,500 -- --
Stockholders' equity
Preferred stock,................ -- -- -- -- --
Common stock,................... 26,083 -- 26,083 11,553(2)(4) --
Additional paid in capital...... 233,701,690 -- 233,701,690 117,070,247(2)(4) --
Accumulated deficit............. (1,233,510) (4,186,378) (5,419,888) (2,068,000)(2)(4) --
------------ ----------- ------------ ------------ ------------
Total stockholders' equity.... 232,494,263 (4,186,378) 228,307,885 115,013,800 --
------------ ----------- ------------ ------------ ------------
TOTAL LIABILITIES AND
STOCKHOLDERS' EQUITY........ $326,304,079 $(7,055,493) $323,248,586 $115,013,800 $ --
============ =========== ============ ============ ============

COMPANY
PRO FORMA
------------

ASSETS
Real estate assets
Land............................ $ 14,654,643
Buildings and improvements...... 161,108,264
Construction in progress........ 36,757,429
Intangible lease assets......... 7,394,288
------------
Gross investment in real
estate assets............... 219,914,624
Accumulated depreciation and
amortization.................. (2,320,877)
------------
Net investment in real estate
assets...................... 217,593,747
Cash and cash equivalents......... 162,226,562
Interest and rent receivable...... 748,677
Unbilled rent receivable.......... 5,177,925
Loans............................. 42,498,111
Other assets...................... 6,017,364
------------
TOTAL ASSETS.................. $434,262,386
============
LIABILITIES AND STOCKHOLDERS'
EQUITY
Liabilities
Long-term debt.................. $ 74,141,667
Accounts payable and accrued
expenses...................... 7,203,082
Deferred revenue................ 4,518,896
Lease deposits.................. 3,314,556
------------
Total liabilities............. 89,178,201
Minority interest................. 1,762,500
Stockholders' equity
Preferred stock,................ --
Common stock,................... 37,636
Additional paid in capital...... 350,771,937
Accumulated deficit............. (7,487,888)
------------
Total stockholders' equity.... 343,321,685
------------
TOTAL LIABILITIES AND
STOCKHOLDERS' EQUITY........ $434,262,386
============

See accompanying notes to Unaudited Pro Forma Consolidated Financial Statements.

F-3

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Unaudited Pro Forma Consolidated Statement of Operations
For the Three Months Ended March 31, 2005

COMPLETED PROBABLE
ACQUISITION ACQUISITION
TRANSACTIONS TRANSACTIONS
------------ PRO FORMA ------------
DESERT EFFECT OF GULF
VALLEY -- COMPLETED STATES COMPANY
HISTORICAL VICTORVILLE TRANSACTIONS HEALTH PRO FORMA
----------- ------------ ------------ ------------ -----------

REVENUES
Rent income................... $ 5,268,490 $529,449(5) $ 5,797,939 $871,917(6) $ 6,669,856
Interest income from loans.... 1,212,038 -- 1,212,038 -- 1,212,038
----------- -------- ----------- -------- -----------
Total revenues............. 6,480,528 529,449 7,009,977 871,917 7,881,894
EXPENSES
Depreciation and
amortization............... 842,407 115,316(5) 957,723 172,439(6) 1,130,162
Property expenses............. 29,466 -- 29,466 -- 29,466
General and administrative.... 1,698,249 -- 1,698,249 -- 1,698,249
Costs of terminated
acquisitions............... 23,095 -- 23,095 -- 23,095
----------- -------- ----------- -------- -----------
Total operating expenses... 2,593,217 115,316 2,708,533 172,439 2,880,972
----------- -------- ----------- -------- -----------
Operating income...... 3,887,311 414,133 4,301,444 699,478 5,000,922
OTHER INCOME (EXPENSE)
Interest income............... 383,772 -- 383,772 -- 383,772
Interest expense.............. (711,149) -- (711,149) -- (711,149)
----------- -------- ----------- -------- -----------
Net other expense.......... (327,377) -- (327,377) -- (327,377)
----------- -------- ----------- -------- -----------
NET INCOME............... $ 3,559,934 $414,133 $ 3,974,067 $699,478 $ 4,673,545
=========== ======== =========== ======== ===========
NET INCOME PER SHARE --
BASIC................. $ 0.14 $ 0.12
NET INCOME PER SHARE --
DILUTED............... $ 0.14 $ 0.12
WEIGHTED AVERAGE SHARES
OUTSTANDING -- BASIC... 26,099,195 37,652,195(7)
WEIGHTED AVERAGE SHARES
OUTSTANDING -- DILUTED... 26,103,259 37,656,259(7)

See accompanying notes to Unaudited Pro Forma Consolidated Financial Statements.

F-4

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Unaudited Pro Forma Consolidated Statement of Operations
For the Year Ended December 31, 2004

PROBABLE
COMPLETED ACQUISITION ACQUISITION
TRANSACTIONS PRO FORMA TRANSACTIONS
----------------------------- EFFECT OF ------------
VIBRA DESERT VALLEY- COMPLETED GULF STATES COMPANY
HISTORICAL FACILITIES VICTORVILLE TRANSACTIONS HEALTH PRO FORMA
----------- ----------- -------------- ------------ ------------ -----------

REVENUES
Rent income................... $ 8,611,344 $ 9,774,139(8) $3,228,104(9) $21,613,587 $3,487,670(10) $25,101,257
Interest income from loans.... 2,282,115 2,754,934(8) -- 5,037,049 -- 5,037,049
----------- ----------- ---------- ----------- ---------- -----------
Total revenues.............. 10,893,459 12,529,073 3,228,104 26,650,636 3,487,670 30,138,306
EXPENSES
Depreciation and
amortization................ 1,478,470 1,660,526(8) 691,894(9) 3,830,890 689,755(10) 4,520,645
Property expenses............. 93,502 93,502(8) -- 187,004 -- 187,004
General and administrative.... 5,057,284 -- -- 5,057,284 -- 5,057,284
Costs of terminated
acquisitions................ 585,345 -- -- 585,345 -- 585,345
----------- ----------- ---------- ----------- ---------- -----------
Total operating expense..... 7,214,601 1,754,028 691,894 9,660,523 689,755 10,350,278
----------- ----------- ---------- ----------- ---------- -----------
Operating income.......... 3,678,858 10,775,045 2,536,210 16,990,113 2,797,915 19,788,028
OTHER INCOME (EXPENSE)
Interest income............... 930,260 -- -- 930,260 -- 930,260
Interest expense.............. (32,769) -- -- (32,769) -- (32,769)
----------- ----------- ---------- ----------- ---------- -----------
Net other income............ 897,491 -- -- 897,491 -- 897,491
----------- ----------- ---------- ----------- ---------- -----------
NET INCOME................ $ 4,576,349 $10,775,045 $2,536,210 $17,887,604 $2,797,915 $20,685,519
=========== =========== ========== =========== ========== ===========
NET INCOME PER
SHARE -- BASIC......... $ 0.24 $ .67
NET INCOME PER
SHARE -- DILUTED....... $ 0.24 $ .67
WEIGHTED AVERAGE SHARES
OUTSTANDING -- BASIC... 19,310,833 30,863,833(11)
WEIGHTED AVERAGE SHARES
OUTSTANDING -- DILUTED... 19,312,634 30,865,634(11)

See accompanying Notes to Unaudited Pro Forma Consolidated Financial Statements.

F-5

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS

ADJUSTMENTS FOR UNAUDITED PRO FORMA CONSOLIDATED BALANCE SHEET AS OF MARCH 31,
2005

(1) Record the $.11 per share distribution declared and accrued in March,
2005, and paid in April, 2005, and the $.16 per share distribution declared in
May, 2005, payable in July, 2005.

Shares of common stock outstanding at March 31,
2005.......................................... 26,082,862 26,082,862
Restricted shares issued to employees on April
25, 2005...................................... -- 82,000
----------- -----------
Total shares.................................... 26,082,862 26,164,862
Cash distribution per share..................... $ 0.11 $ 0.16
----------- -----------
Total cash distribution......................... $ 2,869,115 $ 4,186,378 $ 7,055,493
=========== =========== ===========

(2) Records the issuance of 11,365,000 common shares at a public offering
price of $11.00 per share less underwriting commission and other expenses,
calculated as follows:

Number of Shares Offered.................................... 11,365,000
Price per Share............................................. $ 11.00
------------
Gross Proceeds.............................................. $125,015,000
Less: Underwriting discounts, commissions and other
transaction costs......................................... (10,001,200)
------------
Net proceeds from offering.................................. $115,013,800
============
Common stock at par value................................... $ 11,365
Additional paid in capital.................................. 115,002,435
------------
Pro forma adjustment to cash................................ $115,013,800
============

(3) Probable Acquisition: Records the acquisition of the three Gulf States
Health facilities as though we acquired them on March 31, 2005. The Company has
not closed on the acquisition of this facilities, but the Company believes that
the acquisitions are probable.

TOTAL FOR GULF STATES
HEALTH PROBABLE
COVINGTON DENHAM SPRINGS HAMMOND ACQUISITIONS
----------- -------------- ----------- ---------------------

Land....................... $ 821,429 $ 428,571 $ 734,643 $ 1,984,643
Building................... 10,234,101 5,339,532 9,152,846 24,726,479
Intangible lease assets.... 444,470 231,897 397,511 1,073,878
----------- ---------- ----------- -----------
Total cost................. $11,500,000 $6,000,000 $10,285,000 $27,785,000
=========== ========== =========== ===========

F-6

(4) Records compensation expense related to restricted stock awards made to
senior management upon completion of this offering, calculated by multiplying
the number of shares awarded times the price per share of common stock in this
offering:

Shares of common stock awarded.............................. 188,000
Price per share of common stock in this offering............ $ 11.00
----------
Total value of shares awarded............................... $2,068,000
==========
Common stock at par value................................... $ 188
Additional paid in capital.................................. 2,067,812
----------
Pro forma adjustment to accumulated deficit................. $2,068,000
==========

No adjustment for this is shown in the accompanying pro forma statement of
operations since the impact is non-recurring as defined in Regulation S-X
210.11-02(b)(5).

ADJUSTMENTS FOR UNAUDITED PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS FOR THE
THREE MONTHS ENDED MARCH 31, 2005:

(5) Completed Acquisition: Records three months of rent income for the
Desert Valley -- Victorville facility as though we owned it from January 1,
2005, to March 31, 2005. This facility was acquired on February 28, 2005. Rent
income is based on the straight-line rent (as required by SFAS No. 13) in the
lease agreements between the Company and the lessee. Pro forma rent income for
the Desert Valley -- Victorville for the three months ended March 31, 2005
consists of the following:

RENT
--------

Rent income for three months of the first year.............. $807,026
Historical rent for the period February 28 - March 31,
2005...................................................... 277,577
--------
Pro forma rent income....................................... $529,449
========

Depreciation of buildings (straight line using a 40 year life) and
amortization of intangible lease assets (straight line using a fifteen year
life) for the three months ended March 31, 2005 as though the properties were
occupied on January 1, 2005.

HISTORICAL
DEPRECIATION AND
ANNUAL DEPRECIATION AND AMORTIZATION FOR PRO FORMA
DEPRECIATION AND AMORTIZATION FOR FEBRUARY 28 - DEPRECIATION AND
COST AMORTIZATION THREE MONTHS MARCH 31, 2005 AMORTIZATION
----------- ---------------- ---------------- ---------------- ----------------

Land................. $ 2,000,000 $ -- $ -- $ -- $ --
Buildings............ 24,994,553 624,864 156,216 52,072 104,144
Intangible lease
assets............. 1,005,447 67,030 16,758 5,586 11,172
----------- -------- -------- ------- --------
$28,000,000 $691,894 $172,974 $57,658 $115,316
=========== ======== ======== ======= ========

(6) Probable Acquisition: Records three months of rent income for the three
Gulf States Health facilities as though we owned them from January 1, 2005, to
March 31, 2005. Rent income is based on the straight-line rent (as required by
SFAS No. 13) in the lease agreements between the Company and the lessee. Pro
forma rent income for the Gulf States Health facilities for the three months
ended March 31, 2005 consists of the following:

ANNUAL RENT THREE MONTHS RENT
----------- -----------------

Gulf States -- Covington................................ $1,443,520 $360,880
Gulf States -- Denham Springs........................... 753,141 188,285
Gulf States -- Hammond.................................. 1,291,009 322,752
---------- --------
$3,487,670 $871,917
========== ========

F-7

Depreciation of buildings (straight line using a 40 year life) and
amortization of intangibles (straight-line using a 15 year life) for the three
months ended March 31, 2005 as though the properties were occupied on January 1,
2005.

COST ANNUAL DEPRECIATION AND
COST -- DENHAM COST DEPRECIATION AND AMORTIZATION FOR
-- COVINGTON SPRINGS -- HAMMOND AMORTIZATION THREE MONTHS
-------------- ----------- ------------ ---------------- ----------------

Land.................. $ 821,429 $ 428,571 $ 734,643 $ -- $ --
Buildings............. 10,234,101 5,339,532 9,152,846 618,163 154,541
Intangible lease
assets.............. 444,470 231,897 397,511 71,592 17,898
----------- ---------- ----------- -------- --------
$11,500,000 $6,000,000 $10,285,000 $689,755 $172,439
=========== ========== =========== ======== ========

(7) Pro forma weighted average shares outstanding, basic and diluted, are
calculated as follows:

BASIC DILUTED
---------- ----------

Historical.................................................. 26,099,195 26,103,259
Effect of this offering..................................... 11,365,000 11,365,000
Restricted shares awarded to management and employees....... 188,000 188,000
---------- ----------
Pro forma weighted average shares........................... 37,652,195 37,656,259
========== ==========

The shares issued in this offering and the restricted shares awarded to
management and employees are shown as though they were issued on January 1,
2005.

F-8

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS

ADJUSTMENTS FOR UNAUDITED PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS FOR THE
YEAR ENDED DECEMBER 31, 2004:

(8) Completed Acquisition: Records year of rent income for the six Vibra
initial property purchases as though we owned them from January 1, 2004, to
December 31, 2004. Rent income is based on the monthly straight-line rent (as
required by SFAS No. 13) for each property. Rent income from the Vibra
properties is as follows:

ANNUAL RENT
-----------

Bowling Green............................................... $ 5,471,964
Fresno...................................................... 2,675,182
Kentfield................................................... 1,094,393
Marlton..................................................... 4,752,598
New Bedford................................................. 3,171,528
Denver...................................................... 1,219,818
-----------
TOTAL..................................................... 18,385,483
Historical rent income for July 1 - December 31, 2004....... 8,611,344
-----------
Pro forma rent income....................................... $ 9,774,139
===========

Records interest income from loans to Vibra entities as though the loans
were made on January 1, 2004 and interest income was earned for the year ended
December 31, 2004, at the stated rate of 10.25%.

ANNUAL INTEREST
LOANS INCOME
----------- ---------------

Bowling Green............................................ $11,771,389 $1,206,567
Fresno................................................... 6,561,308 672,534
Kentfield................................................ 5,422,387 555,795
Marlton.................................................. 11,203,366 1,148,345
New Bedford.............................................. 8,361,930 857,098
Denver................................................... 5,821,564 596,710
----------- ----------
TOTAL.................................................. $49,141,944 5,037,049
===========
Historical interest income for July 1 - December 31,
2004................................................... 2,282,115
----------
Pro forma interest income................................ $2,754,934
==========

F-9

Depreciation of buildings (straight line using a 40 year life) and
amortization of intangible lease assets (straight line using a fifteen year
life) for the year ended December 31, 2004 as though the properties were
acquired on January 1, 2004.

TOTAL
ANNUAL ANNUAL DEPRECIATION AND
DEPRECIATION AMORTIZATION AMORTIZATION
------------ ------------ ----------------

Bowling Green................................ $ 839,268 $104,736 $ 944,004
Fresno....................................... 409,080 51,204 460,284
Kentfield.................................... 119,124 23,808 142,932
Marlton...................................... 772,572 90,972 863,544
New Bedford.................................. 494,304 60,384 554,688
Denver....................................... 150,324 23,220 173,544
---------- -------- ----------
TOTAL...................................... 2,784,672 354,324 3,138,996
Historical depreciation and amortization for
July 1 - December 31, 2004................. 1,311,757 166,713 1,478,470
---------- -------- ----------
Pro forma depreciation and amortization...... $1,472,915 $187,611 $1,660,526
========== ======== ==========

Property expenses consist primarily of payments for the ground lease at
Marlton for the year ended December 31, 2004.

(9) Completed Acquisition: Records one year of rent income for the Desert
Valley -- Victorville facility as though we owned it from January 1, 2004, to
December 31, 2004. Rent income is based on the straight-line rent (as required
by SFAS No. 13) in the lease agreements between the Company and the lessee. Pro
forma rent income for the Desert Valley -- Victorville for the year ended
December 31, 2004 consists of the following:

ANNUAL RENT
-----------

Desert Valley -- Victorville................................ $3,228,104

ANNUAL
DEPRECIATION AND
COST AMORTIZATION
----------- ----------------

Land..................................................... $ 2,000,000 $ --
Buildings................................................ 24,994,553 624,864
Intangible lease assets.................................. 1,005,447 67,030
----------- --------
$28,000,000 $691,894
=========== ========

(10) Probable Acquisition: Records one year of rent income for the three
Gulf States Health facilities as though we owned them from January 1, 2004, to
December 31, 2004. Rent income is based on the straight-line rent (as required
by SFAS No. 13) in the lease agreement between the Company and the lessee. Pro
forma rent income for the Gulf States Health facilities for the year ended
December 31, 2004 consists of the following:

ANNUAL RENT
-----------

Gulf States -- Covington.................................... $1,443,520
Gulf States -- Denham Springs............................... 753,141
Gulf States -- Hammond...................................... 1,291,009
----------
$3,487,670
==========

Depreciation of buildings (straight-line using a 40 year life) for the year
ended December 31, 2004 as though the properties were occupied on January 1,
2004.

F-10

ANNUAL
COST -- COST -- COST -- DEPRECIATION AND
COVINGTON DENHAM SPRINGS HAMMOND AMORTIZATION
----------- -------------- ------------ ----------------

Land......................... $ 821,429 $ 428,571 $ 734,643 $ --
Buildings.................... 10,234,101 5,339,532 9,152,846 618,163
Intangible lease assets...... 444,470 231,897 397,511 71,592
----------- ---------- ----------- --------
$11,500,000 $6,000,000 $10,285,000 $689,755
=========== ========== =========== ========

(11) Pro forma weighted average shares outstanding, basic and diluted, are
calculated as follows:

BASIC DILUTED
---------- ----------

Historical.................................................. 19,310,833 19,312,634
Effect of this offering..................................... 11,365,000 11,365,000
Restricted shares awarded to management and employees....... 188,000 188,000
---------- ----------
Pro forma weighted average shares........................... 30,863,833 30,865,634
========== ==========

The shares issued in this offering and the restricted shares awarded to
management and employees are shown as though they were issued on January 1,
2005.

F-11

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Consolidated Balance Sheets
March 31, 2005 and December 31, 2004

MARCH 31, 2005 DECEMBER 31, 2004
-------------- -----------------
(UNAUDITED) (AUDITED)

ASSETS
Real estate assets
Land...................................................... $ 12,670,000 $ 10,670,000
Buildings and improvements................................ 136,381,785 111,387,232
Construction in progress.................................. 36,757,429 24,318,098
Intangible lease assets................................... 6,320,410 5,314,963
------------ ------------
Gross investment in real estate assets................. 192,129,624 151,690,293
Accumulated depreciation.................................. (2,059,997) (1,311,757)
Accumulated amortization.................................. (260,880) (166,713)
------------ ------------
Net investment in real estate assets................... 189,808,747 150,211,823
Cash and cash equivalents................................... 82,053,255 97,543,677
Interest and rent receivable................................ 748,677 419,776
Unbilled rent receivable.................................... 5,177,925 3,206,853
Loans....................................................... 42,498,111 50,224,069
Other assets................................................ 6,017,364 4,899,865
------------ ------------
TOTAL ASSETS................................................ $326,304,079 $306,506,063
============ ============

LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities
Long-term debt............................................ $ 74,141,667 $ 56,000,000
Accounts payable and accrued expenses..................... 10,072,197 10,903,025
Deferred revenue.......................................... 4,518,896 3,578,229
Lease deposits............................................ 3,314,556 3,296,365
------------ ------------
Total liabilities...................................... 92,047,316 73,777,619
Minority interest........................................... 1,762,500 1,000,000
Stockholders' equity (deficit)
Preferred stock, $0.001 par value. Authorized 10,000,000
shares; no shares outstanding.......................... -- --
Common stock, $0.001 par value. Authorized 100,000,000
shares; issued and outstanding -- 26,082,862 shares at
March 31, 2005 and December 31, 2004................... 26,083 26,083
Additional paid in capital................................ 233,701,690 233,626,690
Accumulated deficit....................................... (1,233,510) (1,924,329)
------------ ------------
Total stockholders' equity............................. 232,494,263 231,728,444
------------ ------------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY.................. $326,304,079 $306,506,063
============ ============

See accompanying notes to consolidated financial statements.
F-12

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Consolidated Statements of Operations
For the Three Months Ended March 31, 2005 and March 31, 2004
(Unaudited)

THREE MONTHS ENDED THREE MONTHS ENDED
MARCH 31, 2005 MARCH 31, 2004
------------------ ------------------

REVENUES
Rent billed............................................ $3,923,049 $ --
Unbilled rent.......................................... 1,345,441 --
Interest income from loans............................. 1,212,038 --
---------- ---------
Total revenues...................................... 6,480,528 --
EXPENSES
Real estate depreciation............................... 748,240 --
Amortization of intangible lease assets................ 94,167 --
Other property expenses................................ 29,466 --
General and administrative............................. 1,698,249 485,504
Costs of terminated acquisitions....................... 23,095 --
---------- ---------
Total operating expenses............................ 2,593,217 485,504
---------- ---------
Operating income (loss)........................... 3,887,311 (485,504)
OTHER INCOME (EXPENSE)
Interest income........................................ 383,772 --
Interest expense....................................... (711,149) (8,222)
---------- ---------
Net other expense................................... (327,377) (8,222)
---------- ---------
NET INCOME (LOSS)................................. $3,559,934 $(493,726)
========== =========
NET INCOME (LOSS) PER SHARE, BASIC................ $ 0.14 $ (0.30)
WEIGHTED AVERAGE SHARES OUTSTANDING -- BASIC...... 26,099,195 1,630,435
NET INCOME (LOSS) PER SHARE, DILUTED.............. $ 0.14 $ (0.30)
WEIGHTED AVERAGE SHARES OUTSTANDING -- DILUTED.... 26,103,259 1,630,435

See accompanying notes to consolidated financial statements.
F-13

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows
For the Three Months Ended March 31, 2005 and March 31, 2004
(Unaudited)

THREE MONTHS ENDED THREE MONTHS ENDED
MARCH 31, 2005 MARCH 31, 2004
------------------ ------------------

OPERATING ACTIVITIES
Net income (loss)......................................... $ 3,559,934 $(493,726)
Adjustments to reconcile net income (loss) to net cash
provided by operating activities
Depreciation and amortization......................... 874,730 --
Amortization of deferred financing costs.............. 143,172 --
Unbilled rent revenue................................. (1,345,441) --
Deferred fee revenue.................................. (34,964) --
Deferred stock units issued to directors.............. 75,000 --
Increase in:
Interest and rent receivable.......................... (328,901) --
Other assets.......................................... (837,057) (25,173)
Increase in:
Accounts payable and accrued expenses................. (830,828) 375,964
Deferred revenue...................................... 350,000 --
Lease deposits........................................ 18,191 --
------------ ---------
Net cash provided by (used for) operating activities...... 1,643,836 (142,935)
INVESTING ACTIVITIES
Real estate acquired.................................... (28,000,000) --
Loans receivable........................................ 7,725,958 --
Construction in progress................................ (12,439,331) (4,143)
Equipment acquired...................................... (15,698) (4,972)
------------ ---------
Net cash used for investing activities.................... (32,729,071) (9,115)
FINANCING ACTIVITIES
Addition to long-term debt.............................. 19,000,000 --
Proceeds from loan payable.............................. -- 100,000
Payments of long-term debt.............................. (858,333) --
Deferred financing costs................................ (440,239) --
Distributions paid...................................... (2,869,115) --
Sale of partnership units............................... 762,500 --
------------ ---------
Net cash provided by financing activities................. 15,594,813 100,000
------------ ---------
Increase in cash and cash equivalents for period.......... (15,490,422) (52,050)
Cash and cash equivalent at beginning of period......... 97,543,677 100,000
------------ ---------
CASH AND CASH EQUIVALENTS AT END OF PERIOD.................. $ 82,053,255 $ 47,950
============ =========
Supplemental schedule of non-cash investing activities:
Additions to unbilled rent receivable recorded as deferred
revenue................................................. $ 625,631 $ --
Supplemental schedule of non-cash financing activities:
Distributions declared, not paid.......................... 2,869,115 --
Additional paid in capital from deferred stock units
issued to directors..................................... 75,000 --
Interest paid, net of capitalized interest of $395,401 in
2005...................................................... 567,977 8,222

See accompanying notes to consolidated financial statements.
F-14

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED MARCH 31, 2005 AND 2004
(UNAUDITED)

1. ORGANIZATION

Medical Properties Trust, Inc., a Maryland corporation (the Company), was
formed on August 27, 2003 under the General Corporation Law of Maryland for the
purpose of engaging in the business of investing in and owning commercial real
estate. The Company's operating partnership subsidiary, MPT Operating
Partnership, L.P. (the Operating Partnership), was formed in September 2003.
Through another wholly owned subsidiary, Medical Properties Trust, LLC, the
Company is the sole general partner of the Operating Partnership. The Company
presently owns directly all of the limited partnership interests in the
Operating Partnership.

The Company succeeded to the business of Medical Properties Trust, LLC, a
Delaware limited liability company, which was formed in December 2002. On the
day of formation, the Company issued 1,630,435 shares of common stock, and the
membership interests of Medical Properties Trust, LLC were transferred to the
Company. Medical Properties Trust, LLC had no assets, but had incurred
liabilities for costs and expenses related to acquisition due diligence, a
planned offering of common stock, consulting fees and office overhead in an
aggregate amount of approximately $423,000, which was assumed by the Operating
Partnership and has been included in the accompanying consolidated statement of
operations.

The Company's primary business strategy is to acquire and develop real
estate and improvements, primarily for long term lease to providers of
healthcare services such as operators of inpatient physical rehabilitation
hospitals, long-term acute care hospitals, surgery centers, centers for
treatment of specific conditions such as cardiac, pulmonary, cancer, and
neurological hospitals, and other healthcare-oriented facilities. The Company
considers this to be a single business segment as defined in Statement of
Financial Accounting Standard (SFAS) No. 131, Disclosures about Segments of an
Enterprise and Related Information.

On April 6, 2004, the Company completed the sale of 25.6 million shares of
common stock in a private placement to qualified institutional buyers and
accredited investors. The Company received $233.5 million after deducting
offering costs. The proceeds are being used to purchase properties, to pay debt
and accrued expenses and for working capital and general corporate purposes.

The Company has filed with the Securities and Exchange Commission (SEC) a
Form S-11 registration statement for an Initial Public Offering (IPO) of common
stock. The Company has not determined the number of shares nor price per share
to be offered in the IPO. The size of the offering will be determined based on
the volume of purchase commitments which the Company has entered into at the
time the registration statement becomes effective with the SEC.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Use of Estimates: The preparation of financial statements in conformity
with accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and
liabilities at the date of the financial statements and the reported amounts of
revenues and expenses during the reporting period. Actual results could differ
from those estimates.

Principles of Consolidation: Property holding entities and other
subsidiaries of which the Company owns 100% of the equity or has a controlling
financial interest evidenced by ownership of a majority voting interest are
consolidated. All inter-company balances and transactions are eliminated. For
entities in which the Company owns less than 100% of the equity interest, the
Company consolidates the property if it has the direct or indirect ability to
make decisions about the entities' activities based upon the terms of the
respective entities' ownership agreements. For entities in which the Company
owns less than 100% and
F-15

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED MARCH 31, 2005 AND 2004 -- (CONTINUED)

does not have the direct or indirect ability to make decisions but does exert
significant influence over the entities' activities, the Company records its
ownership in the entity using the equity method of accounting.

The Company periodically evaluates all of its transactions and investments
to determine if they represent variable interests in a variable interest entity
as defined by FASB Interpretation No. 46 (revised December 2003) (FIN 46-R),
Consolidation of Variable Interest Entities, an interpretation of Accounting
Research Bulletin No. 51, Consolidated Financial Statements. If the Company
determines that it has a variable interest in a variable interest entity, the
Company determines if it is the primary beneficiary of the variable interest
entity. The Company consolidates each variable interest entity in which the
Company, by virtue of its transactions with or investments in the entity, is
considered to be the primary beneficiary. The Company re-evaluates its status as
primary beneficiary when a variable interest entity or potential variable
interest entity has a material change in its variable interests.

Unaudited Interim Consolidated Financial Statements: The accompanying
unaudited interim consolidated financial statements have been prepared in
accordance with accounting principles generally accepted in the United States
for interim financial information. Accordingly, they do not include all the
information and footnotes required by generally accepted accounting principles
for complete financial statements. In the opinion of management, all adjustments
(consisting of normal recurring accruals) considered necessary for a fair
presentation have been included. Operating results for the three-month period
ended March 31, 2005, are not necessarily indicative of the results that may be
expected for the year ending December 31, 2005.

3. REAL ESTATE AND LENDING ACTIVITIES

On February 9, 2005, Vibra paid $7.8 million of principal and interest on
various loans from the Company. The payments left a $41.4 million loan payable
to the Company by Vibra. The Company has no commitments to make additional loans
to Vibra.

In February, 2005, the Company purchased a general acute care hospital for
$28 million. The purchase price was paid from loan proceeds and from the
proceeds of the Company's private placement. Upon closing the purchase of the
hospital, the Company and the seller entered into a fifteen year lease of the
hospital back to the seller, with renewal options for three additional five year
terms. The Company has recorded the following assets from this transaction:

Land........................................................ $ 2,000,000
Building.................................................... 24,994,553
Intangible lease assets..................................... 1,005,447
-----------
$28,000,000
===========

The Company has amended its leases with Vibra effective March 31, 2005. The
amendment revises the financial covenants to cover a full twelve months period
of operations, revises the percentage rents calculations to clarify the effects
of Vibra reducing its loan balances with the Company, and allows the Company to
require Vibra to escrow future insurance and property tax payments on the leased
properties.

As of March 31, 2005, the Company has sold $762,500 of limited partnership
units to qualified individual investors in a private offering of the Company's
general acute care hospital and medical office building limited partnerships in
Texas. The period of the offering will extend through April 30, 2005.

F-16

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED MARCH 31, 2005 AND 2004 -- (CONTINUED)

4. LONG-TERM DEBT

In December 2004, the Company received $56 million as part of a $75
million, three year term loan. In February 2005, the Company received the
remaining $19 million on this loan. All other terms and conditions of the loan
remain unchanged.

Maturities of long-term debt at March 31, 2005, for each successive twelve
month period are as follows:

2006........................................................ $ 3,750,000
2007........................................................ 3,750,000
2008........................................................ 66,641,667
-----------
$74,141,667
===========

5. STOCK AWARDS

In February, 2005, the Company awarded 7,500 deferred stock units valued at
$10 per share to three new independent directors elected to the Company's board.
The total value of $75,000 has been recorded as additional paid-in-capital in
the consolidated balance sheet at March 31, 2005, and an expense in the
consolidated income statement for the three months ended March 31, 2005.

6. EARNINGS PER SHARE

The following is a reconciliation of the weighted average shares used in
net income per common share to the weighted average shares used in net income
per common share -- assuming dilution for the three months ended March 31, 2005
and 2004, respectively:

2005 2004
---------- ---------

Weighted average number of shares issued and outstanding.... 26,082,862 1,630,435
Vested deferred stock units................................. 16,333 --
---------- ---------
Weighted average shares -- basic............................ 26,099,195 1,630,435
Common stock warrants and options........................... 4,425 --
---------- ---------
Weighted average shares -- diluted.......................... 26,103,620 1,630,435
========== =========

F-17

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Stockholders
Medical Properties Trust, Inc.:

We have audited the accompanying consolidated balance sheets of Medical
Properties Trust, Inc. and subsidiaries as of December 31, 2004 and 2003, and
the related consolidated statements of operations, stockholders' equity
(deficit), and cash flows for the year ended December 31, 2004 and for the
period from inception (August 27, 2003) to December 31, 2003. In connection with
our audits of the consolidated financial statements, we have also audited the
accompanying financial statement Schedule III. These consolidated financial
statements and schedule are the responsibility of the Company's management. Our
responsibility is to express an opinion on these consolidated financial
statements and schedule based on our audits.

We conducted our audits in accordance with the standards of the Public
Company Accounting Oversight Board (United States). Those standards require that
we plan and perform the audits to obtain reasonable assurance about whether the
financial statements are free of material misstatement. An audit includes
examining, on a test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the accounting
principles used and significant estimates made by management, as well as
evaluating the overall financial statement presentation. We believe that our
audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above
present fairly, in all material respects, the financial position of Medical
Properties Trust, Inc. and subsidiaries as of December 31, 2004 and 2003, and
the results of their operations and their cash flows for the year ended December
31, 2004 and for the period from inception (August 27, 2003) to December 31,
2003 in conformity with U.S. generally accepted accounting principles. Also in
our opinion, the related financial statement schedule, when considered in
relation to the basic consolidated financial statements taken as a whole,
presents fairly in all material respects the information set forth therein.

/s/ KPMG LLP

Birmingham, Alabama
March 16, 2005

F-18

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Consolidated Balance Sheets
December 31, 2004 and December 31, 2003

DECEMBER 31, 2004 DECEMBER 31, 2003
----------------- -----------------

ASSETS
Real estate assets
Land...................................................... $ 10,670,000 $ --
Buildings and improvements................................ 111,387,232 --
Construction in progress.................................. 24,318,098 166,301
Intangible lease assets................................... 5,314,963 --
------------ -----------
Gross investment in real estate assets................. 151,690,293 166,301
Accumulated depreciation.................................. (1,311,757) --
Accumulated amortization.................................. (166,713) --
------------ -----------
Net investment in real estate assets................... 150,211,823 166,301
Cash and cash equivalents................................... 97,543,677 100,000
Interest receivable......................................... 419,776 --
Unbilled rent receivable.................................... 3,206,853 --
Loans receivable............................................ 50,224,069 --
Other assets................................................ 4,899,865 201,832
------------ -----------
TOTAL ASSETS................................................ $306,506,063 $ 468,133
============ ===========

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Liabilities
Long-term debt............................................ $ 56,000,000 $ --
Accounts payable and accrued expenses..................... 10,903,025 1,389,779
Deferred revenue.......................................... 3,578,229 --
Lease deposit............................................. 3,296,365 --
Loan payable.............................................. -- 100,000
------------ -----------
Total liabilities...................................... 73,777,619 1,489,779
Minority interest........................................... 1,000,000 --
Stockholders' equity (deficit)
Preferred stock, $0.001 par value. Authorized 10,000,000
shares; no shares outstanding.......................... -- --
Common stock, $0.001 par value. Authorized 100,000,000
shares; issued and outstanding -- 26,082,862 shares at
December 31, 2004 and 1,630,435 shares at December 31,
2003................................................... 26,083 1,630
Additional paid in capital................................ 233,626,690 --
Accumulated deficit....................................... (1,924,329) (1,023,276)
------------ -----------
Total stockholders' equity (deficit)................... 231,728,444 (1,021,646)
------------ -----------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)........ $306,506,063 $ 468,133
============ ===========

See accompanying notes to consolidated financial statements.
F-19

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Consolidated Statements of Operations

For The Year Ended December 31, 2004 and

Period from Inception (August 27, 2003) through December 31, 2003

YEAR ENDED PERIOD FROM INCEPTION
DECEMBER 31, (AUGUST 27, 2003)
2004 THROUGH DECEMBER 31, 2003
------------ -------------------------

REVENUES
Rent billed............................................. $ 6,162,278 $ --
Unbilled rent........................................... 2,449,066 --
Interest income from loans.............................. 2,282,115 --
----------- -----------
Total revenues....................................... 10,893,459 --
EXPENSES
Real estate depreciation................................ 1,311,757 --
Amortization of intangible lease assets................. 166,713 --
Other property expenses................................. 93,502 --
General and administrative.............................. 5,057,284 992,418
Costs of terminated acquisitions........................ 585,345 30,858
----------- -----------
Total operating expenses............................. 7,214,601 1,023,276
----------- -----------
Operating income (loss)............................ 3,678,858 (1,023,276)
OTHER INCOME (EXPENSE)
Interest income......................................... 930,260 --
Interest expense........................................ (32,769) --
----------- -----------
Net other income..................................... 897,491 --
----------- -----------
NET INCOME (LOSS).................................. $ 4,576,349 $(1,023,276)
=========== ===========
NET INCOME (LOSS) PER SHARE, BASIC................. $ 0.24 $ (0.63)
WEIGHTED AVERAGE SHARES OUTSTANDING -- BASIC....... 19,310,833 1,630,435
NET INCOME (LOSS) PER SHARE, DILUTED............... $ 0.24 $ (0.63)
WEIGHTED AVERAGE SHARES OUTSTANDING -- DILUTED..... 19,312,634 1,630,435

See accompanying notes to consolidated financial statements.
F-20

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows

For The Year Ended December 31, 2004 and

Period from Inception (August 27, 2003) through December 31, 2003

PERIOD FROM INCEPTION
YEAR ENDED (AUGUST 27, 2003) THROUGH
DECEMBER 31, 2004 DECEMBER 31, 2003
----------------- --------------------------

OPERATING ACTIVITIES
Net income (loss)......................................... $ 4,576,349 $(1,023,276)
Adjustments to reconcile net income (loss) to net cash
provided by operating activities
Depreciation and amortization......................... 1,517,530 --
Unbilled rent revenue................................. (2,449,066) --
Warrant issued to lender.............................. 24,500 --
Deferred stock units issued to directors.............. 125,000 --
Increase in:
Interest receivable................................... (419,776) --
Other assets.......................................... (309,769) --
Increase in:
Accounts payable and accrued expenses................. 6,644,130 1,391,409
Deferred revenue...................................... 210,000 --
------------- -----------
Net cash provided by operating activities................. 9,918,898 368,133
INVESTING ACTIVITIES
Real estate acquired.................................... (127,372,195) --
Loans receivable........................................ (44,317,263) --
Construction in progress................................ (23,151,797) (166,301)
Equipment acquired...................................... (759,387) --
------------- -----------
Net cash used for investing activities.................... (195,600,642) (166,301)
FINANCING ACTIVITIES
Addition to long-term debt.............................. 56,000,000 --
Proceeds from loan payable.............................. 200,000 100,000
Payment of loan payable................................. (300,000) --
Deferred financing costs................................ (3,869,767) (201,832)
Distributions paid...................................... (2,608,286) --
Sale of common stock, net of offering costs............. 233,703,474 --
------------- -----------
Net cash provided by (used for) financing activities...... 283,125,421 (101,832)
------------- -----------
Increase in cash and cash equivalents for period.......... 97,443,677 100,000
Cash at beginning of period............................. 100,000 --
------------- -----------
CASH AND CASH EQUIVALENTS AT END OF PERIOD.................. $ 97,543,677 $ 100,000
============= ===========
Supplemental schedule of non-cash investing activities:
Additions to unbilled rent receivables recorded as
deferred revenue........................................ $ 757,787 $ --
Additions to loans receivable recorded as lease deposits
and deferred revenue.................................... 5,906,807 --
Supplemental schedule of non-cash financing activities:
Minority interest granted for contribution of land to
development project................................... 1,000,000 --
Distributions declared, not paid........................ 2,869,116 --
Deferred offering costs charged to proceeds from sale of
common stock.......................................... 201,832 --
Additional paid in capital from deferred stock units
issued to directors................................... 125,000 --
Conversion of accounts payable and accrued expenses to
common stock.......................................... -- 1,630
Interest expense paid....................................... 32,769 --

See accompanying notes to consolidated financial statements.
F-21

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Consolidated Statements of Stockholders' Equity (Deficit)

For the Year Ended December 31, 2004

and Period from Inception (August 27, 2003) through December 31, 2003

PREFERRED COMMON TOTAL
------------------ ---------------------- ADDITIONAL PAID ACCUMULATED STOCKHOLDERS'
SHARES PAR VALUE SHARES PAR VALUE IN CAPITAL DEFICIT EQUITY
------ --------- ---------- --------- --------------- ----------- -------------

BALANCE AT INCEPTION
(AUGUST 27, 2003)....... -- $ -- -- $ -- $ -- $ -- $ --
Issuance of common
stock................. -- -- 1,630,435 1,630 -- -- 1,630
Net loss................ -- -- -- -- -- (1,023,276) (1,023,276)
---- ----- ---------- ------- ------------ ----------- ------------
BALANCE AT DECEMBER 31,
2003.................... -- -- 1,630,435 1,630 -- (1,023,276) (1,021,646)
Redemption of founders'
shares................ -- -- (1,108,527) (1,108) 1,108 -- --
Issuance of common stock
in private placement
(net of offering
costs)................ -- -- 25,560,954 25,561 233,476,082 -- 233,501,643
Value of warrants
issued................ -- -- -- -- 24,500 -- 24,500
Deferred stock units
issued to directors... -- -- -- -- 125,000 -- 125,000
Distributions declared
($.21 per common
share)................ -- -- -- -- -- (5,477,402) (5,477,402)
Net income.............. -- -- -- -- -- 4,576,349 4,576,349
---- ----- ---------- ------- ------------ ----------- ------------
BALANCE AT DECEMBER 31,
2004.................... -- $ -- 26,082,862 $26,083 $233,626,690 $(1,924,329) $231,728,444
==== ===== ========== ======= ============ =========== ============

See accompanying notes to consolidated financial statements.
F-22

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2004 AND

PERIOD FROM INCEPTION (AUGUST 27, 2003) THROUGH DECEMBER 31, 2003

1. ORGANIZATION

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2004 AND

PERIOD FROM INCEPTION (AUGUST 27, 2003) THROUGH DECEMBER 31, 2003 -- (CONTINUED)

Cash and Cash Equivalents: Certificates of deposit and short-term
investments with remaining maturities of three months or less when acquired and
money-market mutual funds are considered cash equivalents.

Deferred Costs: Costs incurred prior to the completion of offerings of
stock or other capital instruments that directly relate to the offering are
deferred and netted against proceeds received from the offering. Costs incurred
in connection with anticipated financings and refinancing of debt are
capitalized as deferred financing costs in other assets and amortized over the
lives of the related loans as an addition to interest expense to produce a
constant effective yield on the loan (interest method). Costs that are
specifically identifiable with, and incurred prior to the completion of,
probable acquisitions are deferred and capitalized upon closing. The Company
begins deferring costs when the Company and the seller have executed a letter of
intent (LOI), commitment letter or similar document for the purchase of the
property by the Company. Deferred acquisition costs are expensed when management
determines that the acquisition is no longer probable. Leasing commissions and
other leasing costs directly attributable to tenant leases are capitalized as
deferred leasing costs and amortized on the straight-line method over the terms
of the related lease agreements. Costs identifiable with loans made to lessees
are recognized as a reduction in interest income over the life of the loan by
the interest method.

Revenue Recognition: The Company receives income from operating leases
based on the fixed, minimum required rents (base rent) and from additional rent
based on a percentage of tenant revenues once the tenant's revenue has exceeded
an annual threshold (percentage rent). Rent revenue is recorded on the
straight-line method over the terms of the related lease agreements for new
leases and the remaining terms of existing leases for acquired properties. The
straight-line method records the periodic average amount of rent earned over the
term of a lease, taking into account contractual rent increases over the lease
term. The straight-line method has the effect of recording more rent revenue
from a lease than a tenant is required to pay during the first half of the lease
term. During the last half of a lease term, this effect reverses with less rent
revenue recorded than a tenant is required to pay. Rent revenue as recorded on
the straight-line method in the consolidated statement of operations is shown as
two amounts. Billed rent revenue is the amount of rent actually billed to the
customer each period as required by the lease. Unbilled rent revenue is the
difference between rent revenue earned based on the straight-line method and the
amount recorded as billed rent revenue. These differences between rental
revenues earned and amounts due per the respective lease agreements are charged,
as applicable, to unbilled rent receivable. Percentage rents are recognized in
the period in which revenue thresholds are met. Rental payments received prior
to their recognition as income are classified as rent received in advance.

Fees received from development and leasing services for lessees are
initially recorded as deferred revenue and recognized as income over the initial
term of an operating lease to produce a constant effective yield on the lease
(interest method). Fees from lending services are recorded as deferred revenue
and recognized as income over the life of the loan using the interest method.

F-24

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2004 AND

PERIOD FROM INCEPTION (AUGUST 27, 2003) THROUGH DECEMBER 31, 2003 -- (CONTINUED)

Acquired Real Estate Purchase Price Allocation: The Company allocates the
purchase price of acquired properties to net tangible and identified intangible
assets acquired based on their fair values in accordance with the provisions of
SFAS No. 141, Business Combinations. In making estimates of fair values for
purposes of allocating purchase prices, the Company utilizes a number of
sources, including independent appraisals that may be obtained in connection
with the acquisition or financing of the respective property and other market
data. The Company also considers information obtained about each property as a
result of its pre-acquisition due diligence, marketing and leasing activities in
estimating the fair value of the tangible and intangible assets acquired.

The Company records above-market and below-market in-place lease values, if
any, for its facilities which are based on the present value (using an interest
rate which reflects the risks associated with the leases acquired) of the
difference between (i) the contractual amounts to be paid pursuant to the
in-place leases and (ii) management's estimate of fair market lease rates for
the corresponding in-place leases, measured over a period equal to the remaining
non-cancelable term of the lease. The Company amortizes any resulting
capitalized above-market lease values as a reduction of rental income over the
remaining non-cancelable terms of the respective leases. The Company amortizes
any resulting capitalized below-market lease values as an increase to rental
income over the initial term and any fixed-rate renewal periods in the
respective leases. Because the Company's strategy largely involves the
origination of long term lease arrangements at market rates, management does not
expect the above-market and below-market in-place lease values to be significant
for many anticipated transactions.

The Company measures the aggregate value of other intangible assets to be
acquired based on the difference between (i) the property valued with existing
in-place leases adjusted to market rental rates and (ii) the property valued as
if vacant. Management's estimates of value are expected to be made using methods
similar to those used by independent appraisers (e.g., discounted cash flow
analysis). Factors considered by management in its analysis include an estimate
of carrying costs during hypothetical expected lease-up periods considering
current market conditions, and costs to execute similar leases. Management also
considers information obtained about each targeted facility as a result of
pre-acquisition due diligence, marketing and leasing activities in estimating
the fair value of the tangible and intangible assets acquired. In estimating
carrying costs, management also includes real estate taxes, insurance and other
operating expenses and estimates of lost rentals at market rates during the
expected lease-up periods, which are expected to range primarily from three to
eighteen months, depending on specific local market conditions. Management also
estimates costs to execute similar leases including leasing commissions, legal
and other related expenses to the extent that such costs are not already
incurred in connection with a new lease origination as part of the transaction.

The Company amortizes the value of in-place leases, if any, to expense over
the initial term of the respective leases, which range primarily from 10 to 15
years. The value of customer relationship intangibles is amortized to expense
over the initial term and any renewal periods in the respective leases, but in
no event will the amortization period for intangible assets exceed the remaining
depreciable life of the

F-25

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2004 AND

PERIOD FROM INCEPTION (AUGUST 27, 2003) THROUGH DECEMBER 31, 2003 -- (CONTINUED)

building. Should a tenant terminate its lease, the unamortized portion of the
in-place lease value and customer relationship intangibles would be charged to
expense.

Real Estate and Depreciation: Depreciation is calculated on the
straight-line method over the estimated useful lives of the related assets, as
follows:

Buildings and improvements....................... 40 years
Tenant origination costs......................... Remaining terms of the related leases
Tenant improvements.............................. Term of related leases
Furniture and equipment.......................... 3-7 years

Real estate is carried at depreciated cost. Expenditures for ordinary
maintenance and repairs are expensed to operations as incurred. Significant
renovations and improvements which improve and/or extend the useful life of the
asset are capitalized and depreciated over their estimated useful lives. In
accordance with SFAS No. 144, Accounting for the Impairment of Long-Lived Assets
and for Long-Lived Assets to Be Disposed Of the Company records impairment
losses on long-lived assets used in operations when events and circumstances
indicate that the assets might be impaired and the undiscounted cash flows
estimated to be generated by those assets, including an estimated liquidation
amount, during the expected holding periods are less than the carrying amounts
of those assets. Impairment losses are measured as the difference between
carrying value and fair value of assets. For assets held for sale, impairment is
measured as the difference between carrying value and fair value, less cost of
disposal. Fair value is based on estimated cash flows discounted at a
risk-adjusted rate of interest.

Construction in progress includes the cost of land, the cost of
construction of buildings, improvements and equipment and costs for design and
engineering. Other costs, such as interest, legal, property taxes and corporate
project supervision, which can be directly associated with the project during
construction, are also included in construction in progress.

Loans Receivable: Real estate related loans consist of working capital
loans and long-term loans. Interest income on loans is recognized as earned
based upon the principal amount outstanding. The working capital and long-term
loans are generally secured by interests in receivables and corporate and
individual guaranties.

Losses from Rent Receivables and Loans Receivable: A provision for losses
on rent receivables and loans receivable is recorded when it becomes probable
that the loan will not be collected in full. The provision is an amount which
reduces the rent or loan to its estimated net realizable value based on a
determination of the eventual amounts to be collected either from the debtor or
from the collateral, if any. At that time, the Company discontinues recording
interest income on the loan or rent receivable from the tenant.

Net Income (Loss) Per Share: The Company reports earnings per share
pursuant to SFAS No. 128, Earnings Per Share. Basic net income (loss) per share
is computed by dividing the net income (loss) to common stockholders by the
weighted average number of common shares and potential common stock outstanding
during the period. Diluted net income (loss) per share is computed by dividing
the net income (loss) available to common shareholders by the weighted average
number of common shares outstanding during the period, adjusted for the assumed
conversion of all potentially dilutive outstanding share options.

Income Taxes: For the period from January 1, 2004 through April 5, 2004,
the Company has elected Sub-chapter S status for income tax purposes, at which
time the Company filed its final tax returns as a Sub-chapter S company. Since
April 6, 2004, the Company has conducted its business as a real estate
investment trust (REIT) under Sections 856 through 860 of the Internal Revenue
Code of 1986, as

F-26

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2004 AND

PERIOD FROM INCEPTION (AUGUST 27, 2003) THROUGH DECEMBER 31, 2003 -- (CONTINUED)

amended (the Code). The Company will file its initial tax return as a REIT for
the period from April 6, 2004, through December 31, 2004, at which time it must
formally make an election to be taxed as a REIT. To qualify as a REIT, the
Company must meet certain organizational and operational requirements, including
a requirement to currently distribute to shareholders at least 90% of its
ordinary taxable income. As a REIT, the Company generally will not be subject to
federal income tax on taxable income that it distributes to its shareholders. If
the Company fails to qualify as a REIT in any taxable year, it will then be
subject to federal income taxes on its taxable income at regular corporate rates
and will not be permitted to qualify for treatment as a REIT for federal income
tax purposes for four years following the year during which qualification is
lost, unless the Internal Revenue Service grants the Company relief under
certain statutory provisions. Such an event could materially adversely affect
the Company's net income and net cash available for distribution to
shareholders. However, the Company believes that it will be organized and
operate in such a manner as to qualify for treatment as a REIT and intends to
operate in the foreseeable future in such a manner so that the Company will
remain qualified as a REIT for federal income tax purposes.

The Company's financial statements include the operations of a taxable REIT
subsidiary, MPT Development Services, Inc. (MDS) that is not entitled to a
dividends paid deduction and is subject to federal, state and local income
taxes. MDS is authorized to provide property development, leasing and management
services for third-party owned properties and makes loans to lessees and
operators.

Stock-Based Compensation: The Company currently sponsors a stock option
and restricted stock award plan that was established in 2004. The Company
accounts for its stock option plan under the recognition and measurement
provisions of Accounting Principles Board Opinion No. 25, Accounting for Stock
Issued to Employees (APB No. 25) and related interpretations. Under APB No. 25,
no expense is recorded for options which are exercisable at the price of the
Company's stock at the date the options are granted. Deferred compensation on
restricted stock relates to the issuance of restricted stock to employees and
directors of the Company. Deferred compensation is amortized to compensation
expense based on the passage of time and certain performance criteria.

Fair Value of Financial Instruments: The Company has various assets and
liabilities that are considered financial instruments. The Company estimates
that the carrying value of cash and cash equivalents, interest receivable and
accounts payable and accrued expenses approximates their fair values. The fair
value of unbilled rent receivable has been estimated based on expected payment
dates and discounted at a rate which the Company considers appropriate for such
assets considering their credit quality and maturity. The fair value of loans
receivable is estimated based on the present value of future payments,
discounted at a rate which the Company considers appropriate for such assets
considering their credit quality and maturity. The Company estimates that the
carrying value of the Company's long term debt should approximate fair value
because the debt is variable rate and adjusts daily with changes in the
underlying interest rate index.

Reclassifications: Certain reclassifications have been made to the 2003
consolidated financial statements to conform to the 2004 consolidated financial
statement presentation. These reclassifications have no impact on shareholders'
equity or net income.

New Accounting Pronouncements: The following is a summary of recently
issued accounting pronouncements which have been issued but not yet adopted by
the Company and which could have a material effect on the Company's financial
position and results of operations.

In December 2004, the Financial Accounting Standards Board (FASB) issued
SFAS No. 123(R), Share-Based Payment, which is a revision of SFAS No. 123(R),
Accounting for Stock Based

F-27

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2004 AND

PERIOD FROM INCEPTION (AUGUST 27, 2003) THROUGH DECEMBER 31, 2003 -- (CONTINUED)

Compensation. SFAS No. 123(R) establishes standards for the accounting for
transactions in which an entity exchanges its equity instruments for goods or
services. This Statement focuses primarily on accounting for transactions in
which an entity obtains employee services in share-based payment transactions.
SFAS No. 123(R) requires that the fair value of such equity instruments be
recognized as expense in the historical financial statements as services are
performed. Prior to SFAS No. 123(R), only certain pro-forma disclosures of fair
value were required. SFAS No. 123(R) becomes effective for public companies with
their first annual reporting period that begins after June 15, 2005. For
non-public companies, the standard becomes effective for their first fiscal year
beginning after December 15, 2005. The Company does not expect SFAS No. 123(R)
to have a material effect on its financial position or the results of its
operations.

3. PROPERTY ACQUISITIONS AND LOANS

On July 1, 2004, the Company purchased four rehabilitation facilities at a
price of $96.8 million, which were then leased to a new operator of the
facilities, Vibra Healthcare, LLC and its operating subsidiaries (collectively,
Vibra). The Company also made loans of $33.3 million to Vibra. On August 18,
2004, the Company purchased two additional rehabilitation facilities for $30.6
million, which were then leased to Vibra, and made additional loans to Vibra of
$13.8 million. The Company made an additional $2 million loan to Vibra on
October 1, 2004. Loans totaling $42.9 million accrue interest at the rate of
10.25% per year and are to be paid over 15 years with interest only for the
first three years and the principal balance amortizing over the remaining 12
year period. Loans totaling $6.2 million accrue interest at the rate of 10.25%
per year. Vibra will pay fees of $1.5 million to the Company for transacting the
leases and loans. The Company has determined that Vibra is a variable interest
entity as defined by FIN 46-R. The Company has also determined that it is not
the primary beneficiary of Vibra and, therefore, has not consolidated Vibra in
the Company's consolidated financial statements. For the year ended December 31,
2004, Vibra has been the only tenant which is required to make payments under
operating leases and loans from the Company.

The Company recorded intangible lease assets of $5,314,963 representing the
estimated value of the Vibra leases which were entered into at the date the
Company acquired the facilities. The Company recorded amortization expense of
$166,713 and expects to recognize amortization expense of $354,324 in each of
the next five years.

As security for the loans, each of the Vibra tenants and Vibra have granted
the Company a security interest in their respective rights to receive payments,
directly or indirectly, for any goods or services provided to any persons or
entities; any records or data related to those rights; and all cash and non-cash
proceeds resulting from those rights. As additional security, Vibra has pledged
to the Company all of its interests in each of the tenants. One individual is
the majority owner of Vibra, The Hollinger Group and Vibra Management, LLC. The
owner of Vibra has pledged his interest in Vibra to secure the loans. In
addition, The Hollinger Group and Vibra Management have guaranteed the loans.
The owner of Vibra has also provided a $5 million personal guarantee.

4. LONG-TERM DEBT AND LOAN PAYABLE

In 2003, the Company entered into a loan agreement which provided for
maximum borrowings of $300,000 if certain conditions were met by the Company.
Borrowings under the agreement ($100,000 at December 31, 2003) accrued interest
at 20% per annum and were due upon the earlier of (i) the third business day
following the funding of the Company's private placement or (ii) March 29, 2004.
During the first three months of 2004, the Company increased its borrowings on
the loan to $300,000, which was paid

F-28

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2004 AND

PERIOD FROM INCEPTION (AUGUST 27, 2003) THROUGH DECEMBER 31, 2003 -- (CONTINUED)

in full in April 2004. Contemporaneous with the private placement, the Company
issued to the lender a warrant to purchase up to 35,000 shares of the Company's
common stock at a price per share equal to 93% of the price at which the
Company's shares were offered to investors in the private placement. The warrant
has been recorded in the consolidated balance sheet using the intrinsic value
method as an addition to Additional Paid-in Capital and as additional interest
expense at a value of $.70 per warrant ($10.00 per share private placement price
less $9.30 exercise price per warrant) or a total of $24,500. The Company
considers any differences which would result between the intrinsic method and
another fair value method to not be material to the Company's financial
position, results of its operations or changes in its cash flows.

In December 2004, the Company received $56 million as part of a $75
million, three year term loan. In February 2005, the Company received the
remaining $19 million of this loan. The loan requires monthly payments based on
a 20 year amortization schedule and interest at the one month London Interbank
Offered Rate (LIBOR) plus 300 basis points, which results in an interest rate of
5.42% at December 31, 2004. The loan is secured by the six Vibra facilities,
which have a book value of $125.9 million, and requires the Company to meet
financial coverage, ratio and total debt covenants typical of such loans.

In December 2004, the Company closed a $43 million loan with a bank to
finance the construction of the Company's medical office building and community
hospital development project in Houston, Texas. The loan carries a construction
period term of eighteen months, with the option to convert the loan into a
thirty month term loan thereafter with a twenty-five year amortization. The loan
requires interest payments only during the initial eighteen month term, and
principal and interest payments during the optional thirty month term. The loan
is secured by mortgages on the development property. The loan bears interest at
a rate of one month LIBOR plus 225 basis points (4.67% at December 31, 2004)
during the construction period and one month LIBOR plus 250 basis points (4.92%
at December 31, 2004) during the thirty month optional period. The Company has
paid a commitment fee of one per-cent for the construction loan with an
additional .25% per-cent fee due if the Company exercises the term loan option.
Proceeds may be drawn down by periodically presenting to the lender
documentation of construction and development costs incurred. The Company has
not drawn down any proceeds from this loan as of December 31, 2004.

Maturities of long-term debt at December 31, 2004, are as follows:

2005........................................................ $ 2,566,663
2006........................................................ 2,799,996
2007........................................................ 50,633,341
-----------
$56,000,000
===========

5. COMMITMENTS AND CONTINGENCIES

In June 2004, the Company began construction of a hospital and medical
office building with an expected total cost of $63.4 million. The Company plans
to fund this project with a combination of its own and borrowed funds. At
December 31, 2004, the Company has funded $24.2 million of the cost which has
been financed with funds from the April 6, 2004 private placement. The remaining
commitment for construction and development contracts at December 31, 2004,
totals $32.1 million.

F-29

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2004 AND

PERIOD FROM INCEPTION (AUGUST 27, 2003) THROUGH DECEMBER 31, 2003 -- (CONTINUED)

Fixed minimum payments due under operating leases with non-cancellable
terms of more than one year at December 31, 2004 are as follows:

2005........................................................ $ 275,106
2006........................................................ 339,570
2007........................................................ 346,158
2008........................................................ 352,746
2009........................................................ 359,334
Thereafter.................................................. 2,133,005
----------
$3,805,919
==========

A former consultant to the Company has made a claim for 2003 and 2004
consulting compensation under the terms of a now terminated consulting agreement
with the Company. The Company disputes this claim and has made an offer of
settlement based on the terms of the consulting agreement. The Company has made
provision for the amount (which the Company has determined is not material to
the consolidated financial statements) that it estimates is owed to the former
consultant.

6. EQUITY INCENTIVE PLAN AND OTHER STOCK AWARDS

The Company has adopted the Medical Properties Trust, Inc. 2004 Amended and
Restated Equity Incentive Plan (the Equity Incentive Plan) which authorizes the
issuance of options to purchase shares of common stock, restricted stock awards,
restricted stock units, deferred stock units, stock appreciation rights and
performance units. The Company has reserved 791,180 shares of common stock for
awards under the Equity Incentive Plan. The Equity Incentive Plan contains a
limit of 300,000 shares as the maximum number of shares of common stock that may
be awarded to an individual in any fiscal year.

Upon their election to the board in April, 2004, each of our original
independent directors was awarded options to acquire 20,000 shares of our common
stock. These options have an exercise price of $10 per option, vested one-third
upon grant and the remainder will vest one-half on each of the first and second
anniversaries of the date of grant, and expire ten years from the date of grant.
The Company has determined that the exercise price of these options is equal to
the fair value of the common stock because the options were granted immediately
following the private placement of its common stock in April, 2004. Accordingly,
the options have no intrinsic value as that term is used in SFAS No. 123,
Accounting for Stock-Based Compensation. No other options have been granted.

SHARES EXERCISE PRICE
-------- --------------

Outstanding at January 1, 2004.............................. -- --
Granted..................................................... 100,000 $10.00
Exercised................................................... -- --
Forfeited................................................... -- --
-------- ------
Outstanding at December 31, 2004............................ 100,000 $10.00
======== ======
Options exercisable at December 31, 2004.................... 33,333 $10.00
Weighted-average grant-date fair value of options granted... $ 1.21

F-30

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2004 AND

PERIOD FROM INCEPTION (AUGUST 27, 2003) THROUGH DECEMBER 31, 2003 -- (CONTINUED)

Options exercisable at December 31, 2004, are as follows:

OPTIONS OPTIONS AVERAGE REMAINING
EXERCISE PRICE OUTSTANDING EXERCISABLE CONTRACTUAL LIFE (YEARS)
- -------------- ----------- ----------- ------------------------

$10.00 100,000 33,333 9.6

The Company follows APB No. 25 and related Interpretations in accounting
for the Plan. In accordance with APB 25, no compensation expense has been
recognized for stock options. Had compensation expense for the Company's stock
option plans been determined based on the fair value at the grant dates for
awards under those plans consistent with the methods prescribed in SFAS No. 123,
the Company's net income and income per share for the year ended December 31,
2004, would have been decreased by $67,000 and would have had no per share
effect, respectively.

In addition to these options to purchase common stock, each independent
director was awarded 2,500 deferred stock units in October, 2004, valued by the
Company at $10 per unit, which represent the right to receive 2,500 shares of
common stock in October, 2007. Beginning in 2005, each independent director will
receive 2,000 shares of restricted common stock annually, which will be
restricted as to transfer for three years. The Company has recognized expense in
the amount of $125,000 for the deferred stock units awarded to its' independent
directors in 2004. The Company has also allocated 114,500 shares of restricted
stock to be awarded to employees upon completion of its IPO.

The Company uses the Black-Scholes pricing model to calculate the fair
values of the options awarded, which are included in the pro forma amounts
above. The following assumptions were used to derive the fair values: an option
term of four to six years; no estimated volatility; a weighted average risk-
free rate of return of 3.63%; and a dividend yield of 1.00% for 2004.

7. LEASING OPERATIONS

For the properties purchased in July and August, 2004 (see Note 3), minimum
rental payments due in future periods under operating leases which have
non-cancelable terms extending beyond one year at December 31, 2004, are as
follows:

2005........................................................ $ 14,343,635
2006........................................................ 16,082,461
2007........................................................ 16,484,523
2008........................................................ 16,896,636
2009........................................................ 17,319,052
Thereafter.................................................. 188,238,038
------------
$269,364,346
============

The leases are with tenants engaged in medical operations in California
(two facilities), Colorado, Kentucky, Massachusetts, and New Jersey. Each of the
six lease agreements are for an initial term of 15 years with options for the
tenant to renew for three periods of five years each. Lease payments are
calculated based on the total acquisition cost (aggregating approximately
$127,000,000) and an initial lease rate of 10.25%; the rate increases to 12.23%
on the first anniversary of lease commencement and upon each January 1
thereafter escalates at a rate of 2.5%. At such time that the tenants' aggregate
net revenue exceeds a certain level, the leases further provide that the tenants
will pay additional rent of between 1% and 2% of total net revenue. All of the
leases are cross-defaulted.

F-31

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2004 AND

PERIOD FROM INCEPTION (AUGUST 27, 2003) THROUGH DECEMBER 31, 2003 -- (CONTINUED)

In addition, the Company is funding the acquisition and development costs
for a community hospital and adjacent medical office building in Houston, Texas
on land that is leased to the operator/tenant. During the development and
construction period, the tenant is charged rent (construction period rent) based
on the lease rates (which average 10.4%) and the amount funded, which aggregated
$16,225,907 at December 31, 2004. The Company has recorded $757,787 of
construction period rent as unbilled rent receivable and as deferred revenue as
of December 31, 2004. Upon completion of development and occupancy by the
tenant, the fixed lease term (15 and 10 years for the hospital and medical
office building, respectively) will commence and any accrued construction period
rent will be paid, with interest calculated at the lease rate, over the term of
the respective lease. Upon occupancy, the Company will begin recognizing as rent
revenue, using the straight-line method, all construction period rent recorded
during the construction period. The Company expects to complete the construction
of the hospital and the medical office building in October 2005 and August 2005,
respectively.

8. FAIR VALUE OF FINANCIAL INSTRUMENTS

DECEMBER 31, 2004 DECEMBER 31, 2003
------------------------- -----------------------
BOOK VALUE FAIR VALUE BOOK VALUE FAIR VALUE
----------- ----------- ---------- ----------

Cash and cash equivalents.......... $97,543,677 $97,543,677 $ 100,000 $ 100,000
Interest receivable................ 419,776 419,776 -- --
Unbilled rent receivable........... 3,206,853 1,679,450 -- --
Loans.............................. 50,224,069 50,646,695 100,000 100,000
Long-term debt..................... 56,000,000 56,000,000 -- --
Accounts payable and accrued
expenses......................... 10,903,025 10,903,025 1,389,779 1,389,779

9. INCOME TAXES

The following table reconciles the Company's net income as reported in its
consolidated statement of operations prepared in accordance with generally
accepted accounting principles with its taxable income under the REIT income tax
regulations for the year ended December 31, 2004:

Net income as reported...................................... $ 4,576,349
Less: Net income of the taxable REIT subsidiary............. (63,905)
-----------
Net income from REIT operations............................. 4,512,444
Unbilled rent receivable.................................... (2,449,066)
GAAP depreciation and amortization in excess of tax
depreciation.............................................. 198,266
Expenses deductible in future tax periods................... 2,434,535
Other....................................................... 289,759
-----------
Taxable income subject to REIT distribution requirements.... $ 4,985,938
===========

The Company paid distributions of $2,608,286 ($.10 per share) on October
10, 2004, and $2,869,115 ($.11 per share) on January 11, 2005. All of the
October distribution and $755,546 of the January 2005, distribution will be
subject to federal incomes taxes by the Company's stockholders in 2004. The
remainder of the January, 2005, distribution will be subject to federal income
taxes by the Company's stockholders in 2005. All of the distributions are
taxable to the Company's shareholders at ordinary income federal tax rates.

F-32

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2004 AND

PERIOD FROM INCEPTION (AUGUST 27, 2003) THROUGH DECEMBER 31, 2003 -- (CONTINUED)

10. SUBSEQUENT EVENTS

On February 9, 2005, Vibra made a $7.8 million payment of principal and
interest on its transaction fee and working capital loans from the Company. The
payments left a $41.4 million loan payable to the Company by Vibra. The Company
has no commitments to make additional loans to Vibra.

In February, 2005, the Company purchased a community hospital for $28
million. The purchase price was paid from loan proceeds and from the proceeds of
the Company's private placement. Upon closing the purchase of the hospital, the
Company and the seller entered into a fifteen year lease of the hospital back to
the seller, with renewal options for three additional five year terms.

11. EARNINGS PER SHARE

The following is a reconciliation of the weighted average shares used in
net income (loss) per common share to the weighted average shares used in net
income (loss) per common share -- assuming dilution for the year ended December
31, 2004, and for the period from Inception (August 27, 2003) through December
31, 2003, respectively:

2004 2003
---------- ---------

Weighted average number of shares issued and outstanding.... 19,308,511 1,630,435
Vested deferred stock units................................. 2,322 --
---------- ---------
Weighted average shares -- basic............................ 19,310,833 1,630,435
Common stock warrants....................................... 1,801 --
---------- ---------
Weighted average shares -- diluted.......................... 19,312,634 1,630,435
========== =========

12. RELATED PARTIES

The Company's lead underwriter for its IPO and private placement is the
largest stockholder, including shares owned directly and indirectly through
funds it manages. In connection with services provided for its managing and
underwriting of the private placement, the underwriter received approximately
261,000 shares of the Company's common stock. The Company also manages its cash
and cash equivalents (approximately $96.1 million at December 31, 2004) through
the underwriter.

F-33

SCHEDULE III -- REAL ESTATE AND ACCUMULATED DEPRECIATION

DECEMBER 31, 2004 AND DECEMBER 31, 2003

ADDITIONS SUBSEQUENT TO
INITIAL COSTS ACQUISITION
--------------------------- ------------------------------
LOCATION TYPE OF PROPERTY LAND BUILDINGS IMPROVEMENTS CARRYING COSTS
- -------- ----------------------- ----------- ------------ ------------ --------------

Bowling Green, KY.............. Rehabilitation hospital $ 3,070,000 $ 33,570,541 $ -- $ --
Thornton, CO................... Rehabilitation hospital 2,130,000 6,013,142 -- --
Fresno, CA..................... Rehabilitation hospital 1,550,000 16,363,153 -- --
Kentfield, CA.................. Long term acute care 2,520,000 4,765,176 -- --
hospital
Marlton, NJ.................... Rehabilitation hospital -- 30,903,051 -- --
New Bedford, NJ................ Long term acute care 1,400,000 19,772,169 -- --
hospital
----------- ------------ -----
TOTAL $10,670,000 $111,387,232 $ -- $ --
=========== ============ =====

COST AT DECEMBER 31, 2004
------------------------------------------ ACCUMULATED DATE OF DATE
LOCATION LAND BUILDINGS(1) TOTAL DEPRECIATION CONSTRUCTION ACQUIRED
-------- ----------- ------------- ------------ ------------ ----------------- ---------------

Bowling Green, KY................. $ 3,070,000 $ 33,570,541 $ 36,640,541 $ 419,634 1992 July 1, 2004
Thornton, CO...................... 2,130,000 6,013,142 8,143,142 56,371 1962, 1975 August 17, 2004
Fresno, CA........................ 1,550,000 16,363,153 17,913,153 204,540 1990 July 1, 2004
Kentfield, CA..................... 2,520,000 4,765,176 7,285,176 59,562 1963 July 1, 2004
Marlton, NJ....................... -- 30,903,051 30,903,051 386,286 1994 July 1, 2004
New Bedford, NJ................... 1,400,000 19,772,169 21,172,169 185,364 1962, 1975, 1992 August 17, 2004
----------- ------------ ------------ ----------
TOTAL $10,670,000 $111,387,232 $122,057,232 $1,311,757
=========== ============ ============ ==========

DEPRECIABLE
LOCATION LIFE (YEARS)
-------- ------------

Bowling Green, KY................. 40
Thornton, CO...................... 40
Fresno, CA........................ 40
Kentfield, CA..................... 40
Marlton, NJ....................... 40
New Bedford, NJ................... 40
TOTAL

DECEMBER 31, 2004 DECEMBER 31, 2003
----------------- -----------------

COST
Balance at beginning of period.......... $ -- $ --
Additions during the period
Acquisitions........................ 122,057,232 --
------------ --------
Balance at end of period................ $122,057,232 $ --
============ ========

DECEMBER 31, 2004 DECEMBER 31, 2003
------------------ -----------------

ACCUMULATED DEPRECIATION
Balance at beginning of period.......... $ -- $ --
Additions during the period
Depreciation........................ 1,311,757 --
------------ --------
Balance at end of period................ $ 1,311,757 $ --
============ ========

- ---------------

(1) The gross cost for Federal income tax purposes is $116,702,195.

F-34

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

Consolidated Balance Sheet

March 31, 2005 (Unaudited) and December 31, 2004 (Audited)

MARCH 31, 2005 DECEMBER 31, 2004
-------------- -----------------
(UNAUDITED) (AUDITED)

ASSETS
Current assets:
Cash and cash equivalents................................. $ 2,707,976 $ 2,280,772
Patient accounts receivable, net of allowance for doubtful
collections of $435,816 at March 31, 2005 and $302,988
at December 31, 2004................................... 19,911,175 17,319,154
Third party settlements receivable........................ 59,457 346,141
Prepaid insurance......................................... 553,683 719,480
Deposit for workers' compensation claims.................. -- 1,375,000
Other current assets...................................... 562,437 518,650
----------- -----------
Total current assets................................... 23,794,728 22,559,197
Restricted investment....................................... 100,000 --
Property and equipment, net................................. 2,673,223 2,662,546
Goodwill.................................................... 24,650,800 24,510,296
Intangible assets........................................... 4,260,000 4,260,000
Deposits.................................................... 3,485,387 3,485,387
Deferred financing and lease costs.......................... 1,667,390 1,543,424
----------- -----------
Total assets........................................... $60,631,528 $59,020,850
=========== ===========

LIABILITIES AND PARTNERS' DEFICIT
Current liabilities:
Accounts payable.......................................... $ 3,248,677 $ 5,142,345
Accounts payable -- related parties....................... 200,871 262,144
Accrued liabilities....................................... 3,899,378 4,387,292
Accrued insurance claims.................................. 1,738,985 1,441,516
----------- -----------
Total current liabilities.............................. 9,087,911 11,233,297
Deferred rent............................................... 3,769,231 2,460,308
Long-term debt.............................................. 52,482,304 49,141,945
----------- -----------
Total liabilities........................................... 65,339,446 62,835,550
Partners' deficit........................................... (4,707,918) (3,814,700)
----------- -----------
Total liabilities and partners' deficit................ $60,631,528 $59,020,850
=========== ===========

The accompanying notes are an integral part of these consolidated financial
statements.

F-35

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

Consolidated Statement of Operations and Changes in Partners' Deficit
For the Three Months Ended March 31, 2005 (Unaudited)

REVENUE:
Net patient service revenue............................... $29,328,088
-----------
EXPENSES:
Cost of services.......................................... 20,067,059
General and administrative................................ 3,354,649
Rent expense.............................................. 5,121,583
Interest expense.......................................... 1,263,356
Management fee -- Vibra Management, LLC................... 586,593
Depreciation and amortization............................. 194,293
Bad debt expense.......................................... 167,233
-----------
Total expenses......................................... 30,754,766
-----------
Loss from operations................................. (1,426,678)
Non-operating revenue..................................... 533,460
-----------
Net loss............................................. (893,218)
Partners' deficit -- beginning.............................. (3,814,700)
-----------
Partners' deficit -- ending................................. $(4,707,918)
===========

The accompanying notes are an integral part of these consolidated financial
statements.

F-36

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

Consolidated Statement of Cash Flows
For Three Months Ended March 31, 2005 (Unaudited)

Operating activities:
Net loss.................................................. $ (893,218)
Adjustments to reconcile net loss to net cash used in
operating activities:
Depreciation and amortization........................ 194,293
Provision for bad debts.............................. 167,233
Changes in operating assets and liabilities, net of effects
from acquisition of business:
Accounts receivable including third party
settlements......................................... (2,613,072)
Prepaids and other current assets.................... 122,010
Deposits............................................. 1,375,000
Accounts payable..................................... (1,893,668)
Accounts payable -- related party.................... (61,273)
Accrued liabilities.................................. (190,445)
Deferred rent........................................ 1,308,923
------------
Net cash used in operating activities....................... (2,484,217)
------------
Investing activities:
Purchase of restricted investment.................... (100,000)
Purchases of property and equipment.................. (163,463)
------------
Net cash used in investing activities....................... (263,463)
------------
Financing activities:
Borrowings under revolving credit facility........... 24,098,291
Repayments of revolving credit facility.............. (13,189,000)
Repayment of notes payable........................... (7,725,957)
Payment of deferred financing costs.................. (8,450)
------------
Net cash provided by financing activities................... 3,174,884
------------
Net increase in cash and cash equivalents................... 427,204
Cash and cash equivalents -- beginning...................... 2,280,772
------------
Cash and cash equivalents -- ending......................... $ 2,707,976
============
Supplemental cash flow information:
Cash paid for interest............................... $ 1,263,356
============
Non-cash transactions:
Deferred financing costs funded by revolving credit
facility............................................ $ 157,025
============
Business acquisition adjustment of goodwill.......... $ 140,504
============

The accompanying notes are an integral part of these consolidated financial
statements.

F-37

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2005 (UNAUDITED)

1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Organization: Vibra Healthcare, LLC ("Vibra" and the "Company") was formed
May 14, 2004, and commenced operations with the acquisition of its subsidiaries
consisting of four independent rehabilitation hospitals ("IRF") and two
long-term acute care hospitals ("LTACH") located throughout the United States on
July 1, 2004 and August 17, 2004, respectively. Vibra, a Delaware limited
liability company ("LLC"), has an infinite life. The members' liability is
limited to the capital contribution. Vibra was previously named Highmark
Healthcare LLC until a name change in December 2004. Vibra's wholly-owned
subsidiaries consist of:

SUBSIDIARIES LOCATION
- ------------ -----------------

92 Brick Road Operating Company LLC......................... Marlton, NJ
4499 Acushnet Avenue Operating Company LLC.................. New Bedford, MA
1300 Campbell Lane Operating Company LLC.................... Bowling Green, KY
8451 Pearl Street Operating Company LLC..................... Denver, CO
7173 North Sharon Avenue Operating Company LLC.............. Fresno, CA
1125 Sir Francis Drake Boulevard Operating Company LLC...... Kentfield, CA

The Company provides long-term acute care hospital services and inpatient
acute rehabilitative hospital care at its hospitals. Patients in the Company's
LTACHs typically suffer from serious and often complex medical conditions that
require a high degree of care. Patients in the Company's IRFs typically suffer
from debilitating injuries including traumatic brain and spinal cord injuries,
and require rehabilitation care in the form of physical, psychological, social
and vocational rehabilitation services. The Company also operates ten outpatient
clinics affiliated with five of its six hospitals.

Principles of Consolidation: The consolidated financial statements include
the accounts of the Company and its wholly-owned subsidiaries controlled through
majority membership interests in limited liability companies. All significant
intercompany balances and transactions are eliminated in consolidation.

Use of Estimates: The preparation of financial statements in conformity
with accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and
liabilities at the date of the financial statements and reported amounts of
revenues and expenses during the reporting period. Actual results could differ
from those estimates.

Cash and Cash Equivalents: The Company considers all highly liquid
investments with a maturity of three months or less when purchased to be cash
equivalents. Cash equivalents are stated at cost which approximates market.

Patient Accounts Receivable: Patient accounts receivable are reported at
net realizable value. Accounts are written off when they are determined to be
uncollectible based upon management's assessment of individual accounts. The
allowance for doubtful collections is estimated based upon a periodic review of
the accounts receivable aging, payor classifications and application of
historical write-off percentages.

Inventories: Inventories of pharmaceuticals and pharmaceutical supplies
are stated at the lower of cost or market value. Cost is determined on a
first-in, first-out basis. These inventories totaled $429,654 at March 31, 2005,
and are included in other current assets in the accompanying consolidated
balance sheet.

Restricted Investment: The restricted investment consists of a five year
certificate of deposit with a local bank pledged as collateral for a letter of
credit benefiting the California Department of Health Services ("CDHS"). CDHS
can draw on the letter of credit to reimburse any medicaid overpayments.

F-38

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2005 (UNAUDITED)

Property and Equipment: Property and equipment are stated at cost net of
accumulated depreciation. Depreciation and amortization are computed using the
straight-line method over the estimated useful lives of the assets or the term
of the lease, as appropriate. The general range of useful lives is as follows:

Leasehold improvements...................................... 15 years
Furniture and equipment..................................... 2-7 years

In accordance with Statement of Financial Accounting Standards No. 144,
"Accounting for the Impairment or Disposal of Long-Lived Assets" (SFAS No 144),
the Company reviews the realizability of long-lived assets whenever events or
circumstances occur which indicate recorded costs may not be recoverable.

Intangible Assets: The Company adopted Statement of Financial Accounting
Standards (SFAS) No. 142, "Goodwill and Other Intangible Assets". Under SFAS No.
142, goodwill and other intangible assets with indefinite lives are no longer
subject to periodic amortization but are instead reviewed annually or more
frequently if impairment indicators arise. These reviews require the Company to
estimate the fair value of its identified reporting units and compare those
estimates against the related carrying values. Identifiable assets and
liabilities acquired in connection with business combinations accounted for
under the purchase method are recorded at their respective fair values. For each
of the reporting units, the estimated net realizable value is determined using
current transaction information and the present value of future cash flows of
the units.

Management has allocated the intangible assets between identifiable
intangibles and goodwill. Intangible assets, other than goodwill, consist of
values assigned to certificates of need ("CONs") and licenses. The useful life
of each class of intangible assets is as follows:

Goodwill.................................................... Indefinite
Certificates of Need/Licenses............................... Indefinite

Deferred Financing and Lease Costs: Costs and fees incurred in connection
with the MPT acquisition note and leases and the Merrill Lynch revolving credit
facility have been deferred and are being amortized over the term of the loans
and leases using the straight-line method, which approximates the effective
interest method. Amortization expense was $41,510 for the three months ended
March 31, 2005.

Insurance Risk Programs: Under the Company's insurance programs, the
Company is liable for a portion of its losses. The Company estimates its
liability for losses based on historical trends that will be incurred in a
respective accounting period and accrues that estimated liability. These
programs are monitored quarterly and estimates are revised as necessary to take
into account additional information. The Company has accrued $1,738,985 related
to these programs at March 31, 2005. A deposit for workers' compensation claims
of $1,375,000 at December 31, 2004, consisted of cash provided to Vibra's
insurance carrier to fund workers' compensation claims. In February 2005, Vibra
used $1,375,000 of its borrowing base on the Merrill Lynch loan to collateralize
a letter of credit for the claims and the cash deposit was refunded.

Deferred Rent: The excess of straight line rent expense over rent paid is
credited to deferred rent on a monthly basis. At March 31, 2005, rent expense
exceeded rent paid by $3,769,231.

Revenue Recognition: Net patient service revenue consists primarily of
charges to patients and are recognized as services are rendered. Net patient
service revenue is reported net of provisions for contractual allowances from
third-party payors and patients. The Company has agreements with third-party
payors that provide for payments to the Company at amounts different from its
established rates. The differences between the estimated program reimbursement
rates and the standard billing rates are

F-39

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2005 (UNAUDITED)

accounted for as contractual adjustments, which are deducted from gross revenues
to arrive at net patient service revenues. Payment arrangements include
prospectively determined rates per discharge, reimbursed costs, discounted
charges and per diem payments. Retroactive adjustments are accrued on an
estimated basis in the period the related services are rendered and adjusted in
future periods as final settlements are determined. Patient accounts receivable
resulting from such payment arrangements are recorded net of contractual
allowances.

A significant portion of the Company's net patient service revenues are
generated directly from the Medicare and Medicaid programs. Net patient service
revenues generated directly from the Medicare and Medicaid programs represented
approximately 65% and 14%, respectively, of the Company's consolidated net
patient service revenue for the three month period ended March 31, 2005.
Approximately 46% and 22% of the Company's gross patient accounts receivable at
March 31, 2005, are from Medicare and Medicaid, respectively. As a provider of
services to these programs, the Company is subject to extensive regulations. The
inability of a hospital to comply with regulations can result in changes in that
hospital's net patient service revenues generated from these programs.

Concentration of Credit Risk: Financial instruments that potentially
subject the Company to concentration of credit risk consist primarily of cash
balances and patient accounts receivables. The Company deposits its cash with
large banks. The Company grants unsecured credit to its patients, most of whom
reside in the service area of the Company's facilities and are insured under
third-party payor agreements. Because of the geographic diversity of the
Company's facilities and non-governmental third-party payors, Medicare and
Medicaid represent the Company's primary concentration of credit risk.

Income Taxes: Vibra and its subsidiaries have elected to be a LLC for
federal and state income tax purposes. In lieu of corporate income taxes, the
member of a LLC is taxed on their proportionate share of the Company's taxable
income or loss. Therefore, no provision or liability for federal or state income
taxes has been provided for in the consolidated balance sheet or consolidated
statement of operations.

Unaudited Interim Consolidated Financial Statements: The accompanying
unaudited interim consolidated financial statements have been prepared in
accordance with accounting principles generally accepted in the United States of
America for interim financial information. In the opinion of management, all
adjustments (consisting of normal recurring accruals) considered necessary for a
fair presentation have been included. Operating results for the three month
period ended March 31, 2005, are not necessarily indicative of the results that
may be expected for the year ending December 31, 2005.

2. ACQUISITIONS

In July and August 2004, Vibra entered into agreements with Medical
Properties Trust, Inc. (MPT) to acquire the operations of six specialty
hospitals. MPT, a healthcare real estate investment trust based in Birmingham,
Alabama, acquired the real estate for approximately $127.4 million and assigned
to Vibra its rights to acquire the operations of the hospitals from Care One
Realty of Hackensack, New Jersey for approximately $38.1 million net of cash
acquired and $7.5 million of liabilities assumed which was financed by MPT. The
assignment of the LLC interests to Vibra transferred the operations, assets and
liabilities of each LLC. The purchase price of the operations may be adjusted
either upward or downward pursuant to a post-closing working capital adjustment
with the seller. The purchase price of the operations has been allocated to net
assets acquired, and liabilities assumed based on valuation studies subject to
purchase price adjustments. The excess of the amount of purchase price over the
net asset value, including

F-40

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2005 (UNAUDITED)

identifiable intangible assets, was allocated to goodwill. The purchase price
was negotiated based on management's evaluation of future operational
performance of the hospitals as a group under Vibra. The results of operations
of the hospitals acquired have been included in the Company's consolidated
financial statements since the date of acquisition. The following table
summarizes the acquisition date and other relevant information regarding each
hospital:

LOCATION TYPE BEDS ACQUISITION DATE
- -------- ----- ---- ----------------

Marlton, NJ........................................ IRF 46(1) July 1, 2004
Bowling Green, KY.................................. IRF 60 July 1, 2004
Fresno, CA......................................... IRF 62 July 1, 2004
Kentfield, CA...................................... LTACH 60 July 1, 2004
New Bedford, MA.................................... LTACH 90 August 17, 2004
Thornton, CO....................................... IRF 117(2) August 17, 2004

- ---------------

(1) Vibra subleases a floor of the Marlton building to an unaffiliated provider
which operates 30 pediatric rehabilitation beds which are in addition to the
46 beds operated by Vibra.

(2) Includes beds licensed as skilled nursing and beds licensed as psychiatric.

Information with respect to the businesses acquired in purchase
transactions is as follows:

Notes issued, net of cash acquired.......................... $ 38,093,842
Liabilities assumed......................................... 7,477,988
------------
45,571,830
Fair value of assets acquired:
Accounts receivable....................................... (13,640,825)
Property and equipment.................................... (2,749,840)
CONs/Licenses............................................. (4,260,000)
Other..................................................... (410,869)
------------
Cost in excess of fair value of net assets acquired
(goodwill) at December 31, 2004........................... $ 24,510,296
============

Based on an analysis of pre-acquisition accounts receivable at March 31,
2005, the Company estimated the fair value of the acquired accounts receivable
required a downward adjustment of $140,504. This adjustment increased the
goodwill recorded at March 31, 2005 to $24,650,800.

3. PROPERTY AND EQUIPMENT

Property and equipment consists of the following:

MARCH 31, 2005
--------------

Leasehold improvements...................................... $ 93,530
Furniture and equipment..................................... 2,987,673
----------
3,081,203
Less: accumulated depreciation and amortization............. 407,980
----------
Total....................................................... $2,673,223
==========

Depreciation expense was $152,783 for the three months ended March 31,
2005.

F-41

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2005 (UNAUDITED)

4. DEPOSITS

The facility lease agreements with MPT require deposits equal to three
months rent. The funds are on deposit with MPT in non-interest bearing accounts.
Deposits consist of the following:

MARCH 31, 2005
--------------

MPT lease deposits.......................................... $3,296,365
Other deposits.............................................. 189,022
----------
Total....................................................... $3,485,387
==========

5. INTANGIBLE ASSETS

The Company adopted SFAS No. 142. Under SFAS No. 142, goodwill and other
intangible assets with indefinite lives are not subject to periodic amortization
but are instead reviewed annually as of June 30, or more frequently if
impairment indicators arise. These reviews require the Company to estimate the
fair value of its identified reporting units and compare those estimates against
the related carrying values. For each of the reporting units, the estimated net
realizable value is determined using current transaction information and the
present value of future cash flows of the units. The following table summarizes
intangible assets:

MARCH 31, 2005
--------------

Goodwill.................................................... $24,650,800
===========
CONs/Licenses............................................... $ 4,260,000
===========

The CONs/Licenses have not been amortized as they have indefinite lives.

6. LONG-TERM DEBT

The components of long-term debt are shown in the following table:

MARCH 31, 2005
--------------

MPT 10.25% hospital acquisition note........................ $41,415,988
Merrill Lynch $14 million revolving credit facility......... 11,066,316
-----------
$52,482,304
===========

As of December 31, 2004, MPT had advanced $49,141,945 to Vibra under four
notes for the hospital acquisition and working capital. Three notes for working
capital and transaction fees totaling $7,725,957 were interest only, with a
balloon payment due on March 31, 2005. Vibra may prepay the notes at any time
without penalty.

The hospital acquisition note is interest only through June 2007, and then
amortized over the next 12 years with a final maturity in 2019. Substantially
all of the assets of Vibra and its subsidiaries, as well as Vibra's membership
interests in its subsidiaries, secure the MPT note. In addition the majority
member of Vibra, an affiliated company owned by the majority member and Vibra
Management, LLC have jointly and severally guaranteed the notes payable to MPT,
although the obligation of the majority member is limited to $5 million and his
membership interest in Vibra. A default in any of the MPT lease terms will also
constitute a default under the notes.

The revolving credit facility has a balloon maturity on February 8, 2008.
Interest is payable monthly at the rate of 30 day LIBOR plus 3% (5.85% as of
March 31, 2005). The loan is secured by a first

F-42

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2005 (UNAUDITED)

position in the Company's accounts receivable through an intercreditor agreement
with MPT. Up to $14 million can be borrowed based on a formula of qualifying
accounts receivable. A portion of the proceeds were used to pay off $7,725,957
in working capital and transaction fee notes to MPT which had a maturity of
March 31, 2005. The Company is subject to various financial and non-financial
covenants under the credit facility. A default in any of the MPT note and lease
terms will also constitute a default under the credit facility. At March 31,
2005, Vibra was not in compliance with a facility rent coverage covenant. The
Merrill Lynch credit facility documents were subsequently amended to
retroactively change the rent coverage covenant from a by facility rent coverage
to a consolidated rent coverage calculation. At March 31, 2005, the Company met
the amended covenant (Note 11).

Maturities of long-term debt for the next five years are as follows:

MARCH 31 (IN THOUSANDS)
- -------- --------------

2006........................................................ $ --
2007........................................................ --
2008........................................................ 12,436
2009........................................................ 1,999
2010........................................................ 2,214
Thereafter.................................................. 35,833
-------
$52,482
=======

7. RELATED PARTY TRANSACTIONS

The Company has entered into agreements with Vibra Management, LLC (a
company affiliated through common ownership) to provide management services to
each hospital. The services include information system support, legal counsel,
accounting/tax, human resources, program development, quality management and
marketing oversight. The agreements call for a management fee equal to 2% of net
patient service revenue, and are for an initial term of five years with
automatic one-year renewals. Management fee expense amounted to $586,593 for the
three months ended March 31, 2005. At March 31, 2005, $200,871 was payable to
Vibra Management, LLC and is included accounts payable -- related party in the
accompanying consolidated balance sheet.

The spouse of the majority member of the Company provided legal consulting
services to the Company on the hospital acquisition and on various operational
licensing and financing matters. During the period from inception through
December 31, 2004, legal consulting services from this person totaled $176,187,
of which $98,137 was payable at December 31, 2004. The balance was paid during
the three months ended March 31, 2005, and no additional services were provided.

8. COMMITMENTS AND CONTINGENCIES

LEASES

Vibra entered into triple-net long-term real estate operating leases with
MPT at each hospital. Each lease is for an initial term of 15 years and contains
renewal options at Vibra's option for three additional five-year terms. Vibra
has the option to purchase the leased property at the end of the lease term,
including any extension periods, for the greater of the fair market value of the
leased property, or the purchase price increased by 2.5% per annum from the
commencement date.

F-43

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2005 (UNAUDITED)

2006, and each January 1, thereafter, the base rate increases by an inflator of
2.5% (i.e. base rate becomes 12.54% of APP on January 1, 2006).

Each lease also contains a percentage rent provision ("Percentage Rent").
Beginning January 1, 2005, if the aggregate monthly net patient service revenues
of the six hospitals exceed an annualized net patient service revenue run rate
of $110,000,000, additional rent equal to 2% of monthly net patient service
revenue is triggered. The percentage rent is payable within ten days after the
end of the applicable quarter. The percentage rent declines from 2% to 1% on a
pro rata basis as Vibra repays the $41.416 million in notes to MPT. For the
three months ended March 31, 2005, percentage rents totaling $405,582 have been
accrued and are included in accrued liabilities in the accompanying consolidated
balance sheet.

Commencing on July 1, 2005, Vibra must make quarterly deposits to a capital
improvement reserve at the rate of $375 per quarter per bed or $652,500 on an
annual basis for all hospitals leased from MPT. The reserve may be used to fund
capital improvements and repairs as agreed to by the parties.

Beginning with the quarter ending September 30, 2006, the MPT leases will
be subject to various financial covenants including limitations on total debt to
100% of the total capitalization of the guarantors (as defined) or 4.5 times the
12 month total EBITDAR (as defined) of the guarantors whichever is greater,
coverage ratios of 125% of debt service and 150% of rent (as defined), and
maintenance of average daily patient census. A default in any of the loan terms
will also constitute a default under the leases. All of the MPT leases are cross
defaulted.

Vibra has entered into operating leases for six outpatient clinics which
expire on various dates through 2008.

Minimum future lease obligations on the leases are as follows (in
thousands):

MPT RENT OUTPATIENT
MARCH 31 OBLIGATION CLINICS TOTAL
- -------- ---------- ---------- --------

2006................................................. $ 15,077 $173 $ 15,250
2007................................................. 16,183 112 16,295
2008................................................. 16,588 55 16,643
2009................................................. 17,002 -- 17,002
2010................................................. 17,427 -- 17,427
Thereafter........................................... 184,027 -- 184,027
-------- ---- --------
$266,304 $340 $266,644
======== ==== ========

Substantially, all of the assets of Vibra and its subsidiaries, as well as
Vibra's membership interests in its subsidiaries, secure the MPT leases. In
addition the majority member of Vibra, an affiliated Company owned by the
majority member, and Vibra Management, LLC have jointly and severally guaranteed
the leases to MPT, although the obligation of the majority member is limited to
$5 million and his membership interest in Vibra.

The Company has sublet a floor of its Marlton, NJ hospital to an
independent pediatric rehabilitation provider. Three other hospitals have
entered into numerous sublease arrangements. These subleases generated rental
income of $433,883 for the three months ended March 31, 2005, which is included
in

F-44

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2005 (UNAUDITED)

non-operating revenue in the accompanying consolidated statement of operations.
The following table summarizes amounts due under sub leases (in thousands):

MARCH 31
- --------

2006........................................................ $ 1,126
2007........................................................ 1,151
2008........................................................ 1,177
2009........................................................ 1,203
2010........................................................ 1,230
Thereafter.................................................. 4,524
-------
$10,411
=======

LITIGATION

The Company is subject to legal proceedings and claims that have arisen in
the ordinary course of its business and have not been finally adjudicated
(including claims against the hospitals under prior ownership). In the opinion
of management, the outcome of these actions will not have a material effect on
consolidated financial position or results of operations of the Company.

CALIFORNIA MEDICAID

The Company is in the process of fulfilling change of ownership
requirements imposed by Medi-Cal, the California Medicaid administrator that
date back to the prior owners' acquisition of the California hospitals. Accounts
receivable at March 31, 2005, include $1,399,464 due from Medi-Cal, including
$657,000 prior to the acquisition. In March 2005 the California Department of
Health Services approved the Company as a provider and agreed to enter into
contracts that would allow the Company to retro-bill Medi-Cal for services
provided after August 1, 2003. The Company expects to submit bills for these
services in May and June 2005.

CALIFORNIA SEISMIC UPGRADE

For earthquake protection California requires hospitals to receive an
approved Structural Performance Category 2 (SPC-2) by January 1, 2008, to
maintain its license. Hospitals may request a five year implementation
extension. The Fresno, CA hospital is expected to meet the SPC-2 standard by
January 1, 2008, with capital outlays that are not material to the consolidated
financial statements. The Kentfield, CA hospital has applied for a three year
extension to meet the requirement. Management is in preliminary consultations
with consulting architects and engineers to develop a plan for Kentfield to meet
the requirements. The capital outlay required to meet the standards at Kentfield
cannot be determined at this time.

9. RETIREMENT SAVINGS PLAN

In November 2004, the Company began sponsorship of a defined contribution
retirement savings plan for substantially all of its employees. Employees may
elect to defer up to 15% of their salary. The Company matches 25% of the first
3% of compensation employees contribute to the plan. The employees vest in the
employer contributions over a five-year period beginning on the employee's hire
date. The expense incurred by the Company related to this plan was $29,870 for
the three months ended March 31, 2005.

F-45

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2005 (UNAUDITED)

10. SEGMENT INFORMATION

SFAS No. 131, "Disclosure about Segments of an Enterprise and Related
Information", establishes standards for reporting information about operating
segments and related disclosures about products and services, geographic areas
and major customers.

The Company's segments consist of (i) IRFs and (ii) LTACHs. The accounting
policies of the segments are the same as those described in the summary of
significant accounting policies. The Company evaluates performance of the
segments based on loss from operations.

The following table summarizes selected financial data for the Company's
reportable segments:

FOR THE THREE MONTHS ENDED MARCH 31, 2005
--------------------------------------------------
IRF LTACH OTHER TOTAL
----------- ----------- -------- -----------

Net patient service revenue........ $13,822,924 $15,505,164 $ -- $29,328,088
Net loss from operations........... (1,153,003) (189,409) (84,266) (1,426,678)
Interest expense................... 744,998 518,358 -- 1,263,356
Depreciation and amortization...... 95,348 82,435 16,510 194,293
Deferred rent...................... 2,749,822 1,019,409 -- 3,769,231
Total assets....................... 31,853,471 28,175,098 602,959 60,631,528
Purchases of property and
equipment........................ 73,182 86,220 4,061 163,463
Goodwill........................... 16,409,877 8,240,923 -- 24,650,800

11. SUBSEQUENT EVENT

On April 16, 2005, Vibra entered into a letter of intent to acquire a
California specialty hospital. In connection with this transaction, Vibra
entered into a financing commitment with MPT. Vibra paid non-refundable deposits
totaling $228,000 related to this transaction. The acquisition is subject to
final negotiation of definitive documents, due diligence and licensing.

On June 1, 2005, Merrill Lynch and Vibra amended their credit facility
documents for no consideration. The amendment changed a rent coverage covenant
from a by facility rent coverage to a consolidated rent covenant calculation.

F-46

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Member
Vibra Healthcare, LLC

We have audited the accompanying consolidated balance sheet of Vibra
Healthcare, LLC and subsidiaries (the "Company") as of December 31, 2004, and
the related consolidated statements of operations, changes in partner's capital,
and cash flows for the period from inception (May 14, 2004) through December 31,
2004. These financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on these financial
statements based on our audit.

We conducted our audit in accordance with the standards of the Public
Company Accounting Oversight Board (United States). Those standards require that
we plan and perform the audit to obtain reasonable assurance about whether the
financial statements are free of material misstatement. An audit includes
examining, on a test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the accounting
principles used and significant estimates made by management, as well as
evaluating the overall financial statement presentation. We believe that our
audit provides reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above
present fairly, in all material respects, the financial position of Vibra
Healthcare, LLC and subsidiaries as of December 31, 2004, and the results of
their operations and their cash flows for the period from inception (May 14,
2004) through December 31, 2004 in conformity with accounting principles
generally accepted in the United States of America.

/s/ Parente Randolph, LLC

Harrisburg, Pennsylvania
March 8, 2005, except Note 11,
as to which the date is March 31, 2005

F-47

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

Consolidated Balance Sheet
December 31, 2004

ASSETS
Current assets:
Cash and cash equivalents................................. $ 2,280,772
Patient accounts receivable, net of allowance for doubtful
collections of $302,988................................ 17,319,154
Third party settlements receivable........................ 346,141
Prepaid insurance......................................... 719,480
Deposit for workers' compensation claims.................. 1,375,000
Other current assets...................................... 518,650
-----------
Total current assets................................... 22,559,197
Property and equipment, net................................. 2,662,546
Goodwill.................................................... 24,510,296
Intangible assets........................................... 4,260,000
Deposits.................................................... 3,485,387
Deferred financing and lease costs.......................... 1,543,424
-----------
Total assets........................................... $59,020,850
===========

LIABILITIES AND PARTNER'S CAPITAL
Current liabilities:
Accounts payable.......................................... $ 5,142,345
Accounts payable -- related parties....................... 262,144
Accrued liabilities....................................... 4,387,292
Accrued insurance claims.................................. 1,441,516
-----------
Total current liabilities.............................. 11,233,297
Deferred rent............................................... 2,460,308
Long-term debt, net of current maturities................... 49,141,945
-----------
Total liabilities........................................... 62,835,550
-----------
Partner's capital........................................... (3,814,700)
-----------
Total liabilities and partner's capital................ $59,020,850
===========

The accompanying notes are an integral part of these consolidated financial
statements.
F-48

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

Consolidated Statement of Operations and Changes in Partner's Capital
For the Period from Inception (May 14, 2004) through December 31, 2004

REVENUE:
Net patient service revenue............................... $48,266,019
-----------
EXPENSES:
Cost of services.......................................... 34,528,924
General and administrative................................ 5,631,229
Rent expense.............................................. 8,859,233
Interest expense.......................................... 2,293,402
Management fee -- Vibra Management, LLC................... 982,668
Depreciation and amortization............................. 302,194
Bad debt expense.......................................... 776,780
-----------
Total expenses......................................... 53,374,430
-----------
Loss from operations................................. (5,108,411)
Non-operating revenue..................................... 1,293,711
-----------
Net loss............................................. (3,814,700)
Partner's capital -- beginning............................ --
-----------
Partner's capital -- ending............................... ($3,814,700)
-----------

The accompanying notes are an integral part of these consolidated financial
statements.
F-49

VIBRA HEALTHCARE LLC AND SUBSIDIARIES

Consolidated Statement of Cash Flows
For the Period from Inception (May 14, 2004) through December 31, 2004

Operating activities:
Net loss.................................................. $(3,814,700)
Adjustments to reconcile net loss to net cash used in
operating activities:
Depreciation and amortization........................ 302,194
Provision for bad debts.............................. 776,780
Changes in operating assets and liabilities, net of effects
from acquisition of business:
Accounts receivable including third party
settlements......................................... (4,801,250)
Prepaids and other current assets.................... (2,257,611)
Deposits............................................. (133,671)
Accounts payable..................................... 1,884,531
Accounts payable -- related party.................... 262,144
Accrued liabilities.................................. 1,608,634
Deferred rent........................................ 2,460,308
-----------
Net cash used in operating activities....................... (3,712,641)
-----------
Investing activities:
Purchases of property and equipment.................. (167,900)
Cash acquired in business acquisition................ 201,280
-----------
Net cash provided by investing activities................... 33,380
-----------
Financing activities:
Proceeds of notes payable............................ 6,050,458
Payment of deferred financing costs.................. (90,425)
-----------
Net cash provided by financing activities................... 5,960,033
-----------
Net increase in cash and cash equivalents................... 2,280,772
Cash and cash equivalents -- beginning...................... --
-----------
Cash and cash equivalents -- ending......................... $ 2,280,772
===========
Supplemental cash flow information:
Cash paid for interest............................... $ 2,293,402
===========
Non-cash transactions:
Notes issued relating to acquisition................. $38,093,842
===========
Lease deposits funded by notes payable............... $ 3,296,365
===========
Deferred financing costs funded by notes payable..... $ 1,500,000
===========

The accompanying notes are an integral part of these consolidated financial
statements.
F-50

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
PERIOD FROM INCEPTION (MAY 14, 2004) THROUGH DECEMBER 31, 2004

1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Organization: Vibra Healthcare LLC ("Vibra" and the "Company") was formed
May 14, 2004, and commenced operations with the acquisition of its subsidiaries
consisting of four independent rehabilitation hospitals ("IRF") and two
long-term acute care hospitals ("LTACH") located throughout the United States on
July 1, 2004, and August 17, 2004. Vibra, a Delaware limited liability company
("LLC"), is a single member LLC with an infinite life. The members liability is
limited to the capital contribution. Vibra was previously named Highmark
Healthcare LLC until a name change in December 2004. Vibra's wholly-owned
subsidiaries consist of:

SUBSIDIARIES LOCATION
- ------------ -----------------

Principles of Consolidation: The consolidated financial statements include
the accounts of the Company and its wholly owned subsidiaries controlled through
sole membership interests in limited liability companies. All significant
intercompany balances and transactions are eliminated in consolidation.

Use of Estimates: The preparation of financial statements in conformity
with accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and
liabilities at the date of the financial statements and reported amounts of
revenues and expenses during the reporting period. Actual results could differ
from those estimates.

Inventories: Inventories of pharmaceuticals and pharmaceutical supplies
are stated at the lower of cost or market value. Cost is determined on a
first-in, first-out basis. These inventories totaled $363,720 at December 31,
2004, and are included in other current assets in the accompanying consolidated
balance sheet.

F-51

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
PERIOD FROM INCEPTION (MAY 14, 2004) THROUGH DECEMBER 31, 2004

Leasehold improvements...................................... 15 years
Furniture and equipment..................................... 2-7 years

Goodwill.................................................... Indefinite
Certificates of Need/Licenses............................... Indefinite

Deferred Financing and Lease Costs: Costs and fees incurred in connection
with the MPT loans and leases have been deferred and are being amortized over
the 15 year term of the loans and leases using the straight-line method, which
approximates the effective interest method. Amortization expense was $47,000 for
the period from inception through December 31, 2004.

Insurance Risk Programs: Under the Company's insurance programs, the
Company is liable for a portion of its losses. The Company estimates its
liability for losses based on historical trends that will be incurred in a
respective accounting period and accrues that estimated liability. These
programs are monitored quarterly and estimates are revised as necessary to take
into account additional information. At December 31, 2004, the Company has
accrued $1,441,516 related to these programs. Deposits for workers' compensation
claims consist of cash provided to Vibra's insurance carrier to fund workers'
compensation claims. In February 2005, Vibra used $1,375,000 of its borrowing
base on the Merrill Lynch loan (see Note 11) to collateralize a letter of credit
for the claims and the cash deposit was refunded.

Deferred Rent: The excess of straight line rent expense over each rent
paid is credited to deferred rent on a monthly basis. For the period from
inception through December 31, 2004, rent expense exceeded the rent paid in cash
by $2,460,308.

F-52

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
PERIOD FROM INCEPTION (MAY 14, 2004) THROUGH DECEMBER 31, 2004

A significant portion of the Company's net patient service revenues are
generated directly from the Medicare and Medicaid programs. Net patient service
revenues generated directly from the Medicare and Medicaid programs represented
approximately 63% and 13%, respectively, of the Company's consolidated net
patient service revenues for the period from inception through December 31,
2004. Approximately 46% and 21% of the Company's gross patient accounts
receivable at December 31, 2004, are from Medicare and Medicaid, respectively.
As a provider of services to these programs, the Company is subject to extensive
regulations. The inability of a hospital to comply with regulations can result
in changes in that hospital's net patient service revenues generated from these
programs.

2. ACQUISITIONS

F-53

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
PERIOD FROM INCEPTION (MAY 14, 2004) THROUGH DECEMBER 31, 2004

statements since the date of acquisition. The following table summarizes the
acquisition date and other relevant information regarding each hospital:

LOCATION TYPE BEDS ACQUISITION DATE
- -------- ----- ---- ----------------

- ---------------

(1) Vibra subleases a floor of the Marlton building to an unaffiliated provider
which operates 30 pediatric rehabilitation beds which are in addition to the
46 beds operated by Vibra.

(2) Includes beds licensed as skilled nursing and beds licensed as psychiatric.

Information with respect to the businesses acquired in purchase
transactions is as follows:

Notes issued, net of cash acquired.......................... $ 38,093,842
Liabilities assumed......................................... 7,477,988
------------
45,571,830
Fair value of assets acquired:
Accounts receivable....................................... (13,640,825)
Property and equipment.................................... (2,749,840)
CONs/Licenses............................................. (4,260,000)
Other..................................................... (410,869)
------------
Cost in excess of fair value of net assets acquired
(goodwill)................................................ $ 24,510,296
============

3. PROPERTY AND EQUIPMENT

Property and equipment at December 31, 2004, consists of the following:

Leasehold improvements...................................... $ 48,055
Furniture and equipment..................................... 2,869,685
----------
2,917,740
Less: accumulated depreciation and amortization............. 255,194
----------
Total....................................................... $2,662,546
==========

Depreciation expense was $255,194 for the period from inception through
December 31, 2004.

F-54

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
PERIOD FROM INCEPTION (MAY 14, 2004) THROUGH DECEMBER 31, 2004

4. DEPOSITS

The facility lease agreements with MPT require deposits equal to three
months rent. The funds are on deposit with MPT in non-interest bearing accounts.
Deposits at December 31, 2004, consist of the following:

5. INTANGIBLE ASSETS

The Company adopted SFAS No. 142. Under SFAS No. 142, goodwill and other
intangible assets with indefinite lives are not subject to periodic amortization
but are instead reviewed annually as of April 30, or more frequently if
impairment indicators arise. These reviews require the Company to estimate the
fair value of its identified reporting units and compare those estimates against
the related carrying values. For each of the reporting units, the estimated net
realizable value is determined using current transaction information and the
present value of future cash flows of the units.

Goodwill in the amount of $24,510,296 and CONs/Licenses of $4,260,000 have
been recorded in connection with the acquisition of the six hospitals, and have
not been amortized as both have indefinite lives.

6. NOTES PAYABLE

As of December 31, 2004, MPT had advanced $49,141,945 to Vibra under four
notes for the hospital acquisition and working capital. The notes bear interest
at 10.25%. Three notes totaling $7,725,958 are interest only, with a balloon
payment due on March 31, 2005. The remaining note for $41,415,988 is payable
interest only for the first 36 months and then amortized over the next 12 years
with a final maturity in 2019. Vibra may prepay the notes at any time without
penalty. Maturities for the next five years are:

(IN THOUSANDS)
--------------

December 31, 2005........................................... $ --
2006........................................................ --
2007........................................................ 902
2008........................................................ 9,675
2009........................................................ 2,158
Thereafter.................................................. 36,407
-------
$49,142
=======

Substantially all of the assets of Vibra and its subsidiaries, as well as
Vibra's membership interests in its subsidiaries, secure the loans. In addition
the sole member of Vibra, an affiliated company owned by the sole member and
Vibra Management, LLC have jointly and severally guaranteed the notes payable to
MPT, although the obligation of the sole member is limited to $5 million and his
membership interest in Vibra. A default in any of the MPT lease terms will also
constitute a default under the notes.

As discussed in Note 11, Vibra used a portion of the proceeds of a
long-term revolving credit facility from Merrill Lynch Capital to repay the MPT
notes due March 31, 2005. As a result of this refinancing,

F-55

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
PERIOD FROM INCEPTION (MAY 14, 2004) THROUGH DECEMBER 31, 2004

the notes due MPT have been classified as long-term at December 31, 2004 in the
accompanying consolidated balance sheet.

7. RELATED PARTY TRANSACTIONS

The Company has entered into agreements with Vibra Management, LLC (a
company affiliated through common ownership) to provide management services to
each hospital. The services include information system support, legal counsel,
accounting/tax, human resources, program development, quality management and
marketing oversight. The agreements call for a management fee equal to 2% of net
patient service revenue, and are for an initial term of five years with
automatic one-year renewals. Management fee expense amounted to $982,668 for the
period from inception through December 31, 2004. At December 31, 2004, $164,007
was payable to Vibra Management, LLC and is included accounts payable -- related
party in the accompanying consolidated balance sheet.

The spouse of the sole member of the Company provided legal consulting
services to the Company on the hospital acquisition and on various operational
licensing and financing matters. During the period from inception through
December 31, 2004, legal consulting services from this person totaled $176,187,
of which $98,137 was payable at December 31, 2004.

8. COMMITMENTS AND CONTINGENCIES

LEASES

The base rate at commencement is calculated at 10.25% of MPT's adjusted
purchase price of the real estate ("APP"). The base rate increases to 12.23% of
APP effective July 1, 2005. Beginning January 1, 2006, and each January 1,
thereafter, the base rate increases by an inflator of 2.5% (i.e. base rate
becomes 12.54% of APP on January 1, 2006).

The MPT leases are subject to various financial covenants including
limitations on total debt to 100% of the total capitalization of the guarantors
(as defined) or 4.5 times the 12 month total EBITDAR of the guarantors,
whichever is greater, coverage ratios of 125% of debt service and 150% of rent
(as defined), and maintenance of average daily patient census. As of December
31, 2004, Vibra was not in compliance with the debt service and rent coverage
covenants. The MPT lease agreements were subsequently amended to delay the
initial measurement date with respect to these financial covenants (Note 11). A
default in

F-56

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
PERIOD FROM INCEPTION (MAY 14, 2004) THROUGH DECEMBER 31, 2004

any of the loan terms will also constitute a default under the leases. All of
the MPT leases are cross defaulted.

Vibra has entered into operating leases for six outpatient clinics which
expire on various dates through 2008.

Minimum future lease obligations on the leases are as follows (in
thousands):

MPT RENT OUTPATIENT
OBLIGATION CLINICS TOTAL
---------- ---------- --------

December 31, 2005.................................... $ 14,344 $205 $ 14,549
2006................................................. 16,082 122 16,204
2007................................................. 16,485 84 16,569
2008................................................. 16,897 55 16,952
2009................................................. 17,319 -- 17,319
Thereafter........................................... 188,465 -- 188,465
-------- ---- --------
$269,592 $466 $270,058
======== ==== ========

Substantially, all of the assets of Vibra and its subsidiaries, as well as
Vibra's membership interests in its subsidiaries, secure the MPT leases. In
addition the sole member of Vibra, an affiliated Company owned by the sole
member, and Vibra Management LLC have joint and severally guaranteed the leases
to MPT, although the obligation of the sole member is limited to $5 million and
his membership interest in Vibra.

The Company has sublet a floor of its Marlton, NJ, hospital to an
independent pediatric rehabilitation provider. Three other hospitals have
entered into numerous sublease arrangements. These subleases generated rental
income of $884,913 for the period from inception through December 31, 2004 and
is included in non-operating revenue in the accompanying consolidated statement
of operations. The following table summarizes amounts due under sub leases (in
thousands):

December 31, 2005........................................... $ 1,119
2006........................................................ 1,144
2007........................................................ 1,170
2008........................................................ 1,197
2009........................................................ 1,223
Thereafter.................................................. 4,614
-------
$10,467
=======

LITIGATION

The Company is subject to legal proceedings and claims that have arisen in
the ordinary course of its business and have not been finally adjudicated
(including claims against the hospitals under prior ownership). In the opinion
of management, the outcome of these actions will not have a material effect on
the financial position or results of operations of the Company.

CALIFORNIA MEDICAID

F-57

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
PERIOD FROM INCEPTION (MAY 14, 2004) THROUGH DECEMBER 31, 2004

hospitals. Amounts receivable at December 31, 2004, include $1,015,959 due from
Medi-Cal, including $657,000 prior to the acquisition. Management is continuing
to negotiate with Medi-Cal. The amount that will ultimately be received cannot
be determined at this time.

CALIFORNIA SEISMIC UPGRADE

For earthquake protection California requires hospitals to receive an
approved Structural Performance Category 2 (SPC-2) by January 1, 2008, to
maintain its license. Hospitals may request a five year implementation
extension. The Fresno, CA, hospital is expected to meet the SPC-2 standard by
January 1, 2008, with capital outlays that are not material to the consolidated
financial statements. The Kentfield, CA, hospital has applied for a three year
extension to meet the requirement. Management is in preliminary consultations
with consulting architects and engineers to develop a plan for Kentfield to meet
the requirements. The capital outlay required to meet the standards at Kentfield
cannot be determined at this time.

9. RETIREMENT SAVINGS PLAN

10. SEGMENT INFORMATION

The following table summarizes selected financial data for the Company's
reportable segments:

FOR THE PERIOD FROM INCEPTION (MAY 14, 2004) THROUGH
DECEMBER 31, 2004
------------------------------------------------------
IRF LTACH OTHER TOTAL
------------ ------------ --------- ------------

Net patient service revenue........ $24,741,573 $23,524,446 $ -- $48,266,019
Net operating loss................. (3,649,867) (1,395,339) (63,205) (5,108,411)
Interest expense................... 1,493,279 800,123 -- 2,293,402
Depreciation and amortization...... 185,746 116,448 -- 302,194
Deferred rent...................... 1,833,216 627,092 -- 2,460,308
Total assets....................... 32,175,207 26,702,535 143,108 59,020,850
Purchases of property and
equipment........................ 75,582 92,318 -- 167,900
Goodwill........................... 16,664,491 7,845,805 -- 24,510,296

F-58

VIBRA HEALTHCARE, LLC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
PERIOD FROM INCEPTION (MAY 14, 2004) THROUGH DECEMBER 31, 2004

11. SUBSEQUENT EVENT

On February 9, 2005, Vibra closed on a revolving credit facility (the
"Revolver") with Merrill Lynch Capital secured by a first position in the
Company's accounts receivable through an intercreditor agreement with MPT. Up to
$14 million can be borrowed based on a formula of qualifying accounts
receivable. The terms of the Revolver are interest only for three years at 30
day LIBOR plus 3% with a balloon maturity on February 8, 2008. The proceeds were
used to repay $7,725,958 of notes payable to MPT and for general corporate
purposes.

On March 31, 2005, MPT and Vibra amended the hospital leases for no
consideration. The amendments included delaying the initial measurement date
with respect to limitations on total debt and coverage ratios until the quarter
ending September 30, 2006, aggregating the six hospitals financial results in
calculating the financial covenants, establishing an escrow for property taxes
and insurance, and certain other terms.

F-59

------------------------------------------------------
------------------------------------------------------

NO DEALER, SALESMAN OR OTHER PERSON HAS BEEN AUTHORIZED TO GIVE ANY INFORMATION
OR TO MAKE ANY REPRESENTATIONS OTHER THAN THOSE CONTAINED IN THIS PROSPECTUS,
AND IF GIVEN OR MADE SUCH INFORMATION OR REPRESENTATION MUST NOT BE RELIED UPON
AS HAVING BEEN AUTHORIZED BY US OR THE UNDERWRITERS. THE STATEMENTS IN THIS
PROSPECTUS ARE MADE AS OF THE DATE HEREOF, UNLESS ANOTHER DATE IS SPECIFIED, AND
NEITHER THE DELIVERY OF THIS PROSPECTUS NOR ANY SALE MADE HEREUNDER SHALL, UNDER
ANY CIRCUMSTANCES, CREATE AN IMPLICATION THAT THERE HAS BEEN NO CHANGE IN THE
FACTS SET FORTH HEREIN SINCE THE DATE HEREOF. THIS PROSPECTUS IS NOT AN OFFER TO
SELL OR SOLICITATION OF AN OFFER TO BUY THESE SHARES OF COMMON STOCK IN ANY
CIRCUMSTANCES UNDER WHICH THE OFFER OR SOLICITATION IS UNLAWFUL.

TABLE OF CONTENTS

Summary............................... 1
Risk Factors.......................... 16
A Warning About Forward Looking
Statements.......................... 39
Use of Proceeds....................... 40
Capitalization........................ 41
Dilution.............................. 42
Distribution Policy................... 44
Selected Financial Information........ 45
Management's Discussion and Analysis
of Financial Condition and Results
of Operations....................... 47
Our Business.......................... 56
Our Portfolio......................... 71
Management............................ 96
Compensation Committee Interlocks and
Insider Participation............... 107
Institutional Trading of Our Common
Stock............................... 107
Principal Stockholders................ 108
Selling Stockholders.................. 109
Registration Rights and Lock-up
Agreements.......................... 109
Certain Relationships and Related
Transactions........................ 112
Investment Policies and Policies with
Respect to Certain Activities....... 114
Description of Capital Stock.......... 118
Material Provisions of Maryland Law
and of our Charter and Bylaws....... 122
Partnership Agreement................. 127
United States Federal Income Tax
Considerations...................... 131
Underwriting.......................... 151
Legal Matters......................... 155
Experts............................... 155
Where You Can Find More Information... 155
Index to Financial Statements and
Financial Statement Schedules....... F-1

UNTIL , 2005, ALL DEALERS EFFECTING TRANSACTIONS IN THE
REGISTERED SECURITIES, WHETHER OR NOT PARTICIPATING IN THIS DISTRIBUTION, MAY BE
REQUIRED TO DELIVER A PROSPECTUS. THIS IS IN ADDITION TO THE OBLIGATION OF
DEALERS TO DELIVER A PROSPECTUS WHEN ACTING AS UNDERWRITERS AND WITH RESPECT TO
THEIR UNSOLD ALLOTMENTS OR SUBSCRIPTIONS.

11,365,000 SHARES

(MEDICAL PROPERTIES TRUST LOGO)
COMMON STOCK
-------------------------

PROSPECTUS
-------------------------

FRIEDMAN BILLINGS RAMSEY

JPMORGAN
, 2005
- ------------------------------------------------------
- ------------------------------------------------------

PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

ITEM 31. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.

The following table sets forth the costs and expenses payable by the
Registrant in connection with the issuance and distribution of common stock
being registered. All amounts except the SEC registration fee and NASD fee are
estimates.

AMOUNT TO BE PAID
-----------------

SEC registration fee........................................ 31,675
NASD Fee.................................................... 25,500
NYSE Listing Fees........................................... *
Transfer agent and registrar fees........................... *
Legal fees and expenses..................................... *
Accounting fees and expenses................................ *
Printing and mailing fees................................... *
Miscellaneous............................................... *
Total....................................................... *

- ---------------

* To be filed by amendment.

ITEM 32. SALES TO SPECIAL PARTIES.

Not applicable.

ITEM 33. RECENT SALES OF UNREGISTERED SECURITIES.

On April 6, 2004 and April 7, 2004, we sold in a private placement
21,857,329 shares of common stock to Friedman, Billings, Ramsey & Co., Inc., as
initial purchaser, pursuant to the exemptions from registration provided in
Section 4(2) of the Securities Act of 1933, as amended , or the Securities Act,
and Rule 506 of Regulation D thereunder. Friedman, Billings, Ramsey & Co., Inc.
promptly resold 20,244,426 of these shares to qualified institutional buyers in
accordance the resale exemption provided in Rule 144A under the Securities Act
and to non-U.S. persons in accordance with the exemption provided in Regulation
S under the Securities Act. Friedman, Billings, Ramsey & Co., Inc. paid us a
purchase price of $9.30 per share for the shares it purchased and resold the
shares that it resold for a price of $10.00 per share.

Also on April 7, 2004, the Company sold in a concurrent private placement
3,442,671 shares of common stock directly to institutional and individual
accredited investors pursuant to the exemptions from registration provided in
Section 4(2) of the Securities Act and Rule 506 of Regulation D thereunder.
These shares were sold for $10.00 per share; however, Friedman, Billings, Ramsey
& Co., Inc., which acted as placement agent, received a placement agent fee of
$0.70 per share. In addition, we issued 260,954 shares of our common stock on
April 7, 2004, to Friedman, Billings, Ramsey & Co., Inc. in a private placement
under Section 4(2) of the Securities Act and Rule 506 of Regulation D thereunder
as payment for financial advisory services.

Each of the private placements that we made in reliance on the exemptions
from registration provided under Section 4(2) of the Securities Act and Rule 506
of Regulation D thereunder, as described in the two proceeding paragraphs, did
not involve any public offering of the common stock. In addition, each purchaser
of privately placed shares provided us with written representations that it was
an accredited investor within the meaning of Rule 501(e) of Regulation D, that
it was a sophisticated investor and that it had the knowledge and experience
necessary to evaluate the risks and merits of the investment in our

II-1

common stock. In addition, each purchaser of our common stock in the private
placements and resales that occurred on April 6 and April 7, 2004 was solicited
on a private and confidential basis in a manner not involving any general
solicitation or advertising in compliance with Regulation D.

Pursuant to our 2004 Equity Incentive Plan, we have granted options to
purchase a total of 160,000 shares of common stock, and awarded 20,000 deferred
stock units, to our current or former independent directors. In addition, on
April 25, 2005, we awarded 82,000 shares of restricted common stock to certain
of our employees. In granting these options to purchase common stock and
deferred stock units and in making these restricted stock awards, we relied upon
exemptions from registration set forth in Section 4(2) of the Securities Act and
Rule 701 under the Securities Act.

In August and September 2003, Mr. Aldag, Mr. McLean, Mr. McKenzie and Mr.
Hamner, or our founders, were collectively issued 1,630,435 shares of our common
stock in exchange for nominal cash consideration. Upon completion of our private
placement in April 2004, 1,108,527 shares of common stock held by our senior
management were redeemed for nominal value and they now collectively hold
557,908 shares of our common stock, including shares purchased in our April 2004
private placement. We relied upon Section 4(2) of the Securities Act in issuing
these shares of common stock to our founders.

ITEM 34. INDEMNIFICATION OF DIRECTORS AND OFFICERS.

We maintain a directors and officers liability insurance policy. Our
charter limits the personal liability of our directors and officers for monetary
damages to the fullest extent permitted under current Maryland law, and our
charter and bylaws provide that a director or officer shall be indemnified to
the fullest extent required or permitted by Maryland law from and against any
claim or liability to which such director or officer may become subject by
reason of his or her status as a director or officer of our company. Maryland
law allows directors and officers to be indemnified against judgments,
penalties, fines, settlements, and expenses actually incurred in a proceeding
unless the following can be established:

- the director or officer actually received an improper personal benefit in
money, property or services; or

- with respect to any criminal proceeding, the director or officer had
reasonable cause to believe his or her act or omission was unlawful.

In addition to any indemnification to which our directors and officers are
entitled pursuant to our charter and bylaws and the MGCL, our charter and bylaws
provide that we may indemnify other employees and agents to the fullest extent
permitted under Maryland law, whether they are serving us or, at our request,
any other entity.

We have entered into indemnification agreements with each of our directors
and executive officers, which we refer to in this context as indemnitees. The
indemnification agreements provide that we will, to the fullest extent permitted
by Maryland law, indemnify and defend each indemnitee against all losses and
expenses incurred as a result of his current or past service as our director or
officer, or incurred by reason of the fact that, while he was our director or
officer, he was serving at our request as a director, officer, partners,
trustee, employee or agent of a corporation, partnership, joint venture, trust,
other enterprise or employee benefit plan. We have agreed to pay expenses
incurred by an indemnitee before the final disposition of a claim provided that
he provides us with a written affirmation that he has met the standard
II-2

of conduct required for indemnification and a written undertaking to repay the
amount we pay or reimburse if it is ultimately determined that he has not met
the standard of conduct required for indemnification. We are to pay expenses
within 20 days of receiving the indemnitee's written request for such an
advance. Indemnitees are entitled to select counsel to defend against
indemnifiable claims.

ITEM 35. TREATMENT OF PROCEEDS FROM STOCK BEING REGISTERED.

None of the proceeds will be credited to an account other than the
appropriate capital share account.

ITEM 36. FINANCIAL STATEMENTS AND EXHIBITS.

(a) Financial Statements. See page F-1 for an index of the financial
statements included in the Registration Statement.

(b) Exhibits. The following exhibits are filed as part of this
registration statement on Form S-11.

EXHIBIT
NUMBER EXHIBIT TITLE
- ------- -------------

II-3

EXHIBIT
NUMBER EXHIBIT TITLE
- ------- -------------

10.14** Third Amended and Restated Lease Agreement between San
Joaquin Health Care Associates Limited Partnership and 7173
North Sharon Avenue Operating Company, LLC, dated December
20, 2004.
10.15** First Amendment to Third Amended and Restated Lease
Agreement between San Joaquin Health Care Associates Limited
Partnership and 7173 North Sharon Avenue Operating Company,
LLC, dated December 31, 2004.
10.16** Second Amended and Restated Lease Agreement between 8451
Pearl Street, LLC and 8451 Pearl Street Operating Company,
LLC, dated December 20, 2004.
10.17** First Amendment Second Amended and Restated Lease Agreement
between 8451 Pearl Street, LLC and 8451 Pearl Street
Operating Company, LLC, dated December 31, 2004.
10.18** Second Amended and Restated Lease Agreement between 4499
Acushnet Avenue, LLC and 4499 Acushnet Avenue Operating
Company, LLC, dated December 20, 2004.
10.19** First Amendment to Second Amended and Restated Lease
Agreement between 4499 Acushnet Avenue, LLC and 4499
Acushnet Avenue Operating Company, LLC, dated December 31,
2004.
10.20** Third Amended and Restated Lease Agreement between Kentfield
THCI Holding Company, LLC and 1125 Sir Francis Drake
Boulevard Operating Company, LLC, dated December 20, 2004.
10.21** First Amendment to Third Amended and Restated Lease
Agreement between Kentfield THCI Holding Company, LLC and
1125 Sir Francis Drake Boulevard Operating Company, LLC,
dated December 31, 2004.
10.22** Loan Agreement between Colonial Bank, N.A., and MPT West
Houston MOB, L.P., dated December 17, 2004.
10.23** Loan Agreement between Colonial Bank, N.A., and MPT West
Houston Hospital, L.P., dated December 17, 2004.
10.24** Loan Agreement between Merrill Lynch Capital and 4499
Acushnet Avenue, LLC, 8451 Pearl Street, LLC, 92 Brick Road,
LLC, 1300 Campbell Lane, LLC, Kentfield THCI Holding
Company, LLC and San Joaquin Health Care Associates, LP,
dated December 31, 2004.
10.25** Payment Guaranty made by the Registrant and MPT Operating
Partnership, L.P. in favor of Merrill Lynch Capital, dated
December 31, 2004.
10.26** Purchase Agreement among THCI Company, LLC, THCI of
California, LLC, THCI of Massachusetts, LLC, THCI Mortgage
Holding Company, LLC and MPT Operating Partnership, L.P.,
dated May 20, 2004.
10.27** Purchase and Sale Agreement among MPT Operating Partnership,
L.P., MPT of Victorville, LLC, Prime A Investments, L.L.C.,
Desert Valley Health System, Inc., Desert Valley Hospital,
Inc. and Desert Valley Medical Group, Inc., dated February
28, 2005.
10.28** Lease Agreement between MPT of Victorville, LLC and Desert
Valley Hospital, Inc., dated February 28, 2005.
10.29** Purchase and Sale Agreement among MPT Operating Partnership,
L.P., MPT of Bucks County Hospital, L.P., Bucks County
Oncoplastic Institute, LLC, Jerome S. Tannenbaum, M.D., M.
Stephen Harrison and DSI Facility Development, LLC, dated
March 3, 2005.
10.30** Employment Agreement between the Registrant and Michael G.
Stewart, dated April 28, 2005.
10.31** Letter of Commitment between MPT Operating Partnership, L.P.
and Monroe Hospital Operating Hospital, dated February 28,
2005.
10.32** Letter of Commitment between MPT Operating Partnership,
L.P., Covington Healthcare Properties, LLC and Denham
Springs Healthcare Properties, LLC, dated March 14, 2005.
10.33** Letter of Commitment between MPT Operating Partnership, L.P.
and North Cypress Medical Center Operating Partnership,
Ltd., dated March 16, 2005.
10.34** Letter of Commitment between MPT Operating Partnership,
L.P., Hammond Healthcare Properties, LLC and Hammond
Rehabilitation Hospital, LLC, dated April 1, 2005.
10.35** Letter of Commitment between MPT Operating Partnership, L.P.
and Diversified Specialty Institutes, Inc., dated March 3,
2005.

II-4

EXHIBIT
NUMBER EXHIBIT TITLE
- ------- -------------

10.36** Amendment to Letter of Commitment between MPT Operating
Partnership, L.P. and Diversified Specialty Institutes,
Inc., dated March 31, 2005.
10.37** Letter of Commitment between MPT Operating Partnership,
L.P., MPT of Victorville, LLC and Desert Valley Hospital,
Inc. dated February 28, 2005.
10.38** Amendment to Purchase and Sale Agreement among MPT Operating
Partnership, L.P., MPT of Bucks County Hospital, L.P., Bucks
County Oncoplastic Institute, LLC, DSI Facility Development,
LLC, Jerome S. Tannenbaum, M.D., M. Stephen Harrison and G.
Patrick Maxwell, M.D., dated April 29, 2005.
21.1* Subsidiaries of the Registrant
23.1 Consent of KPMG LLP
23.2 Consent of Parente Randolph, LLC
23.3* Consent of Baker, Donelson, Bearman, Caldwell & Berkowitz,
P.C. (included in Exhibits 5.1 and 8.1)
24.1** Power of Attorney, included on signature page of the
Registrant's Form S-11 filed with the Commission on October
26, 2004.
24.2** Power of Attorney, included on signature page of Amendment
No. 3 to the Registrant's Form S-11 filed with the
Commission on May 13, 2005.

- ---------------

* To be filed by amendment.

** Previously filed.

ITEM 37. UNDERTAKINGS.

(a) The undersigned registrant hereby undertakes to provide to the
underwriters at the closing specified in the underwriting agreement certificates
in such denominations and registered in such names as required by the
underwriters to permit prompt delivery to each purchaser.

(b) Insofar as indemnification for liabilities arising under the Securities
Act of 1933, as amended, may be permitted to directors, officers or controlling
persons of the registrant pursuant to the foregoing provisions, or otherwise,
the registrant has been advised that in the opinion of the Securities and
Exchange Commission such indemnification is against public policy as expressed
in the Securities Act of 1933, as amended, and is, therefore, unenforceable. In
the event that a claim for indemnification against such liabilities (other than
the payment by the registrant of expenses incurred or paid by a director,
officer or controlling person of the registrant in the successful defense of any
action, suit or proceeding) is asserted by such director, officer or controlling
person in connection with the securities being registered, the registrant will,
unless in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in the
Securities Act of 1933, as amended, and will be governed by the final
adjudication of such issue.

(1) For purposes of determining any liability under the Securities Act
of 1933, as amended, the information omitted from the form of prospectus
filed as part of this registration statement in reliance under Rule 430A
and contained in a form of prospectus filed by the Registrant pursuant to
Rule 424(b)(1) or (4), or 497(h) under the Securities Act shall be deemed
to part of this registration statement as of the time it was declared
effective.

(2) For the purpose of determining any liability under the Securities
Act of 1933, as amended, each post-effective amendment that contains a form
of prospectus shall be deemed to be a new registration statement relating
to the securities offered herein, and the offering of such securities at
that time shall be deemed to be the initial bona fide offering thereof.

II-5

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, the
registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-11 and has duly caused this
registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in Birmingham, Alabama on June 3, 2005.

MEDICAL PROPERTIES TRUST, INC.

By: /s/ R. STEVEN HAMNER
------------------------------------
R. Steven Hamner
Executive Vice President,
Chief Financial Officer and Director

Pursuant to the requirements of the Securities Act of 1933, as amended,
this registration statement has been signed by the following persons in the
capacities and on the dates listed.

SIGNATURE TITLE DATE
--------- ----- ----

* Chairman of the Board, President and June 3, 2005
- -------------------------------------- Chief Executive Officer
Edward K. Aldag, Jr.

/s/ R. STEVEN HAMNER Executive Vice President, Chief June 3, 2005
- -------------------------------------- Financial Officer and Director
R. Steven Hamner

* June 3, 2005
- -------------------------------------- Director
Virginia A. Clarke

* June 3, 2005
- -------------------------------------- Director
G. Steven Dawson

* June 3, 2005
- -------------------------------------- Director
Bryan L. Goolsby

* June 3, 2005
- -------------------------------------- Director
Robert E. Holmes, Ph.D.

* June 3, 2005
- -------------------------------------- Vice Chairman of the Board
William G. McKenzie

* June 3, 2005
- -------------------------------------- Director
L. Glenn Orr, Jr.

*By: /s/ R. STEVEN HAMNER June 3, 2005
------------------------------
R. Steven Hamner
Attorney-in-Fact

II-6

EXHIBIT
NUMBER EXHIBIT TITLE
- ------- -------------

1.1* Form of Underwriting Agreement
3.1** Registrant's Second Articles of Amendment and Restatement
3.2 Registrant's Amended and Restated Bylaws
4.1* Form of Common Stock Certificate
5.1* Opinion of Baker, Donelson, Bearman, Caldwell & Berkowitz,
P.C. with respect to the legality of the shares being
registered
8.1* Opinion of Baker, Donelson, Bearman, Caldwell & Berkowitz,
P.C. with respect to certain tax matters
10.1* First Amended and Restated Agreement of Limited Partnership
of MPT Operating Partnership, L.P.
10.2* Amended and Restated 2004 Equity Incentive Plan
10.3** Employment Agreement between the Registrant and Edward K.
Aldag, Jr., dated September 10, 2003
10.4** First Amendment to Employment Agreement between the
Registrant and Edward K. Aldag, Jr., dated March 8, 2004
10.5** Employment Agreement between the Registrant and Emmett E.
McLean, dated September 10, 2003
10.6** Employment Agreement between the Registrant and R. Steven
Hamner, dated September 10, 2003
10.7** Amended and Restated Employment Agreement between the
Registrant and William G. McKenzie, dated September 10, 2003
10.8** Lease Agreement between MPT West Houston MOB, L.P. and
Stealth L.P., dated June 17, 2004.
10.9** Lease Agreement between MPT West Houston Hospital, L.P. and
Stealth L.P., dated June 17, 2004.
10.10** Third Amended and Restated Lease Agreement between 1300
Campbell Lane, LLC and 1300 Campbell Lane Operating Company,
LLC, dated December 20, 2004.
10.11** First Amendment to Third Amended and Restated Lease
Agreement between 1300 Campbell Lane, LLC and 1300 Campbell
Lane Operating Company, LLC, dated December 31, 2004.
10.12** Second Amended and Restated Lease Agreement between 92 Brick
Road, LLC and 92 Brick Road, Operating Company, LLC, dated
December 20, 2004.
10.13** First Amendment to Second Amended and Restated Lease
Agreement between 92 Brick Road, LLC and 92 Brick Road,
Operating Company, LLC, dated December 31, 2004.
10.14** Third Amended and Restated Lease Agreement between San
Joaquin Health Care Associates Limited Partnership and 7173
North Sharon Avenue Operating Company, LLC, dated December
20, 2004.
10.15** First Amendment to Third Amended and Restated Lease
Agreement between San Joaquin Health Care Associates Limited
Partnership and 7173 North Sharon Avenue Operating Company,
LLC, dated December 31, 2004.
10.16** Second Amended and Restated Lease Agreement between 8451
Pearl Street, LLC and 8451 Pearl Street Operating Company,
LLC, dated December 20, 2004.
10.17** First Amendment to Second Amended and Restated Lease
Agreement between 8451 Pearl Street, LLC and 8451 Pearl
Street Operating Company, LLC, dated December 31, 2004.
10.18** Second Amended and Restated Lease Agreement between 4499
Acushnet Avenue, LLC and 4499 Acushnet Avenue Operating
Company, LLC, dated December 20, 2004.
10.19** First Amendment to Second Amended and Restated Lease
Agreement between 4499 Acushnet Avenue, LLC and 4499
Acushnet Avenue Operating Company, LLC, dated December 31,
2004.
10.20** Third Amended and Restated Lease Agreement between Kentfield
THCI Holding Company, LLC and 1125 Sir Francis Drake
Boulevard Operating Company, LLC, dated December 20, 2004.

II-7

EXHIBIT
NUMBER EXHIBIT TITLE
- ------- -------------

10.21** First Amendment to Third Amended and Restated Lease
Agreement between Kentfield THCI Holding Company, LLC and
1125 Sir Francis Drake Boulevard Operating Company, LLC,
dated December 31, 2004.
10.22** Loan Agreement between Colonial Bank, N.A., and MPT West
Houston MOB, L.P., dated December 17, 2004.
10.23** Loan Agreement between Colonial Bank, N.A., and MPT West
Houston Hospital, L.P., dated December 17, 2004.
10.24** Loan Agreement between Merrill Lynch Capital and 4499
Acushnet Avenue, LLC, 8451 Pearl Street, LLC, 92 Brick Road,
LLC, 1300 Campbell Lane, LLC, Kentfield THCI Holding
Company, LLC and San Joaquin Health Care Associates, LP,
dated December 31, 2004.
10.25** Payment Guaranty made by the Registrant and MPT Operating
Partnership, L.P. in favor of Merrill Lynch Capital, dated
December 31, 2004.
10.26** Purchase Agreement among THCI Company, LLC, THCI of
California, LLC, THCI of Massachusetts, LLC, THCI Mortgage
Holding Company, LLC and MPT Operating Partnership, L.P.,
dated May 20, 2004.
10.27** Purchase and Sale Agreement among MPT Operating Partnership,
L.P., MPT of Victorville, LLC, Prime A Investments, L.L.C.,
Desert Valley Health System, Inc., Desert Valley Hospital,
Inc. and Desert Valley Medical Group, Inc., dated February
28, 2005.
10.28** Lease Agreement between MPT of Victorville, LLC and Desert
Valley Hospital, Inc., dated February 28, 2005.
10.29** Purchase and Sale Agreement among MPT Operating Partnership,
L.P., MPT of Bucks County Hospital, L.P., Bucks County
Oncoplastic Institute, LLC, Jerome S. Tannenbaum, M.D., M.
Stephen Harrison and DSI Facility Development, LLC, dated
March 3, 2005.
10.30** Employment Agreement between the Registrant and Michael G.
Stewart, dated April 28, 2005.
10.31** Letter of Commitment between MPT Operating Partnership, L.P.
and Monroe Hospital Operating Hospital, dated February 28,
2005.
10.32** Letter of Commitment between MPT Operating Partnership,
L.P., Covington Healthcare Properties, LLC and Denham
Springs Healthcare Properties, LLC, dated March 14, 2005.
10.33** Letter of Commitment between MPT Operating Partnership, L.P.
and North Cypress Medical Center Operating Partnership,
Ltd., dated March 16, 2005.
10.34** Letter of Commitment between MPT Operating Partnership,
L.P., Hammond Healthcare Properties, LLC and Hammond
Rehabilitation Hospital, LLC, dated April 1, 2005.
10.35** Letter of Commitment between MPT Operating Partnership, L.P.
and Diversified Specialty Institutes, Inc., dated March 3,
2005.
10.36** Amendment to Letter of Commitment between MPT Operating
Partnership, L.P. and Diversified Specialty Institutes,
Inc., dated March 31, 2005.
10.37** Letter of Commitment between MPT Operating Partnership,
L.P., MPT of Victorville, LLC and Desert Valley Hospital,
Inc. dated February 28, 2005.
10.38** Amendment to Purchase and Sale Agreement among MPT Operating
Partnership, L.P., MPT of Bucks County Hospital, L.P., Bucks
County Oncoplastic Institute, LLC, DSI Facility Development,
LLC, Jerome S. Tannenbaum, M.D., M. Stephen Harrison and G.
Patrick Maxwell, M.D., dated April 29, 2005.
21.1* Subsidiaries of the Registrant
23.1 Consent of KPMG LLP
23.2 Consent of Parente Randolph, LLC
23.3* Consent of Baker, Donelson, Bearman, Caldwell & Berkowitz,
P.C. (included in Exhibits 5.1 and 8.1)

II-8

EXHIBIT
NUMBER EXHIBIT TITLE
- ------- -------------

24.1** Power of Attorney, included on signature page of the
Registrant's Form S-11 filed with the Commission on October
26, 2004.
24.2** Power of Attorney included on signature page of Amendment
No. 3 to the Registrant's Form S-11 filed with the
Commission on May 13, 2005.

- ---------------

* To be filed by amendment.

** Previously filed.

II-9


                                                                     EXHIBIT 3.2

                         MEDICAL PROPERTIES TRUST, INC.
                           AMENDED AND RESTATED BYLAWS


                                    ARTICLE I
                                  STOCKHOLDERS

Section 1.01. Annual Meeting. The annual meeting of the stockholders of Medical
Properties Trust, Inc. (the "Corporation") shall be held at the principal office
of the Corporation in the State of Maryland or at any other place within or
without the State of Maryland as may be designated by the Board of Directors.
The annual meeting shall be held at such time and on such date in May of each
year as is determined by the Board of Directors; provided, however, that the
2005 annual meeting shall be held at such time and on such date during August
2005 as is determined by the Board of Directors. The business to be transacted
at the meeting shall be the election of directors and such other business as is
properly brought before the meeting. Failure to hold an annual meeting does not
invalidate the Corporation's existence or affect any otherwise valid corporate
acts.

Section 1.02. Notification of Stockholder Business. At the annual meeting of
stockholders only such business shall be conducted, and only such proposals
shall be acted upon, as shall have been properly brought before the annual
meeting (a) pursuant to the notice of meeting delivered to stockholders in
accordance with Section 1.04 below, (b) by, or at the direction of, a majority
of the Board of Directors or (c) by any stockholder of the Corporation who is a
stockholder of record at the time of giving notice provided for in this Section
1.02 and at the time of the meeting is entitled to vote at the meeting and
complies with the notice procedures set forth in this Section 1.02. For a
proposal to be properly brought before an annual meeting by a stockholder, the
stockholder must have given timely notice thereof in writing to the Secretary of
the Corporation. To be timely, a stockholder's notice must be delivered to, or
mailed and received at, the principal executive office of the Corporation not
less than ninety (90) days nor more than one hundred twenty (120) days prior to
the first anniversary of the date of the mailing of the notice for the preceding
year's annual meeting; provided, however, that in the event that the date of the
annual meeting is more than thirty (30) days before or more than sixty (60) days
after the anniversary date of the preceding year's annual meeting, notice by the
stockholder to be timely must be so delivered not earlier than one hundred
twenty (120) days prior to such annual meeting and not later than the later of
sixty (60) days prior to such annual meeting and ten (10) days following the
issuance by the Corporation of a press release announcing the meeting date. In
no event shall the public announcement of a postponement or adjournment of an
annual meeting commence a new time period for the giving of a stockholder's
notice as described above.

A stockholder's notice must contain, as of the date such notice is delivered to
the Secretary of the Corporation:

         (a) a brief description of the business desired to be brought before
         the meeting and the reasons for conducting such business at the
         meeting;





         (b) the name and address of the stockholder who intends to propose such
         business;

         (c) a representation that the stockholder is a holder of record of
         shares of the Corporation entitled to vote at such meeting and intends
         to appear in person or by proxy at such meeting to propose such
         business;

         (d) any material interest of the stockholder in such business; and

         (e) as to the stockholder giving the notice and the beneficial owner,
         if any, on whose behalf the proposal is made (i) the name and address
         of such stockholder, as they appear on the Corporation's books, and of
         such beneficial owner and (ii) the class and number of shares of the
         Corporation which are owned beneficially and of record by such
         stockholder and such beneficial owner.

The presiding officer of the meeting shall have the discretion to declare at the
meeting that any business proposed by a stockholder to be considered at the
meeting is out of order and that such business shall not be transacted at the
meeting if the presiding officer concludes that the matter has been proposed in
a manner inconsistent with the procedures set out in this Section 1.02.

Section 1.03. Special Meetings. Special meetings of the stockholders may be
called by the President, the Board of Directors, or, subject to the provisions
of Section 2-502 of the Maryland General Corporation Law, by the holders of at
least twenty-five percent (25%) of the stock entitled to vote at that meeting.

Section 1.04. Notice Of Meetings. A written notice of all annual meetings of
stockholders stating the time, date and place of such annual meetings and, to
the extent required by the Maryland General Corporation Law, the purpose for
which the meeting has been called shall be given by the Secretary or an
Assistant Secretary (or other person authorized by these Bylaws or by law) not
less than ten (10) days nor more than ninety (90) days before the meeting,
unless any provisions of the Maryland General Corporation Law prescribe a
different period of notice, to each stockholder entitled to vote at such meeting
or to each stockholder who, under the Corporation's Articles of Incorporation,
as amended from time to time (the "Charter") or under these Bylaws, is entitled
to such notice, by delivering such notice to him or by mailing it, postage
prepaid, addressed to such stockholder at the address of such stockholder as it
appears on the Corporation's stock transfer books or by any other means
permitted by Maryland law. At any time, upon the written request of any person
or persons entitled to call a special meeting, it shall be the duty of the
Secretary to send out notice of the special meeting, to be held within or
without the State of Maryland and at such time and on such date as may be fixed
by the Board of Directors, such notice to be given to each stockholder not less
than ten (10) nor more than ninety (90) days before such meeting is to take
place in the same manner as provided for annual meetings of stockholders and to
state the time, date and place of such special meeting and the purpose or
purposes for which the meeting has been called. Only those matters set forth in
the notice of a special meeting may be considered or acted upon at such special
meeting. Such notices shall be deemed to be delivered when hand delivered to
such stockholder's address or if mailed, when deposited in the mail so
addressed, with postage prepaid. A stockholder may






                                       2

waive the notice of any meeting of stockholders by attendance, either in person
or by proxy, at the meeting, or by delivery of a written waiver or a waiver by
electronic transmission, either before or after the meeting, which is filed with
the records of stockholders meetings. Attendance at a meeting for the express
purpose of objecting that the meeting was not lawfully called or convened shall
not, however, constitute a waiver of notice.

Section 1.05. Adjournment. Any meeting of stockholders may be adjourned from
time to time, whether or not there is a quorum, by the President or the vote of
a majority of the shares present. When a meeting is adjourned to another time or
place, notice need not be given of the adjourned meeting if the time and place
thereof are announced at the meeting at which the adjournment is taken except as
provided by law. At the adjourned meeting the Corporation may transact any
business which might have been transacted at the original meeting. If the
adjournment is to a date more than one hundred twenty (120) days after the
original record date, or if after the adjournment a new record date is fixed for
the adjourned meeting, a notice of the adjourned meeting shall be given to each
stockholder of record entitled to vote at the meeting.

Section 1.06. Quorum. Except as otherwise provided by law, stockholders entitled
to cast a majority of all the votes entitled to be cast at the meeting,
represented in person or by proxy, shall constitute a quorum at any annual or
special meeting of stockholders; but if less than a quorum is present at a
meeting, stockholders present or the presiding officer may adjourn the meeting
from time to time, and the meeting may be held as adjourned without further
notice, except as provided in Section 1.04 above. At such adjourned meeting at
which a quorum is present, any business may be transacted which might have been
transacted at the meeting as originally noticed. The stockholders present at a
duly constituted meeting may continue to transact business until adjournment,
notwithstanding the withdrawal of enough stockholders to leave less than a
quorum.

Section 1.07. Voting And Proxies. Stockholders shall have one vote for each
share of stock entitled to vote owned by them of record according to the books
of the Corporation, unless otherwise provided by law or by the Charter.
Stockholders may vote either in person or by written proxy, but no proxy shall
be voted or acted upon after eleven months from its date, unless the proxy
provides for a longer period. Proxies shall be filed with the Secretary of the
meeting before being voted. A proxy purporting to be executed by or on behalf of
a stockholder shall be deemed valid unless challenged at or prior to its
exercise, and the burden of proving invalidity shall rest on the challenger.

Section 1.08. Action At Meeting. When a quorum is present, any matter before any
annual or special meeting of stockholders, other than the election of directors,
shall be decided by vote of the holders of a majority of the shares of stock
voting on such matter, except where a larger vote is required by law, by the
Charter or by these Bylaws. Any election of directors by stockholders shall be
determined by a plurality of the votes cast, except where a larger vote is
required by law, by the Charter or by these Bylaws. The Corporation shall not
directly or indirectly vote any shares of its own stock except as to shares
which it holds in a fiduciary capacity or except as otherwise permitted by law.
An abstention shall not be deemed a vote cast.



                                       3

Section 1.09. Conduct of Stockholders Meetings. The presiding officers at
stockholder meetings shall be determined as provided in Article III hereof. The
precedence of, and procedure on, motions and other procedural matters at such
meetings shall be as determined by the presiding officer of the meeting, in his
sole discretion, provided that he acts in a manner not inconsistent with law,
with the Charter or with these Bylaws. The date and time of the opening and the
closing of the polls for each matter upon which the stockholders will vote at
the meeting shall be announced at the meeting. Voting by the stockholders shall
be by voice or by ballot as determined by the presiding officer of the meeting.

Section 1.10. Inspectors Of Election. The Board of Directors by resolution may
appoint one or more inspectors, which inspector or inspectors may include
individuals who serve the Corporation in other capacities, including, without
limitation, as officers, employees, agents or representatives, to act at a
meeting of stockholders and make a written report thereof. One or more persons
may be designated as alternate inspectors to replace any inspector who fails to
act. If no inspector or alternate has been appointed by the Board of Directors
to act or is able to act at a meeting of stockholders, the presiding officer of
the meeting may appoint one or more inspectors to act at the meeting. Each
inspector, before discharging his or her duties, shall take and sign an oath
faithfully to execute the duties of inspector with strict impartiality and
according to the best of his or her ability. The inspectors shall have the
duties prescribed by law. The presiding officer of the meeting shall fix and
announce at the meeting the date and time of the opening and the closing of the
polls for each matter upon which the stockholders will vote at a meeting.

Section 1.11. List Of Stockholders Entitled To Vote. The Secretary shall make,
or shall cause to be made, at least ten (10) days before every meeting of
stockholders, a complete list of the stockholders entitled to vote at the
meeting, arranged in alphabetical order, and showing the address of each
stockholder and the number of shares of stock registered in the name of each
stockholder. Such list shall be open to the examination of any stockholder, for
any purpose germane to the meeting, during ordinary business hours, for a period
of at least ten (10) days prior to the meeting, either at a place within the
city where the meeting is to be held, which place shall be specified in the
notice of the meeting, or, if not so specified, at the place where the meeting
is to be held. The list shall also be produced and kept at the time and place of
the meeting during the whole time thereof and may be inspected by any
stockholder who is present.


                                   ARTICLE II
                                    DIRECTORS

Section 2.01. Powers. The business and affairs of the Corporation shall be
managed by or under the direction of the Board of Directors except as otherwise
provided by the Charter or required by law.

Section 2.02. Number and Term. The number of directors shall not be less than
one (1) nor or more than fifteen (15), as fixed from time to time by the Board
of Directors, with the initial Board of Directors consisting of three (3)
directors; provided, however, that the tenure of office of a director shall not
be affected by any increase or decrease in the number of directors so made





                                       4

by the Board of Directors. Directors shall be elected at the annual meeting of
the stockholders, and each director shall serve until the next annual meeting of
stockholders and until his successor shall be duly elected and qualify.

Section 2.03. Notification of Stockholder Nominations. Nomination of candidates
for election as directors of the Corporation at any annual or special meeting of
stockholders may be made (a) by, or at the direction of, a majority of the Board
of Directors or (b) by any stockholder entitled to vote at such annual meeting.
Only persons nominated in accordance with the procedures set forth in this
Section 2.03 shall be eligible for election as directors at an annual or special
meeting of stockholders.

Nominations, other than those made by, or at the direction of, the Board of
Directors shall be made pursuant to timely notice in writing to the Secretary of
the Corporation as set forth in this Section 2.03. To be timely, a stockholder's
notice must be delivered to, or mailed and received at, the principal executive
office of the Corporation not less than ninety (90) days nor more than one
hundred twenty (120) days prior to the first anniversary of the date of the
mailing of the notice for the preceding year's annual meeting; provided,
however, that in the event that the date of the annual meeting is more than
thirty (30) days before or more than sixty (60) days after the anniversary date
of the preceding year's annual meeting, notice by the stockholder to be timely
must be so delivered not earlier than one hundred twenty (120) days prior to
such annual meeting and not later than the later of sixty (60) days prior to
such annual meeting and ten (10) days following the issuance by the Corporation
of a press release announcing the meeting date. In no event shall the public
announcement of a postponement or adjournment of an annual meeting commence a
new time period for the giving of a stockholder's notice as described above.
Such stockholder's notice shall set forth, as of the date such notice is
delivered to the Secretary of the Corporation:

         (a) as to each person whom the stockholder proposes to nominate for
         election or re-election as a director:

    1.   the name, age, business address and residence address of such person;

    2.   the principal occupation or employment of such person;

    3.   the class and number of shares of the Corporation's capital stock which
         are beneficially owned by such person on the date of such stockholder
         notice;

    4.   the consent of each nominee to serve as a director of the Corporation
         if so elected; and

    5.   any other information relating to such person that would have been
         required to be included in a proxy statement filed pursuant to the
         proxy rules of the Securities and Exchange Commission had each nominee
         been nominated, or intended to be nominated, by the Board of Directors;
         and

         (b) as to the stockholder giving the notice:




                                       5

    1.   a brief description of the nominations desired to be brought before the
         meeting and the reasons for making such nominations at the meeting;

    2.   the name and address of the stockholder who intends to make such
         nominations;

    3.   a representation that the stockholder is a holder of record of shares
         of the Corporation entitled to vote at such meeting and intends to
         appear in person or by proxy at such meeting to make such nominations;

    4.   a description of all arrangements or understandings between the
         stockholder and each nominee and any other person (naming such person
         or persons) pursuant to which the nominations are to be made by the
         stockholder; and

    5.   as to the stockholder giving the notice and the beneficial owner, if
         any, on whose behalf the nomination is made (A) the name and address of
         such stockholder, as they appear on the Corporation's books, and of
         such beneficial owner and (B) the class and number of shares of the
         Corporation which are owned beneficially and of record by such
         stockholder and such beneficial owner.

The presiding officer of the meeting may refuse to acknowledge the nomination of
any person made without compliance with the foregoing procedure.

Section 2.04. Qualification. Directors need not be a stockholders of the
Corporation. Unless waived by a vote of the Board of Directors, no individual
may serve as a director of the Corporation if he has reached the age of
seventy-five (75) years at the time of election.

Section 2.05. Vacancies. Vacancies occurring in the Board of Directors, other
than those resulting from an increase in the number of directors, may be filled
by the affirmative vote of a majority of the remaining directors though less
than a quorum of the Board of Directors. Vacancies resulting from an increase in
the number of directors may be filled by a majority of the entire Board of
Directors. A director elected to fill a vacancy shall be elected to serve until
the next election of directors and until his successor shall be elected and
qualified.

Section 2.06. Resignation. Any director may resign at any time by giving written
notice to the Board of Directors, effective upon execution and delivery to the
Corporation of such written notice or upon any future date specified in the
notice, unless the resignation otherwise provides.

Section 2.07. Regular Meetings. Regular meetings of the Board of Directors shall
be held, without other notice than this Bylaw, on the same date and at the same
place as the annual meeting of stockholders following the close of such meeting
of stockholders and at such other times as the Board of Directors may by
resolution from time to time determine without other notice than such
resolution.

Section 2.08. Special Meetings. Special meetings of the Board of Directors may
be called, orally or in writing, by or at the request of a majority of the
directors, the Chairman of the Board, if one





                                       6

is elected, or the President. The person calling any such special meeting of the
Board of Directors may fix the hour, date and place thereof.


Section 2.09. Notice Of Meetings. Notice of the hour, date and place of all
special meetings of the Board of Directors shall be given to each director by
the Secretary or an Assistant Secretary, or in case of the death, absence,
incapacity or refusal of such persons, by the Chairman of the Board, if one is
elected, or the President or such other officer designated by the Chairman of
the Board, if one is elected, or the President. Notice of any special meeting of
the Board of Directors shall be given to each director in person or by
telephone, electronic mail, facsimile transmission or by telegram sent to his
business or home address at least twenty-four (24) hours in advance of the
meeting, or by written notice mailed to his business or home address at least
seventy-two (72) hours in advance of the meeting. Such notice shall be deemed to
be delivered when hand delivered to such address, read to such director by
telephone, deposited in the mail so addressed, with postage thereon prepaid if
mailed, upon transmission of the message by electronic mail, upon completion of
transmission of a facsimile message and receipt of a completed answer back
indicating receipt or when delivered to the telegraph company if sent by
telegram.

When any meeting of the Board of Directors, either regular or special, is
adjourned for more than thirty (30) days, notice of the adjourned meeting shall
be given as in the case of an original meeting. It shall not be necessary to
give any notice of the hour, date or place of any meeting adjourned for thirty
(30) days or less or of the business to be transacted at such meeting, other
than an announcement at the meeting at which such adjournment is taken of the
hour, date and place to which the meeting is adjourned.

A written waiver of notice executed, or a waiver of notice sent by electronic
mail, before or after a meeting by a director and filed with the records of the
meeting shall be deemed to be equivalent to notice of the meeting. The
attendance of a director at a meeting shall constitute a waiver of notice of
such meeting. Except as otherwise required by law, by the Charter or by these
Bylaws, neither the business to be transacted at, nor the purpose of, any
meeting of the Board of Directors need be specified in the notice or waiver of
notice of such meeting.

Section 2.10. Quorum. At any meeting of the Board of Directors, a majority of
the Board of Directors then in office shall constitute a quorum for the
transaction of business, but if less than a quorum is present at a meeting, a
majority of the directors present may adjourn the meeting from time to time, and
the meeting may be held as adjourned without further notice, except as provided
in this Section 2.10. Any business which might have been transacted at the
meeting as originally noticed may be transacted at such adjourned meeting at
which a quorum is present.

Section 2.11. Action At Meeting. At any meeting of the Board of Directors at
which a quorum is present, a majority of the directors present may take any
action on behalf of the Board of Directors, unless otherwise required by law, by
the Charter or these Bylaws.

Section 2.12. Action By Consent. Any action required or permitted to be taken at
any meeting of the Board of Directors may be taken without a meeting if all
members of the Board of Directors





                                       7

consent thereto in writing. Such written consent shall be filed with the records
of the proceedings of the Board of Directors and shall be treated for all
purposes as a vote at a meeting of the Board of Directors.

Section 2.13. Manner Of Participation. Members of the Board of Directors or of
committees elected by the Board of Directors pursuant to Section 2.14 below may
participate in meetings of the Board or of such committees by means of
conference telephone or similar communications equipment by means of which all
directors participating in the meeting can hear each other at the same time, and
participation in a meeting in accordance herewith shall constitute presence in
person at such meeting for purposes of these Bylaws.

Section 2.14. Committees. The Board of Directors, by the affirmative vote of a
majority of the directors then in office, may appoint from its number directors
to serve on one or more committees, including an Audit Committee, a Compensation
Committee, an Ethics, Nominating and Corporate Governance Committee and an
Investment Committee, and may delegate thereto some or all of its powers except
those which by law, by the Charter or by these Bylaws, may not be delegated.
Except as the Board of Directors may otherwise determine or as required by law,
by the Charter or these Bylaws, any such committee may make rules for conduct of
its business, but unless otherwise provided by the Board of Directors or in such
rules, its business shall be conducted so far as possible in the same manner as
is provided by the Charter and by these Bylaws for the Board of Directors. The
Board of Directors may abolish any such committee, other than the Audit
Committee, at any time. Any committee to which the Board of Directors delegates
any of its powers or duties shall keep records of its meetings and shall report
its action to the Board of Directors.

The Board of Directors shall have power to rescind any action of any committee,
other than the Audit Committee, but no such rescission shall have retroactive
effect. With the approval of the Board of Directors, the Chief Executive Officer
may appoint such other committees consisting of such directors as the Chief
Executive Officer shall select. Any recommendations of such committees appointed
by the Chief Executive Officer shall be submitted to the Board of Directors for
its approval.

Section 2.15. Compensation Of Directors. Directors shall receive compensation
for their services as shall be determined by a majority of the Board of
Directors, except that directors who are serving the Corporation as officers or
employees and who receive compensation for their services as such ("Employee
Directors") shall not receive any salary or other compensation for their
services as directors of the Corporation; provided, however, that such Employee
Directors may be paid their reasonable expenses incurred as a director.


                                   ARTICLE III
                                    OFFICERS

Section 3.01. Enumeration. The officers of the Corporation shall consist of a
President, a Chief Executive Officer, a Secretary and a Treasurer and such other
officers, including without limitation a Chairman of the Board, a Chief
Operating Officer, a Chief Financial Officer, a Chief




                                       8


Accounting Officer, one or more Vice Presidents (including Executive Vice
Presidents or Senior Vice Presidents), Assistant Vice Presidents, Assistant
Treasurers and Assistant Secretaries, as the Board of Directors may determine.

Section 3.02. Election And Appointment. At the regular meeting of the Board of
Directors following the annual meeting of stockholders, the Board of Directors
shall elect the President, the Chief Executive Officer, the Chief Financial
Officer, the Treasurer and the Secretary. Other officers may be elected by the
Board of Directors at such regular meeting of the Board of Directors or at any
other regular or special meeting.

Section 3.03. Qualification. No officer need be a stockholder or a director,
except that the Chairman of the Board must be a director. Any person may occupy
more than one office of the Corporation at any time except the offices of
President and Vice President. Any officer may be required by the Board of
Directors to give bond, at the Corporation's expense, for the faithful
performance of his duties in such amount and with such sureties as the Board of
Directors may determine.

Section 3.04. Tenure. Except as otherwise provided by the Charter or by these
Bylaws, each of the officers of the Corporation shall hold office until the
regular meeting of the Board of Directors following the next annual meeting of
stockholders and until his successor is elected and qualified or until his
earlier resignation or removal. Election or appointment of an officer, employee
or agent shall not of itself create contract rights. The Board of Directors may,
however, authorize the Corporation to enter into an employment contract with any
officer in accordance with law, but no such contract right shall prohibit the
right of the Board of Directors to remove any officer at any time in accordance
with Section 3.06 below.

Section 3.05. Resignation. Any officer may resign by delivering written notice
of his resignation to the Corporation addressed to the President or the
Secretary, and such resignation shall be effective upon receipt unless it is
specified to be effective at some other time or upon the happening of some other
event. Unless otherwise specified in the notice, the acceptance of a resignation
shall not be necessary to make the resignation effective.

Section 3.06. Removal. If the Board of Directors in its judgment finds that the
best interests of the Corporation will be served, the Board of Directors may
remove any officer by the affirmative vote of a majority of the directors then
in office. Such removal shall be without prejudice to the contract rights, if
any, of the person so removed.

Section 3.07. Absence Or Disability. In the event of the absence or disability
of any officer, the Board of Directors may designate another officer to act
temporarily in place of such absent or disabled officer.

Section 3.08. Vacancies. Any vacancy in any office may be filled for the
unexpired portion of the term by the Board of Directors.

Section 3.09. Chief Executive Officer. The President shall be the Chief
Executive Officer, unless the Board of Directors shall elect another officer to
be the Chief Executive Officer. The





                                       9


Chief Executive Officer shall, subject to the direction of the Board of
Directors, have general supervision and control of the Corporation's business
and shall preside, when present, at all meetings of the stockholders.

Section 3.10. Chairman Of The Board. The Chairman of the Board shall preside at
all meetings of the Board of Directors. If the Chairman of the Board is absent,
the President shall preside at meetings of the Board of Directors. If the
Chairman of the Board is not the Chief Executive Officer and in the absence of
the Chief Executive Officer, the Chairman of the Board shall preside, when
present, at all meetings of the stockholders. The Chairman of the Board shall
have such other powers and shall perform such other duties as the Board of
Directors may from time to time designate. If the Chairman of the Board is not
the Chief Executive Officer, he shall also have such powers and perform such
duties as the Chief Executive Officer may from time to time designate.

Section 3.11. President. In the absence of the Chairman of the Board, the
President shall preside, when present, at all meetings of the Board of
Directors. If the President is not the Chief Executive Officer or Chairman of
the Board and in the absence of such persons, the President shall preside, when
present, at all meetings of the stockholders. If the President is not the Chief
Executive Officer, he shall have such powers and perform such duties as the
Board of Directors or the Chief Executive Officer may from time to time
designate.

Section 3.12. Chief Operating Officer, Chief Financial Officer And Chief
Accounting Officer. Any Chief Operating Officer, Chief Financial Officer or
Chief Accounting Officer shall have such powers and shall perform such duties as
the Board of Directors or the Chief Executive Officer may from time to time
designate.

Section 3.13. Vice Presidents And Assistant Vice Presidents. Any Vice President
(including any Executive Vice President or Senior Vice President) and Assistant
Vice President shall have such powers and shall perform such duties as the Board
of Directors or the Chief Executive Officer may from time to time designate.

Section 3.14. Treasurer And Assistant Treasurers. The Treasurer shall have all
the powers and duties usually incident to the office of Treasurer, except as the
Board of Directors may otherwise provide. He shall have custody of all funds,
securities, and valuable documents of the Corporation. He shall have such other
duties and powers as may be designated from time to time by the Board of
Directors. In the absence of a Chief Financial Officer, the Treasurer shall be
deemed to be the Chief Financial Officer of the Corporation whenever the
signature of the Chief Financial Officer is required on any document or
instrument, by the laws of the United States or any state, or elsewhere in the
Bylaws, and the Treasurer shall have authority to affix his signature in such
capacity. Any Assistant Treasurer shall have such powers and perform such duties
as the Board of Directors may from time to time designate.

Section 3.15. Secretary And Assistant Secretaries. The Secretary shall have all
the powers and duties usually incident to the office of Secretary, except as the
Board of Directors may otherwise provide. The Secretary shall record all the
proceedings of the meetings of the stockholders and the Board of Directors
(including committees of the Board) in books kept for that purpose. In





                                       10


the absence of the Secretary from any such meeting, a secretary chosen at the
meeting shall record the proceedings thereof. The Secretary shall have charge of
the stock ledger (which may, however, be kept by any transfer or other agent of
the Corporation). The Secretary shall have custody of the seal of the
Corporation, and the Secretary, or an Assistant Secretary, shall have authority
to affix it to any instrument requiring it, and, when so affixed, the seal may
be attested by the signature of the Secretary or an Assistant Secretary. The
Secretary shall have such other duties and powers as may be designated from time
to time by the Board of Directors. In the absence of the Secretary, any
Assistant Secretary may perform the duties and responsibilities of the
Secretary.

Any Assistant Secretary shall have such powers and perform such duties as the
Board of Directors may from time to time designate.

Section 3.16. Salaries. The salaries of the officers shall be fixed from time to
time by the Board (or an appropriately designated committee of the Board) and no
officer shall be prevented from receiving such salary by reason of the fact that
he is also a director of the Corporation.

Section 3.17. Other Powers And Duties. Subject to these Bylaws and to such
limitations as the Board of Directors may from time to time prescribe, the
officers of the Corporation shall each have such powers and duties as generally
pertain to their respective offices, as well as such powers and duties as from
time to time may be conferred by the Board of Directors.


                                   ARTICLE IV
                                      STOCK

Section 4.01. Certificates Of Stock. Unless otherwise provided by the Board of
Directors or by law, each stockholder shall be entitled to a certificate of the
stock of the Corporation in such form as may from time to time be prescribed by
the Board of Directors. Such certificate shall bear the seal of the Corporation,
if one has been adopted, and shall be signed by the Chairman of the Board of
Directors, President or a Vice President and countersigned by the Treasurer or
an Assistant Treasurer or the Secretary or an Assistant Secretary. The seal of
the Corporation, if one has been adopted, and any and all signatures on the
certificate may be a facsimile, including those of any transfer agent or
registrar. In case any officer, transfer agent or registrar who has signed or
whose facsimile signature has been placed on such certificate shall have ceased
to be such officer, transfer agent or registrar before such certificate is
issued, it may be issued by the Corporation with the same effect as if he were
such officer, transfer agent or registrar at the time of its issue. Every
certificate for shares of stock which are subject to any restriction on transfer
and every certificate issued when the Corporation is authorized to issue more
than one class or series of stock shall contain such legend with respect thereto
as is required by law.

Section 4.02. Transfers. Subject to any restrictions on transfer and unless
otherwise provided by the Board of Directors, shares of stock may be transferred
only on the books of the Corporation by the surrender to the Corporation or its
transfer agent of the certificate therefor properly endorsed or accompanied by a
written assignment or power of attorney properly executed, with




                                       11

transfer stamps (if necessary) affixed, and with such proof of the authenticity
of signature as the Corporation or its transfer agent may reasonably require.

Section 4.03. Record Holders. Except as may otherwise be required by law, by the
Charter or by these Bylaws, the Corporation shall be entitled to treat the
record holder of stock as shown on its books as the owner of such stock for all
purposes, including the payment of dividends and the right to vote with respect
thereto, regardless of any transfer, pledge or other disposition of such stock,
until the shares have been transferred on the books of the Corporation in
accordance with the requirements of these Bylaws.

Section 4.04. Record Date. In order that the Corporation may determine the
stockholders entitled to receive notice of or to vote at any meeting of
stockholders or any adjournments thereof, or entitled to receive payment of any
dividend or other distribution or allotment of any rights, or entitled to
exercise any rights in respect of any change, conversion or exchange of stock or
for the purpose of any other lawful action, the Board of Directors may fix, in
advance, a record date, which shall not be more than ninety (90) days nor less
than ten (10) days before the date of such meeting, nor more than ninety (90)
days prior to any other action. In such case, only stockholders of record on
such record date shall be so entitled, notwithstanding any transfer of stock on
the stock transfer books of the Corporation after the record date.

If no record date is fixed:

(a)  the record date for determining stockholders entitled to receive notice of
     or to vote at a meeting of stockholders shall be the later of (i) the close
     of business on the day on which notice is mailed or (ii) the 30th day
     before the meeting; and

(b)  the record date for determining stockholders entitled to receive payment of
     a dividend or an allotment of any rights shall be at the close of business
     on the day on which the Board of Directors adopts the resolution relating
     thereto.

Section 4.05. Lost, Destroyed, or Stolen Certificates. No certificate for shares
of stock in the Corporation shall be issued in place of any certificate alleged
to have been lost, destroyed, or stolen except on production of evidence,
satisfactory to the Board of Directors, of that loss, destruction or theft, and,
if the Board of Directors so requires, upon the furnishing of an indemnity bond
in such amount (but not to exceed twice the value of the shares represented by
the certificate) and with such terms and surety as the Board of Directors, if
any, in its discretion, require.

Section 4.06. Transfer Agents And Registrars. The Corporation may serve as the
transfer agent and registrar of the shares of stock, or the Board of Directors
may, in its discretion, appoint one or more responsible banks, trust companies
or other entity as the Board of Directors may deem advisable, from time to time,
to act as transfer agents and registrars of shares of stock. No certificate for
shares of stock shall be valid until countersigned by the transfer agent and
registered by the registrar.



                                       12

Section 4.07. Stockholders' Addresses. Every stockholder or transferee shall
furnish the Secretary or a transfer agent with the address to which notice of
meetings and all other notices may be served upon or mailed to such stockholder
or transferee, and in default thereof, such stockholder or transferee shall not
be entitled to service or mailing of any such notice.

Section 4.08. Stock Ledger. The Corporation shall maintain a stock ledger which
contains the name and address of each stockholder and the number of shares of
stock of each class which the stockholder holds. The stock ledger may be in
written form or in any other form, which can be converted within a reasonable
time into written form for visual inspection. The original or a duplicate of the
stock ledger shall be kept at the offices of a transfer agent for the particular
class of stock, or, if none, at the principal executive offices of the
Corporation.


                                    ARTICLE V
                                 INDEMNIFICATION

Section 5.01. Right To Indemnification. The Corporation shall, to the maximum
extent permitted by the Maryland General Corporation Law in effect from time to
time, indemnify, and, without a preliminary determination of the ultimate
entitlement to indemnification, pay or reimburse reasonable expenses in advance
of final disposition of a proceeding to (a) any individual who is a present or
former director or officer of the Corporation or (b) any individual who, while a
director or officer of the Corporation and at the request of the Corporation,
serves or has served another corporation, real estate investment trust,
partnership, joint venture, trust, employee benefit plan or any other enterprise
as a director, officer, partner or trustee from and against any claim or
liability to which such person may become subject or which such person may incur
by reason of his status as a present or former director or officer of the
Corporation or director, officer, partner or trustee of such other entity (each,
an "Indemnitee"). The Corporation shall, to the maximum extent permitted by the
Maryland General Corporation Law in effect from time to time, provide such
indemnification and advancement of expenses to a person who served a predecessor
of the Corporation in any of the capacities described above (any such person
shall also be deemed to be an "Indemnitee").

Section 5.02. Indemnification Of Employees And Agents Of The Corporation. With
the approval of the Board of Directors, the Corporation shall, to the maximum
extent permitted by the Maryland General Corporation Law in effect from time to
time, and to such further extent as it shall deem appropriate under the
circumstances, provide such indemnification and advancement of expenses as
described in Section 5.01 above, to any employee or agent of the Corporation or
a predecessor of the Corporation (each such person shall also be deemed to be an
"Indemnitee").

Section 5.03. Right Of Indemnitee To Bring Suit. If a claim under this Article V
is not paid in full by the Corporation within sixty days after a written claim
has been received by the Corporation, except in the case of a claim for an
advancement of expenses, in which case the applicable period shall be twenty
days, the Indemnitee may at any time thereafter bring suit against the
Corporation to recover the unpaid amount of the claim. If the Indemnitee is
successful in whole or in part in any such suit, or in a suit brought by the
Corporation to recover





                                       13

an advancement of expenses pursuant to the terms of an undertaking, the
Indemnitee shall also be entitled to be paid the expense of prosecuting or
defending such suit. In any suit brought by an Indemnitee who is a present or
former director to enforce a right to indemnification hereunder (but not in a
suit brought by the Indemnitee to enforce a right to an advancement of
expenses), it shall be a defense that such Indemnitee has not met the applicable
standard of conduct set forth in the Maryland General Corporation Law. In
addition, in any suit by the Corporation to recover an advancement of expenses
pursuant to the terms of an undertaking, the Corporation shall be entitled to
recover such expenses upon a final adjudication that the Indemnitee who is a
present or former director has not met the applicable standard of conduct set
forth in the Maryland General Corporation Law. Neither the failure of the
Corporation (including its Board of Directors, independent legal counsel, or
stockholders) to have made a determination prior to the commencement of such
suit that indemnification of the Indemnitee is proper in the circumstances
because the Indemnitee has met the applicable standard of conduct set forth in
the Maryland General Corporation Law, nor an actual determination by the
Corporation (including its Board of Directors, independent legal counsel, or
stockholders) that the Indemnitee has not met such applicable standard of
conduct, shall create a presumption that the Indemnitee has not met the
applicable standard of conduct. In any suit brought by the Indemnitee to enforce
a right to indemnification or to an advancement of expenses hereunder, or by the
Corporation to recover an advancement of expenses pursuant to the terms of an
undertaking, the burden of proving that the Indemnitee is not entitled to be
indemnified, or to such advancement of expenses, under this Article V or
otherwise shall be on the Corporation.

Section 5.04. Non-Exclusivity Of Rights. The rights to indemnification and to
advancement of expenses conferred in this Article V shall not be exclusive of
any other right which any person may have or hereafter acquire under these
Bylaws, the Charter or any statute, agreement, vote of stockholders or
disinterested directors or otherwise.

Section 5.05. Insurance. The Corporation may maintain insurance, at its expense,
to protect itself and any director, officer, employee or agent of the
Corporation or any director, officer, employee or agent of another corporation,
partnership, joint venture, trust or other enterprise against any expense,
liability or loss, whether or not the Corporation would have the power to
indemnify such person against such expense, liability or loss under the Maryland
General Corporation Law.


                                   ARTICLE VI
                            MISCELLANEOUS PROVISIONS

Section 6.01. Fiscal Year. The fiscal year of the Corporation shall end on
December 31 of each year or on such other date as may be fixed by the Board of
Directors.

Section 6.02. Seal. The seal of the Corporation shall be in the form of a circle
and shall have inscribed thereon the name of the Corporation and the year of its
organization. The seal may be used by causing it or a facsimile thereof to be
impressed or affixed or reproduced.



                                       14

Section 6.03. Investment Policies. The directors may from time to time adopt,
amend, revise or terminate any policy or policies with respect to investments by
the Corporation as they shall deem appropriate in their sole discretion.

Section 6.04. Execution Of Instruments. All deeds, leases, transfers, contracts,
bonds, notes and other obligations to be entered into by the Corporation in the
ordinary course of its business without director action may be executed on
behalf of the Corporation by the Chairman of the Board, if one is elected, the
Chief Executive Officer the President or the Treasurer or any other officer,
employee or agent of the Corporation as the Board of Directors may authorize.

Section 6.05. Voting Of Securities. Unless the Board of Directors otherwise
provides, the Chairman of the Board, if one is elected, the Chief Executive
Officer, the President or the Treasurer may waive notice of and act on behalf of
this Corporation, or appoint another person or persons to act as proxy or
attorney in fact for this Corporation with or without discretionary power or
power of substitutions, at any meeting of stockholders of any other corporation
or organization the securities of which are held by this Corporation.

Section 6.06. Resident Agent. The Board of Directors may appoint a resident
agent upon whom legal process may be served in any action or proceeding against
the Corporation.

Section 6.07. Corporate Records. The original or attested copies of the Charter,
Bylaws and records of all meetings of the incorporators, stockholders and the
Board of Directors and the stock transfer books, which shall contain the names
of all stockholders, their record addresses and the amount of stock held by
each, may be kept outside the State of Maryland and shall be kept at the
principal office of the Corporation, at the office of its counsel or at an
office of its transfer agent.

Section 6.08. Amendments. These Bylaws may be altered, amended or repealed, and
new bylaws adopted, by the vote of a majority of the entire Board of Directors
or by a vote of a majority of the voting power of the common stock of the
Corporation.

Section 6.09. Offices. The principal office of the Corporation within the State
of Maryland shall be located at such place as the Board of Directors may
designate. The Corporation may have additional offices, including a principal
executive office, at such place or places both within and without the State of
Maryland as the Board of Directors may from time to time determine or the
business of the Corporation may require.


                        As amended through March 4, 2005.




                                       15


                                                                    EXHIBIT 23.1


            CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


The Board of Directors
Medical Properties Trust, Inc.:

         We consent to the use of our report included herein and to the
references to our firm under the heading "Experts", "Summary Selected Financial
Data" and "Selected Financial Data" in the prospectus.



/s/ KPMG LLP

June 3, 2005
Birmingham, Alabama



                                                                   EXHIBIT 23.2


                       [PARENTE RANDOLPH, LLC LETTERHEAD]


            CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


To the Member
Vibra Healthcare, LLC:

We hereby consent to the incorporation in this Amendment No. 4 to Registration
Statement of Medical Properties Trust, Inc. on Form S-11 (No. 333-119957) of our
report dated March 8, 2005, except for Note 11, as to which the date is March
31, 2005, relating to the consolidated financial statements of Vibra Healthcare,
LLC and subsidiaries as of December 31, 2004 and for the period from inception
(May 14, 2004) through December 31, 2004. We also consent to the references to
us under the heading "Experts" in such Registration Statement.

/s/ Parente Randolph, LLC

Parente Randolph, LLC
Harrisburg, Pennsylvania
June 3, 2005




June 3, 2005

VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
450 Fifth Street, N.W.
Washington, D.C. 20549
Attention: Owen Pinkerton, Senior Counsel

Ladies and Gentlemen:


     On behalf of Medical Properties Trust, Inc. (the "Company"), enclosed
herewith is Amendment No. 4 to the Company's Registration Statement on Form S-11
(the "Amendment"), as filed with the Securities and Exchange Commission on
October 26, 2004 (the "Registration Statement"). The Company has amended the
Registration Statement in response to comments contained in the letter from the
Staff, dated May 26, 2005 (the "Comment Letter"), and addressed to Edward K.
Aldag, Jr., Chairman, President and Chief Executive Officer of the Company. We
will separately deliver copies of the amended Registration Statement, marked to
show changes responsive to the Comment letter, to members of the Staff specified
in the Comment Letter.


     The numbered responses below correspond to the numbered paragraphs of the
Comment Letter.

General

 1.  We have reviewed your revisions in response to comment 37 from our last
     comment letter. In light of the fact that the "guarantors" of the Vibra
     loans are entities that "do not have substantial assets," it is unclear how
     these entities provide a guaranty, as the term is typically understood.
     Please revise your disclosure accordingly since the plain meaning of such
     term would imply that the company has relevant recourse in the event of a
     default under the loan, which does not appear to be the case. In addition,
     please supplementally advise us as to what activities, if any, you
     anticipate the Vibra entities will conduct that would render their
     guarantee of this loan more meaningful.


     RESPONSE: We have revised the Registration Statement as requested. See
     pages 3, 18-19, 20 and 74.



     We supplementally advise the Staff that we believe Vibra has existing
     enterprise value and opportunities to generate additional value that makes
     its guaranty meaningful. This value is derived from Vibra's existing value
     assuming no additional growth and additional value created if Vibra
     acquires other hospitals and operations. We are aware that Vibra or Vibra
     Management, LLC has entered into at least one management agreement whereby
     it is earning management fees from unrelated third parties. In addition,
     Vibra has made offers to acquire and operate additional hospitals from
     parties other than MPT. Accordingly, as and if Vibra generates additional
     cash flow, MPT has incremental value available in the event that we are
     required to call on Vibra's guaranty.


Summary

     Other Letters of Commitment, page 5

 2.  It does not appear that any of the proposed transactions listed under this
     heading represent commitments of the registrant. We note, for example, that
     DVH has no obligation to present you with a development agreement, and
     absent such an agreement, you have no obligation to provide development
     funds to DVH. In addition, with respect to the two transactions with
     unidentified tenants, your obligation to purchase the property is
     contingent upon the tenant first entering into an agreement and
     subsequently purchasing such properties. In the case of the second
     transaction, the tenant has not even entered into a letter of intent to
     purchase the property. In light of the preliminary nature of these proposed
     transactions and the fact that proceeds from the proposed offering will not

                                        1


     be used to fund them, it is not appropriate to highlight them in the
     summary. Please remove your description of these items from the summary.


     RESPONSE: We have revised the Registration Statement to remove the
     description of these proposed transactions from the summary as requested.


 3.  In light of the substantial conditions in place with respect to the
     "Letters of Commitment" described here and elsewhere in the prospectus,
     please revise your disclosure throughout the prospectus to refer to these
     proposed transactions in a way that makes clear that there is no
     "commitment" at this time to complete them.


     RESPONSE: We have revised the Registration Statement as requested. See
     pages 78 and 93 through 95.



     Summary Risk Factors, page 7


 4.  Please include a summary risk factor regarding the underwriter conflict of
     interest risk described on page 39.


     RESPONSE: A summary risk factor regarding the underwriter conflict of
     interest risk was included in Amendment No. 3 to the Registration
     Statement. See page 8.


The Offering, page 14

 5.  Please revise the use of proceeds bullet points to conform to the bullet
     points on page 41.


     RESPONSE: We have revised the Registration Statement as requested. See page
     13.


Risk Factors, page 16

 6.  We note your response to comment 10. However, it still may be unclear to an
     investor that the risk factors disclose all known material risks. Please
     revise accordingly.


     RESPONSE: We have revised the Registration Statement as requested. See page
     16.


We may not consummate the transactions contemplated by our other letters of
commitment, which could adversely affect our ability to make distributions to
our stockholders, page 18

 7.  Please disclose, if true, that DSI is not obligated to present you with a
     development agreement and, if that were to occur, you would have no
     obligation to provide funding to DSI.


     RESPONSE: We have revised the Registration Statement as requested. See
     pages 17 and 93.


Our Portfolio, page 72

       Vibra Facilities and Loans, page 73

 8.  Please disclose the fixed charge coverage ratio not complied with by Vibra.


     RESPONSE: We have revised the Registration Statement as requested. See page
     74.


     Our Pending Acquisitions and Developments, page 83

 9.  We refer to the Bloomington, Indiana and Houston, Texas transactions where
     the facilities will be operated by newly-formed entities that have no
     significant operations to date. Please describe how these entities will be
     able to run the facilities and make rental payments to you.


     RESPONSE: We have revised the Registration Statement to include the
     requested descriptions. See pages 90 and 92.


       Other Letters of Commitment, page 91

                                        2


10.  Please revise the date of your May 9th letter of commitment referenced on
     page 93. In addition, please disclose the tenants with whom you executed
     letters of commitment on May 3, 2005 and May 9, 2005.


     RESPONSE: We have revised the Registration Statement as requested. See
     pages 94 and 95.


Selling Stockholders, page 108

11.  Please advise us as to whether you expect to have information regarding the
     selling securityholders in this offering prior to the printing of red
     herrings and circulation of a preliminary prospectus. We may have comments
     on your disclosure within this section.


     RESPONSE: We supplementally advise the Staff that we expect to include
     information regarding the selling securityholders in this offering in the
     preliminary prospectus.


     Financial Statements and Notes

12.  Update Vibra financial statements in your next amendment to the
     Registration Statements. Financial statements for the lessee should be
     included for the periods specified in Rules 3-01 and 3-02 of Regulation
     S-X.


     RESPONSE: We have revised the Registration Statement as requested. See
     pages F-35 through F-46.


13.  Refer to independent auditors' consent within exhibit 23.1. Please have
     your auditors provide conforming signature in the consent within exhibit
     23.1 in your next amendment to the Registration Statement.

     RESPONSE: We have revised the Registration Statement as requested. See
     Exhibit 23.1.

14.  Refer to response to comment 3. We will await the inclusion of pro forma
     per share information in your next amendment to the Registration Statement.

     RESPONSE: We have revised the Registration Statement throughout as
     requested.

15.  We have read and considered your response to comment 29. We understand that
     you plan to exercise your purchase option to acquire Hammond facility
     within 12 months of January 2005. Explain to us your basis not to provide
     pro forma effects of the rental operations of Hammond facility given it is
     a probable acquisition or revise to include this information. If the
     acquisition is not probable you should revise accordingly to only show the
     pro forma impact of the loan and related interest.


     RESPONSE: We have revised the pro forma income statements to show the
     effects of purchasing the Hammond facility as though we acquired it on
     January 1, 2004 and on January 1, 2005. We believe the acquisition to be
     probable. See pages F-4, F-5, F-7 and F-10.


16.  We note on page 93 that you have entered into letters of commitment with
     two tenants to purchase two hospital facilities in California for $45.8
     million. Explain to us why you did not include the pro forma effects of
     these probable acquisitions in the pro forma financial statements. If these
     acquisitions arc not probable at this time, clearly state that and the
     basis for your determination.


     RESPONSE: We do not consider the two hospital facilities in California to
     be probable acquisitions at this time. Therefore, we have not included
     these two facilities in the pro forma financial statements. We have revised
     the Registration Statement to state this more explicitly. See page 95.


17.  We have reviewed your response to comment 37. Please provide clarifying
     disclosure in your document to explain the basis for the financial
     statements you have presented. In this regard, you should explain why you
     believed financial statements of the lessee were more meaningful than the
     financial statements of the property and the guarantors due to the lack of
     rental history and the lack of substantive assets of the guarantors.


     RESPONSE: We have revised the Registration Statement as requested. See page
     74.

                                        3


Tax Opinion

18.  The second, third and sixth assumptions appear to relate to future events
     that are beyond the scope of the opinion. The opinion with respect to
     "proposed operations" already appears to be limited to the operations as
     described in the registration statement, the company representation letter
     and other documents as of the date of the opinion. Please revise or advise.

     RESPONSE: We have revised the Tax Opinion as requested. The revised Tax
     Opinion has been supplementally provided to the Staff.

19.  Please revise the fourth assumption to exclude the company from the
     definition of "Partner."

     RESPONSE: We have revised the Tax Opinion as requested.

20.  Please supplementally advise us why you are incorporating the tax section
     of the prospectus into the opinion.

     RESPONSE: We have revised the Tax Opinion to eliminate the incorporation of
     the tax section of the prospectus.

21.  Please revise opinion (a) to refer to the registration statement, rather
     than "as represented to us." Since investors do not have access to the tax
     representation letter, such a reference may obscure the scope of the
     opinion. We note that it is appropriate for counsel to rely on your
     representations as to factual matters.

     RESPONSE: We have revised the Tax Opinion as requested.

22.  Please revise the penultimate paragraph to reflect that after-market
     purchasers in the offering may rely on the opinion. The current disclosure
     refers to "holders of the common stock."

     RESPONSE: We have revised the Tax Opinion as requested.

Directed Share Program Materials

23.  Please revise the materials to clarify that shares purchased in this
     program will be subject to lock-up restrictions. Refer to page 153 of the
     prospectus.


     RESPONSE: We have revised the Directed Share Program materials as
     requested. These materials will be supplementally provided to the Staff.


Supplemental Materials

24.  We note your supplemental response to comments 3 and 4 of our letter dated
     November 24, 2004. However, it does not appear that you have provided
     supporting materials in response to comment 3. For example, you have not
     provided supporting information for the following data:

       - U.S. Department of Commerce and Department of Health and Human Services
         data, page 9;

       - U.S. Department of Commerce data, page 58; and

       - CMS information, page 69 and 71.


     RESPONSE: These materials have been supplementally provided to the Staff.


                                        4


Please do not hesitate to contact the undersigned or, in his absence, Thomas O.
Kolb (205) 250-8321, if you have any questions or comments relating to the
Company's response to the Comment letter.

                                          Very truly yours,

                                          /s/ B. G. MINISMAN, JR.
                                          --------------------------------------
                                          B. G. Minisman, Jr.
                                          of Baker, Donelson, Bearman, Caldwell
                                          & Berkowitz, PC

cc: Andrew Mew
Cicely Luckey
Michael McTiernan
Medical Properties Trust, Inc.
Hunton & Williams, LLP

                                        5